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Abstract 
Incidence of cervical cancer has fallen dramatically since the introduction of the NHS 
Cervical Cancer Screening Programme, yet this largely preventable disease 
disproportionately affects women of lower socioeconomic status (SES).  This thesis set out 
to explore the evidence for, and possible mechanisms of, socioeconomic inequalities in 
cervical screening uptake in England.   
Studies 1-3 were cross-sectional observational studies exploring the relationship between 
routinely collected Primary Care Trust (PCT)-level cervical and breast screening coverage 
and area-level deprivation, and testing for associations between population- and 
programme-delivery characteristics and cervical screening coverage. Study 4 used semi-
structured qualitative interviews to explore the views of health professionals on the 
factors that support or hinder cervical screening uptake.  Study 5 used cross-sectional 
observational survey data to assess whether perceived benefits of cervical screening 
explained the association between SES and screening attendance.  Study 6 was a cross-
sectional, observational analysis of the relationship between colposcopy attendance and 
area deprivation.   
Analysis of variance showed no significant reduction in cervical screening inequalities from 
2007-12 but an improvement in breast screening coverage among lower SES women. 
Regression analyses revealed that population factors explained more of the variation in 
PCT-level cervical screening coverage than did programme-delivery factors. Health 
professionals considered programme-specific factors to support, and population factors to 
hinder, cervical screening participation.  Women from lower SES backgrounds were more 
sceptical about the benefits of cervical screening but these beliefs explained little of the 
variance in screening attendance.  Logistic regression analysis demonstrated that although 
colposcopy attendance was high, it was lower in income-deprived areas.   
This thesis demonstrated persistent SES inequalities in cervical screening attendance 
despite efforts to address the problem, and delayed uptake of colposcopy among women 
living in deprived areas. The work points strongly to the influence of population factors in 
explaining variation in cervical screening in women of all ages. Programme-delivery factors 
Abstract 
 
 
- 5 - 
 
were also important for screening uptake in younger women. Some PCTs (now CCGs), 
were identified as exemplars of good practice and others as requiring further support. 
Women of lower SES delay attendance at colposcopy appointments, but earlier 
attendance may be achieved with support.   
 (Abstract: 343 words) 
Thesis: 75,708 words (excluding Table of Contents, References and Appendices)  
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Chapter 1: Background to Socioeconomic Inequalities in Cervical 
Cancer 
1.1 Overview 
Socioeconomic inequalities in health are not new. Nor, sadly, are they old news.  While the 
understanding of socioeconomic inequalities in health has evolved considerably over the 
years, their resolution is problematic.  For developed countries at least, the threat of 
infectious disease such as cholera and typhoid has largely been eradicated and is an 
indication of the potential for successful outcomes.  Health improvements in 
communicable diseases have been attributed to the introduction of vaccination 
programmes or other prevention programmes, rendering some diseases technically 
preventable.  However, chronic diseases, such as heart disease and cancer, now pose 
significant health problems and are often graded by socioeconomic status.   
Globally, cervical cancer is the fourth most common cancer in women (Ferlay et al., 2014).  
It is the most common cancer in women in developing countries, but the sixth most 
common cancer in women in Europe overall, and the twelfth most common cancer in 
women in the UK.  The reduced burden of cervical cancer is associated with the availability 
of preventative health programmes such as cervical screening and Human Papillomavirus 
(HPV) immunisation (Kesic et al., 2012).  Successive UK governments have pledged to 
reduce avoidable cancer deaths (Department of Health, 2000; Dept of Health, 2011).  The 
National Health Service Cervical Screening Programme (NHSCSP) was implemented in the 
UK in 1988 and, more recently, the HPV Vaccination Programme was introduced.  While 
cervical cancer incidence and mortality rates have fallen and survival has increased, 
around 800 women still die from this preventable disease in England every year (Trent 
Cancer Registry et al., 2012), and a disproportionate percentage of these women are of 
lower socioeconomic status (Baker and Middleton, 2003).   
This thesis sought to ascertain the current status of socioeconomic inequalities in 
attendance at cervical screening and at colposcopy (where further diagnostic tests or 
treatment are carried out, if required), and explored the factors associated with cervical 
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screening attendance in order to contribute to policy recommendations to reduce 
avoidable deaths of cervical cancer.   
In this chapter, socioeconomic inequalities in health and socioeconomic inequalities in 
cancer will be introduced, including a section on the development of relevant UK policies.  
Finally, more detailed information will be provided on the specific evidence for 
socioeconomic inequalities in cervical cancer in the UK, the pathways to such inequalities 
and the available means to prevent cervical cancer.   
1.1.1 Socioeconomic Inequalities in Health 
Lower life expectancy and a higher prevalence of disease is consistently seen in people 
with fewer social and economic resources (Wilkinson and Marmot, 2003).  At higher socio-
economic levels health is considerably better, indicating what is known as a social gradient 
in health.  Ever expanding evidence of health inequalities is reported across and between 
countries, indicating that health inequalities may narrow or widen over time or place.  
Such wide disparities in life expectancy and disease indicate that poor health outcomes are 
not in themselves inevitable (Marmot, 2005).  This indicates that we can do something 
about health inequalities.   
Both financial and psychosocial factors contribute to poorer health outcomes (Wilkinson 
and Marmot, 2003).  The specific disadvantage experienced by individuals and 
communities may relate to a wide variety of factors including poverty (or relatively less 
material wealth), lower levels of education, poor quality housing or stressful life 
circumstances.  This indicates that these wider social issues should be taken into 
consideration when evaluating health inequalities.  Improving health across the 
population, therefore, not only needs to extend beyond health policy, but also requires 
action on the social factors that support, or suppress, health and wellbeing overall.  
Understanding socioeconomic inequalities in health is complex.  The approach that 
researchers have taken has changed over the years, and each approach has offered new 
forms of knowledge.  Adler and Stewart’s (2010) five eras of health inequalities research 
provide a useful overview of health inequalities research.  These will now be discussed.  
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The first era of health inequalities research was often limited by its concept of the 
relationship between socioeconomic status and health (Adler and Stewart, 2010). The idea 
that social factors may contribute to socioeconomic inequalities in health was evident in 
work by Farr and Durkheim in the first era of health inequalities research. However, 
research, particularly in the USA, considered socioeconomic status almost as a binary 
concept, rich versus poor, where a poverty level was drawn and ill-health was seen to be 
more common beneath it.  Research largely failed to associate socioeconomic status with 
other confounding factors such as ethnic differences, level of education or employment 
status, although it may independently associate these with poor health outcomes.     
The second era, the era in which Adler and Stewart believe health inequalities research 
really began, is where an appreciation that disease often has an inverse, linear association 
with socioeconomic status (SES) evolved.  SES and health were now considered on a 
continuum, rather than as binary concepts or measures. A classic, pioneering example of 
social gradients in health was found in the Whitehall studies where the prevalence of 
angina and symptoms of chronic bronchitis were found to increase in a linear association 
with lower socioeconomic status (Marmot et al., 1991).  Social gradients in health have 
continued to be documented and are evident across and within many countries in the 
world, both developed and developing, and across many diseases, both infectious and 
non-communicable (Wilkinson and Pickett, 2010). However, the strength and pattern of 
the social gradient may differ according to the health outcome (Adler and Stewart, 2010).  
The work of this second era continues to have contemporary relevance to the 
identification and status of inequalities in health, and can therefore be seen to continue in 
tandem with subsequent eras.   
The third era began to address the mechanisms by which SES affects health, or what was 
termed as, ‘how does socioeconomic status get under the skin?’  Explanations have 
included the significance of material resources on health and psychosocial factors, and 
how these may lead to differential access to health care, exposure to risk factors (including 
stress) and health-related behaviours.   
The fourth era broadened to extend the focus from mechanisms operating at the 
individual level to addressing mechanisms that operate at the neighbourhood or 
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community level.  The key distinction of this work was in the identification of the means by 
which characteristics of the neighbourhood or community affect health, rather than 
assuming, as is more traditionally the case, that the characteristics of the neighbourhood 
are merely a proxy of the characteristics of the people living there.  In this fourth era, the 
effect of place is in itself a contributory factor to social patterns in health.  Examples of 
such research address the effects of living in areas where tobacco/alcohol products and 
fast food outlets are prolific while affordable, healthy foods or safe environments for 
exercise are scarce. This provides a means to understand how individual health behaviours 
may be constrained or supported by the characteristics of the neighbourhood in which 
people live or work.  This innovative research area has moved beyond addressing the main 
effects of neighbourhood factors on health to looking at the effect of a combination of 
factors and is beginning to address interactions within multilevel analyses.   
The fifth era is concerned with how the effects of SES are moderated by a combination of 
factors.  This includes interaction effects of SES and other sociodemographic factors; as 
well as biology, genetics and the life course.  One example of this type of research may be 
to explore how the effects of SES on health or health behaviours differ among ethnic 
groups.   
Contemporary research on health inequalities may still span several of these eras.  
Theories of ‘absolute deprivation’ from the first era have largely been replaced by theories 
of ‘relative deprivation’ from the second era.  The measurement of social gradients in 
health outcomes, or health behaviours, continues to be necessary to acknowledge the 
status of health issues or to ascertain if policies or interventions are having an effect on 
health inequalities.   Work to explore the mechanisms through which SES affects health, 
the various levels which operationalise these mechanisms and the complex interaction 
effects is key to our understanding of how health inequalities are manifest and, 
importantly, how we may intervene to reduce them. 
1.1.2 Socioeconomic Inequalities in Cancer Outcomes 
Population growth and ageing are estimated to contribute to an increase in the number of 
cases of cancer in the UK by 55% and 35% for men and women respectively between 2007 
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and 2030 (Mistry et al., 2011).  Incidence and mortality rates are particularly high for 
breast, colorectal and lung cancer (Ferlay et al., 2014).  Since the 1980s, perhaps even 
earlier, the UK has had higher mortality rates for the most common cancers than other 
European countries, which suggests that these deaths are avoidable (Ferlay et al., 2014).   
In England, socioeconomic variation in cancer incidence is found across a number of 
different cancer sites (NCIN, 2008).  Generally, people of lower socioeconomic status have 
higher incidence of cancer of the head and neck, lung, stomach, liver and cervix; although 
in breast cancer and malignant melanoma of the skin incidence has been found to be 
higher in people of higher socioeconomic status (Shack et al., 2008).  The variation in 
cancer incidence may be attributable to environmental or lifestyle factors, differences in 
health-seeking behaviour or access to healthcare services.  For example, people in lower 
socioeconomic groups are more likely to smoke and this has been associated with higher 
incidence of lung cancer (Soerjomataram et al., 2011). Conversely, women of higher 
socioeconomic groups may be more likely to use hormone replacement therapy, have 
fewer children, and have children at a later stage and these factors have been associated 
with higher incidence of breast cancer (Shack et al., 2008).   
The overall mortality rates for cancer can be viewed in three ways: expected mortality; 
excess mortality and avoidable deaths (Ellis et al., 2012).  Expected mortality is derived 
from the number of all-cause deaths in the general population.  Excess mortality is 
estimated as survival from cancer after adjustment for other causes of death (the relative 
survival approach).  Avoidable deaths are the proportion of deaths that would not occur if 
the relative survival for all socioeconomic groups were equal to the least deprived group.  
This is also known as the cancer ‘survival gap’.  The cancer ‘survival gap’ is longstanding 
and has been evidenced using a multitude of SES measures (Woods et al., 2006). A study 
of the 21 most common cancers in England found that improvement in survival rates lead 
to a reduction in the number of avoidable deaths from cancer over the period 1996 to 
2006 (Ellis et al., 2012). However, there had been no discernible reduction in the ‘survival 
gap’ between the most and least deprived groups, which indicates that those of lower 
socioeconomic status are not yet benefitting from improvements in survival.  The cancer 
‘survival gap’ may be attributable to a differential stage at diagnosis, which may lead to 
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delayed treatment or differential access to treatment, but this, where evidenced, may vary 
according to the cancer site (Woods et al., 2006).   
1.1.3 Health Policy 
In this section, I will provide an overview of the development of public health policy in the 
UK and then move on to health policy specifically focused on cancer.  
Public health policy to address health inequalities 
A full review, or analyses of the effect of these policies, is beyond the scope of this thesis 
but it is hoped that this section will provide a flavour of how public health policy on health 
inequalities has developed over the years with the advent of successive governments.   
Health inequalities and policy have been intertwined in the UK since at least the 19th 
century (Oliver, 2008).  Edwin Chadwick, a social reformer, undertook an independent 
inquiry into sanitation to produce a report entitled The Sanitary Condition of the Labouring 
Population of Great Britain in 1842.  The report concluded that damp, dirty and 
overcrowded living conditions contributed to disease and early death in deprived areas.  
While this report informed the 1848 Public Health Act, specific healthcare policies were 
not to advance for a further 100 years when the National Health Service was introduced in 
1948.  It was assumed that universal health care would resolve health inequalities and this 
contributed to the virtual removal of health inequalities from the health policy agenda for 
many years. 
The Black Report (1980) 
It was not until the 1970s that concern about health inequalities returned to political 
circles resulting in the commissioning of the Black Report (Macintyre, 1997).  The Black 
Report, published in 1980, reported that people of lower social class were more likely to 
experience poor health and that the gap in reported health outcomes between the higher 
and lower social classes was widening.  The report presented four hypotheses for health 
inequalities: artefact; natural/social selection; materialist/structural; and 
cultural/behavioural (“The Black Report,” 1981).  The artefact hypothesis suggested that if 
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a relationship exists between class and mortality it is purely an artefact of measurement, 
and that the magnitude of difference across social class vary according to the unit of 
measurement.  The natural/social selection hypothesis suggested that health determines 
social class.  The materialist/structural hypothesis suggested that material, physical and 
psychosocial characteristics of class structure provided at least a partial, if not complete, 
explanation for observed health inequalities. And finally, the cultural/behavioural 
hypothesis suggested that health behaviours, good and bad, are socially patterned and 
hence contribute to observed health inequalities.  The strengths and weaknesses of these 
differing theories of the cause of health inequalities continue to be widely discussed 
(Macintyre, 1997), and dependent upon the favoured view of the government of the time 
may affect its adoption or direction of public health policy.   
The Black Report’s recommendations for health and social policy included: children to 
have a better start in life, health to be promoted through improved education and 
prevention, and an anti-poverty strategy.  It advocated the use of research to promote 
better understanding of health behaviours (smoking, diet, exercise, etc.), the development 
of social and health indicators and better understanding of the effects of social factors on 
health over time and place.   
Acheson Report (1988) 
Unfortunately, the Conservative government did not support action on the Black Report 
recommendations, and it was not until the Labour government regained power in 1997 
that a further inquiry into health inequalities was commissioned.  This culminated in the 
publication of the Acheson Report in 1988, sometimes referred to as the ‘second Black 
Report’.  The Acheson Report essentially picked up on the available evidence in the 
intervening period since the publication of the Black Report (late 1970s – late 1990s) and 
concluded that socioeconomic inequalities in health remained a significant problem, and 
that inequalities in health between the most and least deprived had actually widened.  Of 
its recommendations three were identified as key: 1) all policies that are likely to affect 
health should be considered in relation to their effect on health inequalities, 2) priority 
should be given to families with children, and 3) action on income inequalities and 
improving the living standards of the most deprived (Acheson, 1998).  The report was 
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largely welcomed.  Although, its critics suggested it failed to prioritise its 
recommendations, that it included recommendations that were either too vague or too 
specific to implement, and it lacked evidence on the cost-effectiveness of proposed 
policies.  The Acheson Report has been considered to have affected policy in four key 
ways: the creation of new policies to tackle health inequalities; the incorporation of health 
inequality approach to existing policies; the promotion of a favourable political climate in 
which to tackle health inequalities; and as a reference to examine health inequalities 
policies (Exworthy, Blane, & Marmot, 2003).   
Fair Society, Healthy Lives (2010) 
Fair Society, Healthy Lives: The Strategic Review of Health Inequalities in England post 
2010, is the output of a review commissioned by the Secretary of State for Health in 2008 
to apply the recommendations of the World Health Organisation Commission on the Social 
Determinants of Health (CSDH) to a strategic plan for England (Marmot Review, 2010).  
The CSDH’s three principal recommendations: 1) to improve everyday living conditions in 
which people are born into, grow, live and work, 2) to address the unequal distribution of 
money, power and resources across age, gender and ethnicity, and across and between 
countries, 3) to seek greater understanding of health inequalities through regular 
measurement of the scale of the problem and the potential impact of policy and action 
(Marmot et al., 2008).  The tasks set out by the strategic review were broadly to accrue the 
relevant and available evidence to guide policy and action.  This included the need to 
demonstrate how the evidence could be put into action, to recommend further objectives 
and measures to improve infant mortality and life expectancy and, finally, to contribute to 
the development of a post-2010 strategy to reduce health inequalities.  The report 
reiterated the CSDH’s view that health inequalities are the product of social inequalities, 
and therefore action for health should consider the social determinants of health – what is 
considered an ‘upstream’ approach to health inequalities.  It also underlined the concept 
of ‘proportionate universalism’ – that the social gradient in health, where people with 
greater social disadvantage have poorer health, cannot be reduced by purely focusing 
upon the most deprived, but that the balance of invested energy and resource are 
proportionate to the level of disadvantage.   Among the report’s recommendations for 
policy objectives were action to enable people of all ages to have control over their lives 
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and to achieve their potential, to create fair employment and good work practices, to 
create healthy and sustainable places for people to live and to place focus on the 
prevention of ill-health (Marmot Review, 2010).   
Healthy People, Healthy Lives (2011) 
When the coalition government was elected in 2010 they responded to the Fair Society, 
Healthy Lives report with the publication their own White Paper entitled Healthy Lives, 
Healthy People: Our Strategy for Public Health in England (Dept of Health, 2010a).  Its 
approach to health inequalities highlighted lifestyle-driven health behaviours and the 
empowerment of individuals to make healthy choices – what may be considered a 
‘downstream’ approach to health inequalities. It also proposed the establishment of Public 
Health England (PHE) as an integrated public health service that would, in its words, give 
local government and local communities the responsibility and funding to improve health 
in their local areas.   
Summary of Public Health Policy to address socioeconomic inequalities 
In this brief history of public health policy development in the UK, it is interesting that the 
introduction of the National Health Service in 1948 was considered the solution to 
inequalities in health.  On the face of it, it may have appeared logical that health care, free 
at the point of access for all, would suffice.  However, the Black Report opened the door to 
the sheer complexity of health inequalities.  In this respect, we can begin to understand 
that while free access to health care dealt with an important barrier, it fell short of 
addressing other socially patterned barriers to good health, including the need to tackle 
the causes of ill-health, and therefore the social determinants of health.  Unfortunately, 
the Black Report did not appear to have affected policy and it was the Acheson Report that 
brought the issue back into the political arena, to consider potential pathways from 
socioeconomic inequalities to population health and to recommend action for change.  
The Fair Society, Health Lives (2010) report placed its focus on ‘upstream’ approaches to 
health inequalities – the need to tackle the wider social and structural factors.  The 
Healthy People, Healthy Lives (2011) report placed its focus on ‘downstream’ approaches – 
the need to address lifestyle factors and a focus upon individual choice. In this respect, the 
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political will of the incumbent government has appeared to guide the policy of the day, 
although it is likely that both approaches are valid and necessary (Bosma, 2014).   
Health policy to address socioeconomic inequalities in cancer 
In this section I will move onto a discussion of some of the key health policies that have 
addressed concerns about rising cancer incidence and poor cancer outcomes, as well as 
socioeconomic inequalities in cancer.  
Calman-Hine Report (1995) 
Concerns about the human and economic cost of cancer led to the establishment of the 
Expert Advisory Group on Cancer (EAGC) by the Chief Medical Officers for England and 
Wales, Dr Kenneth Calman and Dr Deirdre Hine (Calman and Hine, 1995).  The EAGC 
produced a report entitled A Policy Framework for Commissioning Cancer Services, more 
commonly known as the Calman-Hine Report.  The policy framework was set up in 
response to rising cancer incidence and poor survival rates in England and Wales.  There 
had been a steady recognition of geographical variation in cancer outcomes and emerging 
evidence that cancer survival in the UK was worse than in other European countries 
(Berrino et al., 1999, 1995).  The Calman-Hine report indicated that survival rates may be 
associated with socioeconomic status, but a lack of robust evidence, particularly a dearth 
of population-based studies, made it difficult for any real conclusion to be drawn at that 
time.  The Calman-Hine report recommended the establishment of a comprehensive 
cancer service through the integration of three levels of care.  Firstly, primary care, then 
designated cancer units in local hospitals, and finally, designated cancer centres to provide 
specialist diagnostic and treatment services, including radiotherapy.  The report 
specifically stated that ‘all cancer patients should have access to a uniformly high standard 
of care’ (Calman and Hine 1995, p22).   
NHS Cancer Plan (2000) 
The NHS Cancer Plan acknowledged the cancer burden within the UK and set out to save 
more lives and reduce health inequalities in a strategy which aimed to improve cancer 
prevention, screening, diagnosis, treatment and care (Department of Health, 2000).  The 
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plan aimed to tackle some of the reasons for the occurrence of inequalities.  Broadly, 
these reasons comprised greater exposure to the risk factors that may affect the incidence 
of cancer; lower awareness of the symptoms of cancer, later presentation to the GP and 
lower uptake of screening, which may affect the stage of diagnosis of cancer (or 
precancerous abnormalities); and differential access to cancer treatments, which may 
affect mortality rates and survival.   
In terms of improving prevention of cancer, the NHS Cancer Plan aimed to reduce smoking 
in disadvantaged groups where smoking rates are higher and to improve diet by increasing 
the consumption of fruit and vegetables (low-income groups are considered to eat less 
fruit and vegetables than higher income groups) (Department of Health, 2000).   
In terms of cancer screening, the NHS Cancer Plan set out to extend the eligible age 
criteria for inclusion in the breast screening programme, to use technological advances to 
improve the cervical screening test (the use of liquid-based cytology, LBC) and to assess 
the feasibility of introducing a Human Papillomavirus (HPV) test in the future.  With 
specific reference to inequalities in cervical screening, Primary Care Trusts (PCTs) were 
advised to set up plans to improve cervical screening coverage among deprived and ethnic 
minority groups.  In particular, thirteen health authorities, all in deprived inner city areas, 
who were identified as having failed to reach the minimum 80% cervical screening 
coverage, were set specific targets to increase cervical screening coverage.  A Health 
Improvement Programme was set up to support improvements in cervical screening 
coverage that included workshops and training to share best practice for health 
professionals and General Practice staff, update contact information on GP registers and 
local, targeted health support campaigns (Department of Health, 2000).    
Inequalities in access to care were supported by Personal Medical Services (PMS) contracts 
that rewarded GPs for providing services targeted to the needs of the local area, and were 
considered to be particularly useful in supporting services in more deprived areas 
(Department of Health, 2000).  Improving cervical screening coverage and rapid referrals 
to hospital were key components of PMS contracts.  Further investment in the 
employment of more healthcare workers, considering the geographical location and 
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availability of healthcare staff, and support of further training were also included in the 
plan. 
The Cancer Reform Strategy (2007) 
The Cancer Reform Strategy (2007) was viewed as building on the progress made by the 
NHS Cancer Plan.  It recognised that poor cancer outcomes are experienced by different 
social groups, including those from socioeconomically deprived communities, ethnic 
minorities, and people with disabilities.  To reduce cancer inequalities overall, its aims 
continued to be to promote healthy behaviours; increase awareness of cancer prevention 
and cancer signs and symptoms; improve routes to early diagnosis; and expand available 
treatments (Department of Health, 2007).  However, insufficient evidence on the different 
forms of inequalities, their causes, and how best to tackle them continued to be a major 
challenge in the reduction of cancer.  A National Cancer Equality Initiative was set up with 
three key aims: to support data collection thus promoting further understanding of cancer 
inequalities; to provide support to research activities in order to fill the gaps in current 
evidence; and to share best practice.  The National Cancer Equality Initiative also worked 
with Strategic Health Authorities (SHAs) and Primary Care Trusts (PCTs) to set specific 
goals to reduce mortality rates in socioeconomically deprived groups, such as targeting a 
reduction in smoking and increasing awareness of cancer and the benefits of early 
detection.  These actions would support an increase in screening uptake and encourage 
earlier presentation with cancer symptoms.   
In March 2010, the National Cancer Equality Initiative (NCEI) published its report entitled 
Reducing cancer inequality: evidence, progress and making it happen (Dept of Health, 
2010b).  It acknowledged that inequalities continued to occur along the patient pathway 
from awareness, access to timely diagnoses and treatment, and cancer outcomes in many 
different groups including socioeconomically deprived groups.  It reported on the progress 
made, in conjunction with the National Cancer Intelligence Network (NCIN), to bring 
together a wide range of data from multiple sources (including cancer registries, lifestyle 
and awareness surveys, Hospital Episode Statistics) to provide further evidence of the 
magnitude and nature of cancer inequalities, and to identify areas where further data 
were required.  The provision of this evidence enabled the NCEI to facilitate events where 
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experts could assess the current known status of cancer inequalities and plan how to 
tackle cancer inequalities, define areas for further research and ensure that current best 
practice was implemented within cancer services.  It also set out wide-ranging action to 
promote cancer equality including the acquisition of more data and the launch of the 
Cancer Patient Experience Survey (to assess the extent to which the experience varies by 
deprivation, age, gender and ethnicity and so on). Targeted initiatives by the National 
Awareness and Early Diagnosis Initiative (NAEDI) to raise cancer awareness in groups 
where later presentation for symptoms is a known problem were also developed.  The full 
extent of the NCEI activities and plans are beyond the scope of this introduction but suffice 
it to say that initial progress to establish the current status of cancer inequalities and to 
initiate actions to tackle them are ongoing.   
A Department of Health report on the Cancer Reform Strategy, published in November 
2010, after the formation of the coalition government in the same year, evaluated three of 
the Strategy’s actions to improve cancer services: improving the quality of information; 
strengthening commissioning; and making better use of resources (National Audit Office, 
2010).  While the report acknowledged some achievements of the Cancer Reform 
Strategy, it was largely critical.  It reported that the introduction of the National Cancer 
Intelligence Network (NCIN) had led to significant improvements in the quality of available 
data but that gaps and limitations were still evident.  The commissioning of services in 
PCTs were found to have made improvements in the delivery of some cancer services, 
including improved coverage of cancer screening, but were largely criticised in the report 
for not making best use of the available information or applying their knowledge to make 
services more cost effective.  Finally, wide variation within and between PCTs from one 
year to the next in areas such as emergency admissions for cancer and length of stay for 
cancer patients suggested that improvements to services were possible.  The Cancer 
Reform Strategy would be replaced by the Department of Health’s Improving Outcomes: A 
Strategy for Cancer in 2011 (Dept of Health, 2011).  
Improving Outcomes: A Strategy for Cancer (2011) 
Improving Outcomes: A Strategy for Cancer was introduced by the incoming coalition 
government in January 2011 (Dept of Health, 2011).  The strategy was enforced by three 
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key principles: to put the patient at the centre of public services by endorsing the no 
decision about me without me principle; to switch the focus from measuring processes 
‘which do not matter’ (p2, Dept of Health 2011) to delivering improvement; and to give 
local organisations and professionals the power to improve services for patients and 
service users.  The strategy acknowledged the work of the National Cancer Equality 
Initiative and supported its work to continue to gather evidence on cancer inequalities, 
provide advice on action for change and support the dissemination of good practice. Its 
advisory group was transformed into an implementation advisory group whose purpose 
was to ensure equality issues are considered in actions to improve outcomes.   
In the fourth annual update of the Improving Outcomes: A Strategy for Cancer, progress 
was reported in its aim to tackle cancer inequalities through targeted interventions to 
increase cancer awareness or improve screening uptake (Dept of Health et al., 2014).  
These included the Be Clear on Cancer campaigns that have targeted breast cancer 
awareness in older women, prostate cancer awareness in black men in London and 
interventions to improve screening uptake in socioeconomically deprived groups.   
Summary of health policy to address socioeconomic inequalities in cancer 
The Calman-Hine Report (1995) was pivotal in drawing attention to the need for specific 
cancer services within health care, and for citing concern about the possibility of 
socioeconomic inequalities in cancer and the need for further research in this area.  By the 
time of the NHS Cancer Plan (2000) specific strategies were recommended to address the 
pathways to inequalities in cancer, largely aimed at downstream approaches, such as 
increasing awareness of cancer symptoms, differential access to cancer treatments and 
reducing smoking in disadvantaged groups.  With regard to cervical cancer, the cancer plan 
supported technological advances that would improve the screening programme and also 
advised PCTs to set out plans to address poorer screening coverage.   The Cancer Reform 
Strategy (2007) maintained a commitment to tackling cancer inequalities by setting up the 
National Care Equality Initiative, addressing the need for more and better information by 
setting up the National Cancer Intelligence Network and tackling poorer cancer outcomes 
overall through the National Awareness and Early Diagnosis Initiative.  The Improving 
Outcomes: A Strategy for Cancer (2011) has continued to support the work of the NCEI, 
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has established an implementation advisory group to ensure equality issues are 
considered in actions to improve cancer outcomes and supported targeted interventions 
to improve cancer outcomes in disadvantaged groups.  Therefore, cancer policy over the 
years has sought to strengthen the services available to cancer patients and has worked, at 
least in a downstream capacity, to tackle cancer inequalities. 
1.2 Socioeconomic Inequalities in Cervical Cancer  
Cervical cancer has both a known aetiology and is preventable, yet inequalities in cervical 
cancer incidence and mortality are still evident.  If risk-related health behaviours can be 
improved there will be a measurable health impact.  This, I believe, makes cervical cancer 
screening an important area of socioeconomic inequalities research.   
The pattern of socioeconomic inequality in cancer varies according to the specific cancer 
type, the pathways to exposure to its risk factors, its means of prevention (if any), and the 
routes to timely diagnosis and treatment (Adler and Stewart, 2010).  In this section I will 
briefly introduce cervical cancer and then I will outline the socioeconomic inequalities in 
cervical cancer outcomes; addressing incidence, mortality and survival.  In the subsequent 
sections I will introduce the potential pathways to socioeconomic inequalities in cervical 
cancer and then address the available means to prevent it in the UK.  
1.2.1 Cervical Cancer 
Globally, cervical cancer is the fourth most common cancer in women (age-standardised 
incidence rates), with the greatest burden of this disease found in developing countries 
(Ferlay et al., 2014).  In the UK, cervical cancer is the 12th most common cancer in women, 
and the third most common among women aged 15-44 years (ranked using crude 
incidence rates).    Cervical cancer mortality rates in Great Britain (England, Wales & 
Scotland) exceed European rates with 9% of cervical cancer deaths estimated to be 
avoidable in the UK if it were to attain the mean European 5-year survival rate (Abdel-
Rahman et al., 2009).   Nonetheless, around 800 women die from this disease in England 
every year (NHS Cancer Screening Programme, 2011).   
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The primary cause of cervical cancer is human papillomavirus (HPV) infection. HPV is a 
sexually transmitted virus with many genotypes (Castellsagué, 2008; Muñoz et al., 2006).  
Two high-risk HPV genotypes, HPV-16 and HPV-18, are known to cause around 70% of 
cervical cancers, with the rest being attributable to other oncogenic types.  Cervical cancer 
has two subtypes: squamous cell carcinoma (cancer that develops in the squamous cells of 
the cervix); and adenocarcinoma (cancer that develops in the gland cells of the cervix) 
(Berrington de González et al., 2007).  HPV is associated with both subtypes; however 
squamous cell carcinoma is more common, accounting for around 80% of cervical cancers.   
Many women acquire and clear HPV infection without ever being aware of its presence, 
but persistent high-risk HPV infection can lead to the development of cervical 
intraepithelial neoplasia (CIN), and without treatment, to invasive cervical cancer.  There 
are four key stages in cervical cancer development: acquiring high-risk HPV infection at the 
cervical transformation zone; persistent high-risk HPV infection; development of pre 
cancer, cervical intraepithelial neoplasia (CIN); and progression to invasive cervical cancer 
(Schiffman et al., 2007).   CIN1 denotes mild cell changes in response to HPV infection, and 
is not considered as pre cancer. CIN2 is considered to have cancer potential and CIN3, also 
known as carcinoma in situ, denotes severe cell changes, is not considered to be cancer 
but will result in immediate referral to colposcopy for treatment.   
1.2.2 Cervical Cancer Outcomes 
Cervical cancer outcomes vary greatly between and within countries according to wealth 
and are likely to be influenced by both patient and healthcare system factors (Albrow et 
al., 2012; Brown et al., 1997; Ellis et al., 2012; Singh et al., 2004; Woods et al., 2006).  Even 
in wealthy countries like the UK, where an organised screening programme is free and 
widely available, there are clear socioeconomic inequalities in cervical cancer.   In this 
section, cervical cancer incidence, mortality and survival rates will be described alongside 
the current evidence of socioeconomic inequalities in cervical cancer.   
Incidence 
The overall incidence of cervical cancer in England has decreased by around 30% in the last 
20 years, yet the overall downward trend may mask between-group variation in incidence 
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(Trent Cancer Registry et al., 2012).   Sharp falls in age-standardised incidence rates (ASIR) 
after the establishment of the NHS Cervical Screening Programme (NHSCSP, to be 
described in further detail later in the chapter) culminated in a drop in ASIR from 15.0 per 
100,000 in 1989 to 8.0 in 2004.   A spike in cervical cancer incidence between 2008 and 
2009 has been attributed to a rise in cervical screening attendance in women overdue for 
screening around the period of Jade Goody’s diagnosis in 2008 and death in 2009 
(Lancucki et al., 2012), but a gradual upward trend in cervical cancer incidence has been 
occurring since 2004.   
Regional variation in cervical cancer incidence is found across England.  Cancer networks, 
regional areas responsible for promoting high standards of cancer care services, in the 
South and East generally have lower than national average incidence rates, whereas 
cancer networks in the North and Midlands have incidence rates higher than the national 
average (Trent Cancer Registry et al., 2012).  For example, in England in 2005-09, the Age-
Standardised Incidence Rate (ASIR) was 8.7 per 100,000, but was 13.9 per 100,000 in the 
Humber & Yorkshire Coast cancer network (a more deprived area) and only 6.3 per 
100,000 in the North West London cancer network (a more affluent area) (Trent Cancer 
Registry et al., 2012).   Similarly, incidence rates for residents in the South and East of 
England SHAs were lower than the national average incidence rate, and in the North and 
Midlands SHAs were higher than the national average incidence (Trent Cancer Registry et 
al., 2012).  However, in each SHA the incidence rate fell outside 2 standard deviations (-2 
and +2 standard deviations respectively) from the mean incidence.  This suggests that 
there is greater variation in incidence than can be explained by random variation and that 
there is some unaccounted for variability between SHAs.   This is an example of 
overdispersion.  Potential explanations for this unaccounted for variability may include 
underlying variation in deprivation, or indeed in exposure to risk factors for HPV or uptake 
of cervical screening.   
There is evidence that deprivation does indeed explain some regional variation in 
incidence.  A retrospective time-trend analyses of health authorities in England (using 
1999 boundaries) found health authorities with greater deprivation (using the Townsend 
Index) consistently had higher cervical cancer rates than less deprived health authorities 
(Baker and Middleton, 2003).  The gap in incidence between the most and least deprived 
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health authorities narrowed over the period 1991-97.   For the period 2005–09, there was 
an average incidence rate of 10.4 per 100,000 women in the 30 most deprived PCTs (based 
on the income domain of IMD 2010) and 7.8 per 100,000 women in the 30 most affluent 
PCTs across England (Trent Cancer Registry et al., 2012).  Further analysis of cervical cancer 
ASIRs in PCTs in the South East of England found PCTs with greater deprivation (based on 
the income domain of IMD 2004) had a higher incidence of cervical cancer such that 
deprivation was moderately associated with incidence (Spearman r=0.57, p < 0.001) 
(Currin et al., 2009).  Another national comparison of socioeconomic variation in cervical 
cancer incidence used the woman’s postcode at the time of diagnosis (1998-2003) to 
determine IMD at Lower Super Output Area (LSOA) level and then placed these into 
national quintiles of deprivation (Shack et al., 2008).  This study also found incidence 
associated with greater deprivation, with a particularly steep rise between the most 
deprived quintile and the second most deprived. 
At the individual level, women of lower occupational class tend to have greater incidence 
of cervical cancer than women of higher occupational class.  Data from the ONS 
Longitudinal Study (Brown et al., 1997) investigated incidence of cervical cancer from two 
cohorts: those present and classified by their occupation on the 1971 Census; and those 
present and classified on the 1981 Census, including those from the 1971 Census who had 
completed 10 years of follow-up.  For the 1971 cohort, the risk ratio (RR) for cervical 
cancer incidence for manual versus non-manual workers was calculated for three time 
periods: from 1976-80 RR=1.52 (CI not reported), from 1981-85 RR=1.36 and from 1986-89 
RR = 2.09.  For the latter time period the risk ratio for cervical cancer was 1.77 (CIs not 
reported) for the 1981 cohort.  Over the total time period, incidence fell for non-manual 
workers but plateaued for manual workers.  To my knowledge, more recent evidence of 
the association between cervical cancer incidence in England and individual-level SES 
measures is not available.   However, data from the US National Longitudinal Study (using 
individual-level self-reported SES data from the Social and Economic Supplement to the 
Census Bureau’s Current Population Survey) found evidence to suggest that individual-
level SES is an important predictor of cervical cancer incidence in the US (Clegg et al., 
2009).   Women who had not graduated from high school were more likely to have had 
cervical cancer than those with at least college education (RR = 3.24, 95% CI: 1.68-6.24).  
Women with a family income in 1990 of less than $12,500 were more likely to have had 
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cervical cancer than those with a family income in excess of $50,000 (RR=2.96, 95% CI: 
1.61-5.43).  In conclusion, these studies suggest a consistent association between SES and 
cervical cancer incidence.  
Mortality 
Overall, mortality rates have decreased over the last two decades, which has largely been 
attributed to the introduction of the NHSCSP (Peto et al., 2004).  The age-standardised 
mortality rate (ASMR) for cervical cancer in England was 2.4 per 100,000 in 2008, down 
from 5.8 per 100,00 in 1989 (Trent Cancer Registry et al., 2012).   
Regional variation in cervical cancer is found across England.  SHAs and cancer networks 
have been found to have higher mortality rates in the North and Midlands than in 
Southern regions (Trent Cancer Registry et al., 2012).  As found with incidence rates, there 
is also a socioeconomic variation in mortality rates across regions.   
The aforementioned retrospective time-trends analyses of data from 1991 to 1999 found 
mortality rates were consistently higher in health authorities in England with greater 
deprivation (based on the Townsend Index), and remained consistently higher in more 
deprived populations despite the general downward trend in mortality rates overall (Baker 
and Middleton, 2003).  At PCT level during the period from 2006 to 2010, the age-
standardised mortality rate (ASMR) was higher in the 30 most deprived PCTs (3.2 per 
100,000 women) and lower in the 30 least deprived PCTs (1.7 per 100,000).   The 
correlation between the proportion of income-deprived people at PCT level and ASMR in 
England was 0.58 (p < 0.001).  In conclusion, these studies suggest a consistent association 
between SES and cervical cancer mortality.  
Survival 
Overall, survival rates have increased over the last two decades.  The one-year survival 
rate was 84.0% in 1988, based on diagnoses before the NHSCSP was introduced, and 
increased to 87.5% in 2007-2009  (Quinn et al., 2008; Rachet et al., 2008; Trent Cancer 
Registry et al., 2012).  Five-year relative survival increased from 65.8% for women 
diagnosed in 1988 to 69.8% between 2003 and 2005 (Trent Cancer Registry et al., 2012).   
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Differences in survival rates are attributed to the combination of earlier detection through 
screening and improvements in treatment.   
1-year Survival 
An analysis of the 10 most common cancers diagnosed over the period 1998-2004 found 
the gap in one-year and five-year relative survival between Spearhead PCTs (PCTs with 
higher levels of deprivation) and the rest of England had been reduced for most cancers 
but not for cervical cancer (Ellis et al., 2009).   Delays in presentation and diagnosis are 
generally considered to contribute to poorer 1-year survival.   
In 1996, prior to the implementation of the NHS Cancer Plan (2000), one-year cervical 
cancer survival for women living in the most affluent quintile (based upon the income 
domain of the Index of Multiple Deprivation, IMD) was 88.9%  and 81.2% for those living in 
the most deprived quintile (Rachet et al., 2010). In 2006, post-NHS Cancer Plan 
implementation, the survival rates improved to 90.3% and 84.3% respectively. The gap in 
one-year survival between the most and least deprived quintiles therefore dropped from 
7.7% in 1996 to 6.0% in 2006.  However, the latest figures indicate that inequalities in 
cancer survival have since plateaued (Trent Cancer Registry et al., 2012).   
5-year survival 
Data from 2004 found 5-year relative survival for cervical cancer was consistently lower in 
Spearhead PCTs than in other PCTs (Ellis et al., 2009).  In the aforementioned analysis of 
the 10 most common cancers diagnosed over the period 1998–2004, five-year relative 
survival between Spearhead PCTs (PCTs with higher levels of deprivation) and the rest of 
England had also been reduced for most cancers but not for cervical cancer.   
Summary of Cervical Cancer Outcomes 
In conclusion, the evidence presented in this section indicates that socioeconomic 
inequalities in cervical cancer incidence, mortality and survival remain a problem in the 
UK. One of the ways in which we can begin to understand socioeconomic inequalities in 
cervical cancer outcomes is to address the mechanisms by which socioeconomic status 
(SES) affects health (Adler and Stewart, 2010).  These mechanisms include, but are not 
Chapter 1: Background to Socioeconomic Inequalities in Cervical Cancer 
 
 
- 33 - 
 
limited to, biological and psychosocial pathways that link SES and health, equitable access 
to health care, and variation in health behaviours.  Consideration of these different 
mechanisms opens up different questions.  Which biological pathways link socioeconomic 
status to cervical cancer?  If this is a valid pathway, then would we would expect to find 
socioeconomic variation in cervical cancer risk factors. Is there equitable access to health 
care?  Certainly, in the UK the NHS Cervical Screening Programme is nationally organised 
and free at the point of access.  But do all women, regardless of income, education or 
social status, participate equally in cervical screening? 
In the next section, I will explore if the potential pathways to inequalities in cervical cancer 
outcomes.  This will begin with an exploration of socioeconomic variation in exposure to 
the risk factors for cervical cancer, followed by an exploration of socioeconomic variation 
in access to cervical cancer prevention.   
1.2.3 Cervical Cancer Risk Factors 
As mentioned in the earlier section, sexually transmitted HPV infection is a necessary but 
not sufficient cause of cervical cancer (Castellsagué, 2008; Muñoz et al., 2006).  Pre-
cancerous changes, CIN, occur in the presence of persistent infection with high-risk types 
of HPV.  Risk factors for the development of cervical cancer may be categorised as those 
associated with acquiring high-risk HPV in the first place and with developing persistent 
HPV infection (Castellsagué, 2008).  Persistent high-risk HPV infection can lead to the 
development of precancerous changes (cervical intraepithelial neoplasia, CIN) and without 
treatment, this can progress to invasive cervical cancer (Muñoz et al., 2006).  
The risk factors, if considered in terms of progression from exposure to high-risk HPV 
through to the development of cervical cancer, can be viewed in a series of stages.  The 
initial risk factor for cervical cancer originates from behaviours that increase exposure to 
HPV and then those that increase the likelihood of HPV persistence.   Thereafter, poor 
attendance at cervical screening, or at colposcopy where advised, carry the risk that 
cervical abnormalities may progress to invasive cervical cancer.   
The following section will provide evidence of socioeconomic inequalities in high-risk HPV 
status, and then explore the evidence of socioeconomic variation in the underlying risk 
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factors for high-risk HPV acquisition and persistence of high-risk HPV infection.  The 
subsequent section will explore evidence for socioeconomic variation in attendance at 
cervical screening and colposcopy.   Late presentation for symptoms of cervical cancer is 
beyond the scope of this thesis and will, therefore, not be discussed further.  The evidence 
to be discussed in these sections may help to explain the potential pathways in which 
socioeconomic inequalities in cervical cancer outcomes emerge. 
High-Risk HPV status 
The British National Survey of Sexual Attitudes and Lifestyles (Natsal) has been carried out 
in three successive waves: 1990–91 (Natsal-1); 1999-2001 (Natsal-2); and 2010–12 (Natsal-
3). The results of these surveys are important as they are national, population-based 
surveys. A sub-sample of women (aged 16-44 years) were tested for HPV as part of Natsal-
3. Those from deprived residential areas had greater odds of testing positive for the virus 
(OR = 1.40, 95% CI: 1.07–1.84 for women in the most deprived compared with the least 
deprived quintiles) (Sonnenberg et al., 2013).    Further details of findings from Natsal-3 
have been reported more recently and provide more details of the association between 
socioeconomic status and high-risk HPV status in the same sub-sample, as follows (Tanton 
et al., 2015).  When the association between HPV status and deprivation is adjusted for 
age, the trend for greater odds of testing positive in the most versus least deprived 
quintiles remained  (OR = 1.37, 95% CI = 1.05 - 1.80).  Being HPV positive was also found to 
be associated with social status and housing tenure, but not with academic qualifications, 
in Natsal-3. However, earlier evidence from Natsal-2, suggested high-risk HPV was not 
associated with educational status or social class (Johnson et al., 2012).  It is not entirely 
clear why there should be different findings for social class between Natsal-2 and Natsal-3 
but the more recent survey on social class shows clear linear trends from high to lower 
social status.  Compared with women in professional and managerial occupations the odds 
of being high-risk HPV positive were as follows: intermediate occupations (OR = 1.74, 95% 
CI: 1.21 – 2.52); semi-routine/routine occupations (OR = 1.98, 95% CI: 1.45 – 2.69); full-
time student (OR = 2.16, 95% CI: 1.50 – 3.11); and no job/not worked in last 10 years (OR = 
2.53, 95% CI: 1.62 – 3.96).  For housing tenure, women who rented their property were 
more likely to be HPV positive than women with a mortgage (OR = 2.13, 95% CI: 1.64 – 
2.78) (Tanton et al., 2015).   
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Other UK studies reporting the association between HPV status and SES have generally 
recruited participants from within the NHS Cervical Screening Programme.  Being high-risk 
HPV positive was associated with higher educational levels in women with a cervical 
screening test result indicating borderline/mild dyskaryosis, although the authors 
acknowledged that women with lower levels of education were under-represented in their 
study (Maissi et al., 2004).   Two studies that recruited from within the NHSCSP in South 
Wales did not find an association between socioeconomic deprivation (Welsh IMD based 
on women’s postcode) and high-risk HPV status (Hibbitts et al., 2008, 2006).  These studies 
had large sample sizes (total n = 10,000) but participants predominantly lived in more 
affluent areas. However, the TOMBOLA trial (also conducted within the NHSCSP) found 
that in the context of women receiving treatment for borderline/mildly abnormal cytology, 
women aged 20-59 years with university level education were less likely to be high-risk 
HPV positive than those without a degree (OR = 0.72 ; CI 0.61-0.87) (Cotton et al., 2007).   
While the findings for an association between high-risk HPV and measures of SES are 
mixed, with the exception of Natsal, the studies recruited participants from within the NHS 
Cervical Screening Programme.  This may have biased their results since participation in 
the cervical screening programme is itself socially graded (Baker and Middleton, 2003; 
Bang et al., 2012; Sutton and Rutherford, 2005).  The Natsal survey findings, which are 
drawn from a nationally representative UK sample, may provide a more accurate 
reflection of the general population.  The Natsal studies also specifically report findings 
from women aged 16-44 years who reported at least one sexual partner in the last year, 
perhaps making these findings more significant since the prevalence of high-risk HPV is 
greater in younger women (Sargent et al., 2008).  On balance, it seems likely that HPV 
status is socioeconomically graded and therefore may act as one pathway to 
socioeconomic inequalities in cervical cancer incidence.  Now that HPV testing has been 
introduced into the cervical screening programme (NHS Cervical Screening Programme, 
2015) this may change for future generations, and will make further research into this 
issue more feasible.   
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Risk Factors for High-risk HPV Acquisition 
Since HPV is acquired sexually, some of the risk factors for high-risk HPV acquisition are 
relate to sexual behaviour.  These include early age at first sexual intercourse and number 
of sexual partners over the life course.  Some protection may be offered by the use of 
barrier methods of contraception, such as condoms.   
Age at first sexual intercourse  
The risk of acquiring HPV increases with early age at first sexual intercourse (Castellsagué, 
2008). This may be due to the greater exposure of the transformation zone to HPV in 
younger women whose cervix is less mature (Kahn et al., 2002).   British case-control 
studies have found younger age at first intercourse to be associated with an increased risk 
of cervical cancer with indications that this may influence the progression from HPV 
infection to development of CIN3 (Deacon et al., 2000).   This is supported by findings of an 
association between cervical cancer and younger age at first sexual intercourse over a 
variety of settings and time periods (de Sanjosé et al., 1997; Herrero et al., 1990; Illades-
Aguiar et al., 2009). A recent paper compared the trends in age at first sexual intercourse 
for Natsal-1, -2 and -3, and found that successive birth cohorts have higher proportions of 
women reporting first sexual experience before 16 years of age (Mercer et al., 2013).    
Early age at first intercourse is associated with a number of social, economic and 
educational factors (Hawes et al., 2010; Mercer et al., 2013; NATSAL, 2001; Wight et al., 
2008).  Natsal measures SES at area-level (IMD) and individual level (social class and 
highest educational achievement when leaving school).  Women from areas with greater 
deprivation, in manual occupations or with lower levels of education more often reported 
having had first sexual intercourse under 16 years of age (Mercer et al., 2013).  These 
findings are supported by a literature review of first sexual intercourse in the UK, which 
predominantly focused on survey research.  It found fewer years in education and lower 
educational qualifications were associated with younger age at first sexual intercourse, 
and that level of education was a more sensitive SES measure of early sexual behaviour 
than area-level measures of SES (Hawes et al., 2010).  Family difficulties, living with only 
one or neither natural parent, and living in foster or residential care are all associated with 
younger age at first sexual intercourse (Hawes et al., 2010). Occupational social class also 
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predicts earlier age at first sexual intercourse in the UK, with fewer women aged 20-24 
years in professional or non-manual occupations reporting having had first intercourse 
under 16 years than women in manual occupations (NATSAL, 2001).  Across a range of SES 
markers, women from less privileged backgrounds seem to become sexually active at a 
younger age.   
Number of sexual partners  
Number of sexual partners has been associated with the risk of acquiring HPV infection 
(Deacon et al., 2000; Yetimalar et al., 2011) and risk of cervical cancer (Green et al., 2003).  
The risk of high-risk HPV infection increases with the number of lifetime sexual partners in 
both women and their sexual partners (Kjaer et al., 1997), and when acquiring new sexual 
partners or with non-monogamous partners (Chelimo et al., 2013). A population-based 
case control study conducted in England between 1987 and 1993 found, in comparison to 
women who only had 1 sexual partner, the odds of being HPV positive was higher in those 
who had between 2 and 5 lifetime sexual partners (OR = 2.28, CI 1.40-3.70) and even 
higher for 6+ lifetime sexual partners (OR = 3.52, CI 1.84-6.76) (Deacon et al., 2000). In 
Natsal-3, for women aged 16-44 years, the likelihood of a being high-risk HPV positive was 
significantly higher for those who reported 2 sexual partners in the past year (OR = 2.18, CI 
1.51-3.14) or 3 or more sexual partners in the past year (OR = 3.95, CI 2.87-5.45), 
compared with having had 0 or 1 sexual partners (Sonnenberg et al., 2013). These findings 
indicate that the risk of acquiring HPV increases significantly for women who have had two 
or more sexual partners.  
Comparisons of two cohorts of 18–19 year olds in Scotland between 1990 and 2003 found 
a significant increase in the reported number of sexual partners across the time period, 
but the increase was not socioeconomically patterned, as measured by either social class 
(occupation of head of household) and area-level deprivation (Carstairs-Morris Index) 
(Sweeting et al., 2011).  Natsal-3 found women of higher SES (living in less deprived areas, 
higher occupational social class and more educated) had a greater likelihood of having had 
ten or more sexual partners over their lifetime (Mercer et al., 2013).  To the author’s 
knowledge, there is no other evidence available for the number of sexual partners and 
SES.   
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Barrier Methods 
Women who use barrier methods of contraception, although they are not completely 
protected, are less likely to acquire HPV than women using oral contraceptives (Winer et 
al., 2006). Condom use is associated with reduced transmission and increased clearance of 
HPV infection and regression of CIN (Bleeker et al., 2003; Castellsagué, 2008; Hogewoning 
et al., 2003). The use of condoms has increased in the UK over recent decades (Johnson et 
al., 2001). However, since HPV is transmitted via skin-to-skin contact (Schiffman et al., 
2007), condoms do not safeguard against all means of HPV transmission, even if used 
consistently (Chelimo et al., 2013; Manhart and Koutsky, 2002; Stone et al., 2006).   
Natsal-1 did not report on the relationship between condom use and SES, but found that 
any contraceptive use was positively associated with educational attainment, household 
social class and area level affluence (Bentley et al., 2009).  Natsal-2 found that not using 
contraception at first intercourse was predicted by younger school leaving age and lower 
educational attainment (Wellings et al., 2001).   These findings suggest that condom use 
may be less likely in women of lower SES but this remains uncertain. 
Risk Factors for Persistent HPV Infection 
Once high-risk HPV infection is present, the risk factors for persistent high-risk HPV 
infection include immune-related disorders, co-infection with other sexually transmitted 
infections, prolonged use of oral contraceptives, high parity and smoking.   
Immune-related disorders 
Immune-related disorders increase the risk of persistent HPV infection because they affect 
the individual’s ability to clear the HPV infection (Grulich et al., 2007).  HIV/AIDS has been 
associated with an increased risk of cervical cancer due to immune-suppression (Gallagher 
et al., 2001).  People with other immune-related disorders, and those taking immune-
suppressant drugs following organ transplantation, have also been found to be at 
increased risk of persistent HPV infection (Grulich et al., 2007).   
Approximately one-third of the population living with HIV in the UK are women (Health 
Protection Agency, 2012a).  Rates of HIV are higher in more deprived areas (Madden et al., 
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2011), with clear evidence of a social gradient in HIV prevalence across England and 
London (Health Protection Agency, 2012a).  However, given the relatively low prevalence 
of HIV (1.0 per 1,000), it is unlikely to make a major contribution to cervical cancer 
inequalities (Health Protection Agency, 2012a). 
Co-infection with other sexually transmitted infections (STI) 
Co-infection with other sexually transmitted infections (STI) such as herpes simplex virus 
type-2 or Chlamydia trachomatis has been identified as a potential co-factors in the 
progression from HPV infection to the development of cervical cancer (Bosch et al., 2008; 
Chelimo et al., 2013; Muñoz et al., 2006).  This may be due to the additional strain on the 
immune system to clear multiple infections, leading to prolonged HPV infection (Miller and 
Ko, 2011). Analysis of data from Genito-Urinary Medicine (GUM) clinics across England in 
2012 found chlamydia was the most commonly diagnosed STI, new cases of gonorrhoea 
increased by 21% since 2011, and genital warts and genital herpes were still common 
(Health Protection Agency 2013).   Sexually transmitted infection is therefore of ongoing 
concern at a population level.   
Further analyses of data from GUM clinics across England found syphilis, gonorrhoea, 
genital herpes and genital warts to be greater in more deprived areas (the areas were 
presented in  quintiles of deprivation, using Index of Multiple Deprivation based on 
residential postcode) than less deprived areas (Savage et al., 2011). The contrast in rates of 
STIs between the most and least deprived was most notable for syphilis and gonorrhoea. 
People living in areas in the most deprived quintile were five times more likely to have 
syphilis or gonorrhoea than people in the least deprived quintile.  A Health Protection 
Agency report of sexually transmitted infections in South East England found the rate of 
STIs (syphilis, gonorrhoea, genital herpes and genital warts) to be almost double for those 
diagnosed in GUM clinics in the most deprived versus least deprived quintiles (Health 
Protection Agency, 2012b).  When rates of gonorrhoea were analysed separately, they 
were found to be three times higher in the most deprived quintiles than in the least 
deprived quintiles.    
In a sub-sample of participants in Natsal-3, women who tested positive for chlamydia were 
more likely to come from deprived than less deprived areas (OR = 4.01, CI: 1.67-9.63) 
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(Sonnenberg et al., 2013).  Socioeconomic variation in prevalence of gonorrhoea and HIV 
in the same survey could not be reported due to small numbers (Sonnenberg et al., 2013).  
In Natsal-2, among 18-24 year old women who had first intercourse before 18 years, the 
likelihood of ever having had an STI did not vary by the socioeconomic status of parents 
(manual workers OR = 0.98, CI 0.57-1.67 versus non-manual) but did vary according to 
educational level (left school at 16 year with qualifications OR=0.48 CI 0.25-0.90, left 
school at 16 years with no qualifications OR = 0.71 CI 0.32-1.60, versus left school at 17+ 
years) (Wellings et al., 2001), indicating that lower SES may not affect STI infection in this 
younger sub-sample.   Overall, these findings suggest that women of lower SES may be at 
greater risk of co-infection with other STIs, which could increase the risk of persistent HPV 
infection. 
Prolonged use of oral contraceptives  
The hormonal effects of oral contraceptives increase the risk of developing cervical cancer.  
The mechanism by which oral contraceptives affect progression of HPV infection is unclear 
(Sasieni, 2007). Potential mechanisms include hormonal effects on HPV, which alter its 
genetic expression and/or hormonal effects on the cervix, including changes to cervical 
mucous (Guven et al., 2007), which promote progression from CIN3 to invasive cervical 
cancer (Sasieni, 2007).  A recent re-analysis of 24 international epidemiological studies 
found that current and recent use of oral contraceptives is associated with the 
development of CIN3 and invasive cervical cancer, even after taking into account the 
number of lifetime sexual partners (Appleby et al., 2007).   The risk of cervical cancer 
increased with longer duration of oral contraceptive use and decreased upon cessation of 
oral contraceptives.   
An international meta-analysis, which included data from England, found prolonged oral 
contraceptive use and number of years in full-time education to be positively associated 
(Appleby et al., 2007).  The use of (any) contraception has been positively associated with 
a range of SES measures including less deprived areas, higher level of education and higher 
social class in data collected from Natsal-1 (Bentley et al., 2009).  Natsal-2 did not 
specifically report on prolonged use of hormonal contraception but found use of 
contraception was positively associated with higher levels of education (Saxena et al., 
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2006).   At the time of writing, Natsal-3 has not reported its findings for use of 
contraception.  These findings tentatively suggest that prolonged use of oral 
contraceptives may be less prevalent in women of lower SES and this may be protective, 
rather than a risk factor.    
High parity 
High parity has long been associated with cervical cancer (Castellsagué, 2008; Castellsagué 
and Muñoz, 2003). A reanalysis of 25 international epidemiological studies found evidence 
for the role of parity in the development of cervical cancer after adjusting for other known 
cofactors such as age at first intercourse and number of sexual partners (International 
Collaboration of Epidemiological Studies of Cervical Cancer, 2006). The risk ratio for 
cervical cancer was 1.76 for seven or more full-term pregnancies compared with one to 
two full-term pregnancies.  
Fertility rates are lower in areas with more educated women, possibly due to delay in 
starting a family (Tromans et al., 2008). Having three or more children is not socially 
graded by the occupational status of the father (ONS, 2010). However, fertility rates in 
2011 were found to be 1.9 children per woman in England and Wales (ONS, 2011a).  High 
parity is not likely to contribute to SES differences in persistent high-risk HPV infection in 
women in England.  
Smoking 
Smoking is recognised as a key risk factor for the development of cervical cancer (Deacon 
et al., 2000; Fonseca-Moutinho, 2011; Green et al., 2003; Winkelstein, 1977) and has also 
been associated with poorer treatment success (Acladious et al., 2002; Szarewski et al., 
1996).  Tobacco use is considered to be responsible for 7.2% of cervical cancer incidence in 
the UK (Parkin et al., 2011).  Potential mechanisms for the effect of smoking on the 
development of cervical cancer include reduced immune response, altered hormonal 
metabolism and genetic damage by tobacco-related carcinogens (Muñoz et al., 2006).  
Salient smoking behaviours include smoking status, (current smoker, ex-smoker, never 
smoked) (Haverkos et al., 2003) and the duration and intensity of smoking (Brinton et al., 
1986; Gadducci et al., 2011).   
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Smoking prevalence has fallen in the UK for many years, but rates are consistently higher 
among more deprived populations (Hiscock et al., 2012). In 2010, the General Lifestyle 
Survey (ONS) found smoking prevalence was 31% in households categorised as ‘routine 
occupation’, 15% in ‘professional’ households, and 29% and 21% in unemployed and 
employed adults respectively (“General Lifestyle Survey,” 2012).  In 2012, smoking 
prevalence in the general population in England was 21%; 14.3% for professionals (Social 
classes A-C1); and 29.6% for manual workers (C2-E) (West and Brown, 2013).  Smoking is 
clearly more common in lower SES groups and is therefore likely to contribute to 
differential exposure to persistent high-risk HPV infection. 
Summary of Evidence for Socioeconomic Inequalities in Cervical Cancer Risk Factors 
There is socioeconomic variation in high-risk HPV status, with women of lower 
socioeconomic status being more likely to be high-risk HPV positive. The risk factors for 
cervical cancer can be grouped into those that pertain to the acquisition of HPV (early age 
at first sexual intercourse, number of sexual partners and use of barrier methods, such as 
condom use) and those that support persistent high-risk HPV infection (immune-related 
disorders, co-infection with other STIs, prolonged use of oral contraceptives, high parity 
and smoking).   
Evidence for socioeconomic inequalities in the risk factors associated with acquiring HPV is 
mixed.  Younger age at first intercourse has been associated with lower socioeconomic 
status across a range of markers, including area-level deprivation, individual level social 
class and education. However, higher SES groups may be associated with a greater number 
of sexual partners.  Evidence on socioeconomic variation in condom use is scarce, although 
evidence for contraceptive use more broadly indicates that absent or inconsistent use of 
contraceptives are more prevalent in lower SES women.   This would indicate that condom 
use may be less likely in lower SES women.  Overall, women of lower socioeconomic status 
may be slightly more exposed to the risk factors for acquiring HPV, but some of the SES 
variation remains unexplained.  
Evidence for inequalities in the risk factors associated with prolonged HPV infection is also 
mixed.  With regard to immune-related disorders, there was some evidence that women 
of lower socioeconomic status may be more likely to be HIV positive, but the low 
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prevalence of HIV in the UK may make it unlikely to have any real effect on HPV 
persistence at a population level.  From the evidence presented, it is likely that women of 
lower socioeconomic status are more exposed to co-infection with other STIs.  However, 
women of higher SES may be at greater risk of exposure to prolonged use of oral 
contraceptives.  High parity is not likely to affect socioeconomic inequalities in cervical 
cancer in England.  Finally, there appears to be robust evidence that women of lower SES 
are more likely to smoke.  Women of lower SES are therefore likely to have greater 
exposure to the risk factors for prolonged HPV infection than women of higher SES.   
1.2.4 NHS Cervical Screening Programme 
The National Health Service Cervical Screening Programme (NHSCSP) was introduced in 
the UK in 1988.  This heralded the advent of a nationally organised programme with 
routine, individualised invitations to eligible women (Palencia et al., 2010; Weller and 
Campbell, 2009).  Prior to this, cervical screening in England had operated on an ad hoc 
basis.  Cervical screening can detect abnormalities in the cervix in advance of the 
development of cancer when treatment is less invasive and women have more successful 
outcomes.  The programme has been associated with a reduced risk for both squamous 
cell carcinoma and adenocarcinoma, although the reduction may be greater for squamous 
cell carcinoma (Berrington de González et al., 2007).    The cervical screening programme 
was estimated to have prevented around 80% of deaths from cervical cancer since its 
introduction in an analysis done more than 10 years ago, and there is no reason to expect 
this to have changed (Peto et al., 2004).  
The NHSCSP currently offers 3 yearly screening to women aged 25-49 years, and 5 yearly 
screening to women aged 50-64 years in England, using a call-recall system (the age-range 
and screening interval vary slightly in other parts of the UK) (Albrow et al., 2012).   The 
programme aims to achieve 80% coverage for the eligible population.  Coverage is defined 
as the percentage of the eligible population who are adequately screened within a specific 
time frame.  The time frame is adjusted to account for the recommended recall period for 
younger and older women.  For 25-49 year old women, coverage is therefore defined as 
the percentage of women aged 25-49 years who were adequately screened within the last 
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3.5 years.  This time period is extended to 5 years for coverage of women aged 50-64 
years.   
The cervical screening test, which involves taking cells from the cervix, is called liquid 
based cytology.  Cervical screening works by detecting cellular abnormalities on the cervix, 
known as dyskaryosis (Schiffman et al., 2007).  The classification of cervical cytology is low-
grade dyskaryosis, high-grade dyskaryosis (moderate), high-grade dyskaryosis (severe), 
high-grade dyskaryosis/?invasive squamous cell carcinoma and ?Glandular neoplasia 
(NHSCSP, 2013).     
Cervical screening traditionally used Papanicolaou smear tests, where cells taken from the 
cervix were smeared on a glass slide and sent for cytological examination. The sensitivity 
of cervical smear tests was estimated to be around 76%, although this is highly dependent 
on repeated screens at regular intervals (Kitchener et al., 2013).  Thereafter, liquid-based 
cytology (LBC) was introduced where cells are brushed from the cervix and directly 
inserted into a small vial of preservative fluid. This method introduced two key 
advantages: a reduction in the number of inadequate samples and the ability to test for 
HPV. A reduction in the number of inadequate samples is beneficial as this means fewer 
women need to be re-tested. The ability to test for HPV opened the door to a HPV triage 
protocol. This enabled women with borderline/low-grade dyskaryosis who have a negative 
high-risk HPV test to return to routine recall. Women found to have both borderline/low-
grade dyskaryosis and a positive high-risk HPV test or those with high-grade dyskaryosis or 
worse are referred to colposcopy, an investigative procedure where diagnosis and, if 
necessary, treatment are determined (Health and Social Care Information Centre, 2012a).  
Successful piloting of HPV testing as triage resulted in its adoption in England by late 2011 
(Kelly et al., 2011).   
A ‘see and treat’ strategy, a single colposcopy appointment that offers further diagnostic 
procedures, and where appropriate, treatment for CIN has now been adopted in the 
programme.  This can support timely treatment and reduce the risk of patients not 
returning for a further appointment. Further, using HPV testing as a ‘test of cure’ following 
treatment for CIN can safely promote an earlier return to routine recall (NHS Cancer 
Screening Programme, 2011).  However, different management policies may be applied 
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that require some women to attend for more than one colposcopy appointment (Sharp et 
al., 2011).    
Socioeconomic inequalities in attendance at cervical screening  
In this section, socioeconomic inequalities in the NHS Cervical Screening Programme will 
be split into evidence that considers area-level and individual-level measures of 
socioeconomic status.   Area- and individual-level measures of SES will be discussed 
further in the next chapter.  
Area-level measures of SES 
Lower cervical screening coverage has been found in lower SES areas at general practice, 
health authority and PCT level.  During the period 1991–99, coverage was consistently 
lower for general practices in health authorities with populations living in areas of greater 
deprivation (Baker and Middleton, 2003).  The gap in screening coverage between the 
affluent and deprived areas’ health authorities over this period fell from 39% in the period 
1991–93 to 24% in the period 1997–99, mainly due to a greater improvement in coverage 
rates in more deprived areas in the mid-to-late 1990s.  This may also represent the later 
adoption of cervical screening in more deprived populations as the practice became more 
normative.  A national cross-sectional study of 26.5 million women analysed coverage for 
2008–09 and found socioeconomic inequalities in screening coverage to continue at both 
PCT and general practice level, using NHSCSP and QOF1 data respectively (Bang et al., 
2012).  This indicates that despite a narrowing of the coverage gap in the 1990s 
socioeconomic inequalities in cervical screening are still evident.  This is further supported 
by a 2009 cross-sectional study of practice level deprivation (an aggregate score of IMD 
                                                        
1 The Quality Outcome Framework is an annual reward and incentive scheme for GP surgeries in England 
(Health & Social Care Information Centre, 2014a).  It covers five main domains: Clinical; Public Health; 
Public Health – additional services; Patient Experience; and Quality and Productivity.  This includes 
payments for providing a protocol for the management of cervical screening within the practice 
(call/recall, exception reporting, monitoring of inadequate sample rates), cervical screening rates of 
eligible women registered at the practice, system for monitoring cervical screening rates and a policy for 
auditing its cervical screening service and inadequate screening tests. QOF screening uptake data differs 
from coverage data because GPs are allowed to exception report some women from attending 
screening.  Screening uptake figures may look proportionately higher using QOF data.   
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from patients’ postcodes) which found an inverse association between cervical screening 
coverage and deprivation in PCTs in South West England (O’Neill et al., 2009).   
A cross-sectional study of over 72,000 women aged 30 and over in a former Manchester 
health authority found large practice size (greater than 4,000), single handed practice, 
overseas place of birth, population mobility and deprivation (as measured by Townsend 
index) were associated with lower cervical screening coverage in a multivariate analyses 
(Webb et al., 2004).  After controlling for practice characteristics, and area and individual 
level factors, deprivation accounted for 12.8% of the variance in screening attendance 
(‘Ever’ versus ‘Never Screened’) (Webb et al., 2004).   
Individual measures of SES 
Two national surveys with fieldwork done by ONS in 1999 investigated cervical screening 
uptake and a range of socioeconomic factors, including age completed full-time education, 
social class, employment status, car ownership and housing tenure (Sutton and 
Rutherford, 2005).  Of these, only education was a significant predictor of self-reported 
cervical screening attendance.  Similarly, a study using data collected as part of the Office 
for National Statistics Omnibus Survey in 2005–07 investigated cervical screening uptake 
and education, social class, housing tenure and household car ownership, of which degree 
level education was found to be a significant predictor of self-reported screening 
attendance (Moser et al., 2009).  The British Household Panel Survey found adult learning 
leading to qualifications predicted screening uptake after controlling for income, 
occupation and social class (p < 0.001) (Sabates and Feinstein, 2006).   
In summary, socioeconomic variation in cervical screening coverage can be found at both 
area-level using multiple indicators (IMD, Townsend Index & Carstairs Index) and at an 
individual level.  Education seems to be a particularly sensitive individual level SES 
indicator of cervical screening uptake.  Using occupational social class has produced mixed 
results but this may be due to differences in its measurement.  For example, some surveys 
have measured a women’s social class while others have measured household social class.  
The national surveys reported in this review have not found housing tenure or car 
ownership to be useful predictors of screening attendance at an individual level.  However, 
overall screening attendance has been found to be higher in women of higher SES and this 
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is likely to be a significant contributor to socioeconomic inequalities in cervical cancer 
outcomes. 
Socioeconomic inequalities in attendance at colposcopy 
Women who receive an abnormal result following cervical screening are invited to 
colposcopy for diagnoses and, if necessary, treatment. Non-/late-attendance at 
colposcopy may leave CIN or cervical cancer untreated leading to increased incidence of 
cervical cancer or detection at a later stage when treatment is more invasive and 
outcomes less successful.  Attendance at colposcopy is, therefore, an essential component 
of the cervical screening programme.   
There is little evidence available on the association between socioeconomic status and 
colposcopy attendance, which may in part be due to the reporting of colposcopy 
attendance nationally being at appointment level rather than patient level (Health and 
Social Care Information Centre, 2012a).  An analysis of colposcopy attendance data from a 
single colposcopy clinic in Newcastle in 1989–90 found women of lower social class or 
unemployed were more likely to default from attendance (Sanders et al., 1992).  A cohort 
study  conducted within a randomised control trial (TOMBOLA) in the NHSCSP over the 
period 1999–2002, found two significant SES predictors of default from colposcopy 
attendance in women with low-grade cervical cytology who were referred to immediate 
colposcopy. The odds of default were increased for women not in paid employment 
(OR=2.70, CI:1.64–4.43), compared with those working full-time; and were lower in those 
with some education (OR=0.62 CI:0.41–0.93) or degree-level education (OR=0.40 CI:0.22–
0.71), compared with those with no education (Sharp et al., 2012a).   
Another arm of the TOMBOLA trial, found that level of education was a significant SES 
predictor of default from attendance and late attendance at the first (of two) surveillance 
tests in women with low-grade cervical cytology referred to follow-up cervical screening 
(Sharp et al., 2012b).  The odds of default were decreased for work/college education 
(OR=0.35 CI: 0.18–0.69) and degree education (OR=0.62 CI: 0.30–1.26).  The odds of late 
attendance decreased from work/college education (OR=0.80 CI: 0.56–1.14) and degree 
education (OR=0.41 CI: 0.24–0.70).  Another UK study which recruited women at an initial 
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referral appointment to colposcopy, found that women who did not return for follow-up 
treatment were more likely to be unemployed (Orbell et al., 2006). 
In summary, evidence of colposcopy attendance is largely based upon studies taking place 
within a few colposcopy clinics or embedded within a larger randomised control trial.  A 
mixture of area-level and individual-level measures of SES have been used in these studies.  
Social class, employment status and level of education have found women of lower SES to 
be at greater risk of default from colposcopy at both initial referral and follow-up for 
treatment.  Given that women referred to colposcopy have already received an abnormal 
cervical screening result, poorer attendance at colposcopy by women of lower SES is likely 
to be a contributor to socioeconomic inequalities in cervical cancer incidence.   This may 
be an important mechanism for the observed higher incidence and mortality, and poorer 
survival rates among women from lower SES backgrounds. Further research in this area 
would be beneficial.      
1.2.5 HPV Vaccination Programme 
HPV vaccination now offers a powerful means of preventing the majority of cervical 
cancers and the vaccine has been approved and implemented in many countries (Cuzick et 
al., 2010).  There are two commercially available vaccines: Cervarix and Gardasil.  Cervarix 
is a bivalent vaccine which covers two high-risk genotypes: HPV-16 and HPV-18, which are 
respectively found in around 55% and 15% of cervical cancers worldwide.  This offers 
protection from around 70% of HPV infection known to cause cervical cancer.  Gardasil 
also covers low-risk genotypes, HPV-6 and HPV-11, that are associated with genital warts 
(Cuzick et al., 2010).  The vaccination is effective when given prior to first exposure to HPV. 
So, the programme is targeted to younger girls aged 12-13 years, hopefully in advance of 
sexual activity.   
The NHS HPV Vaccination Programme was introduced in the UK in 2008 as a school-based 
HPV programme to immunise girls aged 12–13 years, with a ‘catch-up’ programme for 
young women up to 18 years (Cuzick et al., 2010).  Originally the programme required 
three doses of the vaccination to be administered over a six-month period but this has 
now been reduced to two doses, with the second dose to be administered within six 
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months to a year from the initial dose (Cancer Research UK, 2014).  It has been projected 
that by 2025, HPV vaccination could reduce cervical cancer incidence in women aged 20–
29 years by 63% (Cuzick et al., 2010).    
The HPV vaccination programme does not supersede cervical screening, but is an 
additional means of supporting cervical cancer prevention (Kitchener et al., 2013).  It is not 
clear the duration of protection offered in the current vaccine. Protection may reduce over 
time; particularly as they become sexually active (Kitchener et al., 2013).  The cervical 
screening programme therefore remains an essential component in this endeavour for the 
time being as it offers further protection for women who received the HPV vaccine 
subsequent to exposure to HPV (when its protective effects are reduced) and helps to 
prevent the 30% of cervical cancer cases caused by HPV variants not covered by the 
vaccine.   
Socioeconomic Inequalities in HPV Vaccination 
A feasibility study in England found that HPV vaccination uptake lower in more deprived 
areas (Roberts et al., 2011). However, encouragingly, since its national implementation, 
uptake of the routine administration of the HPV vaccine has generally been high (Kumar 
and Whynes, 2011). Importantly, national figures indicate that uptake is not socially 
graded (Desai et al., 2010). Its success may be due to the effectiveness of school-based 
programmes to promote access.  However, HPV vaccination uptake has been associated 
with the cervical screening attendance of the girl’s mother, with girls whose mother 
attended screening more likely to receive all three doses (Spencer et al., 2013).    The 
protection offered by vaccination is limited where the girl has already been exposed to 
HPV through early sexual intercourse.  These findings hint that inequalities in the 
protection offered by HPV vaccination may become evident over time. 
1.2.6 Summary of evidence of socioeconomic inequalities in cervical cancer 
Two potential pathways through which socioeconomic status and health may be linked 
have been explored: socioeconomic variation in exposure to risk factors for the acquisition 
and persistence of high-risk HPV infection and socioeconomic variation in participation in 
cervical cancer prevention programmes.  The pathways in which socioeconomic status 
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may lead to poorer cervical cancer outcomes are summarised in the Figure 1.  This outlines 
the ways in which socioeconomic variation in exposure to cervical cancer risk factors and 
participation in the NHS cervical screening programme contribute to socioeconomic 
inequalities in cervical cancer outcomes.  
Figure 1. Socioeconomic Pathways to Cervical Cancer 
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Chapter 2: Approaches to Understanding Socioeconomic Inequalities  
2.1 Introduction 
In the previous chapter, I provided a brief background to inequalities in health in general, 
before focusing upon socioeconomic inequalities in cervical cancer outcomes, and the 
possible mechanisms through which these inequalities may occur.  I discussed the fact that 
despite some evidence that women of lower socioeconomic status may have greater 
exposure to some of the risk factors for cervical cancer, this risk should be mitigated if all 
women attended cervical screening regularly.   However, it is evident that inequalities in 
participation in cervical screening and, potentially, in colposcopy attendance, are also 
important.   
In this chapter, I consider the approach I took to further understanding of socioeconomic 
inequalities in cervical cancer in my thesis.  This will include a discussion of the 
methodological approaches, both qualitative and quantitative, consideration of how 
socioeconomic inequalities are measured and a brief introduction to the geography of 
England and the various measures of SES that are commonly found in the research 
literature at both an area and individual level.   
2.2 The Approach Used in This Thesis 
The philosophical and methodological approaches used in this thesis are pragmatic.  My 
approach is pluralist in the sense that it recognises that different research methods answer 
different research questions and, as such, the different forms of knowledge produced are 
valid.   This, however, does not amount to relativism, where simultaneous forms of 
knowledge are accepted, it is the pursuit of the particular knowledge deemed to best 
serve the aims of the studies.  And finally, it is action-orientated in so far as I hope to 
generate new knowledge that may contribute to health policy.   
In this section, I will provide an overview of qualitative and quantitative methods and 
briefly discuss the merits and limitations of each in relation to my pursuit of the 
understanding of socioeconomic inequalities in cervical cancer. 
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2.3 Quantitative Research 
Quantitative research uses numerical data to quantify the issue under investigation; in this 
case socioeconomic inequalities.  But, how do we measure socioeconomic inequalities? 
One way to answer this question is to define what we mean by socioeconomic status, and 
then to address how we use these data to measure socioeconomic inequalities. 
Socioeconomic status (SES ) is a multi-faceted concept that is indexed and can be 
measured in a variety of different ways (Donnelly and Gavin, 2011; Quaglia et al., 2012).  
Researchers may use either individual-level markers of SES, such as level of education or 
occupation, or area-level markers, such as Index of Multiple Deprivation (IMD) score and 
Townsend Index (Quaglia et al., 2012).   
In this section I will provide more detailed information on the how individual- and area-
level SES data may be sourced in England, including an overview of the geographical units 
in which area-level data may be aggregated, followed by a discussion on the strengths and 
limitations of individual-level and area-level SES data, and on how individual measures of 
SES apply to women.   
2.3.1 Absolute and Relative Deprivation 
Absolute Deprivation 
Absolute deprivation theory is based on the premise that exposure to poverty is the 
primary cause of different health outcomes across SES groups (Ladin et al., 2010). Absolute 
deprivation relates to exposure to poverty or deprivation and may also be referred to as 
absolute poverty (Ladin, 2014).  In straightforward terms, people who live in absolute 
deprivation have access to the bare minimum of resources on which to survive, such as 
food, water, and shelter.  Broader definitions of absolute deprivation may also extend to 
access to other resources, such as healthcare and education.  Absolute deprivation implies 
a division between the poor and the rest of the population that is constant and not subject 
to change over time or place.  However, it is argued that the basic needs of people, that is, 
what is considered to be ‘absolute deprivation’ varies according to the societies in which 
people live, and therefore the concept is flawed (Townsend, 1979).  For example, what 
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may be considered absolute deprivation in developed countries like the UK or USA may 
differ from definitions of absolute deprivation in developing countries.  Different standards 
of absolute deprivation somewhat muddy the waters of the concept, which otherwise may 
seem straightforward.      
Relative Deprivation 
Relative deprivation theory addresses the social gradient in health outcomes, where 
health differentials continue to be evidenced even when basic needs have been met (Ladin 
et al., 2010).  This widens the scope to enable consideration of other factors that 
contribute to differences in health outcomes to include structural issues such as access to 
education and healthcare and employment opportunities, to psychosocial issues such as 
stress and health behaviours. For developed countries, where there are few people who 
could be considered to live in absolute deprivation, relative deprivation theory can be 
considered a more appropriate approach to studying socioeconomic inequalities (Marmot, 
2005).  
2.3.2 Absolute and Relative Inequalities in Health 
Absolute Inequality 
Absolute inequality refers to the actual difference in the rates or percentages of a given 
outcome measure between the highest and lowest SES group. For example, for cervical 
screening coverage this could refer to the difference in the percentage coverage between 
those in the highest SES category and those in the lowest SES category.  This would be 
calculated by subtracting the coverage rate (percentage) in the highest SES category from 
the coverage rate (percentage) in the lowest SES category.  The result of the calculation 
provides a measure of absolute inequality. 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝐼𝑛𝑒𝑞𝑢𝑎𝑙𝑖𝑡𝑦
= 𝑅𝑎𝑡𝑒 𝑖𝑛 𝐿𝑜𝑤𝑒𝑠𝑡 𝑆𝐸𝑆 𝐶𝑎𝑡𝑒𝑔𝑜𝑟𝑦 − 𝑅𝑎𝑡𝑒 𝑖𝑛 𝐻𝑖𝑔ℎ𝑒𝑠𝑡 𝑆𝐸𝑆 𝐶𝑎𝑡𝑒𝑔𝑜𝑟𝑦 
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Absolute inequalities may also be used to record change over time, where the rate of 
change for a health outcome in one SES group differs from the other.  This may result in a 
wider or narrower gap between the highest and lowest SES groups over time.  However, if 
the rate of change is the same across both groups, the absolute inequalities between the 
groups may remain the same, even where there is an overall increase in the outcome over 
time.  See a hypothetical example in Figure 2.  The outcome measure (y axis, health 
outcome, percentage) has increased over time (x axis, period of time, years) for the 
highest and lowest SES group, yet the absolute inequality remains the same, as the rate of 
change has been the same in both SES groups.  That is, there is an absolute difference of 
10% in the outcome measure at the beginning and end of the time period.  
Figure 2. Absolute and Relative Inequalities 
 
 
In the context of public health research, consideration of absolute inequalities of health is 
useful because it supports understanding of poor health outcomes in the most vulnerable 
groups and transparently represents the differences between two population sub-groups.  
An example of absolute inequalities in cervical cancer research includes what is termed the 
‘deprivation gap in cancer survival’ - the difference in relative survival from cervical cancer 
between the least and most deprived SES groups (Rachet et al., 2010).   
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Relative Inequality 
Relative inequality is commonly reported as a ratio (including odds ratios, risk ratios or 
rate ratios) or a proportion of a given outcome for an SES category (King et al., 2012).  
Relative inequality may be calculated as the rate for the lowest SES category divided by the 
rate of the highest SES category.   
𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝐼𝑛𝑒𝑞𝑢𝑎𝑙𝑖𝑡𝑦 =
𝑅𝑎𝑡𝑒 𝑖𝑛 𝐿𝑜𝑤𝑒𝑠𝑡 𝑆𝐸𝑆 𝐶𝑎𝑡𝑒𝑔𝑜𝑟𝑦
𝑅𝑎𝑡𝑒 𝑖𝑛 𝐻𝑖𝑔ℎ𝑒𝑠𝑡 𝑆𝐸𝑆 𝐶𝑎𝑡𝑒𝑔𝑜𝑟𝑦
 
Relative inequalities may change, even where absolute inequalities remain the same.  See 
the hypothetical example in Figure 2.  The relative inequality ratio in 2010 is 0.878 (72% / 
82%) and in 2013 it is 0.895 (86% / 96%) indicating a slight decrease in relative inequality.   
More sophisticated methods of representing health inequalities are available.  One 
example is the Relative Index of Inequality (RII) (Mackenbach and Kunst, 1997).  The RII is 
based on the rates, or ratios, at the extreme points of the social gradient, and therefore 
does not rely on the mean outcome reported for each SES group. It has the additional 
advantage of being able to take into account the population size and the relative 
socioeconomic position between groups. An example of the application of RII within the 
cancer research literature is a study of cancer risk and cancer incidence in relation to 
different measures of SES (Spadea et al., 2010b).  Specifically, cancer incidence was 
analysed according to level of education, occupational class, housing, and index of 
deprivation.  The RII was presented as a ratio to provide a method of comparing the 
association between the different measures of socioeconomic status and cancer incidence.  
The larger the RII ratio, the greater the disparity between those of the highest and those of 
the lowest socioeconomic position (Mackenbach and Kunst, 1997). 
2.3.3 Individual-level Measures of SES 
Whether absolute or relative approaches are taken, SES can be measured at different 
levels.  Individual-level measures of SES include a variety of SES measures that are collated 
and analysed at individual-level.  In the research literature addressing socioeconomic 
variation in cervical cancer or cervical screening, information on socioeconomic status has 
been sourced using a variety of methods including national surveys (Moser et al., 2009) 
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and questionnaires (Cotton et al., 2007; Sharp et al., 2012a).  The measures generally 
include income, employment/occupation, social class and housing.  There is no single, best 
measure of SES as each measure has its strengths and limitations (Galobardes et al., 2006).  
Income 
Income is an indicator of material resource (Galobardes et al., 2006).  Health may be 
promoted by increased wealth through greater access to quality resources (housing and 
food) and services (education, fitness and leisure).  It may be measured as absolute 
income (continuous variable) or categorised into income brackets. Sometimes household 
income may be used, rather than individual income.  This may be to combat cohort effects, 
where older women may be more dependent upon a partner’s income, and thereby act as 
a measure of access to wealth.   
Education 
Education may be considered as an indicator of an individual’s employment or income 
potential and therefore may proximate their access to the material and intellectual 
resources that support health and well-being.    As a measure of SES, it is easy to self-
report and is relevant to people no matter their housing or working status.  However, it is 
subject to cohort effects whereby older people, who tended to leave school sooner, are 
under-represented in higher levels of education.  Therefore, education may not be a good 
marker of SES in older age groups. 
However, the measure has no means of determining the quality of education received and 
therefore this might limit its implications for health literacy (Galobardes et al., 2006).  It 
does allow for international comparisons of SES, which may be more difficult to compare 
with other SES markers.  
Occupation 
Occupation may be viewed as a measure of social class.  Social class in various forms has 
been used for many years, however since 2001 the National Statistics New Socioeconomic 
Classification (NS-SEC) has been used in all official statistics and surveys and is compatible 
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with the European equivalent European Socioeconomic Classification (ESeC) (Office for 
National Statistics, 2010).  The NS-SEC consists of key classes as follows: 
1. Higher managerial, administrative and professional occupations 
1.1. Larger employers and higher managerial and administrative occupations 
1.2. Higher professional occupations 
2. Lower managerial, administrative and professional occupations 
3. Intermediate occupations 
4. Small employers and own account workers 
5. Lower supervisory and technical occupations 
6. Semi-routine occupations 
7. Routine occupations 
8. Never worked and long-term unemployed 
The classifications are sometimes hierarchically categorised into Higher occupation 
(classes 1 and 2), Intermediate occupations (classes 3 and 4) and Lower occupations 
(classes 5-7) (Office for National Statistics, 2010).   Like income, social class may be 
measured at individual and household level.  The latter may be more applicable to 
overcome cohort effects in older women (Galobardes et al., 2006).   
Housing Tenure and Household Amenities 
Housing tenure is another measure of material wealth.  Commonly this is categorised 
according to whether a property is owned (outright or mortgage) or rented (private or 
social landlord).  The validity of these measures may vary across place (urban/rural or 
differing countries) due to differences in the costs of housing in different locations or 
across time as a reflection of earning capacity for different cohorts.   
Other household amenities such as car ownership may be used as a marker of wealth 
(Galobardes et al., 2006).  This may be dichotomous or, in more recent times, perhaps as a 
continuous measure of the number of cars owned per household.   
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2.3.4 Area-level Measures of SES 
Area-level, or ecological, measures of SES are also used as measures of SES.  Individual-
level data, often sourced from the census, may be aggregated into small area data and so 
on into higher areas and regions.  Where an individual’s SES is unknown, it may be inferred 
from the area in which the person lives.  This can be particularly useful for research 
purposes when individual level data are not available or expensive to collect.  However, 
area-level data are subject to the ‘ecological fallacy’ whereby group inferences should not 
be assumed to be the same as that of the individual, or indeed may overlook important 
individual characteristics (Pearce, 2000).   Conversely, to inadequately account for 
population characteristics may be deemed the ‘individualistic fallacy’ as it may fail to 
recognise the significance of population-, group- or place-context.   
Census 
The census is a national survey sent to households in the UK every ten years (ONS 2012a).  
The information collected enables local and national government to more effectively 
develop policies, plan public services and allocate funding to local areas.  With some 
caveats regarding occasional changes to definitions or response categories, it is a useful 
tool to gauge population change over time (ONS, 2012b).   
The census provides rich data on a variety of factors including health, social class, 
employment, education and ethnicity (Geography, 2011; ONS, 2012a).  This makes it a 
useful resource for health inequalities research.   
Census data are available for a variety of geographical units (ONS, 2012b).   The main 
geographical areas include output areas and super output areas (discussed in further detail 
below) but the Office of National Statistics also makes available a variety of other 
geographies and information on how boundaries may have changed in higher level areas 
over time.  The ONS provide a service called Nomis that enables free access to download 
data from their website.   
While individual data items may be used as specific measures in a given area of interest, 
census data are commonly used to calculate indices of deprivation based upon a selection 
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of individual items (ONS, 2012c).    Indices of deprivation may utilise different 
socioeconomic measures or may apply different weights to the measures used.  Common 
indices used in England are the English Indices of Deprivation, or Index of Multiple 
Deprivation, as it is commonly referred to, and the Townsend Index (ONS, 2012c).  The 
Carstairs Index is commonly used in Scotland but has also been adapted to English 
geographies.  Further details of each of these indices are given below.   
Index of Multiple Deprivation (IMD) 
The Index of Multiple Deprivation (IMD) is a measure of area-level deprivation created and 
updated by the Department for Communities and Local Government (DCLG) in England 
(Department for Communities and Local Government, 2011).  The IMD comprises seven 
broad domains: Income; Employment; Health Deprivation and Disability; Education, Skills 
and Training; Barriers to Housing and Services; Crime; and Living Environment.  Each 
domain has a set of indicators (detailed below) which are then weighted and combined to 
construct the full IMD (Department for Communities and Local Government, 2011).  The 
data are sourced from Government Departments, including the Department of Work and 
Pensions, HM Customs and Revenue, the Home Office and census data.   
Income Deprivation Domain constitutes 22.5% of the total IMD weight and comprises 
seven indicators to measure the proportion of the population in an area experiencing 
deprivation related to low income.  These include: 
 Adults and children in Income Support families 
 Adults and children in Income-based Jobseeker’s Allowance families 
 Adults and children in Pension Credit (Guarantee) families 
 Adults and children in Child Tax Credit families whose income (excluding housing 
benefits) is below 60% of the median income 
 Asylum seekers in England in receipt of subsistence and/or accommodation support 
 The proportion of children (0–15 years) living in income deprived households (Income 
Deprivation Affecting Children Index) 
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 The proportion of older people (aged 60 years and older) living in income deprived 
households (Income Deprivation Affecting Older People Index) 
Employment Deprivation Domain constitutes 22.5% of the total IMD weight and comprises 
seven indicators to measure involuntary exclusion from employment by the working age 
population.  The indicators are averaged over four quarters and, unless otherwise 
indicated relate to women aged 18–59 years and men aged 18–64 years.  These include 
claimants of: 
 Jobseeker’s Allowance  
 Incapacity Benefit  
 Severe Disablement Allowance  
 Employment Support Allowance  
 New Deal (18–24 years) 
 New Deal (25 years and older) 
 New Deal for Lone Parents (18 years and older) 
Health Deprivation and Disability Domain constitutes 13.5% of the total IMD weight and 
comprises four indicators physical and mental health.  These include morbidity, disability 
and premature mortality, but do not include characteristics of the environment or 
behaviour that may be associated with future health deprivation:  
 Years of potential life lost (age and sex standardised measure of premature death) 
 Comparative illness and disability ratio (age and sex standardised measure of 
morbidity and disability) 
 Measures of acute morbidity (age and sex standardised rate of emergency 
admissions to hospital) 
 Proportion of adults under 60 suffering from mood or anxiety disorders 
Education, Skills and Training Domain constitutes 13.5% of the total IMD weight and 
comprises six indicators relating to children and young people and one indicator relating to 
adults.   
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The Children and Young People indicators include: 
 Average points score of pupils taking English, Maths, and Science Key Stage 2 
exams 
 Average points score of pupils taking English, Maths, and Science Key Stage 3 
exams 
 Average capped points score of pupils taking Key Stage 4 (GCSE or equivalent 
exams) 
 Proportion of young people not staying on in school (or non-advanced education) 
above age 16 years 
 Proportion of authorised and unauthorised absences from seconder school 
 Proportion of those aged under 21 entering Higher Education 
The adult indicator comprises the proportion of adults aged 25–54 with no or low 
qualifications 
Barriers to Housing and Services constitutes 9.3% of the total IMD weight and comprises 
four indicators relating to geographical barriers and three indicators relating to wider 
barriers: 
The Geographical barriers include: 
 Road distance to GP surgery 
 Road distance to a supermarket or convenience store 
 Road distance to a primary school 
 Road distance to a Post Office 
The Wider Barriers include: 
 Household overcrowding 
 Homelessness  
 Difficulty of access to owner-occupation (local authority district level) 
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Crime constitutes 9.3% of the total IMD weight and comprises the rate of four main crime 
types measured as the number of reported crimes per 1000 population at risk: 
 Violence  
 Burglary  
 Theft 
 Criminal damage 
Living Environment Deprivation constitutes 9.3% of the total weight of the IMD and 
measures the quality of individuals’ indoor and outdoor surroundings.  These include: 
 Social and private housing in poor condition 
 Houses without central heating 
 Air quality 
 Road traffic accidents 
Townsend Index  
The Townsend Index, a measure of material deprivation, is based upon four census-
derived indicators (Townsend et al., 1986).  These indicators are equally weighted across 
the index and comprise of the percentages of: 
 Persons unemployed 
 Households without a car 
 Overcrowded households  
 Households not owner-occupied  
Carstairs Index 
The Carstairs Index, is a measure of material deprivation, and is based on four census-
derived indicators (Morgan and Baker, 2007).  These indicators are not weighted and 
comprise of the percentages of: 
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 Persons unemployed 
 Households without a car 
 Overcrowded households  
 Low social class (Social class IV and V) 
2.3.5 Geography of England 
In this section I will provide relevant details of the geography of England. This is important 
to understand because the data underlying indices of deprivation are collected and 
aggregated at area level.  Also, health services in England are administered within 
geographical boundaries which means that responsibility for health, even if overseen at a 
national level, is held at local area level.   
Administrative Geography 
Geographically, England comprises nine regions, formerly known as Government Offices 
for Regions (GORs) (ONS Geography, 2010a).  Regions are used for the presentation of 
area level statistics.  The nine regions comprise the North East, North West, Yorkshire and 
The Humber, East Midlands, West Midlands, East of England, South West, South East and 
London.   
Census Geography 
The main areas associated with census geography are output areas (OAs) and super output 
areas (SOAs) (Geography, 2011).  These are the base units for census data.  Specifically 
designed for statistical purposes, SOAs are of equal size and are protected from the 
boundary changes that may be applied to other geographical areas, such as electoral 
wards.  Lower Super Output Areas (LSOAs) are particularly useful for statistical purposes as 
they represent relatively small, homogenous areas comprising around 1500 residents and 
650 households.  This supports the representativeness of individual-level data when 
aggregated to area-level (ONS, 2011b).   
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2.3.6 Health Geography 
Health geography relates to the structures of the health service and is therefore subject to 
change (ONS Geography, 2010b).   I will now discuss the hierarchical health geographies in 
place from the late 1990s until 2013, and then the current NHS health geography.     
1999–2013 – Strategic Health Authorities (SHA) and Primary Care Organisations (PCO) 
Between 1999 and 2013 PCOs were the lowest level of health geography.  These were 
overseen by either Health Authorities (1999–2002) or Strategic Health Authorities (2002–
13), which were in turn, respectively under the administration of Regional Offices or 
Directorates of Health & Social Care.  Across the years the number and size of both PCOs 
and SHAs varied, such that by 2013 when the NHS was most recently restructured there 
were 151 PCOs, comprising 146 Primary Care Trusts (PCTs) and 5 Care Trusts (ONS 
Geography, 2010b).  PCOs controlled 80% of the NHS budget and commissioned most NHS 
services (NHS Choices, 2014) .  As such, PCOs were responsible for the services within their 
local area, including cancer screening programmes.   
2013 to present – NHS Commissioning Groups and Clinical Commissioning Groups 
(CCG) 
On 1st April 2013, new health geographies in England came into effect (ONS Geography, 
2010b).   The 151 PCOs were replaced by 211 Clinical Commissioning Groups (CCGs).  
Many CCGs have the same boundary as the PCOs they replaced, while some other PCTs 
now comprise two or more CCGs within their boundaries.  CCGs are co-terminus with 
LSOAs.    CCGs are overseen by NHS Area Teams and, in turn, NHS Commissioning Groups.  
Cancer screening is the responsibility of the national office of the NHS Cancer Screening 
Programmes that is part of Public Health England (PHE), and the commissioning of 
screening is conducted via 27 area teams known as NHS Commissioning Boards (Cancer 
Screening, Early Diagnosis and Skin Cancer Prevention Team, 2013).   
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2.3.7 Strengths and Limitations of SES Measures 
Individual-level and Area-level Measures of SES 
Individual-level measures of SES may be considered to provide a more accurate analysis of 
the relationship between socioeconomic status and health since SES data may be directly 
mapped to health status of the individual.  Individual-level measures of SES are sometimes 
considered to be a more appropriate choice.  However, individual level data may be 
difficult to obtain or may be costly or time consuming to measure at the population level 
(e.g. using surveys, etc.).  For these reasons, area-level measures of SES may be sought as a 
proxy of individual-level measures of SES.         
One of the main strengths of the various area-level indices of deprivation is their ability to 
comprise a variety of factors that reflect the complexity of deprivation.  For the Townsend 
and Carstairs Indices these include aspects of material deprivation, such as car ownership, 
household overcrowding, unemployment and, respectively, household ownership or low 
social class.  The IMD is able to extend beyond these factors to include a broader range of 
factors that also encompass welfare support, health, and geographical and environmental 
barriers.  This makes indices of deprivation valuable tools for identifying areas with specific 
issues, such as high deprivation or low education (Department for Communities and Local 
Government, 2011).   
Indices of deprivation are limited by the timeframe in which the information is collected.  
The Townsend Index and Carstairs Index are derived from census data which are collected 
every 10 years (for example, 1991, 2001, 2011).  This may lead to the use of outdated 
data.  The IMD is based upon routinely collected administrative data and is updated 
periodically to reflect current deprivation levels (for example, 2000, 2004, 2007, 2010) 
(Department for Communities and Local Government, 2011).   The next IMD is due for 
release in 2015 (Department for Communities and Local Government, 2014). 
Caution is advised when using the full IMD to measure effects of deprivation on health, as 
this may confound, or inflate, the association between deprivation and health.  This is 
because poorer health outcomes, part of the health domain, may be considered to 
construct a ‘mathematical coupling’ when associated with other health-related data.  
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Some studies seek to avoid this issue by excluding the health domain from analyses, 
sometimes by using the income domain only.   
Choice of geographic unit may have important implications for how area-level data are 
analysed and evaluated, and may have implications for concerns regarding the ‘ecological 
fallacy’ (Freedman, 1999).  Smaller geographic units have been found to demonstrate a 
stronger association between cancer incidence and socioeconomic status, and, therefore, 
may be a preferred option, where possible (Donnelly and Gavin, 2011). 
In comparison with individual-level measures of SES, area-based measures have been 
found to underestimate the individual-level association of SES with health outcomes 
(Galobardes, Shaw, Lawlor, Lynch, & Smith, 2006).  Area-level measures may dilute the 
association between SES and the health outcome due to the variation in the characteristics 
of the individuals living in the given area. However, as discussed above, this may be 
mitigated by using small geographical areas with high levels of homogeneity within the 
resident population.  That said, in some instances, it is possible that area-based measures 
may inflate the association between SES and health since area-based measures inherently 
include potential independent effects of place (Galobardes, Shaw, Lawlor, Lynch, & Smith, 
2006).   
In conclusion, individual-level measures of SES are generally considered the preferred 
option and should be utilised where possible.  However, area-level measures offer a broad 
choice of SES measures to suit a variety of purposes.  They can often be easily downloaded 
from administrative data websites and may be a quicker and cheaper substitute for 
individual-level measures of SES.  However, they are an imperfect measure of SES and, 
where applied, the interpretation of results should bear in mind the heterogeneity of 
residents within even relatively small, homogenous areas and the potential for 
independent effects of place on health outcomes.   
Women and Appropriate Measures of SES 
As discussed within this section, there are a variety of measures of SES available to choose 
from.  Beyond the pragmatic considerations that often influence the choice of individual-
level or area-level SES measure used in any given study, I will now consider the 
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applicability of various SES measures as they apply to women, as well as consider how SES, 
as indexed in different ways, might operate to affect cervical screening uptake.    
Occupation 
The socioeconomic status of a woman has often been determined by the occupation of 
her husband or male partner. This is because of disparities in opportunity and career 
progression for women, compared with men, in the workplace.  Historically, men, as the 
‘bread winners’, conferred their occupation, and its associated socioeconomic status and 
income, on the household, and therefore on their wives and children.  In some instances, 
SES determined by the occupation of men, may be an appropriate measure for adult 
women, but these are likely to be where a household level of SES is appropriate.   
The use of a man’s occupation as a means of determining a woman’s SES may have less 
relevance in contemporary times, now that women are much more likely to work outside 
the home (ONS, 2013).  Younger women are more likely to have professional careers and 
relatively greater income in their own right than older women (ONS, 2013).  This change 
has been associated with social and labour market changes over the years that have led to 
higher employment rates for women.  These have been supported by legislative changes, 
such as the Equal Pay Act (1970), Sex Discrimination Act (1975), Employment Protection 
Act (1975) and other amendments to benefits and pensions (see Figure 3, reproduced 
from ONS, 2013).   While this may suggest that the use of  occupation as a marker of SES 
for younger women, professional women, or single women, may now be a more accurate 
reflection of her SES, this may be problematic.  Men continue to have higher employment 
rates and work in occupations which command higher rates of pay than women (ONS, 
2013).  Further, even where women are employed in professional occupations, they are 
often subject to the “glass ceiling” effect and may not achieve the promotional 
opportunities available to their male counterparts (Glass and Cook, 2015).  Recent 
evidence suggests that successful career women in more senior positions receive less 
support and remain in post for shorter time periods than male peers, meaning that any 
career advances for women may not translate to the same long term benefits.  Also, 
despite advances in paternity policies, women are still more likely to interrupt their 
careers to have children or stay at home to look after them (Colette Fagan and Helen 
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Norman, 2012).  Therefore, for married women at least, her partner’s occupation may 
remain a more accurate reflection of their household socioeconomic status, which could 
be greater than that inferred by her occupation.   
Figure 3. Employment rates for men and women, aged 16-64, 1971 to 2013. 
 
Copyright: Contains National Statistics Data ©Crown copyright and database right.  
Available for use under the Open Government Licence.  
However, a woman’s individual-level occupational status is key to understanding the 
employment conditions available to her.  In the context of health inequalities research, 
and in terms of the research questions in this thesis, a woman’s occupational status could 
affect her cervical screening attendance.  For example, women who are employed in 
positions which attract health benefits, such as health insurance or private health care 
benefits, may find their employers more supportive of the importance of attending 
cervical screening.  Similarly, women in more advantaged employment conditions may 
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have greater autonomy, trust or flexibility with their time, which may also support 
screening attendance.  Conversely, women in less advantaged employment conditions, 
may find it more difficult to arrange, and subsequently attend, their cervical screening 
appointments, and may incur a loss of income by doing so.  When a woman’s occupation is 
considered within the context of pathways to screening (non) attendance, it may be her 
individual level occupation that is most important.  
Income 
Income as a measure of SES can have some of the same issues for women as the 
occupational measure of SES. That is, for older women in particular, their socioeconomic 
status may be more appropriately determined by their male partner, as there is a greater 
likelihood that the primary household income is derived from his salary.  Further, given 
women’s career prospects continue to be more limited than men’s, this has an effect on 
the salaried income potential of women (Glass and Cook, 2015).   
Women are also more likely than men to be lone parents and are therefore more likely to 
rely on welfare benefits to support the household income (Evans, 2010).  Further, recent 
changes to welfare benefits also mean that household incomes overall may be even lower 
for those on benefits now than in previous times.  Hence, for some women who are now in 
low income jobs, they may be no better off than those on welfare benefits in previous 
years.  Therefore, income as a measure of SES over periods of time should be interpreted 
in light of these potential underlying shifts in net household income.    
A woman’s income could affect her screening attendance via the associated practicalities 
of attending screening or in the prioritisation given to screening.  For example, women 
with low income (low paid job or no job) may have difficulty attending screening due to 
the costs of transport or childcare.  Women living in areas with greater deprivation may 
find their local social networks (neighbours, friends or family living nearby) to be less 
supportive of their screening attendance.  This could potentially be due to lower 
awareness of cervical screening in more deprived areas (Lostao et al., 2001; Sutton and 
Rutherford, 2005; Wardle et al., 2004), and therefore less importance being placed on 
screening attendance.  Indeed, cervical screening attendance may be considered as more 
socially normative in less deprived areas and therefore attending cervical screening 
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attendance is more readily supported.  Additionally, women who are worried about their 
finances may not consider cervical screening (or health in general) to be a priority.  These 
potential pathways to screening non-attendance or screening delay may occur whether 
the income is measured at individual or household level, as these could both be construed 
as a measure of the resources available to her.   
Education 
Education may be particularly relevant to the understanding of health issues as it is likely 
to affect a woman’s occupational status and income, and may also offer other pathways to 
screening attendance. Educational attainment is associated health literacy which supports 
the skills to understand health issues, seek help and make health decisions (Nutbeam, 
2008).  Further, certain health behaviours may be more socially normative in people with 
higher, rather than lower, levels of education (Sutton & Rutherford, 2005) and therefore 
may contribute to socioeconomic variation in health outcomes.  Therefore, a woman’s 
own level of education may personally affect her health behaviours, and as such, may be 
considered a particularly useful measure of SES in women. 
Education as a measure of SES may differ between older and younger age groups.  Older 
women are generally less well educated and have fewer qualifications than younger 
women (Finding, 2013).  Further, younger women now have greater access to education, 
and indeed, girls often outperform boys at school examinations.  The distribution of the 
levels of education is likely to differ across younger and older age groups.  Therefore 
education as a marker of SES should be used cautiously if comparing younger and older 
women. 
In terms of education as a pathway to screening attendance, lower levels of education may 
act to hinder women’s attendance at cervical screening via the socially normative practice 
of a woman’s peers.  Or conversely, it may support attendance for women with higher 
levels of education for the same reason. Women with higher levels of education may be 
exposed to more discussion of cervical screening with their peers due to greater 
awareness of the cervical screening programme and the value of regular screening. This 
may support cervical screening attendance through the opportunity to explore the 
benefits of screening, as well as, the practicalities of attendance.   
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Strengths and Limitations of Measures of SES for women 
Some of the issues raised in this section suggest that household measures may be useful, 
as women’s circumstances are still often strongly associated with their male partner’s 
status (Bartley, 1999).  Certainly, these are often used in longitudinal surveys and also in 
the UK census (Rose and Pevalin, 2005).  The use of a household measure, or a family 
measure, of SES where the household is measured by income of the main breadwinner has 
been widely accepted because all family members are considered to share those 
conditions.   
The interpretation of some individual-level measures, e.g. level of education, may be 
problematic when considering health outcomes of women of different age groups.  In 
some instances, it may be suitable to consider household-level measures. The 
measurement and interpretation of the socioeconomic status of women should consider 
the appropriateness of the measure to women in general, the possible cohort effects for 
that measure, and the contemporary differences in women’s career opportunities in 
comparison with men.  In health inequalities research, it is the consideration of the SES 
measure, in the context of the opportunities or pathways that are associated with the 
health outcome in question, that provides a route to further understanding.  Therefore, 
even where a husband’s occupation may conferred on the household, it is the woman’s 
own occupation that will determine the employment conditions that may affect her 
screening attendance.  
It is evident that there are many issues to be considered when choosing a measure of SES 
for women, and perhaps there is no ideal measure.  It is important, therefore, that 
whichever measure is chosen it is done so while acknowledging not only its limitations but 
also the pathways by which each SES measure may affect the health behaviour under 
consideration.     
2.3.8 Measuring Socioeconomic Inequalities in Health Outcomes 
In quantitative analyses, analysing socioeconomic inequalities in health requires examining 
the association between the health outcome and a particular measure of SES. This may be 
a continuous measure or categorised into social groups in some kind of hierarchical 
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format.  The strength of the association between the health outcome and the SES measure 
can then be determined using the appropriate statistical method.  The hierarchical format 
may already be categorised, for example when using social class.  This approach was used 
in a longitudinal study of the Health of the Nation in which age-standardised incidence 
rates of cervical cancer were found to be significantly higher in manual than non-manual 
workers (Brown et al., 1997).  Continuous measures of SES, such as the percentage of 
income-deprived people living in LSOAs, may be divided into quintiles from high to low 
income deprivation.   For example, a cross-sectional study of colonoscopy uptake following 
a positive faecal occult blood test result found people who lived in the less deprived 
quintiles to be significantly more likely to attend colonoscopy than those living in areas 
categorised with the most deprived quintile (Morris et al., 2012).  Of course, continuous 
measures of SES do not need to be categorised or preserved to demonstrate the strength 
of association across the spectrum.  This approach was used in a cross-sectional analysis of 
colorectal screening uptake across England, which found a significant effect of deprivation 
on the uptake of colorectal screening in people living in areas categorised into quintiles 
from the most to least deprived.   
These are examples of how socioeconomic inequalities in health can be analysed and 
illustrated, and are important for demonstrating where a problem exists or form the basis 
for gauging if differences in the strength of the relationship between health and social 
status may differ over time or place.   There is capacity to control for variables that are 
often confounded with SES, such as ethnicity, to produce complex analyses that may shed 
light on the role of SES and health outcomes.  These examples have focused upon the 
important upstream factors of SES measures that need to be addressed in order to reduce 
health inequalities overall, but are sadly lacking in sufficient knowledge of, or political will 
for, appropriate interventions to act upon them (Marmot Review, 2010). 
There are, of course, many other ways in which quantitative research methods can be 
employed to address downstream factors, including those that may mediate the 
association between SES and health behaviours.  For example, assessing factors that 
mediate the association between SES and cervical screening participation, such as GP 
opening hours, may more readily present factors that could form the basis of interventions 
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to improve screening attendance and improve cervical cancer outcomes (Marmot Review, 
2010).    
2.4 Qualitative Research 
In the previous section I discussed the use of quantitative methods in relation to 
understanding socioeconomic inequalities in cervical screening.  Much of the focus was on 
the measures that may be used to quantify socioeconomic status, and was largely guided 
by the availability of administrative data.  As useful as these measures of socioeconomic 
status are, there are issues in relation to socioeconomic inequalities in cervical cancer that 
cannot be explored by these data.  For example, in Chapter 1 evidence was presented that 
suggested cervical screening may be lower in women of lower socioeconomic status, 
followed by an exploration of the some of the reasons why this may be the case.  Broadly, 
lower cervical screening uptake may be due to issues relating to the women themselves, 
to the delivery of the screening programme, to the efforts of local health promotion 
campaigns or, more likely, a combination of all of these. Routine collection of all these 
types of data is not feasible and, even if it were, it may be difficult to extrapolate the 
complexity in which different factors contribute to poorer cervical screening attendance.  
Further, there may be other factors that are not evident in the existing research and, if 
discoverable, could further understanding of socioeconomic inequalities in cervical cancer.  
To this end, the use of qualitative research methods offer the opportunity to explore other 
types of information through, for example, interviews with health professionals within the 
NHS Cervical Screening Programme.   
Qualitative research may not have always received its due respect as a research 
methodology, with some critics citing it lacks the objective interpretation assumed to be 
inherent in ‘hard’ quantitative research methods, although it is well established now and 
more accepted (Bauer and Gaskell, 2000).  Qualitative research has received justifiable 
criticism of its need to demonstrate reliability and validity; however, this cannot be 
achieved by transferring the same criteria by which the quantitative research methods are 
critiqued.  In this next section, I will briefly introduce indicators of quality in qualitative 
research methods. 
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2.4.1 Validity 
Validity may be considered as an indication of how well the research method represents 
what it is designed to measure (Willig, 2013).  Ways in which the validity of qualitative 
research methods can be supported include the openness of the researcher to allow any 
assumptions about the meaning of the issue being investigated to be challenged by the 
participants and/or to invite the participants to comment on the study findings.  Higher 
ecological validity can be achieved by enabling the research to take place in real-world 
settings where possible.    
2.4.2 Reliability 
Reliability in research methods is focused upon the replicability of research findings (Willig, 
2013). Can the same results be produced on different occasions or with different 
researchers?  The extent to which this can be used as a measure of quality in qualitative 
research is arguable since the epistemological stance of the researcher and the specific 
research question guides the analytic enquiry of any data produced from an in-depth 
interview or focus group study.  Therefore, different results may be derived from the same 
data if the epistemological stance were different.  Thus, what may be more important is 
the transparency of the qualitative research process.  Transparency may be improved 
through reflexivity, a process in which the researcher makes known their own values and 
assumptions, and acknowledges how this may affect the interpretation of the results.  In 
this way, while other interpretations of the same data may be available, the reader is able 
to see how the researcher arrived at their interpretation, and in this sense the results may 
be interpreted as reliable within the constraints of the acknowledged approach.  A form of 
inter-rater reliability can be applied to the analytical process by having more than one 
researcher code the data, initially independently, and then share and discuss the meanings 
each have derived in order to provide shared credibility checks.  
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Chapter 3: Thesis Aims and Research Questions 
3.1 Aims   
In the Chapter 1, I outlined the evidence for socioeconomic inequalities in cervical cancer 
incidence, mortality and survival.  I then explored if there was evidence of socioeconomic 
variation in 1) exposure to risk factors and 2) participation in cervical cancer screening.  
Overall, women of lower SES are more likely to be exposed to some risk factors for the 
acquisition and persistence of high-risk HPV infection, and this is reflected in the evidence 
that they are more likely to be positive for high-risk HPV.  
The NHS Cervical Screening Programme in the UK provides the means for cervical 
abnormalities to be detected in advance of the development of cervical cancer.  Since 
there is a substantial time period between exposure to HPV and the onset of cervical 
cancer, cervical screening should circumvent the development of cervical cancer in women 
who have a greater exposure to the risk factors, so long as they attend regularly.  
However, when uptake of cervical screening in England is considered there are clear 
indications that women of lower SES are less likely to attend cervical screening.  Even 
where women attend cervical screening, there is some evidence that colposcopy 
attendance may be lower.  This is particularly important because women who are referred 
to colposcopy following a cervical screening test are considered to have had an abnormal 
screening result, and are therefore in need of further investigation.   Women who do not 
attend colposcopy following an abnormal screening test result may miss out on the key 
benefit of the cervical screening programme, diagnosis of cervical abnormalities that, if 
treated, prevent cervical cancer from developing.  It is unclear if colposcopy attendance is 
indeed poorer in lower SES women.  The thesis aims to further understand socioeconomic 
inequalities in cervical screening.  In doing so, it is anticipated that this will inform current 
evidence and future strategies to address socioeconomic inequalities in cervical cancer.    
The aims of the thesis are to address the following questions: 
1. Are socioeconomic inequalities in cervical screening coverage in England improving? 
(Study 1 and Study 2) 
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2. Which factors support or hinder cervical screening coverage in PCTs in England (Studies 
3 and 4) 
3. Do perceived benefits of cervical screening mediate the association between 
socioeconomic status and cervical screening coverage?  (Study 5) 
4. Are there socioeconomic inequalities in attendance at referral to colposcopy following 
an abnormal cervical screening test contribute to inequalities in cervical cancer? (Study 
6) 
Chapters 4 to 9 of the thesis address each of these questions in turn, using the theoretical 
and methodological approaches outlined earlier. 
3.1.1 Study 1 
Many of the studies of socioeconomic inequalities in cervical screening coverage in the 
background literature are either from some time in the past or do not cover all areas of 
the country.   In light of this, my first study, a cross-sectional observational study, 
estimated the relationship between cervical screening coverage over the years 2007–12 
and deprivation quintiles using linear regression models.  Primary Care Trust level (n = 151) 
cervical screening coverage data were sourced from the Health & Social Care Information 
Centre (Health and Social Care Information Centre, 2012b).  The income domain of the 
IMD (2010) was used as the measure of deprivation. The ‘coverage gap’, was calculated as 
the difference in mean coverage between the least and most deprived quintiles.  A mixed 
ANOVA model was used to estimate if socioeconomic inequalities in cervical screening 
coverage changed over time, differed between London and the rest of England or differed 
in the younger and older age groups of women.   
3.1.2 Study 2  
In contrast to the results found in Study 1, this cross-sectional observational study 
estimated the relationship between breast screening coverage and deprivation quintiles 
using linear regression models.  Primary Care Trust level (n = 151) breast screening 
coverage data were sourced from the Health & Social Care Information Centre (Health and 
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Social Care Information Centre, 2013).  The income domain of the IMD (2010) was used as 
the measure of deprivation. As before, the ‘coverage gap’, was calculated as the difference 
in mean coverage between the least and most deprived quintiles.  A mixed ANOVA model 
was used to estimate if socioeconomic inequalities in breast screening coverage changed 
over time, differed between London and the rest of England or differed between the NHS 
Breast Screening Programme and the older women eligible for the NHS Cervical Screening 
Programme.  This latter point is the key focus of this study, that is, to contrast the patterns 
of association between deprivation and cervical screening coverage in older women with 
the patterns of association between deprivation and breast screening coverage, where 
there is great overlap in the women simultaneously invited to both.  This was anticipated 
to detect if socioeconomic inequalities in cervical screening coverage may, at least in part, 
be driven by programme-specific factors, or, alternatively, if they are specific to the 
characteristics of the women eligible for screening.    
3.1.3 Study 3 
Factors known to affect screening coverage can be further broken down into area-, 
population- and programme-delivery factors (Crossley, 2011).  The background literature 
highlighted a variation in cervical screening coverage in PCTs (and other areas) across 
England, as well as a number of area-level factors (deprivation, levels of education, etc.).   
Study 3, a cross-sectional observational study, aimed to identify PCTs that have performed 
particularly well (or poorly) in relation to cervical screening coverage with a view to 
providing a characterisation of high- and low-performing PCTs.  Coverage corresponds to 
the percentage of women actually screened among the eligible population.  This study 
sourced the number of women screened and the number of eligible women in 2011–12 
from the Health & Social Care Information Centre (HSCIC).  The income domain of the IMD 
(2010) was used as the measure of deprivation.  Area-level education and ethnicity data 
were sourced from the Office of National Statistics (ONS) via Nomis, the official labour 
market statistics web resource  (ONS, 2014a).  Urban-rural classification of PCTs were 
sourced from the Association of Public Health Observatories website (APHO, 2008).  The 
percentage of women aged 25-29 years registered with a general practice and the 
programme-delivery factors (average practice list size, single-handed general practices, 
practitioner headcount, practice staff and practitioners qualified outside the UK) were 
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sourced from the Health and Social Care Information Centre  (Health & Social Care 
Information Centre, 2010).  Univariate regression models were fitted to consider which 
factors could be included in the full regression model, with Wald tests used as a criterion 
for inclusion.  Three regression models were then fitted to estimate the association 
between cervical screening coverage in younger and older women and i) population 
factors, ii) programme-delivery factors and iii) both population and programme-delivery 
factors.   
3.1.4 Study 4 
Ecological studies (like Study 1, 2 and 3) offer good opportunities to explore health 
inequalities at a national level; however, insight from professionals who work in the NHS 
Cervical Screening Programme may help further explain some of the findings from Studies 
1, 2 and 3.  It may also offer the opportunity to learn about issues that are perhaps evident 
to those who work in the programme but are less obvious to others.  The study also 
explored potential reasons for non-attendance at colposcopy following an abnormal 
screening test result because this had been identified as an area where there was little 
recent evident and for which data are not easily accessible.  For these reasons, Study 4, a 
qualitative study, explored the views of health professionals on local factors associated 
with cervical screening coverage and colposcopy attendance.  Semi-structured telephone 
interviews were conducted, with the guidance of a topic guide.  The data were analysed 
thematically and this was conducted using NVivo software.  
3.1.5 Study 5 
Study 5, a cross-sectional, observational study, took a slightly different approach to 
investigating socioeconomic inequalities in cervical cancer and sought to explore how 
perceived benefits of the NHS Cervical Screening Programme mediate the association 
between SES and cervical screening coverage.  Data were sourced from a TNS-BMRB 
omnibus survey, where women self-completed the Cervical Cancer Awareness Measure 
(Cervical CAM), (Simon et al., 2011) and items relating to screening participation and 
attitudes to screening. This study used mediation analyses, according to the Baron & 
Kenny approach (Baron and Kenny, 1986).  The methods comprised of chi-square tests to 
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assess the associations between i) screening status and SES group, ii) perceived benefits of 
cervical screening and screening status, and iii) perceived benefits and SES group.  Four 
logistic regression models were fitted.  Model 1 was a univariate logistic regression model 
of SES and demographic variables and screening status, Models 2 and 3 fitted the 
independent effects of each belief variable, and Model 4 included both belief variables.      
3.1.6 Study 6 
Finally, Study 6 explored socioeconomic inequalities in patient-level colposcopy 
attendance.  The background literature in the previous chapter found some evidence that 
women of lower SES have lower attendance at colposcopy appointments.  This may 
highlight an additional mechanism by which socioeconomic inequalities in cervical cancer 
outcomes operate.  Yet, the evidence to date is limited.  Study 6, a cross-sectional, 
observational study, explored possible associations between SES and attendance at first 
referral to colposcopy following an abnormal screening result.  Anonymised colposcopy 
attendance data, age and cervical screening indicators were sourced from the East of 
England Cyres Colposcopy database for all women referred to colposcopy between 2006 
and 2013.  The income domain of the IMD (2010) was used as the measure of deprivation.  
Area-level ethnicity were sourced from the Office of National Statistics (ONS) via Nomis, 
the official labour market statistics web resource  (ONS, 2014a). Chi-square tests were 
used to assess differences in colposcopy attendance by area-level quintiles of deprivation, 
age, ethnicity and cervical screening test indicator.  Univariate and multivariate logistic 
regression was used to regress colposcopy attendance status against the aforementioned 
independent variables. Deprivation and age were also tested for potential interaction 
effects.
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Chapter 4: Socioeconomic Inequalities in Cervical Screening Coverage 
(Study 1) 2 
4.1 Introduction 
This study sought to discover whether socioeconomic inequalities in cervical screening 
coverage in England are improving.  The evidence set out in Chapter 1 indicated that lower 
attendance at cervical screening by women of lower SES is likely to be a key contributory 
factor to socioeconomic inequalities in cervical cancer.  There are reasons to believe that 
socioeconomic inequalities in cervical screening coverage could be improving.  The gap in 
screening coverage between less and more deprived health authorities narrowed during 
the 1990s (Baker and Middleton, 2003).  Since then, successive UK governments have 
made policy commitments to tackling inequalities in cancer screening participation 
(Department of Health, 2000), (Dept of Health, 2011) and a range of interventions have 
been introduced to tackle socioeconomic inequalities in cervical screening. In this chapter, 
I will begin by providing further details of the Baker and Middleton study to outline the 
status of the gap in cervical screening coverage in the 1990s.  I will provide a brief recap of 
the cancer policies in place since that time and then present some of the interventions 
that have been introduced to reduce socioeconomic inequalities in cervical cancer 
screening.  And then finally, I will outline the current cervical screening coverage levels in 
England before introducing Study 1, a study of socioeconomic inequalities in cervical 
screening coverage in the 2000s.   
4.1.1 Cervical Screening Coverage Gap in the 1990s 
Baker and Middleton undertook a retrospective time trends analysis of cervical screening 
coverage in England in the 1990s (Baker and Middleton, 2003).  They compared health 
authority level cervical screening coverage (defined as the percentage of GPs for whom at 
least 80% of their eligible registered patients have attended cervical screening in the 
previous five years) at three time points: 1991, 1995 and 1999.  The health authorities 
were placed into three categories of deprivation from most to least deprived, using the 
                                                        
2 A version of this chapter has been published in the Journal of Medical Screening and is available in 
Appendix 1 
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Townsend Index.  The difference in mean coverage between the health authorities in the 
most and least deprived categories was defined and the cervical screening inequity, or 
could be termed as a cervical screening coverage gap.  The study found that the coverage 
gap reduced over the time period of the study, predominantly due to increased coverage 
in the more deprived health authorities.  There was some improvement in the less 
deprived health authorities but the rate of improvement was much slower.  The authors 
suggest that this may be due to the greater capacity for improvement in the more 
deprived areas.  As far as I am aware, there have not been any further studies to ascertain 
if the cervical screening coverage gap has continued to narrow since the late 1990s.   
4.1.2 Cancer Policy in the UK 
As discussed in Chapter 1, cancer policy in the UK has a longstanding commitment to 
reducing health inequalities.  In 2000 the UK government introduced ‘The Cancer Plan: a 
plan for investment, a plan for reform’ (Department of Health, 2000).  Among its aims 
were the reduction of death rates and the promotion of early detection and effective 
screening practice, with a particular emphasis on addressing health inequalities.  In 2007, 
the ‘Cancer Reform Strategy’ further endorsed the government’s commitment to reduce 
inequalities as part of its programme of action to improve cancer outcomes over the 
ensuing five years.  In 2011, the coalition government published ‘Improving Outcomes: a 
strategy for cancer’ outlining its commitment to reducing avoidable cancer deaths and 
reducing cancer inequalities (Dept of Health, 2011).   
4.1.3 Interventions to Increase Cervical Screening Coverage 
A Cochrane database systematic review of randomised control trials of interventions to 
increase coverage of cervical screening published before 2009 was undertaken to assess 
the efficacy of such interventions (Everett et al., 2011).  The types of interventions 
included were reminder interventions (the use of letters, telephone, recommendations, 
prompts and follow-ups to remind women who are overdue for screening); invitation 
interventions (the use of letters, telephone, recommendations, prompts and follow-ups to 
invite a women due for screening); educational interventions to increase knowledge and 
awareness of the cervical screening programme or of cervical cancer; message framing 
interventions; the use of counselling to overcome barriers to screening; risk factor 
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interventions to assess a women’s risk of cervical cancer; procedural interventions (the use 
of different screening tests, length of test); and economic interventions (free screening or 
the use of financial incentives).  Thirty-eight trials met their inclusion criteria.  Invitation 
and education interventions were found to be the most effective means of increasing 
cervical screening coverage overall.  Overall, educational interventions were found to be 
more effective than no education or usual care.  The review was unable to determine if the 
content of any particular intervention was more effective than another.  Invitation letters 
that were endorsed by a general practitioner or health authority were found to be among 
the most effective means of increasing cervical screening attendance, particularly where 
this is supported by an organised administrative system. The use of an endorsed letter 
invitation is encouraging because the NHS Cervical Screening Programme operates such a 
process in its Call and Recall system to invite women for cervical screening (Health and 
Social Care Information Centre, 2014).  These findings have been further supported by a 
more recent systematic review which also found GP endorsed invitation letters and 
telephone reminders to be effective interventions to support cervical screening coverage 
(Camilloni et al., 2013).   
Other strategies to improve screening coverage include interventions that target 
populations with lower screening uptake (Weller and Campbell, 2009).  Over the years, 
research has been undertaken to inform targeted strategies for intervention including 
socially deprived women (Logan and McIlfatrick, 2011; Spadea et al., 2010a), ethnic 
minority women (Lu et al., 2012; Robb et al., 2010) and younger women (Waller et al., 
2011).  Other research has focused on improving coverage by maximising the role of 
general practitioners  (Shroff et al., 1988) or mass media campaigns of real, or fictitious, 
celebrity diagnoses of cervical cancer (Jones et al., 2013; Lancucki et al., 2012). Cancer 
charities such as Cancer Research UK (Cancer Research UK, 2015a) and Jo’s Cervical Cancer 
Trust (Jo’s Cervical Cancer Trust, 2013) also work hard to improve awareness of cervical 
cancer and cervical screening.  This is not intended to be a review of cervical screening 
interventions to improve cervical screening coverage, but to demonstrate that much work 
has been undertaken over the years to improve cervical screening coverage and, 
therefore, it may be reasonable to expect that this may have, over a period of time, led to 
improved coverage and potentially a narrowing of the cervical screening coverage gap. 
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4.1.4 Cervical Screening Coverage 
The national target for cervical screening coverage (within last 5 years) in women aged 25–
64 years is 80%, but this has not been achieved since 2004-05 when it reached 80.3% (see 
Figure 4).   Distinct patterns of screening coverage are evident for the younger and older 
age women invited to screening (Health and Social Care Information Centre, 2012b).  
Cervical screening coverage in younger women (25–49 years, coverage within last 3.5 
years) is noticeably lower than coverage for older women or the full screening programme 
(see Figure 4).  The increased coverage seen around 2008 was attributed to the ‘Jade 
Goody effect’ (Lancucki et al., 2012), but this now appears to be in decline.  In women 
aged 50–-64 years, cervical screening coverage (within last five years) is largely 
comparable to the full screening programme coverage (25–64 years) but has also been in 
gradual decline, falling from 81.0% in 2005 to 77.5% in 2012–13.   
Figure 4. National Cervical Screening in England 2007–2012 
 
Source: Health Care and Information Centre (2013). 
 
Until 31st March 2013, Primary Care Trusts (PCTs) were responsible for cervical screening 
coverage for the population of women who were registered at GPs within their 
boundaries, or if not GP-registered, for women who were residents of the PCT (Health and 
Social Care Information Centre, 2013).   In 2012–13 approximately two-thirds of PCTs 
(102/151) in England did not achieve the 80% national cervical screening coverage target.  
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Figure 5.  London had particularly low PCT coverage: all PCTs with less than 70% coverage 
and 18 of the 27 PCTs with less than 75% coverage are also in London (Health and Social 
Care Information Centre, 2013).  The lower levels of coverage found in London are 
considered to be due to high levels of socioeconomic deprivation, population mobility and 
population diversity (Millett, 2009).  However, as Figure 5 demonstrates, there are other 
areas of low coverage across the country in both urban and rural locations.   
 
Figure 5. PCT-level cervical screening five year coverage (25–64 years) in 2012–13 
 
Source: Graph reproduced from Health and Social Care Information Centre (2013) 
 
4.1.5 Aims of the Study 
The present study used PCT level coverage data from the NHS Cervical Screening 
Programmes (2007–08 to 2012–13) to examine the relationship between cervical 
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screening coverage and deprivation across PCTs in England.  Coverage data are gathered 
as part of the quality assurance process of the NHS Cervical Screening Programme and 
therefore provides an accurate measure of the number of women actually screened across 
the whole country.  Using PCT-level data is a meaningful area-level aggregate because 
PCTs were responsible for cervical screening coverage in their areas at the time the 
coverage figures were accrued.  The study addressed the coverage gap, the difference in 
mean coverage between the least and most deprived PCTs.   This was analysed for each 
year between 2007 and 2002 and the differences in the coverage gap were analysed to 
provide a measure of what changes, if any, occurred over the time period. A reduction in 
the cervical screening coverage gap, may indicate that the longstanding political 
commitment to reduce screening inequalities was having an effect.   
4.2 Methods 
4.2.1 Measures  
This study used cervical coverage data downloaded from the Health & Social Care 
Information Centre (Health and Social Care Information Centre, 2012b) for the years 
commencing 2007–12, where the calendar year of the reported data annually runs from 
1st April through to 31st March.  PCT-level cervical screening coverage data were available 
for all eligible women (25–64 years) using five year coverage figures, younger women (25–
49 years) using three and a half year coverage figures and older women (50–64 years) 
using five year coverage figures.  PCT-level data were grouped to provide a national 
perspective of all PCTs in England (n = 151); and also those excluding London (n = 120); and 
London only (n = 31) because of established differences.   
The income domain score from the Index of Multiple Deprivation (IMD) 2010 was used as 
the measure of deprivation.  The income domain score uses a population-weighted 
average of Lower Super Output Area (LSOA) income deprivation score, which is then 
aggregated to PCT level (NCIN, 2013).  Figure 6 shows the variation in deprivation 
(percentage of households that were income deprived) across all 151 PCTs in England.  The 
percentage of households that were income deprived at PCT level ranged from 6.8% (least 
deprived) to 33.8% (most deprived) with a mean deprivation of 16.2%, SD=5.78.   
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The IMD (2010) was chosen because it is based on data sourced during the time period of 
this study.  The income domain score of the IMD was chosen because, as discussed in 
Chapter 2, the full IMD score contains health domain data that can lead to a mathematical 
duplication of data when associated with other health related data.  However, it is 
acknowledged that limiting the measurement of deprivation to income alone may be 
considered as a weakness of this study.  Therefore, sensitivity analyses using the full Index 
of Multiple Deprivation score was conducted and is reported in Appendix 1.  
Figure 6. PCT level income deprivation  
 
4.2.2 Statistical analysis 
Data were analysed using SPSS statistical software, version 18.0 (PASW Statistics for 
Windows, 2009).  Descriptive statistics were generated for PCT level cervical screening 
coverage for three age groups: 25–64 years (all eligible women); 25–49 years (younger 
women) and 50–64 years (older women).  Analysis of the data for all eligible women was 
necessary to describe the results for the full cervical screening programme.  Coverage data 
for the younger and older groups was useful to discern any age-specific effects.  Data were 
then further grouped by geographical area: all PCTs in England (n = 151); PCTs in England 
excluding London (n = 120); and London PCTs only (n = 31).   
To describe the relationship between cervical screening coverage and deprivation the 
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1) A linear regression model was used to calculate what is termed as the ‘coverage gap’, 
deprivation was divided into quintiles of IMD score for each year.  The ‘coverage gap’ 
is the absolute difference in mean coverage between the least and most deprived 
quintiles. 
2) A mixed ANOVA was used to estimate if socioeconomic inequalities in cervical 
screening changed over time.  This analysis was stratified by region (London versus the 
Rest of England) and age (younger versus older women).  The analysis was then 
descriptively compared across the strata. 
4.3 Results 
Table 1 provides cervical screening coverage at PCT-level (Min, Max, Mean and SD) for all 
eligible women, younger (25–49 years) and older (50–64 years).  This information is also 
grouped by PCT: all English PCTs (n = 151); PCTs excluding London (n = 120); and London 
only (n = 31).  A visual representation of mean coverage for these groups is also presented 
in Figure 7.  Across all age groups the results for all English PCTs and PCTs excluding 
London are broadly comparable, whereas they are visually lower for London PCTs.  
4.3.1 Descriptive Statistics for PCT-Level Cervical Screening Coverage 
All Eligible Women 
Over the time period, mean cervical screening coverage across England for all eligible 
women was around 78%, just below the 80% programme target see Table 1.  Mean 
coverage was slightly higher (79%) when London PCTs were excluded.  Mean coverage was 
lower, at around 74% for London PCTs only, indicating a coverage deficit of around 5.4% 
when compared with PCTs excluding London over the time period.    
Younger and Older Women 
As expected, coverage was lower for younger women than older women (see Figure 7).  In 
2007–08, coverage was notably lower for the younger age group in all PCTs.  A transient 
upward trend in cervical screening coverage for younger women peaked in 2009–10.  
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While mean coverage was higher for older women there has been a gradual decline over 
the time period.   
Across the time period, mean coverage for both age groups was lower in London PCTs, but 
this was more pronounced for younger than older women.  For younger women the 
coverage deficit between London only PCTs was around 7.1% when compared with PCTs 
excluding London.  For older women, the coverage deficit was around 2.3%.  
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Table 1. Descriptive statistics for PCT Level cervical screening coverage (Year Commencing 2007–12) 
 All eligible women 
(25–64 years) 
Younger women 
(25–49 years) 
Older women 
(50–64 years) 
Year  Min–Max Mean SD Min–Max Mean SD Min–Max Mean SD 
All England PCTs (n = 151) 
2007 66.7–85.7 78.1 3.7 57.7–80.1 69.1 5.0 68.6–85.6 79.6 2.8 
2008 65.8–85.8 78.5 3.8 57.9–81.2 72.2 4.7 67.8-85.0 79.3 3.1 
2009 66.4–85.4 78.5 3.6 58.8–81.6 73.7 4.7 68.5–84.4 78.3 2.8 
2010 67.2–84.3 78.3 3.4 60.1–80.5 73.5 4.4 70.0–82.4 77.3 2.6 
2011 65.9–83.8 78.3 3.4 58.7–80.4 73.4 4.4 69.1–82.0 77.2 2.5 
2012 65.5–83.5 78.0 3.4 56.5–78.5 71.4 4.4 69.1–82.0 77.0 2.4 
Excluding London PCTs (n = 120) 
2007 71.6–85.7 79.3 2.7 60.6–80.1 70.4 4.4 73.4–85.6 80.2 2.4 
2008 71.9–85.8 79.7 2.7 64.9–81.2 73.7 3.3 69.7–85.2 79.9 2.7 
2009 72.8–85.4 79.6 2.5 67.0–81.6 75.3 3.1 72.1–84.4 78.7 2.4 
2010 72.9–84.3 79.2 2.4 67.7–80.5 74.9 3.0 70.3–82.4 77.7 2.4 
2011 73.4–83.8 79.3 2.3 67.4–80.4 74.8 3.0 70.1–82.0 77.6 2.3 
2012 72.7–83.5 79.0 2.4 63.7–78.5 72.7 3.0 70.6–82.0 77.4 2.1 
London PCTs (n = 31) 
2007 66.7–81.6 73.6 3.5 57.7–75.4 64.0 4.1 68.6–82.0 77.1 3.2 
2008 65.8–82.1 74.0 4.0 57.9–76.7 66.3 4.5 67.8–83.1 77.2 3.6 
2009 66.4–81.9 74.1 4.0 58.8–77.8 67.7 4.9 68.5–82.6 76.5 3.3 
2010 67.2–81.2 74.1 3.6 60.1–77.6 68.0 4.5 70.0–81.3 75.7 2.6 
2011 65.9–81.2 74.2 3.7 58.7–77.7 67.8 4.6 69.1–80.9 75.7 2.8 
2012 65.5–81.5 74.1 3.9 56.5–77.3 66.2 4.8 69.1–80.4 75.6 2.7 
 
 
Figure 7. PCT-level cervical screening coverage in England (year commencing 2007–12) 
 
Prior to applying further statistical tests the data were tested for assumptions of 
normality.  There were no outliers in the data, however, the data were negatively skewed.  
Figures and visual illustrations refer to the cervical screening coverage for all women in 
2007.  This pattern was consistent across coverage by year (2007 – 2012) and age (all 
women, younger women and older women).  In 2007, for cervical screening coverage for 
all women kurtosis was 0.095 (standard error = 0.392). However, the data were negatively 
skewed with a skewness of -0.724 (standard error = 0.197).  This is visually illustrated in 
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the histograms and Q-Q Plot in Figures 8 and 9.  The data were transformed using the 
Square Root function (SQRT) in SPSS as follows: SQRT((Max Screening coverage + 1) – 
ScreeningCoverage)).  A sensitivity analysis was then conducted by comparing the results 
of the linear regression and mixed ANOVA analyses using the original screening data and 
the transformed screening data.  There were no significant differences in the results (not 
shown) therefore the analysis was conducted using the original (untransformed) coverage 
data.   
Figure 8. Cervical Screening Coverage in 2007 - England (all women) 
 
 
 
Figure 9. Q-Q Plot of Cervical Screening Coverage in 2007 - England (all women) 
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4.3.2 Deprivation Quintiles and Screening Coverage 
Linear regression analysis using IMD quintiles of deprivation were used to ascertain the 
size of the cervical screening ‘coverage gap’, that is, the absolute difference in the mean 
coverage between the least and most deprived quintiles.  The results for all English PCTs (n 
= 151) and those excluding London (n = 120) were broadly comparable.  The results for all 
PCTs in England will be reported in Appendix 1 and this chapter will show the absolute 
difference in mean coverage by deprivation quintile for English PCTs excluding London and 
London PCTs in Tables 5, 6 and 7.  The F-statistic and p-value for the linear regression 
model for each year are presented in the text, where applicable.    
All Eligible Women 
For PCTs in England excluding London, cervical screening coverage was lower in more 
deprived quintiles for all eligible women (see Table 2).  The coverage gap was 4.3% (F (4, 
119) = 12.956, p < 0.001) in 2007 and 4.7% (F (4, 119) = 21.555, p < 0.001) in 2012.  
For London PCTs, the trend for lower cervical screening coverage in more deprived 
quintiles persisted but it was rarely statistically significant, see Table 2.  In 2007, the 
cervical screening coverage gap was 3.6% (F (4, 26) = 3.002, p=0.037), and in 2012 the 
coverage gap was 2.0% (F (4, 26) = 2.528, p=0.065).   
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Table 2. England (excluding London) and London PCTs: Cervical screening coverage – all 
eligible women by deprivation quintile (Q1 – Low, Q5 – High) 
Yr 
Dep.  
Qs 
 
All eligible women 
England (excluding London) 
All eligible women 
London 
B 
95% CIs 
SE p B 
95% CIs 
SE p 
Lower Upper Lower Upper 
07 Q1 80.66 79.82 81.51 0.43  76.59 72.02 81.17 2.23  
Q2 -0.02 -1.25 1.21 0.62 -0.01 0.67 -0.75 6.08 2.63 0.803 
Q3 -1.50 -2.73 -0.27 0.62 -0.23* -3.98 -9.27 1.30 2.57 0.134 
Q4 -1.76 -3.01 -0.50 0.64 -0.26* -4.84 -10.03 0.35 2.52 0.066 
Q5 -4.29 -5.62 -2.96 0.67 -0.59** -3.64 -8.62 1.34 2.42 0.145 
08 Q1 81.23 80.42 82.03 0.41  76.89 71.52 82.26 2.61  
Q2 -0.24 -1.41 0.93 0.59 -0.04 0.76 -5.59 7.12 3.09 0.807 
Q3 -1.70 -2.87 -0.53 0.59 -0.26* -4.22 -10.42 1.98 3.02 0.173 
Q4 -1.97 -3.17 -0.77 0.60 -0.29* -4.75 -10.84 1.34 2.96 0.121 
Q5 -4.74 -6.01 -3.48 0.64 -0.66** -3.21 -9.05 2.63 2.84 0.268 
09 Q1 81.18 80.47 81.90 0.36  77.21 71.67 82.75 2.70  
Q2 -0.32 -1.37 0.73 0.53 -0.05 0.24 -6.31 6.80 3.19 0.940 
Q3 -1.78 -2.83 -0.73 0.53 -0.29* -4.33 -10.73 2.07 3.11 0.176 
Q4 -2.06 -3.13 -0.99 0.54 -0.33** -4.97 -11.25 1.32 3.06 0.116 
Q5 -4.75 -5.88 -3.62 0.57 -0.70** -3.44 -9.46 2.59 2.93 0.252 
10 Q1 80.93 80.27 81.60 0.33  77.41 73.01 81.82 2.14  
Q2 -0.54 -1.51 0.42 0.49 -0.09 0.59 -4.63 5.80 2.54 0.819 
Q3 -1.75 -2.71 -0.78 0.49 -0.30** -4.02 -9.11 1.06 2.47 0.116 
Q4 -2.23 -3.21 -1.24 0.50 -0.37** -5.76 -10.75 -0.77 2.43 0.025 
Q5 -4.98 -6.02 -3.93 0.53 -0.76** -3.68 -8.47 1.11 2.33 0.126 
11 Q1 80.90 80.25 81.55 0.33  77.44 72.70 82.19 2.31  
Q2 -0.55 -1.49 0.39 0.48 -0.10 0.24 -5.38 5.85 2.73 0.932 
Q3 -1.54 -2.48 -0.60 0.48 -0.27* -4.05 -9.52 1.43 2.67 0.141 
Q4 -2.05 -3.01 -1.08 0.49 -0.35** -6.06 -11.44 -0.68 2.62 0.029* 
Q5 -4.80 -5.82 -3.78 0.51 -0.76** -3.21 -8.37 1.95 2.51 0.212 
12 Q1 80.47 79.79 81.15 0.34  76.51 71.35 81.68 2.51  
Q2 -0.53 -1.52 0.46 0.50 -0.09 1.02 -5.10 7.13 2.98 0.735 
Q3 -1.31 -2.29 -0.32 0.50 -0.23* -4.05 -10.02 1.92 2.90 0.175 
Q4 -1.81 -2.82 -0.80 0.51 -0.30* -4.79 -10.65 1.07 2.85 0.105 
Q5 -4.69 -5.76 -3.63 0.54 -0.73** -2.02 -7.64 3.60 2.73 0.467 
* p < 0.01, ** p < 0.001 
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Younger and Older Women 
For PCTs in England excluding London, a statistically significant cervical screening coverage 
gap was found for all age groups, but was stronger for younger women (see Table 3).  The 
cervical coverage gap in younger women was 4.2% (F (4, 119) = 5.084, p=0.001) in 2007 
and 5.9% (F (4, 119) = 19.490, p < 0.001 in 2012).  For older women, the screening 
coverage gap remained at around 4.1% for the duration of the study period.   
For London PCTs (see Table 4), the cervical screening coverage gap was still evident but 
was no longer statistically significant, with the exception of younger women in 2007.  In 
younger women, the coverage gap was 5.8% (F (4,26)=3.478, p=0.021) in 2007 and 2.5% (F 
(4,26)=3.14, p=0.031) in 2012.  The coverage gap was notably weaker in older women. For 
older women, the cervical screening coverage gap was 2.8% (F (4,26)=0.683, p=0.610) in 
2007 and 0.03% (F (4,26)=0.687, p=0.607) in 2012.  
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Table 3. England excluding London: cervical screening coverage in younger and older women 
Yr 
Dep 
Qs 
 
Cervical screening (25–49 years) Cervical screening (50–64 years) 
B 
95% CIs 
SE P B 
95% CIs 
SE P 
Lower Upper Lower Upper 
07 Q1 71.46 69.92 73.01 0.78  81.83 81.10 82.55 0.37  
Q2 1.08 -1.17 3.32 1.13 0.10 -0.58 -1.64 0.48 0.54 -0.10 
Q3 -1.21 -3.45 1.03 1.13 -0.11 -2.26 -3.32 -1.20 0.54 -0.39** 
Q4 -1.76 -4.06 0.53 1.16 -0.16 -1.86 -3.32 -1.20 0.54 -0.31* 
Q5 -4.20 -6.62 -1.11 1.22 -0.35* -4.05 -5.19 -2.90 0.58 -0.63** 
08 Q1 75.74 74.78 76.70 0.48  81.77 80.93 82.61 0.43  
Q2 -0.09 -1.49 1.31 0.71 -0.01 -0.99 -2.22 0.23 0.62 -0.15 
Q3 -2.11 -3.50 -0.71 0.72 -0.26* -2.33 -3.56 -1.10 0.62 -0.35** 
Q4 -3.05 -4.48 -1.62 0.72 -0.37** -2.25 -3.50 -0.99 0.63 -0.33* 
Q5 -5.92 -7.42 -4.41 0.76 -0.66** -4.82 -6.15 -3.49 0.67 -0.65** 
09 Q1 77.17 76.30 78.05 0.44  80.43 79.67 81.19 0.38  
Q2 -0.32 -1.59 0.95 0.64 -0.04 -0.94 -2.05 0.16 0.56 -0.16 
Q3 -1.79 -3.06 -0.52 0.54 -0.24* -2.25 -3.35 -1.14 0.56 -0.38** 
Q4 -2.59 -3.90 -1.29 0.66 -0.33** -2.01 -3.14 -0.88 0.57 0.33* 
Q5 -6.04 -7.42 -4.67 0.69 -0.72** -4.26 -5.45 -3.06 0.60 -0.64** 
10 Q1 76.93 76.11 77.76 0.42  79.56 78.83 80.30 0.37  
Q2 -0.60 -1.80 0.61 0.61 -0.08 -1.13 -2.20 -0.05 0.54 -0.19* 
Q3 -1.82 -3.02 -0.61 0.61 -0.25* -2.24 -3.32 -1.17 0.54 -0.38** 
Q4 -2.67 -3.90 -1.44 0.62 -0.35** -2.29 -3.38 -1.19 0.55 -0.38** 
Q5 -6.23 -7.52 -4.93 0.66 -0.76** -4.45 -5.60 -3.29 0.58 -0.68** 
11 Q1 76.49 75.64 77.35 0.43  79.34 78.65 80.04 0.35  
Q2 -0.53 -1.78 0.71 0.63 -0.07 -1.09 -2.11 -0.07 0.51 -0.19* 
Q3 -1.22 -2.47 0.02 0.63 -0.17 -2.08 -3.10 -1.06 0.51 -0.37** 
Q4 -2.24 -3.51 -0.97 0.64 -0.30* -2.04 -3.08 -0.99 0.52 -0.35** 
Q5 -5.76 -7.10 -4.42 0.68 -0.72** -4.25 -5.35 -3.15 0.56 -0.68** 
12 Q1 74.45 73.55 75.36 0.46  78.98 78.34 79.62 0.32  
Q2 -0.60 -1.92 0.71 0.66 -0.08 -0.97 -1.90 -0.04 0.47 -0.19* 
Q3 -1.11 -1.92 0.71 0.66 -0.15 -1.91 -2.85 -0.98 0.47 -0.37** 
Q4 -2.18 -3.52 -0.84 0.68 -0.28* -1.70 -2.66 -0.75 0.48 -0.48* 
Q5 -5.86 -7.28 -4.44 0.72 -0.70** -4.11 -5.12 -3.10 0.51 -0.71** 
* p < 0.01, ** p < 0.001 
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Table 4. London only: Deprivation (quintiles) and cervical screening coverage in younger and 
older women 
Year 
Dep. 
Quintiles 
Q1 Least  
Q5 Most 
Cervical screening (25–49 years) Cervical screening (50–64 years) 
B 
95% CIs 
SE P B 
95% CIs 
SE P 
Lower Upper Lower Upper 
07 Q1 68.81 63.65 73.97 2.51  79.58 74.80 84.35 2.32  
Q2 -0.58 -6.68 5.52 2.97 0.846 -1.05 -6.70 4.60 2.75 0.705 
Q3 -6.16 -12.11 -0.21 2.90 0.043* -2.87 -8.38 2.65 2.68 0.295 
Q4 -6.41 -12.25 -0.56 2.84 0.033* -3.35 -8.76 2.07 2.63 0.215 
Q5 -5.80 -11.40 -0.19 2.73 0.043* -2.76 -7.95 2.43 2.53 0.284 
08 Q1 70.38 64.43 76.33 2.90  79.16 73.79 84.52 2.61  
Q2 0.15 -6.89 7.19 3.43 0.965 -0.61 -6.95 5.74 3.09 0.846 
Q3 -5.77 -12.65 1.10 3.34 0.096 -2.94 -9.13 3.25 3.01 0.338 
Q4 -6.30 -13.05 0.45 3.28 0.066 -2.84 -8.92 3.25 2.96 0.347 
Q5 -4.45 -10.93 2.02 3.15 0.169 -1.84 -7.68 3.99 2.84 0.521 
09 Q1 71.90 65.30 78.50 3.21  78.37 73.36 83.37 2.44  
Q2 0.29 -7.52 8.11 3.80 0.939 -1.25 -7.18 4.67 2.88 0.667 
Q3 -5.65 -13.28 1.97 3.71 0.140 -2.77 -8.55 3.01 2.81 0.333 
Q4 -6.64 -14.13 0.85 3.64 0.080 -2.32 -7.99 3.36 2.76 0.409 
Q5 -4.50 -11.68 2.68 3.49 0.209 -1.71 -7.15 3.73 2.65 0.523 
10 Q1 72.58 67.20 77.96 2.62  77.03 73.11 80.96 1.91  
Q2 0.55 -5.82 6.92 3.10 0.860 -0.34 -4.98 4.31 2.26 0.883 
Q3 -5.64 -11.85 0.58 3.02 0.074 -1.86 -6.39 2.67 2.21 0.407 
Q4 -7.90 -14.00 -1.80 3.97 0.013* -1.87 -6.32 2.58 2.17 0.395 
Q5 -5.13 -10.98 0.73 2.85 0.083 -1.27 -5.53 3.00 2.08 0.548 
11 Q1 72.04 66.46 77.62 2.72  77.11 72.96 81.25 2.02  
Q2 0.57 -6.03 7.18 3.21 0.859 -0.91 -5.81 3.99 2.38 0.705 
Q3 -5.45 -11.90 0.99 3.14 0.094 -2.27 -7.05 2.51 2.33 0.338 
Q4 -7.58 -13.90 -1.25 3.08 0.021* -2.34 -7.04 2.35 2.28 0.314 
Q5 -4.30 -10.37 1.77 2.95 0.157 -0.90 -5.4 3.60 2.19 0.685 
12 Q1 69.21 63.10 75.31 2.97  76.30 72.25 80.35 1.97  
Q2 1.62 -5.61 8.851 3.52 0.648 0.06 -4.73 4.85 2.33 0.980 
Q3 -5.39 -12.44 1.66 3.43 0.128 -2.03 -6.71 2.65 2.28 0.380 
Q4 -5.93 -12.86 1.00 3.37 0.090 -1.23 -5.82 3.37 2.24 0.588 
Q5 -2.49 -9.13 4.15 3.23 0.448 -0.03 -4.43 4.37 2.14 0.989 
* p < 0.01  
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4.3.3 Socioeconomic Inequalities in Screening Coverage over Time 
Comparison of Cervical Screening Coverage in Rest of England and London 
Rest of England 
A mixed ANOVA was conducted to determine whether there were statistically significant 
differences in cervical screening coverage from 2007 to 2012 and to test if there was an 
interaction between deprivation and time on cervical screening coverage in women aged 
25-64 years. The assumption of sphericity was violated, as assessed by Mauchley’s test of 
sphericity, χ2 (14) = 629.17, p < 0.001, therefore a Greenhouse-Geisser correction was 
applied.  
The main effect of deprivation showed there was a statistically significant difference in 
cervical screening coverage between deprivation quintiles F (4, 115) = 21.54, p < 0.001, 
partial η2 = 0.428. Cervical screening coverage in the most deprived quintile (Q5) was 
notably lower than cervical screening coverage the other quintiles, as illustrated in Figure 
10.   
The main effect of time showed a statistically significant difference in cervical screening 
coverage across the years, F (1.49, 259.21) = 17.204, p < 0.001, η2 = 0.130.  This is likely to 
be due to the increase in coverage in 2008, notable in all quintiles with the exception of 
the least deprived (Q5), and then subsequent fall in coverage in 2010.   
However, there was no significant interaction between deprivation and time on cervical 
screening coverage for all women aged 25-64 years, F (1.77, 259.21) = 1.066, p = 0.385, 
partial η2 = 0.036.   
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Figure 10. Cervical Screening Coverage by Deprivation Quintile - Rest of England 
 
 
London 
A mixed ANOVA was conducted to determine whether there were statistically significant 
differences in cervical screening coverage from 2007 to 2012 and to test if there was an 
interaction between deprivation and time on cervical screening coverage. The assumption 
of sphericity was violated, as assessed by Mauchley’s test of sphericity, χ2 (14) = 84.85, p < 
0.001, therefore a Greenhouse-Geisser correction was applied.  
The main effect of deprivation showed there was a statistically significant difference in 
cervical screening coverage between deprivation quintiles F (4, 26) = 2.93, p = 0.040, 
partial η2 = 0.311. Cervical screening coverage was notable lower in the more deprived 
quintiles (Q3-Q5), as illustrated in Figure 11.  Interestingly, the mean cervical screening 
coverage in the most deprived quintile (Q5) was higher than the mean cervical coverage 
for Q3 and Q4.   
The main effect of time showed there was no statistically significant difference in cervical 
screening coverage across the years, F (2.06, 53.61) = 0.789, p = 0.463, η2 = 0.029.   
There was no significant interaction between deprivation and time on cervical screening 
coverage for all women aged 25-64 years, F (8.25, 53.61) = 0.645, p = 0.741, partial η2 = 
0.090.   
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Figure 11. Cervical Screening Coverage by Deprivation Quintile - London 
 
 
Comparison of Cervical Screening Coverage in Rest of England and London 
There was significant variation in cervical screening coverage across quintiles of 
deprivation in PCTs in England (excluding London) and in London itself, but there was no 
interaction between deprivation and time on cervical screening coverage over the period.  
However, there were differences in the patterns of cervical screening coverage over the 
period in the two areas.  PCTs in England (excluding London) displayed a similar peak in 
screening coverage around 2008 and 2009, and then coverage fell into steady decline.  
This is similar to the ‘Jade Goody effect’.  However, in London there appeared to be 
different trends in coverage across the quintiles (see Figure 11) and no sign of a ‘Jade 
Goody effect’.  
 
The results for all England are reported in Appendix 3.  
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Comparison of Cervical Screening Coverage in Younger and Older Women 
Younger Women 
The analyses were repeated for younger and older women. The assumption of sphericity 
was violated, as assessed by Mauchley’s test of sphericity, χ2 (14) = 853.91, p < 0.001, 
therefore a Greenhouse-Geisser correction was applied.  
The main effect of deprivation showed there was a statistically significant difference in 
cervical screening coverage between deprivation quintiles F (4, 146) = 16.31, p < 0.001, 
partial η2 = 0.309. Cervical screening coverage in the most deprived quintile (Q5) was 
visibly lower than other quintiles, particularly the least deprived quintiles (Q1 and Q2), as 
illustrated in Figure 12. 
The main effect of time showed a statistically significant difference in cervical screening 
coverage across the years, F (1.51, 220.82) = 190.46, p < 0.001, η2 = 0.566.  There was a 
distinct peak in cervical screening coverage in 2009 and 2010, followed by a distinct fall in 
coverage particularly in 2012.    
There was no significant interaction between deprivation and time on cervical screening 
coverage for all women aged 25-49 years, F (6.05, 220.82) = 1.126, p = 0.348, partial η2 = 
0.030.     
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Figure 12. Cervical Screening Coverage by Deprivation Quintile - Younger Women 
 
 
Older Women 
As in previous analyses, the assumption of sphericity was violated, as assessed by 
Mauchley’s test of sphericity, χ2 (14) = 407.13, p < 0.001, therefore a Greenhouse-Geisser 
correction was applied.  
The main effect of deprivation showed there was a statistically significant difference in 
cervical screening coverage between deprivation quintiles F (4, 146) = 13.85, p < 0.001, 
partial η2 = 0.275. Figure 13 illustrates that while the pattern of screening coverage is 
similar across all quintiles over the period, there are distinct differences in the levels of 
coverage between quintiles.   
The main effect of time showed a statistically significant difference in cervical screening 
coverage across the years, F (2.68, 543.73) = 255.09, p < 0.001, η2 = 0.636.  Figure 13 
reveals a relatively similar reduction in cervical screening coverage over the period across 
all quintiles.   
There was no significant interaction between deprivation and time on cervical screening 
coverage for all women aged 50-64 years, F (10.74, 543.73) = 1.432, p = 0.158, partial η2 = 
0.038.   
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Figure 13. Cervical Screening Coverage by Deprivation Quintile - Older Women 
 
 
 
Comparison of Cervical Screening Coverage in Younger and Older Women 
There were significant differences in screening coverage across quintiles of deprivation in 
both younger and older women but there was no interaction between deprivation and 
time on cervical screening coverage over the period.  However, the patterns of association 
between deprivation and coverage were markedly different.  For younger women, cervical 
screening coverage showed evidence of the ‘Jade Goody effect’ with a peak in coverage in 
2009, followed by a steady decline.  For older women, cervical screening coverage has 
been in steady decline over the period.    
4.4 Discussion 
PCT-level income deprivation was found to be negatively associated with cervical 
screening coverage: all eligible women (25–64 years), younger women (25–49 years) and 
older women (50–64 years).  However, different patterns and strength of association were 
evident in younger women in PCTs in England (excluding London) and London only PCTs.  
London only PCTs were also found to have different patterns and strength of association 
between deprivation and cervical screening coverage regardless of the age group of 
analysis (all eligible women, younger and older women).   
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The association between deprivation and cervical screening coverage was consistent 
across PCTs in England excluding London and in London only (and in England as a whole).  
There were significant changes to cervical screening coverage over the time period in 
England (excluding London) in a pattern that followed the ‘Jade Goody’ effect (Lancucki et 
al., 2012).  Unfortunately, the significant increase in cervical screening coverage in 2008 
and 2009 was followed by a subsequent downturn in cervical screening, such that there 
was no significant difference in cervical screening coverage at the end of the period when 
compared with coverage at the beginning of the period.  Similar patterns were found 
across all quintiles of deprivation, consistent with the finding that there was no interaction 
between deprivation and time.   
The association between cervical screening coverage and PCT-level income deprivation 
was different in London PCTs, where it was generally weaker and non-significant, 
regardless of age group under investigation. Overall, London PCTs appeared to be immune 
to the ‘Jade Goody effect’ with no significant changes in cervical screening coverage found 
at any point over the time period.  Like PCTs in the rest of England, there were significant 
and consistent differences in screening coverage by quintiles of deprivation over the time 
period. However, the pattern of association between coverage and deprivation was quite 
different.  In the rest of England the most deprived quintile of deprivation was shown to 
have visibly lower coverage than all other quintiles, while in London, quintiles 3, 4 and 5 
were notably lower than the higher quintiles (Q1 and Q2).   It may be that an area-level 
measure of deprivation is rendered insensitive in London because the affluent and the 
non-affluent often live close together.  For example, affordable housing in new build 
homes and wealthy people buying council flats from tenants.   
The cervical screening coverage gap was wider for younger women than older woman.  In 
younger women it widened over the study period in PCTs in England (excluding London) 
whereas the coverage gap narrowed slightly in these areas for older women.  The 
association between cervical screening coverage and deprivation was stronger in younger 
women than older women and displayed different patterns of association.  In younger 
women, cervical screening coverage peaked around 2009-10 across all quintiles. While 
coverage was significantly higher in 2012-13 than at the start of the period (2007-08) the 
coverage gap between the least and most deprived had widened.   For older women, there 
Chapter 4: Socioeconomic Inequalities in Cervical Screening Coverage (Study 1) 
 
 
- 103 - 
 
was a significant reduction in cervical screening coverage over the period in a pattern that 
is mirrored across quintiles of deprivation with no discernible difference in the cervical 
coverage gap.  The pattern of change observed in younger women in this study was similar 
to that described as the ‘Jade Goody effect’ (Lancucki et al., 2012).  Younger women and 
those from more deprived areas are considered to have been more influenced to attend 
cervical screening by the Jade Goody story and this may explain the different pattern of 
association between screening coverage and deprivation in younger versus older women 
(Marlow et al., 2012).  These results support previous evidence discussed in Chapter 2 of 
the negative association between cervical screening coverage and income deprivation at 
area level (Baker and Middleton, 2003; Bang et al., 2012; O’Neill et al., 2009).  They also 
add to these findings by indicating that, for young women at least, the trend in the cervical 
screening coverage gap is widening and that this should be highlighted as a cause for 
concern.   
Government policy to reduce inequalities in cancer outcomes was in place throughout this 
period: The Cancer Plan from 2000 to 2011 (Department of Health, 2000) and since 2011 
Improving Outcomes: Saving Lives (Dept of Health, 2011).   However, the results in this 
study indicate that there has been no substantive change in the association between 
cervical screening coverage and deprivation from 2007 to 2012. However, the trend for 
the cervical screening coverage gap for younger women is widening albeit, not as yet to a 
statistically significant extent.  Younger women, as has been shown earlier in this chapter, 
also have the lowest rates of coverage in the cervical screening programme. For London 
PCTs, there is a weaker association between cervical screening coverage and deprivation. 
London PCTs also have the lowest mean cervical screening coverage when compared with 
other areas, and this mean coverage is lowest of all for younger women living in London 
PCTs.   
4.4.1 Strengths and Limitations 
This study used area-level measures of socioeconomic status and this inherently limits the 
representation of individual-level SES.  This may have been particularly problematic with 
respect to London PCTs, where heterogeneity in income may be evident within very small 
geographic areas.  However, the income domain measure of PCT-level deprivation is 
aggregated from Lower Super Output Areas (LSOAs) and these may afford a better 
Chapter 4: Socioeconomic Inequalities in Cervical Screening Coverage (Study 1) 
 
 
- 104 - 
 
representation of individual-level deprivation in other parts of the country.  The income 
domain of the IMD was chosen as the measure of deprivation, rather than the full IMD 
score that encompasses all seven domains of the IMD.  It is acknowledged that the use of 
the income domain only is a weakness of the study as this fails to capture the other 
complex dimensions of socioeconomic deprivation.  However, income is considered to be 
a central component to any consideration of deprivation because it is a key indicator of 
material deprivation (Noble et al., 2006). This is further explained in the words of Peter 
Townsend as follows: 
“while people experiencing some forms of deprivation may not all have low 
income, people experiencing multiple or single but very severe forms of 
deprivation are in almost every instance likely to have very little income and 
little or no other resources” (Townsend, 1987, p. 131) 
As mentioned in Chapter 2, the inclusion of the health domain in the full IMD as a 
predictor of a health related outcome may be considered as a mathematical coupling of 
health related data (Adams and White, 2006) and the use of the income domain may offer 
policymakers a more direct measure upon which to focus policy change.   That being said, 
sensitivity analyses using the full IMD were conducted to assess for potential differences 
when multiple domains of deprivation are considered.  The results were similar to those 
using the income domain of IMD only and are reported in Appendix 2. 
The use of area-level cervical screening coverage may also be a limitation because it 
cannot represent individual-level attendance.  However, since these data are gathered 
through the quality assurance processes of the NHS Cervical Screening Programme they do 
represent an accurate measure of coverage across the country, albeit clustered into areas.  
Other methods of gathering individual level cervical screening attendance such as 
population-based surveys, have lower response rates, rely upon self-reported attendance, 
which may be subject to recall bias and may not provide insight into the geographical 
variation in cervical screening coverage.   
This study has estimated the relationship between income deprivation and cervical 
screening coverage using a linear regression coefficient model.  In that respect, the 
obtained coefficient values represent the absolute difference in screening coverage by 
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deprivation group.  The screening coverage gap has been calculated as the actual 
percentage difference in screening coverage in women living in the least and most 
deprived areas. Quintiles of the income domain were used in the study of socioeconomic 
variation in cervical screening coverage to specifically ascertain the aforementioned 
‘coverage gap’.  This was inspired by, and hoped to have some synergy with, other studies 
that calculated a ‘deprivation gap’ in cervical cancer (Rachet et al., 2010; Shack, Jordan, 
Thomson, Mak, & Moller, 2008).  Quintiles of deprivation (using individual domains of the 
IMD or the full IMD) are common in cancer screening literature, including socioeconomic 
variation in cervical screening (Sutton & Rutherford, 2005) and colorectal cancer screening 
(von Wagner et al., 2011). 
This study focused on the simple association between cervical screening coverage and 
income deprivation and as such was unable to determine whether factors specific to the 
cervical screening programme may be hampering progress in reducing cervical screening 
inequalities.  Further investigation of some of these factors was undertaken in Study 3.  
This study’s strengths were that it is the first study in many years to address the cervical 
screening coverage gap over a period of time.  This has provided insight into the potential 
trends for socioeconomic inequalities in cervical screening coverage and indicates that 
further action needs to be taken to address this issue. 
4.5 Conclusion 
Socioeconomic inequalities in cervical screening coverage remain evident in the NHS 
Cervical Screening Programme in England, and show no signs of improvement.  
Longstanding availability of this screening programme and ongoing government 
commitment to improve cancer screening coverage in lower SES groups does not appear 
to have had any effect on inequalities in cervical screening coverage regardless of age or 
location.   
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Chapter 5: Socioeconomic Inequalities in Breast Screening Coverage 
(Study 2)3 
5.1 Introduction 
The preceding chapter provided evidence of the continued association between PCT-level 
socioeconomic deprivation and cervical screening coverage at PCT level in England.  There 
was a significant increase in cervical screening coverage for younger women and a 
significant decrease in older women.  However, there was no significant reduction in the 
association between cervical screening coverage and income deprivation for the cervical 
screening programme overall. The coverage gap did not narrow in any geographical area, 
or for younger or older women.  The study was limited in its ability to infer if the continued 
inequalities in cervical screening coverage may be attributable to characteristics of the 
screening programme itself.  One way of examining which factors may affect the 
association between screening coverage and deprivation at PCT level is to contrast these 
results with a similar study of breast screening coverage.   
The NHS Breast Screening Programme (NHSBSP) has a number of similarities that make it a 
useful comparative screening programme.  It was set up in the UK at the same time as the 
NHS Cervical Screening Programme which has enabled them to become culturally 
normative to a comparable extent.  Women aged 47–73 years (recently extended from 
50–70 years) are eligible for breast screening; an age-group that is broadly comparable 
with women eligible for 5-yearly cervical screening (50-64 years).  A comparison of the 
association between deprivation and coverage in the NHSCSP and the NHSBSP has the 
potential to determine if programme characteristics may be associated with ongoing 
cervical screening coverage inequalities. This rationale is based upon the premise that if 
there is an association between screening coverage and PCT-level income deprivation and 
it is different across screening programmes, then we may be able to infer that this is due 
to the different characteristics of the respective screening programme.  Following on from 
there, we may also infer that if the association between coverage and socioeconomic 
                                                        
3 A version of this chapter has been published in the Journal of Medical Screening and is available in 
Appendix 1 
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deprivation is similar across screening programmes, then this may be due to an association 
with area- or population-level characteristics.   
Similar to cervical screening, breast screening coverage is lower in general practices 
serving more deprived populations (Bang et al., 2012; O’Neill et al., 2009) and in women 
living in areas with higher levels of socioeconomic deprivation (Maheswaran et al., 2006).  
Individual level markers of socioeconomic status, such as car- and home-ownership, 
owner-occupied households and households with cars are significantly more likely to 
attend breast screening (Moser et al., 2009).   
There are, however, some differences in the way in which the breast and screening 
programmes are organised.  Women are routinely invited to breast cancer screening 
according to the general practice where they are registered and could be first invited to 
screening any time within three years of turning 50.  Unlike cervical screening, breast 
cancer screening takes place in a breast screening unit located in a hospital clinic or mobile 
unit.  Therefore, women do not attend their GP for breast screening.  An invitation to 
breast screening will specify a date, time and location for the women to attend breast 
screening.  Unlike cervical screening, this avoids placing the onus on the woman to 
schedule her own screening appointment.  Albeit that a pre-defined breast screening 
appointment may not be suitable for a women and therefore does place some onus on her 
to reschedule to a more convenient time, or failing that, risk missed appointments.   
The similarities across cervical and breast screening programmes make a comparison 
across programmes a useful means of exploring potential divergences in the association 
between coverage and income deprivation.  The present study therefore examined 
associations between area-level deprivation and breast and cervical screening coverage in 
England from 2007 to 2012. 
If the association between PCT-level deprivation and breast screening coverage in England 
differs from the cervical findings in Chapter 4, then we may infer that this could be due to 
differences in the characteristics or delivery of the screening programme.  Conversely, if 
the association between PCT-level deprivation and breast screening coverage is similar to 
the findings for cervical screening coverage then we may infer that population 
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characteristics, such as a being more engaged with health issues generally, probably 
explain the similarities across programmes.   
Using breast screening coverage data, this study followed the same methods as described 
in the previous chapter, and compared results for cervical screening coverage in older 
women as they were eligible for both screening programmes.   
5.2 Methods 
5.2.1 Measures  
PCT data on breast coverage for the period 2007–12, were downloaded from the Health 
and Social Care Information Centre (Health and Social Care Information Centre, 2013; 
Health & Social Care Information Centre, 2014b). Breast screening coverage data were for 
women aged 53–70 years.  Breast screening coverage is defined as the percentage of 
eligible women who have had a test with a recorded result in the last three years (Health 
& Social Care Information Centre, 2014b).   
5.2.2 Statistical Analysis 
Data were analysed using SPSS statistical software, version 18.0 (PASW Statistics for 
Windows, 2009).  Descriptive statistics were generated for PCT-level breast screening 
coverage for all eligible women.  Analysis of the data for all eligible women in all PCTs in 
England was necessary to compare the results for the full cervical screening programme.  
Data were further grouped by geographical area: all PCTs in England (n = 151); PCTs in 
England excluding London (n = 120); and London PCTs only (n = 31).   
To describe the relationship between breast and cervical screening coverage and 
deprivation the following models were fitted and are described below.  The outcome 
measure was breast screening coverage (%).     
1) A linear regression model was used to calculate what is termed as the ‘coverage gap’, 
deprivation was divided into quintiles of IMD score for each year.  The ‘coverage gap’ 
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is the absolute difference in mean coverage between the least and most deprived 
quintiles. 
2) A mixed ANOVA was used to determine if socioeconomic inequalities in breast 
screening coverage changed over time.  This analysis was stratified by region (London 
versus the Rest of England) and age (younger versus older women).  The analysis was 
then descriptively compared across the strata. 
5.3 Results 
5.3.1 Descriptive Statistics 
Annual coverage figures for the two programmes from 2007 to 2012 are shown in Table 8.  
Across all PCTs in England, breast screening coverage was fairly stable at 74–75%, although 
the range shows that there was an improvement in the worst-performing PCTs, with the 
minimum coverage increasing from 42.3% in 2007/8 to 58.3% in 2012/13.   
In PCTs excluding London, breast screening coverage was slightly higher than the national 
mean and fairly stable at 76–77%.  Similarly the range indicates an improvement in the 
worst-performing PCTs, where the minimum coverage increased from 56.6% in 2007/8 to 
64.5% in 2012/13.   
In London PCTs, breast screening coverage was lower than in other areas and the mean 
varied from around 64% to 69%.  The range highlighted an improvement in the worst-
performing PCTs, where the minimum coverage increased from 42.3% in 2007/8 to 58.3% 
in 2012/13.   
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Table 5. Descriptive statistics for screening coverage in the breast and cervical screening 
programmes 
 Breast screening programme 
(53–70 years) 
Cervical screening programme 
(50–64 years) 
Year Commencing Min–Max Mean SD Min-Max Mean SD 
England PCTs (n = 151) 
2007–08 42.3–83.5 73.8 8.2 68.6–85.6 79.6 2.8 
2008–09 50.2–84.3 74.5 7.6 67.8–85.0 79.3 3.1 
2009–10 56.9–84.7 75.2 6.3 68.5–84.4 78.3 2.8 
2010–11 59.4–84.9 75.6 5.4 70.0–82.4 77.3 2.6 
2011–12 59.1–84.4 75.5 5.2 69.1–82.0 77.2 2.5 
2012–13 58.3–83.3 74.8 5.3 69.1–82.0 77.0 2.4 
England, excluding London PCTs (n = 120) 
2007–08 56.6–83.5 76.6 4.9 73.4–85.6 80.2 2.4 
2008–09 57.7–84.3 77.3 4.4 69.7–85.2 79.9 2.7 
2009–10 62.9–84.7 77.5 3.9 72.1–84.4 78.7 2.4 
2010–11 65.8–84.9 77.5 3.5 70.3–82.4 77.7 2.4 
2011–12 64.3–84.4 77.3 3.6 70.1–82.0 77.6 2.3 
2012–13 64.5–83.3 76.6 3.6 70.6–82.0 77.4 2.1 
London PCTs (n = 31) 
2007–08 42.3–78.8 63.0 9.1 68.6–82.0 77.1 3.2 
2008–09 50.2–78.9 64.0 8.2 67.8–83.1 77.2 3.6 
2009–10 56.9–77.9 66.4 5.8 68.5–82.6 76.5 3.3 
2010–11 59.4–78.5 68.2 4.9 70.0–81.3 75.7 2.6 
2011–12 59.1–78.9 68.6 4.9 69.1–80.9 75.7 2.8 
2012–13 58.3–77.9 68.0 5.2 69.1–80.4 75.6 2.7 
 
Prior to applying further statistical tests the breast screening coverage data were tested 
for assumptions of normality.  There were was one outlier in the data for 2007 but for no 
other year over the period. In 2012, for breast screening coverage in all women the z-score 
for kurtosis was 5.589 (standard error = 0.392) and the z-score for skewness of -7.598 
(standard error = 0.197) indicating that the data were not normally distributed.  For 
subsequent years, this was less pronounced, such that in 2009 the z-score for kurtosis was 
0.961 (and therefore within the +- 2.58 range for normality).  Similar patterns were evident 
for kurtosis in all subsequent years.  In 2009, the z-score for skewness was -5.350, with 
similar results for subsequent years, which indicated that the data remained negatively 
skewed across the period.  This is visually illustrated for breast screening coverage in the 
histogram and Q-Q Plots for 2009 (see Figure 14 and 15).   
The data were initially transformed using the LG10 logarithmic function in SPSS as follows:  
LG10 ((Max Screening Coverage + 1) – Screening Coverage).  A sensitivity analyses was 
then conducted by comparing the results of the analyses using the original breast 
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screening data and the transformed screening data.  There were no significant differences 
in the results therefore the analysis was conducted, and will be reported, using the original 
(untransformed) breast screening coverage data.   
Figure 14. Histogram of Breast Screening Coverage in 2009 - England 
 
 
Figure 15. Q-Q Plot of Breast Screening Coverage in 2009 - England 
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5.3.2 Deprivation Quintiles and Breast Cancer Screening Coverage 
In all England PCTs, the breast cancer screening coverage was lower in more deprived 
quintiles (see Table 6).  In 2007, the breast screening coverage gap was 12.3% (F (4, 146) = 
13.987, p < 0.001), and in subsequent years this narrowed, such that the coverage gap was 
8.3% (F (4, 146) = 16.933, p < 0.001) in 2012.   
Table 6. All England: Breast and cervical screening coverage (Dep. Qs: Q1 – Low, Q5 – High) 
Yr 
Dep  
Qs 
Breast screening 
coverage (53–70 years) 
Cervical screening 
coverage (50–64 years) 
B 95% CIs SE p B 95% CIs SE p 
Lower Uppe
r 
Lowe
r 
Uppe
r 
07 Q1 78.61 76.07 81.14 1.28 - 81.68 80.79 82.56 0.49 - 
Q2 -1.27 -4.86 2.31 1.81 0.484 -0.88 -2.13 0.37 0.63 0.165 
Q3 -5.56 -9.12 -2.01 1.80 0.002* -2.67 -3.91 -1.42 0.63 <0.001† 
Q4 -4.94 -8.53 -1.36 1.81 0.007* -2.58 -3.83 -1.33 0.63 <0.001† 
Q5 -12.28 -15.86 -8.69 1.81 <0.001† -4.25 -5.50 -3.00 0.63 <0.001† 
08 Q1 79.24 76.89 81.60 1.19 - 81.59 80.61 82.58 0.50 - 
Q2 -1.28 -4.61 2.05 1.69 0.449 -1.19 -2.58 0.20 0.70 0.092 
Q3 -6.05 -9.36 -2.75 1.67 <0.001† -2.78 -4.15 -1.40 0.70 <0.001† 
Q4 -4.62 -7.95 -1.26 1.68 0.007* -2.82 -4.21 -1.43 0.70 <0.001† 
Q5 -11.51 -14.84 -8.18 1.69 <0.001† -4.51 -5.90 -3.13 0.70 <0.001† 
09 Q1 79.06 77.14 80.99 0.97 - 80.29 79.41 81.18 0.45 - 
Q2 -0.99 -3.71 1.73 1.38 0.472 -1.20 -2.45 0.05 0.63 0.059 
Q3 -4.10 -6.79 -1.40 1.37 0.003* -2.61 -3.85 -1.37 0.63 <0.001† 
Q4 -4.55 -7.27 -1.83 1.38 0.001* -2.42 -3.68 -1.17 0.63 <0.001† 
Q5 -9.70 -12.42 -6.98 1.38 <0.001† -3.94 -5.20 -2.69 0.63 <0.001† 
10 Q1 79.22 77.61 80.83 0.82 - 79.39 78.60 80.19 0.40 - 
Q2 -1.21 -3.49 1.07 1.15 0.296 -1.25 -2.37 -0.12 0.57 0.030* 
Q3 -3.68 -5.94 -1.42 1.14 0.002* -2.49 -3.61 -1.38 0.56 <0.001† 
Q4 -4.45 -6.73 -2.17 1.15 <0.001† -2.61 -3.74 -1.38 0.57 <0.001† 
Q5 -8.84 -11.12 -6.56 1.15 <0.001† -4.04 -5.16 -2.92 0.57 <0.001† 
11 Q1 78.99 77.45 80.54 0.78 - 79.20 78.40 79.99 0.40 - 
Q2 -1.03 -3.22 1.16 1.11 0.355 -1.28 -2.41 -0.16 0.57 0.026* 
Q3 -3.75 -5.93 -1.58 1.10 0.001* -2.40 -3.52 -1.28 0.57 <0.001† 
Q4 -4.12 -6.31 -1.93 1.11 <0.001† -2.48 -3.61 -1.35 0.57 <0.001† 
Q5 -8.70 -10.89 -6.51 1.11 <0.001† -3.69 -4.82 -2.56 0.57 <0.001† 
12 Q1 78.11 76.51 79.71 0.81 - 78.80 78.05 79.56 0.38 - 
Q2 -0.51 -2.78 1.75 1.15 0.655 -1.07 -2.14 0.01 0.54 0.051 
Q3 -3.62 -5.87 -1.38 1.14 0.002* -2.28 -3.34 -1.22 0.54 <0.001† 
Q4 -3.93 -6.20 -1.67 1.15 0.001* -2.04 -3.11 -0.97 0.54 <0.001† 
Q5 -8.34 -10.60 -6.07 1.15 <0.001† -3.42 -4.49 -2.35 0.54 <0.001† 
* p < 0.01, † p < 0.001 
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Figure 16 shows breast screening coverage by quintile of deprivation across the time 
period for all of England, and clearly illustrates the narrowing of the coverage gap between 
the most and least deprived quintiles.   In contrast, there is little difference in the coverage 
gap for older women in cervical screening (see Figure 17) in the midst of a general 
reduction in cervical screening coverage across all quintiles.   
Figure 16. Breast screening coverage by quintile of PCT-level deprivation 
2007–12, mean coverage in table 
 
  
2007 2008 2009 2010 2011 2012
1 - Least Deprived 78.6 79.2 79.1 79.2 79.0 78.1
2 77.3 78.0 78.1 78.0 78.0 77.6
3 73.0 73.2 75.0 75.5 75.2 74.5
4 73.7 74.6 74.5 74.8 74.9 74.2
5 - Most Deprived 66.3 67.7 69.4 70.4 70.3 69.8
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Figure 17. Cervical screening coverage by quintile of PCT-level deprivation, 2007–12 
 
 
For PCTs in England excluding London, the absolute difference in breast screening 
coverage between the least deprived (Q1) and most deprived (Q5) quintile was 8.3% (F (4, 
115) = 13.246, p < 0.001) in 2007 and 7.6% (F (4, 115) = 29.889, p < 0.001) in 2012, which 
showed that there was little difference in the coverage gap between 2007 and 2012 (data 
not shown).  However, linear regression models for each year showed that the more 
deprived quintiles (Q3, Q4 and Q5) had significantly lower coverage (p < 0.01 or p < 0.001) 
than the least deprived quintile.     
For London PCTs (see Table 7), the association between cervical screening coverage and 
deprivation was quite different from PCTs in England excluding London.  The difference in 
breast screening coverage between the least deprived (Q1) and most deprived (Q5) 
quintile was 12.5% (F (4, 26) = 2.757, p=0.049) in 2007 and 2.6% (F (4, 26) = 1.360, p=2.75) 
in 2012.  The breast screening coverage gap was not statistically significant in any year.   
  
2007 2008 2009 2010 2011 2012
1 - Least Deprived 81.7 81.6 80.3 79.4 79.2 78.8
2 80.8 80.4 79.1 78.1 77.9 77.7
3 79.0 78.8 77.7 76.9 76.8 76.5
4 79.1 78.8 77.9 76.8 76.7 76.8
5 - Most Deprived 77.4 77.1 76.3 75.4 75.5 75.4
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%
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Table 7. London only: Breast and cervical screening coverage and deprivation quintiles (Dep 
Qs) 
Yr 
Dep 
Qs 
 
Breast screening coverage 
(53–70 years) 
Cervical screening coverage 
(50–64 years) 
B 
95% CIs 
SE p B 
95% CIs 
SE p 
Lower Upper Lower Upper 
07 Q1 70.98 59.02 82.93 5.82  79.58 74.80 84.35 2.32  
Q2 0.53 -13.62 14.68 6.88 0.939 -1.05 -6.70 4.60 2.75 0.705 
Q3 -10.37 -24.18 3.44 6.72 0.135 -2.87 -8.38 2.65 2.68 0.295 
Q4 -7.40 -20.96 6.16 6.60 0.272 -3.35 -8.76 2.07 2.63 0.215 
Q5 -12.46 -25.46 0.54 6.32 0.060 -2.76 -7.95 2.43 2.53 0.284 
08 Q1 71.47 60.95 81.99 5.12  79.16 73.79 84.52 2.61  
Q2 0.59 -11.85 13.04 6.10 0.923 -0.61 -6.95 5.74 3.09 0.846 
Q3 -10.88 -23.03 1.27 5.91 0.077 -2.94 -9.13 3.25 3.01 0.338 
Q4 -7.10 -19.03 4.83 5.80 0.232 -2.84 -8.92 3.25 2.96 0.347 
Q5 -11.00 -22.43 0.44 5.56 0.059 -1.84 -7.68 3.99 2.84 0.521 
09 Q1 72.13 64.61 79.65 3.66  78.37 73.36 83.37 2.44  
Q2 0.08 -8.83 8.96 4.33 0.986 -1.25 -7.18 4.67 2.88 0.667 
Q3 -7.16 -15.84 1.53 4.23 0.102 -2.77 -8.55 3.01 2.81 0.333 
Q4 -7.59 -16.12 0.94 4.15 0.079 -2.32 -7.99 3.36 2.76 0.409 
Q5 -7.55 -15.73 0.62 3.98 0.069 -1.71 -7.15 3.73 2.65 0.523 
10 Q1 72.11 65.64 78.57 3.15  77.03 73.11 80.96 1.91  
Q2 0.60 -7.05 8.25 3.72 0.873 -0.34 -4.98 4.31 2.26 0.883 
Q3 -3.60 -11.06 3.87 3.63 0.331 -1.86 -6.39 2.67 2.21 0.407 
Q4 -6.37 -13.70 0.96 3.57 0.086 -1.87 -6.32 2.58 2.17 0.395 
Q5 -5.26 -12.19 1.77 3.42 0.136 -1.27 -5.53 3.00 2.08 0.548 
11 Q1 72.52 65.89 79.16 3.23  77.11 72.96 81.25 2.02  
Q2 0.19 -7.66 8.04 3.82 0.960 -0.91 -5.81 3.99 2.38 0.705 
Q3 -3.69 -11.35 3.97 3.73 0.331 -2.27 -7.05 2.51 2.33 0.338 
Q4 -6.34 -13.86 1.19 3.66 0.095 -2.34 -7.04 2.35 2.28 0.314 
Q5 -5.15 -12.36 2.07 3.51 0.154 -0.90 -5.4 3.60 2.19 0.685 
12 Q1 69.97 62.65 77.30 3.56  76.30 72.25 80.35 1.97  
Q2 2.16 -6.51 10.82 4.21 0.613 0.06 -4.73 4.85 2.33 0.980 
Q3 -2.43 -10.88 6.03 4.11 0.560 -2.03 -6.71 2.65 2.28 0.380 
Q4 -4.36 -12.66 3.94 4.04 0.290 -1.23 -5.82 3.37 2.24 0.588 
Q5 -2.57 -10.53 5.39 3.87 0.512 -0.03 -4.43 4.37 2.14 0.989 
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5.3.3 Socioeconomic Inequalities in breast screening and cervical screening in older 
women 
Comparison of Breast Screening and Cervical Screening Programmes 
Breast screening 
A mixed ANOVA was conducted to determine whether there were statistically significant 
differences in breast screening coverage from 2007 to 2012 in all PCTs in England. The 
assumption of sphericity was violated, as assessed by Mauchley’s test of sphericity, χ2 (14) 
= 603.56, p < 0.001, therefore a Greenhouse-Geisser correction was applied.  
The main effect of deprivation showed there was a statistically significant difference in 
breast screening coverage between deprivation quintiles F (4, 146) = 17.77, p < 0.001, 
partial η2 = 0.327. Breast screening coverage in the most deprived quintile (Q5) was visibly 
lower than all other quintiles, as illustrated in Figure 18. 
The main effect of time showed a statistically significant difference in breast screening 
coverage across the years, F (2.17, 317.30) = 12.495, p < 0.001, η2 = 0.079.  Figure 18, 
demonstrates a sharp increase in breast screening coverage among women in the most 
deprived quintile.  There is a similar, though less distinct, increase in coverage in quintile 3, 
but there was little change in breast screening coverage in all other quintiles.   
There was a significant interaction between deprivation and time on breast screening 
coverage, F (8.69, 317.30) = 2.780, p = 0.004, partial η2 = 0.071.   
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Figure 18. Breast Screening Coverage by Deprivation Quintile - England 
 
 
 
Cervical screening coverage in older women 
For ease of reference, the results for socioeconomic inequalities in cervical screening in 
older women are repeated here from the previous chapter.  The assumption of sphericity 
was violated, as assessed by Mauchley’s test of sphericity, χ2 (14) = 407.13, p < 0.001, 
therefore a Greenhouse-Geisser correction was applied.  
The main effect of deprivation showed there was a statistically significant difference in 
cervical screening coverage between deprivation quintiles F (4, 146) = 13.85, p < 0.001, 
partial η2 = 0.275. Figure 19 illustrates that while the pattern of screening coverage is 
similar across all quintiles over the period, there are distinct differences in the levels of 
coverage between quintiles.   
The main effect of time showed a statistically significant difference in cervical screening 
coverage across the years, F (2.68, 543.73) = 255.09, p < 0.001, η2 = 0.636.  Figure 19 
reveals a relatively similar reduction in cervical screening coverage over the period across 
all quintiles.   
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There was no significant interaction between deprivation and time on cervical screening 
coverage for all women aged 50-64 years, F (10.74, 543.73) = 1.432, p = 0.158, partial η2 = 
0.038.   
Figure 19. Cervical Screening Coverage by Deprivation Quintile - Older Women 
 
 
Comparison of Breast Screening and Cervical Screening Programmes 
There was significant variation in breast screening coverage across quintiles of deprivation 
with a significant interaction between deprivation and time driven by an increase in breast 
screening coverage among women in the most deprived quintile.  This is in contrast to the 
significant reduction in cervical screening coverage across all quintiles of deprivation over 
the period and the lack of interaction between deprivation and time.  However, cervical 
screening coverage remains higher than breast screening coverage overall. 
 
Comparison of Breast Screening Coverage in Rest of England and London 
Rest of England 
A mixed ANOVA was conducted as outlined previously for breast screening coverage in 
PCTs in England excluding London. The assumption of sphericity was violated, as assessed 
by Mauchley’s test of sphericity, χ2 (14) = 311.24, p < 0.001, therefore a Greenhouse-
Geisser correction was applied.  
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The main effect of deprivation showed there was a statistically significant difference in 
breast screening coverage between deprivation quintiles F (4, 115) = 26.36, p < 0.001, 
partial η2 = 0.478. Breast screening coverage in the most deprived quintile (Q5) is notably 
lower than in less deprived quintiles, see Figure 20. 
The main effect of time showed a statistically significant difference in breast screening 
coverage across the years, F (2.73, 314.08) = 7.06, p < 0.001, η2 = 0.058.  This may be due 
to an increase in breast screening coverage in 2008 and 2009 (see Figure 20).   
However, there was no significant interaction between deprivation and time on breast 
screening coverage, F(10.92, 314.08) = 0.514, p = 0.892, partial η2 = 0.018.   
Figure 20. Breast Screening Coverage by Deprivation Quintile - Rest of England 
 
 
 
London 
A mixed ANOVA was conducted as outlined previously for breast screening coverage in 
London. The assumption of sphericity was violated, as assessed by Mauchley’s test of 
sphericity, χ2 (14) = 151.90, p < 0.001, therefore a Greenhouse-Geisser correction was 
applied.  
The main effect of deprivation showed there was a statistically significant difference in 
breast screening coverage between deprivation quintiles F (4, 26) = 2.83, p < 0.045, partial 
η2 = 0.303. Breast screening coverage in the least deprived quintiles (Q1 and Q2) were 
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relatively stable over the period (see Figure 21). The more deprived quintiles had lower 
coverage overall.   
The main effect of time showed a statistically significant difference in breast screening 
coverage across the years, F (1.72, 44.72) = 7.03, p < 0.003, η2 = 0.213.  This may be 
reflected in the sharp increase in breast screening coverage in quintiles 3 and 5, in 
particular, over the period.   
However, there was no significant interaction between deprivation and time on breast 
screening coverage, F(6.88, 44.72) = 1.903, p = 0.093, partial η2 = 0.226.   
Figure 21.Breast Screening Coverage by Deprivation Quintile – London 
 
 
 
Comparison of Breast Screening Coverage in Rest of England and London 
There was significant variation in breast screening coverage across quintiles of deprivation 
in PCTs in England (excluding London) and in London itself, but there was no interaction 
between deprivation and time on breast screening coverage over the period.  There were 
differences in the patterns of breast screening coverage over the period in the two areas.  
Breast screening coverage increased in 2009 and 2010 in comparison with 2007 for PCTs in 
England (excluding London) and this pattern was broadly similar across all quintiles.  
However, the observed increase in breast coverage in London in 2011 appeared to be 
driven by improved coverage in deprivation quintiles 3 and 5, although there was no 
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interaction between deprivation and time.  Coverage in London was also strikingly lower 
than coverage in the rest of England.   
5.4 Discussion 
As expected, PCT-level income deprivation had a statistically significant negative 
association with coverage for breast screening.  Over the period from 2007 to 2012, there 
was a significant reduction in the association between breast screening coverage and 
deprivation, as evidenced by the significant interaction between deprivation and time.  
The improvement in breast screening coverage in more deprived PCTs is clearly visible in 
Figures 16 and 18.  There was a significant interaction between deprivation and time on 
breast screening coverage, largely driven by the improvement in breast screening 
coverage in the most deprived areas.  The pattern of association between cervical 
screening coverage in women of comparable age and deprivation was quite different.  For 
cervical screening coverage, there was a significant reduction in coverage across all 
socioeconomic groups over time.  This trend is of concern because it indicates a steady 
decline in cervical screening in all older women with no indication of an improvement in 
the cervical screening coverage gap. Mean cervical screening coverage is, however, 
consistently higher overall than breast screening coverage and even with the observed 
improvements, the coverage gap remains greater for breast than cervical screening.  For 
example, in 2012 the coverage gap was 8.3% for breast screening and 4.9% for cervical 
screening, suggesting there may have been more scope for change within the breast 
screening programme.   
Breast coverage in London was much lower than in the rest of England, such that coverage 
in the least deprived quintiles of London was similar to coverage in the most deprived 
quintiles in the rest of England. Both areas did, however, increase coverage in the middle 
years of the period, although this appeared largely to have reached a plateau or to be in 
decline towards the end of the period, indicating that there may be no further 
improvements.  Improvements in breast screening coverage were evident in the most 
deprived quintile in both London and the rest of England, hence the overall increase found 
for England as a whole.   
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We need to understand more about these screening coverage differentials, particularly 
since they are in women who are simultaneously eligible for both screening programmes.  
The invitation process differs across programmes, such that, cervical screening requires 
the women to call her GP to arrange an appointment for screening in her local general 
practice.  For breast screening, women received an invitation with a prescheduled 
appointment at a breast screening clinic, most likely in a local hospital or mobile breast 
screening unit.  It may be that rescheduling an appointment for breast screening is more 
difficult than rearranging a cervical screening appointment at the GPs.  If efforts to change 
prescheduled breast screening appointments were made easier in recent years then this 
might account for the some of the increase in breast screening coverage in lower SES 
women.   
Mammography can be a painful experience for some women, and breast screening 
attendance is lower for women who experienced pain at a previous breast screening 
appointment (Whelehan et al., 2013).  This may offer an explanation for lower coverage in 
breast screening, and arguably, could contribute to a socioeconomic variation in breast 
screening coverage in lower SES groups who are already reluctant to attend.      
Women of lower SES have also been found to consider tests for breast cancer more 
embarrassing than higher SES women (Grunfeld et al., 2002).  This would contribute to 
their lower attendance at breast screening overall.  However, what is not clear, is whether 
efforts have been made by the NHS Breast Screening Programme to alleviate feelings of 
embarrassment regarding breast screening and that this may have contributed to the 
increase in breast screening coverage evidenced in recent years.   
Despite these differences, an exploration of the barriers to screening attendance found 
that women expressed similar issues for both the cervical and breast screening 
programme, including not getting around to going or not liking the idea of the test (Lo et 
al., 2013). This suggests that there may be other reasons for the disparity across 
programmes. I considered that strategies to increase breast screening coverage in 
deprived areas of England may have been given greater emphasis in recent years or have 
been more successful.  A multi-faceted approach to increase screening coverage, rather 
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than a single best approach, is widely accepted (Weller and Campbell, 2009), although 
evaluation of these approaches is not widely undertaken.  
It may be that lower SES groups have become more aware of breast cancer through the 
media.  For example, the diagnosis and subsequent death of Jade Goody from cervical 
cancer has been discussed in relation to improvements in cervical screening in younger, 
more deprived women.  Similarly, breast cancer was diagnosed in celebrities over the time 
period of the study.  Kylie Minogue was diagnosed with breast cancer in 2005 and there 
was an increase in breast screening in the immediate aftermath of her diagnosis (Twine et 
al., 2006). Increased screening coverage has also been associated with the diagnosis of 
cancer in soap opera characters, including a storyline in Coronation Street (Richardson et 
al., 2002).  A content analysis of newspaper coverage of four most common cancer types 
(breast, lung, prostate and bowel) in 2011-12 found that breast cancer received the 
highest coverage in its awareness month (Konfortion et al., 2014).  
Breast cancer may also have a higher profile in the media through concerns about a family 
history of breast cancer and the availability of genetic testing. Online information seeking 
on breast cancer increased substantially in the immediate aftermath of the high profile 
prophylactic mastectomy by Angelina Jolie (Noar et al., 2015).   
Women of lower SES are more likely to know of friends or family with a breast cancer 
diagnosis.  For example, in 2011 there were 50,285 new cases and, in 2012, 11,716 deaths 
from breast cancer in the UK (Cancer Research UK, 2015b).  There were 3,064 new cases 
and 919 deaths from cervical cancer in the UK over the same periods (Cancer Research UK, 
2015c).  Further, the incidence of breast cancer increases in older women and is therefore 
likely that women will become more aware of others with the disease as they themselves 
get older. Women with no family history of breast cancer have a lower perceived risk of 
breast cancer, and are associated with delay in help seeking for symptoms of cancer 
(Grunfeld et al., 2002).  It may be that this personal knowledge of the impact of breast 
cancer in combination with the aforementioned media attention is driving an increase in 
breast screening coverage in lower SES women.  However, it is acknowledged, that breast 
screening coverage is lower than cervical screening coverage overall.   
Chapter 5: Socioeconomic Inequalities in Breast Screening Coverage (Study 2) 
 
   
- 124 - 
 
Changes to the way in which the benefits and harms of screening are communicated to 
women in the leaflet accompanying their breast screening invitation were introduced in 
2013.  It is unclear how these may affect breast screening coverage (Forbes and Ramirez, 
2014). However, given the time of their introduction this cannot explain the differences 
found over the period of this study.   
The notably weaker association between both breast and cervical screening coverage and 
deprivation in London PCTs indicates that factors associated at this specific area-level, or 
city level, may be more pertinent.  As discussed in the earlier chapter, there are a number 
of issues that may affect screening coverage in London.  As suggested by Kinnear et al. 
organisational issues may be key to lower breast screening coverage in cities (Kinnear et 
al., 2011).  However, this may affect cervical and breast screening coverage since being 
registered with a GP is essential for both programmes.  For example, they may jointly be 
affected by the knock on effect of London’s high population mobility on list inflation.    
5.4.1 Strengths and Limitations 
There were limitations to this study.  This study focused on the simple association 
between breast screening coverage and income, and was therefore not able to take into 
account other factors that are known to affect screening coverage.  These were addressed 
in the following study.  Coverage data sourced from the NHS Health and Social Care 
Information Centre (NHSHSCIC) does not include any information about the demographic 
or socioeconomic characteristics of the women who attended, or did not attend, screening 
programmes.  While national surveys or local area studies are able to provide individual 
socio-demographic and screening attendance data, these can be expensive, relate to 
smaller geographical areas and often rely on self-reported screening attendance.  Area-
based measures of deprivation are generally seen as a proxy for individual-level SES, with 
individual markers considered more accurate.  However, in this study they were based on 
scores at Lower Super Output Areas (LSOA), which are relatively small, homogenised 
geographic units, and then weighted to PCT level, so should be fairly accurate.  
Nonetheless, associations might be stronger with individual-level measures. 
There were limitations to the chosen analytical approach.  These follow those outlined in 
Study 1, as both studies have used the same analytical approach.  
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As discussed in the previous chapter, it is acknowledged that the use of the income 
domain only is a weakness of the study as this fails to capture to other complex 
dimensions of socioeconomic deprivation. Sensitivity analyses using the full IMD was 
conducted to assess for potential differences when multiple domains of deprivation are 
considered.  The results were similar to those using the income domain of IMD only and 
are reported in Appendix 4. 
This study has estimated the relationship between income deprivation and breast 
screening coverage using a linear regression coefficient model to represent the absolute 
difference in screening coverage by deprivation group.  The actual percentage difference 
in screening coverage in women living in the least and most deprived areas constitutes the 
screening coverage gap. This approach has been applied in other studies of deprivation 
and cancer (Rachet et al., 2010; Shack, Jordan, Thomson, Mak, & Moller, 2008) and cancer 
screening (Sutton and Rutherford, 2005; C von Wagner et al., 2011). 
5.5 Conclusion 
There was a significant reduction in the breast screening coverage gap but no 
improvement for the cervical screening coverage gap, although the magnitude of the 
inequality was consistently lower for cervical than breast screening. The differences across 
programmes suggest that characteristics in the delivery of the programme may be 
important explanatory factors.  
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Chapter 6: Cervical Screening Coverage: High- and Low-performing 
PCTs4 (Study 3) 
6.1 Introduction 
Study 2 compared the coverage gap and patterns of association between deprivation and 
coverage over time in older women eligible for screening in the NHS Cervical Screening 
Programme with the same outcomes in the NHS Breast Screening Programme.  Cervical 
screening coverage was higher than breast screening coverage overall.  However, there 
was a significant decrease in cervical screening coverage in older women over the period.  
The pattern of association between cervical screening coverage and deprivation was such 
that, overall, there was no improvement in the cervical screening coverage gap in the NHS 
Cervical Screening Programme.  However, there was a significant increase in breast 
screening coverage, particularly in women living in the most deprived areas.  This led to a 
reduction in the coverage gap for the NHS Breast Screening Programme over the period. 
Why should coverage for older women, who are simultaneously eligible for both screening 
programmes, be different? One possibility is that programme-specific factors may 
contribute to the differences in coverage, and coverage gap, between the two screening 
programmes.   
Studies 1 and 2 also revealed that the pattern of association between PCT-level 
deprivation and screening coverage was different for London PCTs compared with the rest 
of England: much weaker and often not statistically significant. There was no significant 
change in cervical screening coverage over the time period in London, while a ‘Jade Goody 
effect’ was apparent elsewhere. While there was some improvement in breast screening 
coverage in London, this was transient and there was no improvement in the coverage gap 
as was found for England. There may be a number of factors that account for this 
difference.  Further exploration of the factors that may be affecting coverage within 
London PCTs would be beneficial.   
                                                        
4 A version of this chapter has been published in BMJ Open and is available in Appendix 5. 
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In Study 1, there was also wide variation in cervical screening coverage across PCTs.  It is 
evident that some PCTs perform better than others with respect to achieving the national 
target of 80% coverage.  If we were able to identify PCTs that were exceptional in their 
screening performance, for example where PCTs achieve relatively high levels of coverage 
given their high levels of deprivation (or vice versa), then we may be able to learn more 
about the characteristics that support, or hinder, optimal cervical screening coverage.   
This chapter (Study 3) identifies high- and low-performing PCTs which may assist with 
strategies to improve cervical screening coverage by highlighting which PCTs require most 
support and which could potentially be used as examples of best practice.  This chapter 
further describes other characteristics of high- and low-performing PCTs.  This may assist, 
in particular, with strategies to identify and support PCTs that are at risk of poor 
performance.   
The factors of interest can be broadly categorised as population and programme-delivery 
level factors.  The evidence from Study 1 found population-level factors (deprivation and 
age) were associated with coverage, and that the pattern of association was distinctly 
different for women living in London PCTs.   Therefore this study sought to include 
measures of deprivation, age and for living in London PCTs.  In the preceding chapter, 
inequalities in cervical screening coverage were found to be resilient to change, unlike 
breast screening coverage, over the same period.  This indicated that programme-delivery-
specific factors may require further investigation.  For the NHSCSP, programme-delivery 
factors largely relate to general-practice characteristics since they require the necessary 
administrative systems and staff to support women to make appointments for screening 
and ultimately conduct the screening test (Crossley, 2011).  In Chapter 1, additional 
population and programme-delivery level factors were found to be associated with 
cervical screening coverage.  The rationale for which factors should be included in this 
study is presented in greater detail in the section below.   
6.1.1 Factors Associated with Cervical Screening Coverage 
In this section I discuss the rationale used for the inclusion of certain population and 
programme-delivery level factors known to be associated with cervical screening coverage.  
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Further details of the precise measures used and their source can be found in the Methods 
section.   
Population-level characteristics 
Deprivation 
As discussed in the background literature in Chapter 1, income deprivation has been 
associated with lower cervical screening coverage at a variety of area-levels including 
health authorities (Baker and Middleton, 2003), PCTs (Bang et al., 2012) and general 
practice (Baker and Middleton, 2003); Bang et al., 2012).  In the previous chapter we found 
income deprivation to be inversely associated with cervical screening coverage in PCTs 
across England.  Therefore, there is strong evidence to support the inclusion of deprivation 
in the model.  
Education 
As discussed in the background literature in Chapter 1, level of education, including years 
in full-time education (Sutton and Rutherford, 2005), level of educational attainment 
(Moser et al., 2009), and adult learning (Sabates and Feinstein, 2006) has been associated 
with cervical screening attendance.  In PCTs with lower population levels of education, it 
may be reasonable to expect that cervical screening coverage may be lower and that this 
should be accounted for. 
Ethnicity 
The National Statistics Omnibus Survey 2005-07 found attendance at cervical screening to 
be higher in white British women (Moser et al., 2009).  The proportion of ethnic minority 
registered patients has also been negatively associated with cervical screening coverage at 
both PCT and general Practice level (Bang et al., 2012).  However, it would be over-
simplistic to assume that non-white populations are homogenous with respect to 
screening attendance, as there is distinct variation in cervical screening coverage between 
different ethnic populations (Webb et al., 2004).  A population-based study utilising 
screening records from a Manchester Health Authority found non-attendance for cervical 
screening was greater in South Asian women and never having attended screening was 
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significant for women who were born overseas (Webb et al., 2004). In PCTs with a higher 
proportion of non-white population it may be reasonable to expect that cervical screening 
coverage may be lower, but this may vary by ethnic group. 
Urban versus Rural Areas 
Cervical screening coverage has been found to vary according to the geographical area in 
which women live.  Study 1 found lower cervical screening coverage, and a weaker 
association between screening coverage and deprivation, in London than other parts of 
England, and it may be that urbanisation could play a role in explaining these results. As 
previously mentioned, we found distinct patterns of association between deprivation and 
cervical screening coverage in London PCTs compared with the rest of England.  As 
mentioned in Chapter 4, population mobility may play a role in the lower levels of cervical 
screening coverage found in London (Millett, 2009). 
Access to health services have been found to differ across urban and rural areas (Jordan et 
al., 2004).  Living in rural areas may require women to travel a relatively greater distance 
to attend a cervical screening appointment than in more urban areas.  Distance from the 
place of screening has been associated with lower screening coverage (Maheswaran et al., 
2006).   Additionally, it may imply a prohibitive transport cost for lower SES groups.  
Therefore, consideration of where women live and the association of urbanisation and 
screening coverage may be important.   
Age 
In the previous study we found that cervical screening coverage has been lower in younger 
women since at least 2007.  In fact, cervical screening coverage in England has been 
consistently lower among younger women, and in those aged 25-29 years in particular 
(Bang et al., 2012; Health and Social Care Information Centre, 2012a; Lancucki et al., 2010), 
for over a decade.  In PCTs with a higher proportion of 25–29 year old women, it may be 
reasonable to expect that cervical screening coverage may be lower and that this should 
be accounted for.   
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Programme-Delivery Level Factors 
General practices play a key role in the delivery of the Cervical Screening Programme 
(Health and Social Care Information Centre, 2013).  A GP’s capacity to effectively deliver 
the cervical screening programme may be affected by a number of different issues.  
Included in this analyses are factors related to the size of the Practice (number of 
registered patients), the general practice staffing (single-handed practices; practitioner 
headcount; number of full-time practice staff) and the ethnic characteristics of the general 
practitioner. 
Practice List Size 
The number of patients registered to general practices has been associated with non-
attendance at cervical screening, where GPs with greater than 8000 registered patients 
had lower cervical screening attendance than practices with 4000 registered patients 
(Webb et al., 2004).  Higher volumes of patients overall may affect the GP’s capacity to 
offer cervical screening appointments and carry them out.  This may also be influenced by 
the number of staff the general practice has available to support the screening 
programme.  This may be particularly important in terms of supporting women to make 
appointments, send out reminders or proactively supporting women to attend.  PCTs with 
a greater proportion of GPs with high practice lists may have lower cervical screening 
coverage. 
Single-handed General Practices   
Lower cervical screening attendance has been associated with single-handed general 
practices where GP staff numbers are lower (Webb et al., 2004), so this factor was 
included in the model.  
Practitioner Headcount and Number of Full-time Practice Staff 
A higher number of nurses per general practice has been associated with higher cervical 
screening coverage in deprived areas (Baker and Middleton, 2003).  PCTs with more 
general practices with fewer practice staff may have lower cervical screening coverage.  
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Similarly, PCTs with a lower overall Practitioner headcount per 100,000 population may 
also have lower cervical screening coverage. 
GPs Qualified Outside the UK 
Women may be more likely to register with a GP of the same ethnic origin, for example, 
two-thirds of South Asian women in the West Midlands were found to be registered with a 
South Asian GP (Szczepura et al., 2008).  South Asian women who are registered with a 
female South-Asian GP have higher cervical screening attendance when compared with 
South-Asian women registered with a non-South Asian female GP, or a male GP of either 
ethnic origin (Webb et al., 2004).  Cervical screening attendance may be higher when 
patient and GP ethnicity is matched, so we may find higher levels of cervical screening 
coverage in these PCTs.  It may then be pertinent to adjust for GP ethnicity.  
Unfortunately, obtaining GP ethnicity data is difficult and time-consuming (Szczepura et 
al., 2008).  The percentage of general practitioners who obtained their qualifications 
outside UK (reported by ONS at PCT level) was considered as a proxy measure.    
6.1.2 Aims of the Study 
This aim of this study was to identify PCTs whose cervical screening coverage was better 
(or worse) than expected, after adjusting for their level of deprivation and other 
population and programme-delivery factors shown to be associated with cervical 
screening coverage. This may assist with strategies to improve cervical screening coverage 
by highlighting which PCTs require most support and which could potentially be used as 
examples of best practice    
6.2 Methods 
6.2.1 Measures  
Coverage corresponds to the percentage of women actually screened among the women 
eligible for screening.  For this study, the number of women screened and the number of 
eligible women in 2011–12, sourced from the Health & Social Care Information Centre 
(HSCIC).   
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Population Level Factors 
Deprivation 
Like Study 1, the income domain score from the Index of Multiple Deprivation (IMD) 2010 
– a measure of the percentage of households on low income, benefits or other support 
was used as the measure of deprivation.  
Education   
Education data were sourced from the 2011 Census and downloaded from Nomis, the ONS 
web service (ONS, 2014a).  The explanatory variable used was the percentage of the 
population without any higher education. 
Ethnicity  
Ethnicity data were sourced from the 2011 Census and downloaded from Nomis, the ONS 
web service (ONS, 2014b).  Two explanatory variables were used: the percentage of Asian, 
Black, or Mixed ethnic minority groups, and the percentage of ‘other ethnic’ minority 
groups, which includes Asian and African Arabs and any ‘other ethnic’ minority groups (e.g. 
Polynesians, Melanesians and Micronesians). 
Urbanisation versus Rural Areas 
Two measures were used to assess patterns of urbanisation: the Urban-Rural Classification 
assessed PCT-level urbanisation across all PCTs and the London Strategic Health Authority 
(SHA) code was used to distinguish London PCTs. The Urban-Rural Classification of PCTs 
(post October 2006 boundaries) was obtained from the Association of Public Health 
Observatories website (APHO, 2008) and the explanatory variable used was the 
percentage urbanisation within each PCT.   
Age   
The percentage of general practice registered women aged 25–29 years old was retrieved 
from HSCIC (Health & Social Care Information Centre, 2010) to include in the model of 
cervical screening coverage in women aged 25–49 years old. 
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Programme-delivery Factors 
PCT level data for the general practice characteristics described below were sourced from 
the HSCIC (Health & Social Care Information Centre, 2010).  
Average Practice List Size 
Average Practice List Size is the average number of patients registered at general practices 
in each PCT.  
Single-handed General Practices 
Single-handed general practices are the percentage of general practices in each PCT with 
only one working GP.   
Practitioner Headcount 
Practitioner Headcount is the number of all practitioners (excluding retainers and 
registrars) per 100,000 population per PCT. 
Practice Staff FTE (full-time equivalent)  
Practice Staff FTE (full-time equivalent) is the average number of practice staff who are 
neither general practitioners nor registrars at the general practice, including practice 
nurses and those involved in direct patient care (Health & Social Care Information Centre, 
2012).   
Practitioners Qualified outside the UK 
Practitioners Qualified outside the UK is the percentage of General Medical Practitioners 
who attained their primary medical qualification outside the UK. 
6.2.2 Statistical Analysis 
Analysis was undertaken separately for cervical screening coverage in younger (25 to 49 
years) and older (50 to 64 year) women.  The statistical analyses to identify high- and low-
performing PCTs were conducted by NM in R version 3.0.2.   
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Identify High- and Low-Performing PCTs 
PCT-level coverage data (number of screened women; number of eligible women) were 
entered into a grouped logistic regression (Hilbe and Robinson, 2013).  A generalised linear 
model with quasi-binomial error distribution was used to adjust for overdispersion (van 
Engelsdorp et al., 2013).  This enabled the model to account for within-PCT extra-binomial 
variation.   Continuous factors were mean centred and grouped into population and 
programme-delivery factors. 
Univariate regression models for cervical screening coverage in younger and older women 
were fitted to consider which factors could be included in the full regression model.  The 
criterion for inclusion was determined by Wald significance tests, p=0.01.  Correlation was 
evaluated based on Pearson correlation coefficients. Differences in correlation coefficients 
between independent groups were assessed for significance by applying Fisher’s z test on 
z-transformed correlations. Generalized variance-inflation factors for covariate coefficients 
(GVIF) were used to test for multicollinearity (Kabacoff, 2014).  GVIF values of > 2 were 
taken as a general indication of multicollinearity.   
Three regression models were then fitted to both cervical screening coverage in younger 
and older women data with i) population factors, ii) programme-delivery factors and iii) 
both population and programme-delivery factors.  Factors which were significant at the 5% 
level in models i) and ii) were entered into the final model iii).   
Funnel plots were constructed for the younger and older age groups using their respective 
cervical screening coverage, entered as a proportion of the number of women screened to 
the eligible population as the performance indicator (y-axis).  The number of eligible 
women at PCT level was entered as the precision parameter (x-axis).  The target value was 
equivalent to the mean national PCT coverage and 95% and 99.8% control limits were 
plotted around it.   
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The methodological approach adopted in this study was developed in conjunction with Dr 
Nathalie Massat5. 
6.3 Results 
6.3.1 Descriptive Statistics 
PCT-level data on cervical screening coverage for younger and older women are 
summarized in Table 9 for all PCTs in England and for PCTs in London only.  Between-PCT 
variability in coverage was more pronounced in younger women (median 74.6, IQR 5.9) 
than in older women (median 77.5, IQR 3.5, Table 8).  As expected, from our previous 
study, cervical screening coverage was lower in younger women than older women, and 
lower in London overall.   
  
                                                        
5 Dr Nathalie Massat (NM), Senior Statistician at the Wolfson Institute of Preventive 
Medicine, Queen Mary University of London agreed to collaborate with me on seeking a 
suitable statistical method for identifying the high- and low-performing PCTs.  I was fully 
involved in this process.  I guided the research to meet my initial research question, and 
identified and sourced the data for analyses of the factors associated with cervical 
screening coverage.   
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Table 8. Descriptive statistics for PCT-level characteristics in England in 2011 (N = 151) 
 Min–Max Mean  (SD) Median  (IQR) 
Cervical Screening Coverage (%)    
Younger women (25–49 years)    
England (151 PCTs) 58.7 - 80.4 73.4  (4.4) 74.6  (5.9) 
London (30 PCTs) 58.7 - 77.7 67.8  (4.6) 67.8  (5.7) 
Older women (50-64 years)    
England 69.1 - 82.0 77.2  (2.5) 77.5  (3.5) 
London 69.1 - 80.9 75.7  (2.8) 75.6  (3.1) 
Population factors (PCT level)    
% Deprivation 6.8 - 33.8 16.2  (5.8) 15.3  (8.4) 
% Without higher education 10.1 - 35.2 23.0  (5.1) 23.0  (6.8) 
% Asian, Black, or Mixed ethnicity 1.3 - 67.6 15.1  (15.4)  8.9  (20.5)  
% ‘Other ethnic’ minority 0.1 - 11.1 1.2  (1.6) 0.6  (1.3) 
% Urbanisation 31.0 - 100.0 81.2  (21.5) 91.0 (35.03) 
% Registered women aged 25-29 12.2 - 32.2 19.5  (4.2) 18.3  (5.2) 
Programme-delivery factors (PCT level)   
Average practice list size 4026.4 - 9566.2 6656.2 (1371.2) 6537.1 (2236.0) 
% Single-handed practices 0.0 - 41.0 13.45  (10.2) 11.0 (16.0) 
Practitioner headcount per 105 
population 
50.9 - 95.3 68.7  (8.3)  67.7 (10.8)  
Practice staff FTE 146.3 - 1884.2 513.7  (296.7) 424.0  (283.7) 
% Practitioners qualified outside UK 3.0 - 70.0 26.4  (14.7) 25.0  (19.2) 
FTE, Full-Time Equivalent; IQR: Inter Quartile Range; SD, Standard Deviation; SHA, Strategic Health Authority 
 
Differences in correlation coefficients between independent groups were assessed for 
significance by applying Fisher’s z test on z-transformed correlations (see Table 8). 
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Table 9. Correlations between population and general practice factors, and screening coverage, correlation coefficients, p-value 
 %  
Urbani-
zation 
% 
Deprivation 
% Asian, 
Black & 
Mixed 
ethnicity 
% Other 
ethnicity 
% No 
higher 
education 
% 
Registered 
women 
aged 25-29 
Average 
practice list 
size 
% Single-
handed 
practices 
Practitioner 
headcount 
per 105 
pop. 
Practice 
staff FTE 
% 
Practitioners 
qualified 
outside UK 
 
Cervical 
25-49 
Population factors            
% Urbanization -            
% Deprivation .61,<.001 -           
% Asian, Black & 
Mixed ethnicity 
.56,<.001 0.58,<.001 -          
% Other ethnicity .48,<.001 0.39,<.001 .70,<.001 -         
% No higher 
education 
-.002, .9 0.41,<.001 -.27, .001 -0.45,<.001 -        
% Registered women 
aged 25-29 
.63,<.001 0.64,<.001 .62,<.001 0.60,<.001 -.11, 0.2 -       
General practice factors            
Average practice list 
size 
-.50,<.001 -0.58,<.001 -
.35,<.001 
-0.40,<.001 -.26, .001 -.33,<.001 -      
% Single-handed 
practices 
.49,<.001 0.46,<.001 .39,<.001 0.38,<.001 .21, .01 .30,<.001 -.75 <.001 -     
Practitioners 
headcount per 105 
population 
.02, .8 0.23,.006 .14, .1 0.14, .08† -.25, .002 .26, .001 .06, .5† -.35,<.001 -    
Practice staff FTE -.51,<.001 -0.36,<.001 -.25, .002 -0.25, .002 -.04, .7 -.24,.004 .36 <.001 -.27, .001 .06, .4† -   
% Practitioners 
qualified out UK 
.42,<.001 0.54,<.001 .43,<.001 0.22, .006 .37, <.001 .21,.009 -.52 <.001 .61,<.001 -.35,<.001 -
.36,<.001 
-  
Screening coverage            
Cervical 25-49 -.60,<.001 -0.56,<.001 -
.78,<.001 
-0.78,<.001 .31, <.001 -.71,<.001 .42,<.001 -.41,<.001 -.19, .02 .34,<.001 -.29,<.001 - 
Cervical 50-64 -.49,<.001 -0.47,<.001 -.24, .004 -0.45,<.001 .02, .8† -.43,<.001 .39,<.001 -.28,<.001 -.14, .09 .37 <.001 -.18, .03 .68,<.001 
FTE: Full Time Equivalent, † Not significant at 5% level 
Chapter 6: Cervical Screening Coverage: High- and Low-performing PCTs (Study 3) 
 
   
- 138 - 
 
6.3.2 Factors Associated with Cervical Screening Coverage 
Cervical Screening Coverage in Younger Women (25–49 years) 
In univariate analyses, all of the population and programme delivery factors were 
significantly associated with cervical screening coverage in younger women (see Table 10).  
The population factors generally explained more of the deviance in the model than 
programme-delivery factors.   When the population factors were ordered by those that 
explained the greatest deviance in the model, the ethnicity factors each explained 63% of 
the deviance, the percentage of younger women aged 25–29 years living in the PCT 
explained 53%, living in London and urbanisation explained 46% and 42% respectively, 
deprivation explained 41% and the percentage of women without higher education 
explained 7.3% of the deviance.  For the programme-delivery factors, average practice list 
size and the number of full-time general practice staff each explained around 23% of the 
deviance, the percentage of single-handed practices explained 21%, the percentage of 
practitioners qualified outside the UK explained 14%, and finally the practitioner 
headcount per 100,000 population explained 7% of the deviance. 
When the population factors were fitted into the model they collectively explained 79.5% 
of the deviance.  Deprivation, the percentage of Asian, Black, Mixed and Other Ethnic 
groups and the percentage of women aged 25–29 years were negatively associated with 
cervical screening coverage in younger women. The percentage of women without higher 
education was associated with higher cervical screening coverage, but this was not 
statistically significant in the multivariate model.  Living in more urban areas and living in a 
London PCT were negatively associated with cervical screening coverage, but these were 
no longer statistically significant. 
When the programme-delivery factors were fitted into the model they collectively 
explained 46.4% of the deviance.  The percentage of single-handed practices and 
practitioner headcount were negatively associated with cervical screening coverage and 
the number of full-time general practice staff was positively associated with cervical 
screening coverage in younger women.  Average practice list size and the percentage of 
practitioners qualified outside the UK were no longer statistically significant.   
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When the remaining population and programme-delivery factors were fitted to the model 
they collectively explained 80.9% of the deviance (see Table 10).  This was just 1.4% 
greater than the deviance explained by the population factors alone.  Deprivation 
displayed some collinearity with other factors and was no longer statistically significant. 
Asian, Black and Mixed ethnicity, ‘other ethnic’ minority and the percentage of women 
aged 25–29 years were negatively associated with cervical screening coverage in younger 
women.  The percentage of single-handed practices and practitioner headcount were no 
longer significantly associated with cervical screening coverage, however, the number of 
full-time general practice staff was positively associated with cervical screening coverage.   
Chapter 6: Cervical Screening Coverage: High- and Low-performing PCTs (Study 3) 
 
 
- 140 - 
 
Table 10. Regression Modelling for Cervical Screening Coverage in Younger Women (25–49 years) 
Model Univariate Population Programme Delivery Pop. & Prog. Delivery 
Population factors 
OR 
(95% CI) 
p-value 
(Wald, χ2) 
Deviance 
explained 
OR 
(95% CI) 
p-value 
(Wald, χ2) 
OR 
(95% CI) 
p-value 
(Wald, 
χ2) 
OR 
(95% CI) 
p-value 
(Wald, χ2) 
% Deprivation 
0.98 
(0.97–0.98) 
<0.001 41.1% 
0.99 
(0.98–0.99) 
0.03 _ 
1.00 
(0.99–1.01) 
0.52$ 
% Without higher 
education 
1.01 
(1.01–1.02) 
0.001 7.3% 
1.01 
(1.00–1.01) 
0.06 _ _ 
% Asian, Black and 
Mixed ethnicity 
0.99 
(0.99–0.99)† 
<0.001 63.3% 
0.99 
(0.99–0.99)† 
0.004 _ 
0.99 
(0.99–0.99)† 
< 0.001 
% ‘Other ethnic’ minority  
0.90 
(0.89–0.91) 
<0.001 62.4% 
0.96 
(0.95–0.98) 
<0.001 _ 
0.96 
(0.94–0.97) 
< 0.001 
% Urbanization 
0.99 
(0.99–0.99)† 
<0.001 41.9% 
0.99 
(0.99–1.00) 
0.3 _ _ 
London SHA  
0.70 
(0.65–0.74) 
<0.001 46.2% 
0.97 
(0.90–1.05) 
0.5 _ _ 
% Registered women 
aged 25–29 
0.97 
(0.96–0.97) 
<0.001 52.9% 
0.99 
(0.98–0.99) 
0.002 _ 
0.98 
(0.98–0.99) 
<0.001 
Programme delivery factors         
Average practice list size 
1.00 
(1.00–1.00)† 
<0.001 23.3% _ 
0.99 
(0.99–1.00) 
0.6 _ 
% Single-handed 
practices 
0.990 
(0.98–0.99) 
<0.001 20.6% _ 
0.99 
(0.98–0.99) 
<0.001 
0.99 
(0.99–1.00) 
0.06 
Practitioners headcount 
per 105 population 
0.99 
(0.99–0.99)† 
0.001 6.5% _ 
0.99 
(0.98-0.99) 
<0.001 
0.99 
(0.99–-1.00) 
0.06 
Practice staff FTE 
1.00 
(1.00–1.00)† 
<0.001 22.8% _ 
1.00 
(1.00–1.00)† 
<0.001 
1.00 
(1.00–1.00)† 
0.01 
% Practitioners qualified 
outside UK 
0.99 
(0.99–0.99)† 
<0.001 13.7% _ 
0.99 
(0.99–1.00) 
0.2 _ 
Deviance acc’td for by model   79.5% 46.4% 80.9% 
† CI range discernible at > 2 decimal places, CI: Confidence Interval; FTE: Full-Time Equivalent; SHA: Strategic Health Authority.  
$ The variance of the coefficient estimate is being inflated by multicollinearity with other factors (√GVIF = 2.8) 
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Cervical Screening Coverage in Older Women (50–64 years) 
In univariate analyses, all of the population factors, with the exception of the percentage 
of women without higher education, and all of the programme delivery factors, with the 
exception of the practitioner headcount per 100,000 population, were significantly 
associated with cervical screening coverage in older women (see Table 11).  When the 
population factors were ordered by those that explained the greatest deviance in the 
model, deprivation explained 31% of the deviance, urbanisation explained 26% of the 
deviance, the percentage of women aged 25–29 years explained 24% of the deviance, 
‘other ethnic’ minority explained 20%, living in London and Asian, Black and Mixed 
ethnicity explained 11 and 10% respectively, and, finally, the percentage of women 
without higher education explained just 1% (and was not statistically significant) of the 
deviance in the model. For the programme delivery factors, average practice list size and 
the number of full-time general practice staff each explained around 20% of the deviance, 
the percentage of single-handed practices explained 13% of the deviance, the percentage 
of practitioners qualified outside the UK explained 8%, and, finally, the practitioner 
headcount per 100,000 population explained just 1% (and was not statistically significant) 
of the deviance in the model.  
When all of the population factors were fitted into the model they collectively explained 
44.6% of the deviance.  Deprivation, ‘other ethnic’ minority and urbanisation were 
negatively associated with cervical screening coverage in older women and the percentage 
of Asian, Black or Mixed ethnicity was positively associated with coverage.  Living in 
London and a percentage of women aged 25–29 years were no longer statistically 
significant. 
When the programme-delivery factors were fitted into the model they collectively 
explained 26.7% of the deviance.  Average practice list size and number of full-time 
General Practice staff were positively associated with cervical screening coverage.  The 
percentage of single-handed practices and percentage of practitioners qualified outside 
the UK were no longer statistically significant.   
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When the remaining population and programme-delivery factors were fitted into the 
model they collectively explained 45.3% of the deviance.  This was just 0.7% greater than 
the deviance explained by the population factors alone.  Deprivation, ‘other ethnic’ 
minority and urbanisation were negatively associated with cervical screening coverage in 
older women, and Asian, Black and Mixed ethnicity was positively associated with 
coverage.  Of the two remaining programme delivery factors, only the number of full-time 
General Practice staff was significantly associated with cervical screening coverage in older 
women. 
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Table 11. Regression Modelling for Cervical Screening Coverage in Older Women (50-64 years) 
Model Univariate Population Programme Delivery Pop. & Prog. Delivery 
Population factors 
OR 
(95% CI) 
p-value 
(Wald, χ2) 
Deviance 
explained 
OR 
(95% CI) 
p-value 
(Wald, χ2) 
OR 
(95% CI) 
p-value 
(Wald, 
χ2) 
OR 
(95% CI) 
p-value 
(Wald, 
χ2) 
% Deprivation 
0.99 
(0.98–0.99) 
<0.001 31.1% 
0.99 
(0.99–0.99)† 
<0.001 _ 
0.99 
(0.98-0.99) 
<0.001 
% No higher education 
0.99 
(0.99–1.00) 
0.3 0.9% _ _ _ 
% Asian, Black and Mixed 
ethnicity 
0.99 
(0.99–0.99)† 
<0.001 9.9% 
1.01 
(1.00–1.01) 
<0.001 _ 
1.00 
(1.00-1.01) 
<0.001 
% ‘Other ethnic’ minority  
0.96 
(0.95–0.97) 
<0.001 19.6% 
0.97 
(0.95–0.99) 
0.01 _ 
0.96 
(0.95-0.98) 
<0.001 
% Urbanisation 
0.99 
(0.99–0.99)† 
<0.001 25.5% 
0.99 
(0.99–0.99)† 
0.01 _ 
0.99 
(0.99–0.99)† 
0.02 
London SHA (Q36)  
0.89 
(0.84–0.94) 
<0.001 10.6% 
0.93 
(0.87–1.00) 
0.06 _ _ 
% Registered women aged 
25–29 
0.98 
(0.98–0.98)† 
<0.001 23.5% 
0.99 
(0.99–1.00) 
0.3 _ _ 
Programme delivery 
factors 
         
Average practice list size 
1.00 
(1.00–1.01)† 
<0.001 20.2% _ 
1.00 
(1.00–1.00)† 
0.02 
0.99 
(0.99–1.00) 
0.62 
% Single-handed practices 
0.99 
(0.99–0.99)† 
<0.001 13.1% _ 
0.99 
(0.99–1.00) 
0.4 _ 
Practitioner headcount per 
105 population 
0.99 
(0.99–1.00) 
0.2 1.2% _ _ _ 
Practice staff FTE 
1.00 
(1.00–1.00)† 
<0.001 19.5% _ 
1.00 
(1.00–1.00)† 
<0.001 
1.00 
(1.00–1.00)† 
0.03 
% Practitioners qualified 
outside UK 
0.99 
(0.99-0.99) † 
<0.001 7.8% _ 
1.00 
(0.99–1.00) 
0.5 _ 
Deviance explained  44.6% 26.7% 45.3% 
† CI range discernible at > 2 decimal places, CI, Confidence Interval; FTE, Full-Time Equivalent; SHA, Strategic Health Authority 
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Comparison of the Association between Population and Programme-Delivery Factors 
with Cervical Screening Coverage across Both Age Groups  
Population factors explained more of the deviance in cervical screening coverage in 
younger women (81%) and older women (45%) than programme-delivery factors for 
younger (46%) and older women (27%).  However, both population and programme 
delivery factors explained more of the deviance in cervical screening coverage in younger 
women (81% and 46%, respectively) than for cervical screening coverage in older women 
(45% and 27%, respectively).   
For younger women, Asian, Black and Mixed ethnicity, ‘other ethnic’ minority, the 
percentage of women aged 25–29 years remained negatively associated with cervical 
screening coverage and the number of full-time General Practice staff remained positively 
associated with cervical screening overage, when both population and programme-
delivery factors were entered in the model.   While for older women, deprivation, ‘other 
ethnic’ minority and urbanisation remained negatively associated with cervical screening 
coverage and the percentage of Asian, Black or Mixed ethnicity and the number of practice 
staff was positively associated with cervical screening coverage, when both population and 
programme delivery factors were entered into the model.   
6.3.3 Identification of High- and Low-Performing PCTs 
Funnel plots identified two high-performing PCTs and three low-performing PCTs for 
cervical screening coverage in younger women (see Funnel Plot 1) and five high-
performing PCTs and two low-performing PCTs for cervical screening coverage in older 
women (see Funnel Plot 2).  Characteristics of the high and low performing PCTs can be 
found in Appendix 6.  
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Funnel Plot 1. High- and Low-performing PCTs - Younger women 
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Funnel Plot 2. High- and Low-performing PCTs - Older women 
 
 
High- and Low-Performing PCTs for Younger Women 
When cervical screening coverage in younger women was adjusted for population and 
programme-delivery factors there were two PCTs that fell above the 95% control limits but 
none above the 99.8% limits.  These high-performing PCTs were identified as Enfield PCT 
and Nottinghamshire County Teaching PCT.   
When cervical screening coverage in younger women was adjusted for population and 
programme-delivery factors there was one PCT that fell below the 95% control limits and 
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two below the 99.8% limits.  These low-performing PCTs were identified as Harrow PCT, 
Hammersmith & Fulham PCT and Camden PCT and are all based in London.   
High- and Low-Performing PCTs for Older Women 
For cervical screening coverage in older women five high-performing PCTs were identified 
overall, after adjusting for population and programme-delivery factors.  All of these PCTs 
fell above the 95% control limits, but none fell above the 99.8% control limits.  These high-
performing PCTs were identified as Enfield PCT and Nottinghamshire County Teaching PCT, 
North East Lincolnshire Care Trust, Waltham Forest and Sunderland Teaching PCT.   
For cervical screening coverage in older women two low-performing PCTs were identified 
after adjusting for population and programme-delivery factors.  Both PCTs fell between 
the 95% and 99.8% control limits.  The low-performing PCTs were identified as Sefton and 
Birmingham East & North. 
6.4 Discussion 
The combination of risk adjustment modelling and funnel plots enabled the identification 
of PCTs that performed exceptionally well, or poorly, for cervical screening coverage after 
accounting for population and programme delivery factors known to affect coverage.  
Two high-performing PCTs, Enfield and Nottinghamshire County Teaching Hospital PCTs, 
were identified in younger women.  In older women, Enfield PCT and Nottinghamshire 
County Teaching PCT were also identified as high-performing PCTs, alongside North East 
Lincolnshire Care Trust, Waltham Forest and Sunderland Teaching PCT.  This indicates that 
Enfield and Nottinghamshire are performing well for cervical screening coverage across 
both age groups. Further investigation of these PCTs may provide information about why 
they perform so well across both age groups.    
Three low-performing PCTs, Harrow, Hammersmith & Fulham and Camden, were 
identified for in younger women, and two low-performing PCTs, Sefton and Birmingham 
East & North, were identified in older women.  No PCTs were identified as poor 
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performers in both the younger and older age groups.  It may be that these PCTs require 
further support to improve their cervical screening coverage locally.   
Risk adjustment modelling found population factors, rather than programme-delivery 
factors, were of particular importance for PCT coverage levels in both younger and older 
age groups.  Although, it is also fair to say that both population and programme-delivery 
factors explained more of the deviance in cervical screening coverage in younger women, 
than for older women. For younger women, a higher percentage of Asian, Black and Mixed 
ethnic populations and ‘other ethnic’ minority populations, and a higher percentage of 
women aged 25–29 years were associated with poorer coverage after adjusting for both 
population and programme delivery factors.  For older women, deprivation, proportion of 
people from ‘other ethnic’ minority populations and urbanisation were associated with 
poorer cervical screening coverage and Asian, Black and Mixed ethnic populations were 
associated higher cervical screening coverage, after adjusting for population and 
programme delivery factors.   
Overall, these findings indicate that deprivation is negatively associated with cervical 
screening coverage.  This supports previous findings for an association between cervical 
screening coverage and deprivation in England at PCT level (Bang et al., 2012).  For 
younger women, the association between screening coverage and deprivation was 
significant when only the population factors were entered into the model.  The difference 
between the two models may be explained by the significant, positive association between 
cervical screening coverage in younger women and the number of full-time general 
practice staff when programme delivery factors are entered into the full model.  This 
finding is supported by evidence that suggests cervical screening coverage may improve in 
more deprived areas where there are higher numbers of practice nurses (Baker and 
Middleton, 2003).   
Lower levels of education were associated with cervical screening coverage in younger 
women in univariate analyses, but were not associated with screening coverage when 
adjusted for other population factors.  Lower educational attainment has generally been 
considered an important risk factor for lower cervical screening coverage (Moser et al., 
2009; Sabates and Feinstein, 2006; Sutton and Rutherford, 2005), although these studies 
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did not distinguish between cervical screening coverage in younger and older women.  The 
percentage of women without higher education explained around 7% of the deviance in 
univariate analyses, while other population factors such as the percentage of ethnic 
minority populations and the percentage of younger women aged 25–29 years respectively 
explained around 63% and 53% of the deviance in the model.  This may have contributed 
to the muted association between cervical screening coverage and education when the 
model was adjusted for other population factors.   
In the fully adjusted model, the proportion of Asian, Black or Mixed ethnic minority 
populations was negatively associated with cervical screening coverage in younger women 
and positively associated with cervical screening coverage in older women.  The 
percentage of ‘other ethnic’ minority populations was associated with poorer coverage, 
after accounting for population and programme delivery factors, for both younger and 
older women.  This finding is more typical of other findings of a negative association 
between PCT level cervical screening coverage and ethnic minority populations (Bang et 
al., 2012).  However, Bang et al., 2012 did not distinguish between the younger and older 
age groups, nor did they distinguish between different ethnic minority groups.  Differences 
in cervical screening uptake by country of birth, including Arabic countries, have been 
reported (Webb et al., 2004).  Ethnic variation in the knowledge of cervical screening and 
in emotional barriers to screening have been found (Robb et al., 2010) and these may also 
offer potential explanations for the difference in association between cervical screening 
coverage and the Black, Asian and Mixed populations and ‘other ethnic’ minority 
populations found in this study.   
Living in London had a negative association with cervical screening coverage in both 
younger and older women, but was not statistically significant.  It may be that other 
factors associated with London, are more discernible at smaller geographical units of 
measurement, for example, PCTs or LSOAs.  London as a region is hugely diverse and 
therefore this measure may be too broad to represent the diversities of wealth, ethnic and 
cultural diversity (Leeser, 2011).  Population diversity and population mobility may also 
contribute to the lower levels of cervical screening coverage found in London but these 
factors may not be unique to London and are likely to affect other large cities, albeit to a 
lesser extent (Millett et al., 2002).  
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Programme-delivery factors were less pertinent to cervical screening coverage for both 
age groups.  The number of full-time practice staff was the only factor to be significantly 
associated with increased cervical screening coverage in both younger and older women, 
after adjusting for both population and programme delivery factors.  This finding is 
supported by previously cited findings that more practice nurses are associated with 
higher cervical screening coverage (Baker and Middleton, 2003).  The other programme-
delivery factors were not significantly associated with cervical screening coverage in the 
fully-adjusted model.  However, when adjusted for programme delivery factors only, the 
percentage of single-handed practices and percentage of practitioners per 100,000 
population were negatively associated with cervical screening coverage in younger 
women, and average practice list size was negatively associated with cervical screening 
coverage in older women.   The percentage of single-handed practices was negatively 
associated with cervical screening coverage in a population-based sample of women aged 
30–64 years living in Manchester (Webb et al., 2004).  The author is unaware of other 
studies that have used the percentage of practitioners per 100,000 population but other 
studies that have used similar factors to capture the ratio of GPs to patients have found 
conflicting results.  Webb et al., 2004 found GPs with a higher number of patients to have 
poorer screening attendance, whereas Bang et al., 2012 did not find a significant 
association between the number of female patients per GP and cervical screening 
coverage at both PCT and practice-level.  The percentage of practitioners qualified outside 
the UK was negatively associated with cervical screening coverage for both younger and 
older women in univariate analyses, but in both cases was no longer significant when 
entered into the model with other programme-delivery factors.  It may be that the effect 
was explained by other factors entered into the multivariate model.   
There were similarities and differences in the descriptive characteristics of the five high-
performing PCTs.  Enfield and Waltham Forest, both London based PCTs, were found to be 
high-performers even although their coverage for younger women was lower, and their 
coverage for older women was just slightly above, the national mean for all PCTs.  
However, this may be due to their ability to achieve these levels of coverage despite their 
relatively high levels of deprivation and a more ethnically diverse population, both factors 
known to adversely affect screening coverage (Bang et al., 2012).  Conversely, 
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Nottinghamshire County PCT and North East Lincolnshire PCT, with among the highest 
levels of coverage for both younger and older women overall, did not face these 
population level challenges as they had lower levels of deprivation, were less ethnically 
diverse and less urban. However, they had relatively higher levels of women without 
higher education, another factor generally associated with lower screening attendance 
(Sutton and Rutherford, 2005). Cervical screening coverage in Nottinghamshire County 
may also have been supported by its relatively high levels of full-time general practice staff 
(Baker and Middleton, 2003).  Sunderland, with similar levels of urbanisation to the 
London PCTs, was much less ethnically diverse but had higher levels of deprivation from 
the national mean more women without higher education and therefore performed well 
despite these challenges.  The high-performing PCTs therefore did not necessarily have the 
highest levels of coverage overall but did have relatively high levels of coverage given the 
challenges within their areas.  Where, coverage among the highest levels achieved 
nationally, the PCTs were much less likely to comprise populations known to be less likely 
to attend cervical screening.   
Low performing PCTs were broadly similar to each other.  The three PCTs identified as low-
performers for cervical screening coverage in younger women were all based in London 
and were subject to a number of challenges.  Their populations were relatively more 
ethnically diverse, particularly in Harrow.   Camden and Hammersmith & Fulham also had 
particularly high levels of women aged 25-29 years which may have contributed to their 
lower levels of screening coverage.  All three PCTs had relatively fewer full-time general 
practice staff which may have compounded the known challenges of supporting ethnic 
minority populations and younger women to cervical screening.  Although these PCTs 
comprised women with higher levels of education this did not seem to have compensated 
for their other challenges.  The low-performing PCTs for cervical screening coverage in 
older women, Birmingham East & North and Sefton, were also urban PCTs, but differed on 
other population factors.  Birmingham East & North had high levels of deprivation, fewer 
women without higher education and a more ethnically diverse population.  Sefton 
however did not appear to have any of the well documented challenges to cervical 
screening coverage. In comparison with the mean levels for all England PCTs it had similar 
levels of deprivation and women without education, was not ethnically diverse. It had 
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slightly fewer general practice staff working full-time than the national mean, but also its 
average practice list size was below average, which means the practices have fewer 
patients to support overall.  This places Sefton as quite distinct from the other low 
performing PCTs as their challenges are more clearly evident. However, other low-
performing PCTs tended to have a combination of challenging factors, at both population 
and programme-delivery level, and therefore may require additional support to overcome 
these barriers to higher cervical screening coverage. 
6.4.1 Strengths and Limitations 
Funnel plots based on crude cervical screening coverage data to determine the 
performance of PCTs may lead to the overestimation of the number of ‘special cause’ 
PCTs.  Such overdispersion needs to be addressed a priori.  A risk adjustment approach 
was chosen to identify high- and low-performing PCTs with unusually high or low coverage 
after adjustment for population and programme-delivery factors known to be associated 
with cervical screening coverage.  PCTs with adjusted coverage values lying outside control 
limits are considered to display a behaviour which cannot solely be explained by the PCT-
level factors investigated.  However, there is also the potential that other factors may have 
contributed to the ‘special cause’ variation in coverage at that time.  It is possible that 
high-performing PCTs had initiated particularly successful health-promotion campaigns 
during that year, or were better equipped to capitalise on the ‘Jade Goody effect’.  This 
type of data is not available routinely and thus could not be adjusted for within the model.  
To compensate for this weakness, Study 3 was set up to explore the views of health 
professionals on cervical screening coverage rates in their local area.  This enabled factors, 
that are not available routinely or that may be particular to a given area, including issues 
related to health promotion to be considered. 
The study is limited by the aggregated nature of the data, which may conceal ecological 
associations within PCTs. This could account for the weak association found between 
cervical screening coverage and programme-delivery factors.  Programme-delivery factors 
had been considered as being particularly important for cervical screening coverage 
because general practices are involved in the process of appointment booking and 
conducting cervical screening.  Bang et al., 2012 found significant associations between 
Chapter 6: Cervical Screening Coverage: High- and Low-performing PCTs (Study 3) 
 
 
- 153 - 
 
cervical screening coverage and GP characteristics, however, that study consisted of GP 
practice level data which would be overcome the ecological limitations of PCT level data.  
Therefore, the associations between cervical screening coverage and programme-delivery 
factors may have been underestimated in my study.   
6.5 Conclusion 
Identifying high- and low-performing PCTs and understanding the reasons why some PCTs 
perform better (or worse) than expected is complex.  This study attempted to include 
some of the key factors that may affect PCT level screening coverage but was unable to 
adjust for all of the potential explanatory factors. High-performing PCTs appear to do so 
either because they do not have the same challenges as other PCTs or because they seem 
able to overcome them.  Low-performing PCTs appear to have multiple challenges and 
may therefore require further support to improve cervical screening coverage.  
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Chapter 7: Health Professionals’ Views of Cervical Screening Coverage 
(Study 4) 
7.1 Introduction 
To further understand the complex interplay of population and programme factors on 
cervical screening coverage and how they may act to support or hinder cervical screening 
coverage, I decided to draw upon the knowledge and expertise of professionals working in 
the NHS Cervical Screening Programme.   
Health professionals themselves, are known to influence cervical screening coverage, for 
the better or worse (O’Connor et al., 2014; Armstrong et al., 2011) and their perspective 
can be helpful in understanding well documented issues.  For example, health 
professionals were found to provide a programme-delivery perspective to seeking 
understanding about different barriers to cervical screening in women of different ages 
(Waller et al., 2011).   
The studies carried out in this thesis so far, have all focused on PCT level coverage, 
essentially because PCTs were responsible for delivery of the NHS Cervical Screening 
Programme in their area, until 31st March 2013.  This analysis enabled a broad 
consideration of a number of factors that may influence socioeconomic inequalities in 
cervical screening coverage.  However, it was unable to consider the complexity in which 
these factors may manifest nor to reveal any new factors that had not been considered. It 
was therefore important that I was able to speak with health professionals who worked 
within PCTs to gain their insight into some of particular issues that may arise in their area.  
In this way, the interplay between the delivery of the programme and the characteristics 
of the population may be better understood.  
The aims of this study therefore were to speak with professionals working within the NHS 
Cervical Screening Programme to draw upon their perspectives and inside knowledge to 
further understand the complex interplay between the delivery of the programme and the 
women it is intended for, with a view to ascertaining the factors that may act to support or 
hinder cervical screening coverage.    
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7.2 Methods 
7.2.1 Participants  
Twelve telephone interviews were carried out with professionals working in the cervical 
screening programme focusing on their views of factors that may influence cervical 
screening and colposcopy attendance within their local areas (see Table 19 for sample 
characteristics).   
 
Table 12. Sample characteristics of health professionals 
Sample characteristics of Health Professionals (n=12)  
Profession  
Screening Programmes Manager 3 
Screening Programmes Co-ordinator 3 
Screening Programme Quality Assurance Director 2 
Public Health Intelligence Analyst 1 
Public Health Screening Co-ordinator 1 
Lead Colposcopist 1 
Screening & Immunisation Co-ordinator 1 
Sex  
Male 2 
Female 10 
Age  
30–39 1 
40–49 4 
50–59 6 
60–65 1 
Length of time working in the NHS Cervical Screening Programme  
1–10 years 5 
10–20 years 4 
20–40 years 3 
Region  
North West 3 
North East, Yorkshire & Humber 1 
West Midlands 2 
East of England 1 
London 3 
South West 2 
 
7.2.2 Recruitment  
Ideally, I would have liked to have recruited more participants to the study.  However, this 
was greatly challenged by reorganisation of the NHS, such that PCTs ceased to exist on 1st 
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April 2013 (NHS Choices, 2015).  This made it difficult to get in touch with relevant 
professionals in the new organisation within Public Health England (PHE) because it was 
unclear where people now worked or what their job role or responsibilities would be.  I 
therefore decided to contact professionals working in Quality Assurance Reference 
Centres (QARCs) as a conduit. Given QARCs have responsibility for the audit of professional 
activity and the review of performance of the NHS Cervical Screening Programme (Public 
Health England, 2015), I thought they would be in a position to know who to contact. 
Contact details for professionals working in QARCs were easily available from online 
websites.  My recruitment strategy utilised snowball techniques to contact other relevant 
professionals (Sadler et al., 2010). This turned out to be a reasonably successful means of 
recruitment, although it did limit the number of potential contacts I ultimately made 
because I relied on the QARCs as intermediaries to forward my recruitment letter.  A 
recruitment letter was sent to cervical screening leads in ex-PCTs (some of whom I had 
initially contacted in late 2012) and to other contacts identified via QARCs.  Participants 
willing to take part in interviews were asked to contact me via e-mail, telephone or post.  
Ethical approval was sought and obtained from the University College London Research 
Ethics committee prior to recruitment (UCL Ethics Project ID: 4594/001) (see Appendix 7). 
7.2.3 Interview Materials 
The interviews were in-depth and were structured using a topic guide.  The topic guide 
was developed with reference to the existing literature on cervical screening coverage, as 
already discussed in earlier chapters (see Table 18 for the topic guide).  The topic guide 
was considered to be an appropriate tool for the interviews because it offered structure 
and flexibility.  I wanted to be sure that factors considered in Study 3 would be further 
explored with the health professionals but I also wanted to incorporate flexibility to open a 
space in which the dialogue of the interview could flow naturally.  This was important as it 
encourages more discussion which may lead to the revelation of new information that I 
had not anticipated.  
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Table 13. Topic Guide for Interviews 
Topic Guide  
 
1. Introduction 
 Background and aims of the study 
 Confidentiality 
 Timing and tape recording 
 Use of data (reports; papers; data sharing) 
 
2. Job Role 
Role  
 Which PCT were you aligned with prior to April 2013? 
 Responsibility for screening programme delivery 
 Responsibility for achieving coverage rates 
Transfer from PCT to Public Health England (PHE) 
 Views on benefits for screening programme delivery and coverage  
 Views on challenges for screening programme delivery and coverage 
 
3. Screening Programme Delivery 
Issues that support or hinder cervical screening delivery/coverage in the local 
area  
 GP practice characteristics (single handed practices, staffing levels) 
 GP practice incentives (QOF, local incentives) 
 Geography of PCT (rural/urban) 
 Endorsement of screening programme by GPs 
(reluctance/willingness/other priorities) 
 
4. Population Characteristics  
Views on how local demographics affect cervical screening uptake 
(support/challenge) 
 Age  
 Ethnic minority populations  
 Socioeconomically deprived populations 
 Other? 
Local health promotion activities 
 Targeting of health promotion activities (to particular group, or to 
national/local issue) 
 
5. Closing the Interview 
 Thanks 
 Reassure about anonymity 
 Give debrief 
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7.2.4 Procedure 
The interviews were generally around 1 hour in length (minimum 45 minutes, maximum 1 
hour).   Participants were given the option to be interviewed by telephone or in an 
interview room at UCL.  All opted for a telephone interview. Participants were asked to 
complete a consent form and brief demographic questionnaire (see Appendix 7) prior to 
the interview.  
The topic guide was structured to provide a logical flow in the conversation from an initial 
introduction of myself and the study, to allow the participant to introduce themselves 
before moving onto the main discussion related to the delivery of the NHS Cervical 
Screening Programme and the characteristics of the population within their area.  The 
topic guide, however, was used in the context of a semi-structured interview, and as such 
the precise order of topics varied according to the dynamic of the particular conversation.  
In these situations the topic guide was a useful checklist to see if any topics of interest had 
been missed. A general overview of the process is explained in greater detail below. 
After the initial introduction to the study, the first section of the topic guide covered 
information about the professionals’ role and responsibilities in the NHS Cervical Screening 
Programme. This enabled them to provide worthwhile background information on 
themselves and was a good way to establish rapport.   
Participants were then asked how they thought the recent reorganisation of the NHS had 
affected programme delivery and other issues relevant to cervical screening coverage.  It 
was anticipated that this would enable me to contrast issues that may have affected 
cervical screening coverage in the past but which may be handled differently in the new 
organisation.  
The next section covered factors related to the delivery of the NHS Cervical Screening 
Programme, including general practice characteristics, financial incentives and any other 
issues that participants considered important. This section was designed to shed more 
light on the ways in which programme-delivery factors may support or hinder higher 
cervical screening coverage. 
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The fourth section asked how participants thought the local demographic of women 
eligible for screening contributed to coverage rates in their own area.  This was included to 
allow them to consider the different factors that may affect screening coverage for 
different social groups.  This also afforded the opportunity to discuss the effect of local 
health promotion activities and, where relevant, national campaigns.    
The final section closed the interview with an expression of thanks to the health 
professional for their participation and offered them a final opportunity to make any 
outstanding remarks or comments.  I then debriefed the participants on the study.   
7.2.5 Analyses 
All interviews were recorded by electronic recorder and transcribed verbatim.  To ensure I 
was fully immersed in the data I interviewed all participants, transcribed three of the 
transcripts and coded all of the transcripts.  Those transcripts not transcribed by myself 
were transcribed by Devon Transcriptions 6 – a transcription service found to produce 
quality transcripts and recommended by colleagues in my department.  Once the 
transcription process was complete, I read and re-read the transcriptions of all interviews, 
taking notes of points of interest along the way.  If found this a useful process to re-
familiarise myself with the data.   
The data were analysed thematically using guidelines outlined by Braun and Clarke (Braun 
and Clarke, 2006).  The analysis was aided by the NVivo software package (version 10a,  a 
software package designed to aid qualitative data analyses) (QSR International Ltd, 2015). 
The transcripts were uploaded into the software in preparation for coding. 
After familiarisation with the transcripts and notes, I generated initial codes driven by the 
data.  As new codes were generated some codes split into two or more codes as the 
meanings in the data became more nuanced. This initial coding was at a very detailed level 
to allow me to identify all the available information. From there I began to group the initial 
codes of data into broad themes and groups where items related to similar topics or 
where I could identify a relationship between different codes and themes.  A reiterative 
                                                        
6 www.devontranscription.co.uk 
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process ensued where I would review the initial codes, perhaps making some 
modifications to more clearly express the meaning.  Then I reviewed the larger themes 
again to ensure that they remained appropriate and modified them where I considered it 
necessary. From there I drew an initial thematic map to visually represent the data and 
allow me to consider the wider meaning of the data and its inter-relationships.  At this 
point, I was able to stand back and look at the data again and then further refine the 
codes, sub-themes and overarching themes.  This process was influenced by my research 
question relating to gaining an understanding of the factors that support or hinder higher 
cervical screening coverage. That is to say, that while the initial codes and emergent 
themes were driven by the data, I acknowledge that the role that I played as a qualitative 
researcher in shaping the framework of the results was influenced by the over-arching 
desire to seek information in the data that related to the programme-delivery and 
population characteristics.  During this process I sought advice from my supervisor JoW 
and we discussed my approach and the resultant themes.  Earlier versions of the analyses 
were shared and discussed and modifications made before the ultimate set of themes and 
sub-themes were finalised.  
7.3 Results 
Programme-delivery factors and Population Factors were the two overarching themes of 
the factors that support or hinder cervical screening coverage.  These themes consisted of 
four and five subthemes and are visually represented in Figures 22 and 23 respectively. 
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Figure 22. Programme-Delivery Factors 
 
Figure 23. Population Factors 
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7.3.1 Screening Programme Delivery 
This theme consisted of four subthemes: Pros and Cons of a Nationally Organised 
Screening Programme; Role of General Practice; Health Promotion and Geographical 
Challenges to Programme Delivery. 
Pros and Cons of a Nationally Organised Screening Programme 
Screening Invitations 
The screening invitation process was discussed by many of the health professionals, mainly 
with respect to the content and delivery mode of the invitation letter and leaflet.  Some 
participants felt it was important to have a standardised letter to maintain consistency in 
the information being sent out to women, while other participants considered it important 
to be able to tailor these to the needs of their local population, particularly where these 
related to language barriers or literacy barriers.   
A Screening Programme Manager who had responsibility for more than one PCT spoke of 
the dangers of general practices sending out their own letters.  Her concerns related to the 
volume of letters that may be sent, the effect this may have on the decision to attend 
cervical screening and the content of bespoke letters.   
‘Then they’re also getting letters from their practice and they’re getting 
inundated with information and we were aware that in some cases this was 
actually putting women off.  You know they thought they were being bombarded 
or bullied into attending.  Plus, we’ve got no control over what is contained in 
those letters that GPs send out. So we would hope that the letters themselves 
are not frightening, em, but give enough information to enable the women to 
make their own choice. That is a concern of ours cos we have seen some 
shocking letters.’  
(Screening Programme Manager, ID3) 
This example illustrates that the accumulative effect of a women receiving letters from her 
general practice in addition to the standard letter sent as part of the Call Recall process 
may overwhelm the participants and have the undesired effect of putting them off.  The 
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Screening Manager was also concerned that some bespoke letters may inadvertently scare 
women or not portray the necessary information in a suitable manner to support women 
to make an informed choice.   
However, a Screening Programme Manager and a Screening Programme Co-ordinator also 
raised concerns that there was insufficient flexibility within the invitation process.     
‘I must admit, the offer is made that the leaflets are in different languages, but it 
only goes out in English, the letter itself. So unless the person actively rings up 
for some explanation, they are not going to get it in any other language.’   
(Screening Programme Manager, ID 12) 
‘I mean that’s important to maintain some consistency but, I mean, in terms of 
freedom and to reach out to woman locally… I think it’s quite difficult to be able 
to innovate within the service.’  
(Screening Programme Co-ordinator, ID 10) 
The following two examples highlight some of the ways in which the invitation or 
accompanying leaflet has been modified to target a particular social group.   Across the 
interviews, the various social groups which may require targeted intervention included 
younger women, ethnic minority women, women with learning disabilities and gay 
women.   
In this first example, an invitation letter is modified in an attempt to appeal to younger 
women. 
‘I know that in Camden and Islington they looked at the younger age group. They 
sort of tailored the invitation letter and they made it like a magazine to try and 
make it a bit trendy.’  
(Screening Programme Manager, ID 12)  
In this example, leaflets were modified to contain more information in graphic format to 
overcome language or literacy barriers. 
‘We put our own leaflet together with pictures in it… GP surgeries were using 
those leaflets because they found them a lot easier than the national leaflet, 
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particularly when they were talking to patients with language difficulties and 
from different groups, ethnic mixed groups. So they were saying that they were 
useful in having those conversations with women about attending for screening.’  
(Screening Programme Co-ordinator, ID 13) 
Health professionals also considered the mode of invitation to be important.  SMS text 
messaging was considered to be a helpful and fairly popular tool for reminding women of 
screening appointments, but suggested this could also be extended to the cervical 
screening test invitation.  Younger women were highlighted as a group who may engage 
more readily with the screening programme using this method of invitation, rather than a 
standard letter.   
‘But maybe the age group, now with the technology, maybe we should be 
thinking about texts rather than letters. If that was the way of working, people 
want that, sort of, information accessibility straightaway rather than, you know, 
getting a letter and throwing it in the pile of unanswered letters, whatever. That 
could be some of the problem with that younger age group.’  
(Screening Programmes Manager, ID 12) 
Screening Test Results 
Participants also felt that the 14-day turnaround7 for results of screening was an important 
factor for supporting repeated cervical screening attendance.   
‘Women get their result letters within two weeks which is a big thing…  So that 
has actually helped things in the context that you go for a test and you will get 
your result.’  
(Screening Programmes Manager, ID 3) 
                                                        
7 As part of its drive for better efficiency The Cancer Reform Strategy (Department of Health, 2007) 
mandated that women should receive the results of their cervical screening test within 14 days by 2010.  
National policy indicates that 98% of women should receive their results within 14 days, and the actual 
percentage delivered is reported annually in the Cervical Screening Programme Statistics report (Health 
and Social Care Information Centre, 2014). 
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Transition to Public Health England 
These interviews took place within one year of the NHS reorganisation and, as such, the 
transition of the NHS Cervical Screening Programme to Public Health England was still 
being embedded.  Many health professionals discussed the transition to working in Public 
Health England and the effects this would have on the role of those who previously 
supported training within PCTs.  Their perceived benefits and challenges of the new 
structure to support the NHS Cervical Screening Programme were discussed.   
A Screening Programme Co-ordinator felt that the benefits of the changes would become 
evident as the new practices come into place.   
‘Now that we’ve been told what these structures are, and the people who've 
been put into these structures have actually started working against their remit, 
I feel that the system is regaining some stability. … I think a good structure is 
being created there, which I think will support the service appropriately.’  
(Screening Programmes Co-ordinator, ID 8) 
The pros and cons of the new structures impact on running health campaigns was also 
discussed by a Cancer Screening Quality Assurance Director.  
‘In the past, we would have worked with PCTs on local initiatives to improve 
uptake and coverage, but now I don’t see that anymore. I think it will be, sort of, 
nationally led, …in one respect, nationally led is quite good because it saves a lot 
of, sort of, individuals repeating work that’s been done elsewhere…, the 
problems that I’ve seen in the past are that national campaigns tend to target 
the wrong women.’   
(Cancer Screening Quality Assurance Director, ID 1) 
The preceding example has similarities to the earlier views on the rigidity of the invitation 
process, that is, the merits and limitations of a standardised process.   While 
standardisation may be more efficient in terms of manpower and reducing duplication of 
effort, it may be in itself failing to reach specific groups – one size does not fit all.   
Other health professionals were sceptical of the benefits of the transition to Public Health 
England.  Some considered that the transition and the new structure may have a negative 
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impact on cervical screening coverage, at least, in the shorter term.  The points raised 
included the resource capacity of the new structure to meet the demands of supporting 
local areas and the loss of local area knowledge.   
‘Whereas before, they [referring to the Lead Screening Nurse previously 
available in each PCT] were visiting surgeries, doing a bit of training, a lot of 
them were nurses, so they were doing extra clinics, things like that, they can no 
longer do the clinics, they can’t visit surgeries because they’ve got to be more 
high level, they can’t, sort of, be more locally involved. So I think that’s a loss, 
really. And I think, as I say, it may well show in the figures that we see coming 
out this year.’  
(Screening Programmes Manager, ID 12) 
The preceding quotation echoes the views of other health professionals who considered 
that their position with Public Health England made them more remote from the areas 
they had to help.  Other professionals were also concerned that their job role had 
expanded to include screening and immunisation, and therefore they had less time to 
dedicate to cervical screening.  
However, some of the issues raised could be seen in terms of being temporary or transient 
problems.  That is, that large-scale change of this nature means that there will be a 
transition period in which staff renegotiate their role and that of others around them.  In 
the following example, the health professional discusses the difficulties for some staff 
transitioning to the new structure within Public Health England. 
‘They’ve [those employees in the newly appointed Screening and Immunisation 
Lead roles] had to, sort of, negotiate a whole new structure with very patchy 
staffing and it has been really challenging.’   
(Cancer Screening Quality Assurance Director, ID 11) 
In this final example, the loss of local knowledge is considered to be detrimental to the 
identification of areas with specific needs within the new Clinical Commissioning Group 
areas.  
‘And it’s the local knowledge that you need to, sort of, understand how we can 
best tackle it [cervical screening coverage]. And in part, that’s down to people 
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who, in the past, would have been people in public health who would have 
known, you know, specifically, you know, we should target these particular 
places.’  
(Cancer Screening Quality Assurance Director, ID 1) 
The Role of General Practice  
The significant role that general practices play in the delivery of the cervical screening 
programme is highlighted in this theme. Health professionals spoke of the responsibility of 
GPs and the challenges they can face in delivering the cervical screening programme.  
These included the availability of appointments, staff training and financial incentives, 
including how the General Medical Services (GMS) contract, also known as the Quality 
Outcomes Framework8 (QOF), can affect cervical screening uptake.   
Availability of Appointments 
Health professionals discussed the availability of cervical screening test appointments with 
respect to time and location.   Timing issues were highlighted in terms of the duration of 
the appointments, the limited number of appointments available and the lack of out-of-
hours appointments.   
In this first example, a Screening Programmes Co-ordinator discussed how appointment 
times can be quite ‘rigid’.  In other examples within this theme (not quoted), health 
professionals suggested that even varying the day of the week in which cervical screening 
appointments take place can make them more accessible to women.   
                                                        
8 The Quality Outcomes Framework (QOF) is a rewards contract for general practices, and other 
providers of primary care, to set standards and promote improvement to the delivery of medical 
services (Health & Social Care Information Centre, 2014a).  The contract is negotiated annually by NHS 
Employers and the General Practitioners Committee (GPC) of the British Medical Association (BMA).  For 
Cervical Screening, General Practices currently receive points for the following: 1) The general practice 
should have a protocol for the management of cervical screening including staff training, management 
of patient call/recall, exception reporting and monitoring of inadequate sample rates; 2) the percentage 
of women aged 25 years or over and under 65 years who have had a cervical screening test in the last 5 
years; and 3) a policy for auditing inadequate cervical screening tests at individual sample-taker level 
every 2 years.  
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‘I think GP practices can be quite rigid and, in terms of you know, you might be 
given a 5 or a 10 minute appointment… some of these woman need a 15 minute 
appointment and we [speaking on behalf of practice nurses or other sample-
takers] want to make the service accessible and try and encourage uptake.’  
(Screening Programmes Co-ordinator, ID 10)  
In this next example, a Cancer Screening Quality Assurance Director highlights that the 
number of appointments available can lead to problems for women who call to make an 
appointment but are unable to be given an appointment at that time.  Other health 
professionals also suggested that delayed appointments can have knock-on effects where 
women may realise that the future appointment will clash with her period.  This may lead 
to further rescheduling, delay or even unintended non-attendance.  
 ‘And I’ve heard lots of anecdotal reports of people saying that, you know, they 
can’t book an appointment with the sample taker because there are just such a 
limited number of slots.’  
(Cancer Screening Quality Assurance Director, ID 11)  
The scheduled time of appointments were also considered to directly impact some 
women’s ability to attend screening, particularly where a women worked shifts or had 
other practical barriers to ‘normal hours’ appointments.     
‘And these people, who were given less access because of the nature of their 
work for taking time off for screening, or perhaps worked in jobs that required 
different shift patterns, so it was more awkward for them to fit into the normal 
”going to the surgery” working hours, or whatever.’  
(Screening Programmes Co-ordinator, ID 8) 
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The availability of screening tests was also highlighted in terms of women having more 
flexible alternatives to the GP surgery.  Alternative options included having a drop-in 
screening test clinic in town centres or opening up the provision to sexual health clinics.  
‘if woman had a preference or had the options of either going to their surgery or 
somewhere more neutral in the town centre… a lot of woman who comment 
about it say, it’s just thinking about it, if I could just do it impetuously, if I was 
out shopping and there was a surgery next to Tesco’s and I could just go in and 
have it done.’   
(Screening Programmes Co-ordinator, ID 10)  
Some health professionals thought that women would welcome the opportunity to have 
their cervical screening test at a local sexual health clinic.  They discussed how cervical 
screening has become less common in sexual health clinics explaining that the focus of 
sexual health clinics and the financial incentives for conducting cervical screening tests 
were not supportive.   
‘We had some cases where some services [sexual health clinics] were getting a 
bit fed up about the amount of women that were coming for cervical screening 
to those services, and they were saying, “Actually, we’re going to limit these 
women.” We had one service that did that and they had an instant six-week wait 
and they were saying, “Well, we’re not here just to provide cervical screening all 
the time. The GPs are getting paid for this; we’re not.”’ 
(Screening Programmes Manager, ID 2)  
 
A colposcopist also offered an explanation for lower attendance for follow-up colposcopy 
appointments.  A woman may be invited to a follow-up colposcopy appointment and 
subsequent treatment for cervical abnormalities.  Follow-up appointments may comprise 
an HPV test as a ‘test of cure’. These appointments normally take place in a colposcopy 
clinic, which is hospital based.   
‘My feeling is that it’s better for the women to have the follow-up samples done 
in General Practice because it’s more convenient.’  
(Cancer Screening Quality Assurance Director, ID 1)  
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Staff training on issues affecting cervical screening uptake 
GP staff training was deemed important for a variety of general practice staff including 
sample takers, practice managers, administrative staff and receptionists.   
‘I used to visit all the practices all the time. I used to teach the receptionist and 
teach the clinicians, and there were some days you’d bring them right up to date 
with the HPV, the vaccination that is now up and running. You’d go in there, 
“How are you getting on?” You were demonstrating this. “Do these women 
understand about the virus?” You were educators. That’s all been taken away.’ 
(Public Health Screening Co-ordinator, ID 11) 
The promotion of cervical screening was considered to be a task for all general practice 
staff and staff training by those working at PCT level was considered an important factor in 
maintaining the focus on cervical screening within general practice staff.   
‘A lot of practice staff are under the impression that it’s nothing to do with us...  
You know, we just send the letters out and book the appointments and 
everything else but we wanted to highlight to them [through training sessions] 
that they have a key role in raising awareness amongst their population.’   
(Screening Programmes Manager, ID 3) 
Training was also considered necessary in order to tackle misconceptions about the 
relevance for particular groups of women or to support staff who may feel uncomfortable 
tackling certain issues.  In this example, the need for staff to be able to talk about the 
relevance of cervical screening to gay women is highlighted.   
‘”So why do I need to have a smear? I’ve never slept with a man.” GPs and 
nurses don’t want to talk about being gay. Not all of them, but a lot of them 
don’t. So that gives you yet another barrier.’ 
(Public Health Screening Co-ordinator, ID 14) 
Financial incentives to improve cervical screening uptake 
Participants discussed the different incentive schemes that have been in place to 
encourage GPs to facilitate cervical screening, including the current Quality Outcomes 
Framework (QOF).   
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There was concern that some general practices would not follow the criteria set for 
exception reporting 9 women for cervical screening.  This could lead to the illusion that 
their cervical screening rates were better than they were.    
‘There was a big issue within doctors’ surgeries that they didn’t understand 
about data and about coding of women. If they didn’t get any response from 
that patient within a certain allocated time, say, a month, then they would be 
exception reported. And so that took a lot of education because they thought 
they were actually performing a lot better than they were.’  
(Screening Programme Co-ordinator, ID 7) 
There was also some concern that cervical screening coverage is not sufficiently 
incentivised under the current GMS contract and that earlier GMS QOF contracts offered 
greater incentives.  This was considered as a contributory factor to the overall decline in 
cervical screening coverage seen in recent years.    
‘In the screening programme, pre the GMS contract that’s in place now, there 
was a real incentive payment for GPs to get 80% coverage in the screening 
programme. And they would do initiatives to get that… So actually, they no 
longer needed to do all of that work because they were going to get those points 
anyway.’  
(Screening Programmes Manager, ID 2) 
Health Promotion  
The health professionals discussed a number of local and national initiatives aimed at 
increasing cervical screening coverage.  Local area initiatives were often targeted to 
specific population groups, for example, younger women or ethnic minority groups.  Other 
                                                        
9 The Call Recall process of the screening programme invites all eligible women to cervical screening 
(North West Cervical Screening QARC, 2013).  Where, after a given period, no screening test result is 
indicated on the Call Recall system the general practice will be informed.  GPs should send additional 
invitations to the women to attend screening.  If the women still does not attend the GP may ‘exception 
report’ this women from their Quality Outcome Framework (QOF) report, such that the women is not 
counted in the GP’s QOF criteria related to payment for the percentage of eligible women who have 
attended screening at their practice.  As a consequence, the percentage of women who are considered 
to attend cervical screening via QOF may appear higher than the official returns reported in the annual 
coverage figures.  
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initiatives sought to support general practice to achieve higher levels of coverage, for 
example offering general practice staff training or providing the administrative support for 
a period of ‘list cleansing’ 10 of the GP’s records.  Health promotion was often discussed as 
being supportive of improved cervical screening coverage but was also found to have 
some inherent challenges, such as poor evaluation of previous campaigns, the limitation of 
desired outcome and the associated cost.   
Targeted Health Promotion Campaigns 
Lower screening attendance and the need for focused initiatives were discussed in relation 
to a number of population groups based upon their demographic, social or economic 
profile.  Younger and older women, those who are socio-economically disadvantaged, 
ethnic minority women, lesbian and gay women, women with learning difficulties, women 
who have been sexually or physically abused and those living in travelling communities or 
in military communities were all considered important social groups with specific needs or 
barriers.  Earlier, in the section on screening invitations, I discussed the efforts made by 
some PCTs to tailor the invitation letter and accompanying information leaflet to specific 
social groups.  Similar concerns were raised with respect to local campaigns.   
  
                                                        
10 List cleansing is a process in which the general practice registered list of patients is updated with 
patients’ current contact details.  Patients who have moved out of the area but not notified the GP, also 
known as ‘ghost records’ may be removed.   
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Staff Dedication 
However, one of the key components to the success of improved cervical screening 
coverage in a given areas was considered the quality and energy of PCT-level staff to deal 
with issues in their areas.   
‘They had a very motivated public health screening lead, and they also had a 
really good screening coordinator there who got involved with lots of those types 
of issues [socially deprived communities] and did this work. But they invested in 
it, and you could see, you know... Loads of really innovative things…You could 
see the difference in the coverage as well, where you could start to see a rise in 
coverage where the PCT actually invested in the programme’  
(Screening Programmes Manager, ID 2) 
Support to General Practices 
The health professionals also spoke about health promotion in relation to cervical 
screening in terms of supporting the GPs to deliver the programme.  This might be support 
to help in the administration of the system or by acting as a central point for gathering and 
sharing best practice across the PCT. 
Where issues are common across the PCT, health promotion staff were able to lend a hand 
to general practices in the area to address key issues.  The following example is one such 
initiative.  
‘I was involved in one of the projects where we went round to different [general] 
practices, me and another GP that I worked for at the time. We did it across our 
PCT, and we got rid of ghost patients on the lists, and then we invited in women. 
Again, we invited them in saying about a pre-counselling appointment, if they 
wanted and they were given longer appointments, as well. So it was a real push 
to get women in’  
(Screening Programmes Manager, ID 2) 
The PCTs were able to act as a central point to gather and share best practice.  This co-
ordination of this activity at PCT level was seen as a means to provide tailored solutions to 
the common challenges GPs may face.  
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‘We identified key areas where barriers were in place and then looked at other 
areas that had overcome those barriers by doing certain pieces of work. The 
toolkit that we put out actually has a whole section on barriers to uptake.  We’ve 
got them under separate headings, so it’d be like accessibility, barriers to women 
with learning disabilities and physical disabilities and it sort of gives you, you 
know, here’s the barrier here’s what you can do to correct it.  We’ve used that as 
well as part of the training sessions that I’ve done with practices to highlight 
with them.’   
(Screening Programmes Manager, ID 3) 
The professionals either implicitly or explicitly stated that different types of initiatives 
were necessary to improve coverage, and that health promotion is most successful where 
a ‘full-systems approach’ is applied.   
‘The thing that you realise with coverage it has to be a full-system approach. So, 
you could get somebody advertising for people to come in for screening but 
actually if there aren't the appointments there to facilitate that person going for 
the screening, then it stops there.’  
(Screening Programmes Manager, ID 2) 
 
Evaluation of Health Promotion 
The professionals largely discussed health promotion initiatives within the context of their 
perceived level of success.  There was a general view that evaluation of health promotion 
is either difficult to achieve or not undertaken.   
‘To say yes well we introduced this and as a direct result of that we have, you 
know, a kind of effect of 5% uptake [increase]. It’s really difficult to evaluate 
whether something that you have implemented has actually made a direct 
effect.’ (Screening & Immunisation Co-ordinator, ID 4)  
However, even where health promotion activities were viewed as successful, they were 
also considered to support a temporary increase in coverage.  Jade Goody was often cited 
as an example of the powerful yet transient nature of increased cervical screening 
coverage.   
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‘The Jade Goody effect and that's all worn off now. But um yes so lots and lots of 
young people came when something like that happens... it can be quite 
influential but it’s maintaining that which is the problem.’  
(Screening & Immunisation Co-ordinator, ID 4)  
Geographical challenges to delivery of the programme 
Rural areas 
Health professionals discussed the barriers to cervical screening coverage in both rural and 
urban areas.  It was considered that living in rural PCTs could sometimes present 
difficulties in relation to travel or familiarity with GP staff. 
‘Cumbria where you’ve got small areas of population in a vast geographical area 
so that created its own problems.  …women living in say a small village probably 
are friends with the local doctor or the local nurse and that was actually putting 
them off.’   
(Screening Programmes Manager, ID 3) 
The preceding example is also related to issues of embarrassment – not wanting to be 
screened by someone they know – and through the lack of alternative screening options.  
However, this was not found to be a uniform barrier in more rural areas.  
Urban areas – city effects? 
Challenges for achieving higher cervical screening coverage in cities were highlighted by 
some health professionals.  These included population mobility and the knock on effect of 
‘ghost records’ 11 on GP registers, and the number of women who may opt for private 
cervical screening.   
  
                                                        
11 ‘Ghost records’ may be described as records held on a general practice register of patients who no 
longer live in the area.  This routinely happens as, for example, people move house and there may be a 
time lapse to registering with a new GP.  This issue is exacerbated in areas with high population mobility 
and can lead to list inflation, where a GP’s list of registered patients appears higher than it actually is. 
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‘I think the other thing that has a huge impact is the mobility of the population. 
So when you look at the inner city areas – Manchester, Liverpool, Blackpool are 
our worst-performing areas in coverage and that’s because it’s a very mobile 
population there, people coming and going, and higher rates of ethnicity, as 
well. So it doesn’t seem to follow that the rural areas suffer; I would say it’s more 
on social deprivation and the mobility of the population.’  
(Screening Programmes Manager, ID 2) 
In the following example, the Public Health Screening Co-ordinator highlights some of the 
work her team has undertaken to address the administrative issues for the delivery of the 
cervical screening programme in London. 
‘Well, because of the diversity and actually maintaining the amount of data for 
London. It’s got a very dense population. There’s also the figures of what we call 
ghost patients. A lot of work has been done with call and recall on ghost 
women.’ (Public Health Screening Co-ordinator, ID 6)  
The same health professional also considered lower cervical screening coverage in London 
to be attributed, in part, to higher levels of women attending cervical screening at private 
clinics.   
‘And of course, the other problem is that women go privately for smears, don’t 
they?’ 
(Public Health Screening Co-ordinator, ID 6)  
A similar point was also made by a colposcopist who stated that some women referred to 
colposcopy following an abnormal cervical screening test result opt to have the colposcopy 
appointment at a private clinic.  This may occur even where the women’s originating 
cervical screening appointment may have been as a routine invitation to the NHS Cervical 
Screening Programme. 
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7.3.2 Population Factors 
This theme consisted of the five subthemes: Knowledge and Awareness; Previous 
Experiences; Emotional Barriers; Practical Barriers and Issues Related to Socio-
economically Deprived Women. 
Knowledge and Awareness  
Knowledge and awareness of cervical screening was discussed in different contexts.  In 
some instances, it was about raising the awareness of screening and its relevance to 
different groups of women.  Knowledge of changes in the screening programme was also 
considered as a potential contributor to cervical screening attendance.  Finally, having 
sufficient information about screening was also considered important for informed 
decision-making.  
Awareness of Screening 
Variations in the levels of awareness of the screening programme were considered to 
occur across different social groups, and for different reasons.  Broadly, the social groups 
discussed in the interviews in relation to this point included women living in socially 
deprived areas, ethnic minority women, gay women, and women with issues surrounding 
fertility or recent child-birth.   
In this first example the Screening Programme Manager discusses how community 
workers had been employed within their area to raise awareness of cervical screening in a 
socially deprived area of the Manchester.  
 ‘We [PCT health promotion team] did some work with some community workers 
who were working in Manchester [in socially deprived areas] at the time to get 
screening [coverage] up… It’s getting that message across that they can 
understand in a positive way and making it a priority to come forward for 
screening.’  
(Screening Programmes Manager, ID 2) 
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Women who are not familiar with the UK health care system or cervical screening may also 
have other barriers to attendance.    
‘Also you’ve got the Asians and the Somalis, and the people coming from other 
countries where they don’t promote the screening programme. … they don’t see 
the benefit of screening because they’ve not had it in their country and don’t 
possibly understand the language, don’t understand the setup of the GP 
surgeries, let alone screening programmes.’  
(Screenings Programme Co-ordinator, ID 7) 
There was also consideration that greater awareness of changes in the screening 
programme may prompt more women to attend screening.  
‘But it seems very interesting to me that since the introduction of HPV Triage, 
we’ve been doing it since March, the uptake for screening, we feel, has improved 
greatly, and I wonder if it’s because…, this HPV test has brought it to the fore a 
bit more – perhaps brought it more forward in people’s minds.’  
(Screening Programmes Co-ordinator, ID 8) 
Informed Choice 
Decision-making was largely discussed in the context of women having sufficient 
information to make an informed choice, and also where non-participation can be 
accepted as informed choice.   
‘It’s just making sure that she’s making an informed choice to either attend or 
not to attend, particularly if she’s decided not to attend that she’s aware of the 
risks but it’s how that is relayed to women.’  
(Screening Programmes Manager, ID 3) 
‘You know, some women just definitely do not want to have a cervical screening 
test. … well that's up to the women and she’s made an autonomous decision to 
decline and you have to respect that’  
(Screening and Immunisation Co-ordinator, ID 4)  
This point was also raised in relation to the information provided to women in their 
screening invitation letter and accompanying booklet.  However, the health professionals 
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clearly considered that the intention to provide further information was an ongoing 
activity, rather than something that should occur at a particular point in time.  
Previous Experiences 
Previous Appointments 
Previous experience at the cervical screening test and colposcopy was found to be very 
important for future attendance.  This included negative experiences such as physical pain 
or discomfort, psychosexual issues or the way in which the screening test or colposcopy 
examination/treatment was carried out.   
‘For some women they had the test before and it was painful, that have had one 
bad experience… and they’ll never come again.’  
(Public Health Intelligence Analyst, ID 5) 
In this example, a bad experience at cervical screening is considered as a potential 
explanation as to why some women will attend cervical screening but not attend 
colposcopy following an abnormal screening test result. 
‘You’ve got two pinch points in the process in terms of the first smear that you 
have and the first colposcopy that you have as to how good that experience is 
with the woman. So even if you have had a smear test and it’s a god awful 
experience, even if there’s an abnormality, they might not go to colposcopy.’  
(Colposcopist, ID 9)  
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Factors related to the colposcopy clinic itself, such as its layout or whether it was a 
dedicated space for gynaecological procedures, were also considered to put women off 
attending colposcopy.  This may be because the women had experienced these issues 
directly or because they had heard about them through word of mouth.   
‘To give you an example …a colposcopy waiting area shared with endoscopy. So 
you have women, in the main, young women, in a state of undress, waiting in a 
corridor, and opposite are the men waiting to have their colonoscopy 
examinations. .. Things like that that needs to be sorted out… people in the 
community know what hospital wards and departments are like.’  
(Cancer Screening Quality Assurance Director, ID 1) 
Other experiences, such as, opportunistic screening of other health measures was seen to 
deter some women from returning at future appointments.  
‘And there are certain things which definitely put women off... “I’ve been invited 
for a cervical smear, I go in and they want to take my blood pressure and weigh 
me!”’ (Cancer Screening Quality Assurance Director, ID 1) 
 
Domestic Abuse 
Finally, other experiences, such as domestic violence or abuse may also deter women from 
accepting their invitation to cervical screening. 
‘Woman who’d have either very difficult domestic experience, emotionally or 
physical; who’d suffered some sort of sexual abuse, domestic abuse found it 
really difficult to come forward for screening.’   
(Screening Programmes Co-ordinator, ID 10) 
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Emotional Barriers 
Emotional issues were cited as barriers to both screening and colposcopy attendance.  
These included fear, anxiety and embarrassment.   
Fear 
Fear was most often mentioned in relation to its role as a barrier to attending cervical 
screening.  However in this example, a Screening Programmes Manager explains how she 
believes fear may act as a barrier to colposcopy attendance following an abnormal 
screening test result.    
 ‘I think a lot of people do attend for screening never believing there's actually 
going to be anything wrong. How anxious women are, really, really anxious 
coming for colposcopy. I suppose it’s that thing of, when they don't turn up, 
maybe they're just not facing up to actually there is something wrong.’  
(Screening Programmes Manager, ID 2) 
Complacency 
However, not feeling concerned was also cited as a potential reason for the lower 
attendance rates found for women with follow-up colposcopy appointments. 
‘So your follow up is at a much higher DNA [Do Not Attend] rate [than first 
referral to colposcopy]… and I think that’s due to complacency in the patient.  
They think they think are fine, I’ve been treated, it’s not so important, they no 
longer have that letter saying your smear test shows abnormal cells if left 
untreated.’ (Colposcopist, ID 9) 
 
Strategies to overcome emotional barriers 
Health professionals discussed a variety of different emotions that women may experience 
in relation to their cervical screening appointment.  Here, health professionals discuss 
different ways in which women can cope with the anxiety or embarrassment of attending 
cervical screening.  In this first example, having a friend accompany them to the GP 
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surgery or speaking with someone else about going to screening is considered one possible 
strategy.  
‘Maybe some kind of coping strategies if they are anxious about going, what to 
do or to take a friend. And hopefully it’s given them a bit more confidence to 
either go along to have their smear or to actually go and speak to somebody else 
about the importance of it.’  
(Screening Programmes Co-ordinator, ID 13) 
Anonymity was considered an important issue for some women.  Professionals suggested 
that some women may prefer to have their cervical screening test at another clinic, rather 
than at their own GP.  
‘Yeah and I mean some women probably don’t what to go to their own GP 
because of the embarrassment factor don’t they; they’d rather go to a clinic 
where no one knows them’  
(Public Health Intelligence Analyst, ID 5) 
Other professionals considered developing trust between the woman and the health 
professional to be important factors in overcoming barriers to attendance.   
‘It’s the trust in that nurse. …So if you’ve got a good nurse in a poor area that 
can strut her stuff and care enough, there’s a bit of commitment there, it will 
work. It will work.’   
(Screening Programmes Co-ordinator, ID 10) 
Practical Barriers 
The practical barriers included not having the time and, in some instances, distance to 
travel.   
Time constraints 
This particular example is related to the difficulties for women in finding the time to 
attend screening.  It may also be compared to the earlier point made when discussing the 
Chapter 7: Health Professionals’ Views of Cervical Screening Coverage (Study 4) 
 
 
- 183 - 
 
fact that the availability of cervical screening appointments and how inflexible 
appointments may act as practical barriers to screening attendance. 
 ‘the reasons for women not going.  Some of it was, you know, they just didn’t 
have the time and busy lives, and it didn’t fit in… You know – they’ve got children 
to look after, can’t get to the surgery, it’s far more difficult for them to arrange 
the time when they can go on their own. So childcare problems, that sort of 
thing.’  
(Screening Programmes Manager, ID 12) 
Distance to Travel 
Distance to travel was mentioned as a barrier to screening.  This is also related to the 
earlier theme on rural issues, where women may have to travel further than in larger 
towns or cities.  However, this is not necessarily a barrier that is specific to rural areas, or 
one that in itself may be detrimental to attendance. For example, this issue had also been 
mentioned in relation to lower attendance at follow-up colposcopy appointments where 
lower incentive to attend the appointment combined with a potentially inconvenient 
journey may reduce attendance.  
‘I think, unfortunately, the clinics that are available, say, for example, in Sussex, 
they are quite widely spaced out, so for women who do want to go to a clinic, 
they’ve quite often got to travel that bit further.’  
(Screening Programmes Manager, ID 12) 
Socio-economically deprived women 
Those participants who discussed social deprivation agreed that screening coverage is 
generally lower in women of lower socioeconomic status or in those who live in socially 
deprived areas.  The themes of this discussion focused upon why coverage is lower in 
socioeconomically deprived women and explanations why some PCTs with high levels of 
deprivation have higher coverage than would be expected given their level of deprivation.    
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Attitude to Cervical Screening 
The reasons why coverage may be lower in more deprived women included practical 
barriers, lower awareness of screening or competing priorities.  However, the health 
professionals did not seem to think that these were exclusive to more deprived women.   
However, attitudes to health and cervical screening were raised as potential issues. 
‘I suppose what priority they give to their health and how they view screening, 
really, isn't it?’   
(Screening Programmes Manager, ID 2) 
Variation in Coverage in Deprived Areas 
Participants were asked about why some deprived areas had better coverage than may be 
expected given their level of deprivation.  The explanations given were within the context 
of professionals working as ‘active agents’ to effect change in that area and the role of 
education.   
This item is similar to the Staff Dedication theme mentioned earlier within the health 
promotion section. It is mentioned again here that health professionals considered this as 
a key driver to improving cervical screening coverage in more deprived areas within their 
PCTs.  
‘It’s the commitment of the individual working in the area. That makes one hell 
of a difference.  …And that’s why they do well. It’s about the commitment of the 
individual and good health promotion.’  
(Public Health Screening Co-ordinator, ID 6) 
Education is Protective 
Another participant highlighted that coverage may be higher in more deprived areas 
where the inhabitants may be more educated than would be expected given the level of 
deprivation, indicating that this anomaly could be explained at the population level.   
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‘So although it’s economically quite a crummy area, it might have a lot of over 
25s, poor but well-educated people living in it and things like that. …But there’s 
clearly a lot more to it than just access to GP appointments.’  
(Cancer Screening Quality Assurance Director, ID 11) 
7.4 Discussion 
Building on the work undertaken in Study 3, this study aimed to explore the factors that 
hinder or support cervical screening coverage in PCTs in England.  The opportunity to 
interview twelve health professionals who work in the NHS Cervical Cancer Screening 
Programme enabled me to investigate these factors in much greater depth.  
7.4.1 Screening Programme Delivery 
Health professionals considered a broad variety of factors to be important for cervical 
screening coverage. Some factors such as good general practice staff training and 
dedicated staff were considered to be unequivocally supportive of higher cervical 
screening coverage. The role of GP staff has been found to be important to women and 
can support their willingness to attend cervical screening (O’Connor et al., 2014) and their 
experience of the actual test (Armstrong et al., 2011).  Whereas restricted flexibility in the 
provision of cervical screening appointments and the effects of high population mobility 
were found to be detrimental to higher cervical screening coverage. Difficulty making 
appointments has been found to be affect cervical screening attendance, even among 
women who are positively inclined towards cervical screening (Waller et al., 2011, 2009), 
while population mobility is considered to be a particular issue for large cities  (Millett et 
al., 2002). Issues related to population mobility are compatible with the lower levels of 
screening coverage found in London PCTs in studies 1, 2 and 3.    
However, many other programme-delivery factors were more ambiguous. This included 
the standardisation of screening invitations which were welcomed as a means to ensure 
good quality information was sent to all women, yet they were also thought to impede 
higher cervical screening coverage by failing to engage with particular groups of women. 
There has been a great deal of research over the years about what information should 
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accompany an invitation to cervical screening, of which many studies have sought to 
improve the quality of information available to both support screening attendance and 
informed decision-making (Everett et al., 2011; Davey et al., 1998; Forbes and Ramirez, 
2014).  However, there are also many concerns about the appropriateness of a standard 
invitation to different population groups as they may be unable to overcome language 
barriers in ethnic minority groups and may contribute to the lower levels of awareness of 
the purpose of cervical screening in ethnic minority groups (Marlow et al., 2015a, 2015b)   
Health promotion was similarly ambiguous, to the extent that, while health professionals 
often considered them to be valuable tools to improve cervical screening coverage, they 
were simultaneously considered as often having been poorly evaluated or not evaluated at 
all.  Even where health promotion campaigns were evaluated as helpful their impact was 
considered transient or time-limited.  The “Jade Goody effect” may be considered as one 
such example of health promotion, albeit as the result of a tragic, real-life story, rather 
than a manufactured health promotion campaign (MacArthur et al., 2011).  The effect of 
her story visibly increased cervical screening coverage.  However, the impact of her story is 
now dissipating, as reflected in the results in Studies 1 and 2, where cervical attendance is 
now in decline since its peak in 2009/10.  
The factors gathered under the overarching theme of programme-delivery factors varied 
greatly from the type of information I was able to use in Study 2 when using quantitative 
measures. Measures such as the number of full-time practice staff, size of the practice, 
practitioner headcount, or the ethnicity of the general practitioner or sample taker were 
found to be statistically significant, at least in univariate analyses for cervical screening 
coverage for younger and/or older women.  However, these factors were not often 
mentioned in these studies.  This may be due to the difficulty in interpreting the meaning 
behind some of these quantitative measures and how they may impact cervical screening 
coverage in a meaningful way that may be observed by those working in the programme. 
However, the need for general practice staff who are well-trained in the importance of 
supporting cervical screening coverage and helping women to overcome barriers was 
discussed at some length in this qualitative study.  Therefore, both studies in their own 
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ways identified the importance of general practice staff in achieving higher cervical 
screening coverage. 
The reorganisation of the NHS was considered by many health professionals to have an 
effect on the delivery of the NHS Cervical Screening Programme.  While a few health 
professionals considered the new structures to be advantageous, or even that this may 
settle down, there were many concerns that the health professionals were more distant 
from the areas that they support. This insight into the perceived effects of organisational 
change on screening coverage is novel.  As far as the author is aware, these views have not 
been reported elsewhere.    
It was interesting to note that health professionals who worked in different cities in 
England considered there to be specific factors that impacted cervical screening coverage. 
London, in particular, was highlighted, but also were the inner city areas of Birmingham, 
Manchester and Liverpool.  The factors considered salient were population mobility and a 
higher percentage of ethnic minority groups living in these areas.  This is supportive of my 
earlier findings that suggested that there could be specific factors that converge within 
London, at least, to impede improved cervical screening coverage.  
7.4.2 Population Factors 
Evidence from the study suggests that knowledge and awareness of the cervical screening 
programme is very important to support cervical screening coverage across all social 
groups, and was also highlighted as one of the contributing factors for lower attendance of 
women in more deprived areas. This is supported by findings that women of lower SES 
may have lower awareness of the benefits of screening (Lostao et al., 2001; Sutton and 
Rutherford, 2005; Wardle et al., 2004).  Previous bad experiences including domestic 
violence (Cadman et al., 2012), emotional barriers and practical barriers (Waller et al., 
2009) were considered by health professionals in this study to hinder higher cervical 
screening coverage and have also been associated with lower cervical screening coverage 
in other studies. It was interesting to note that a number of factors were considered to 
explain lower attendance both at cervical screening and at colposcopy.  Many factors, 
including a women’s engagement with screening and the ways in which emotional and 
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practical barriers could be overcome, were openly discussed and potential solutions 
proposed.  Many of these solutions related to programme-delivery factors that could be 
improved, such as good training of staff, or increased flexibility of appointment times.  
These latter options highlight the inter-relations between programme-delivery factors and 
engagement with the population for whom the programme assists.    
It is interesting to note that ethnic minority women, women living in deprived areas, those 
with lower levels of education, younger women and those living in more urban areas were 
all mentioned by the health professionals in this study as groups of women or particular 
factors that may require particular attention to achieve higher cervical screening coverage.  
All of these factors were found to be significantly associated with cervical screening in 
Study 2.  With regards to ethnic minority groups, the quantitative study (Study 2) was able 
to decipher clear differences in association between cervical screening coverage and 
particular ethnic minority groups, because I was able to include measures related to Asian, 
Black and Mixed ethnic minorities and ‘other’ minor ethnicities.  However, this study 
(Study 3) was able to provide further explanation as to why screening may be lower in 
these groups.  In particular, one of the health professionals considered higher levels of 
education to be a protective factor in more deprived areas.  PCTs identified as high-
performing in Study 2 were also found to have areas of deprivation associated with areas 
with a higher percentage of educated women. 
7.4.3 Strengths and Limitations 
The use of in-depth interviews in this study enabled the participants’ views of factors 
associated with cervical screening coverage to be explored openly and without the 
constraints of surveys or questionnaires.  The inclusion of participants who worked in the 
NHS Cervical Screening Programme also provided an insider’s perspective, and for many 
participants who had been responsible for cervical screening delivery in one or more PCTs, 
they were able to provide a full-programme overview of how the screening programme 
was delivered and how changes in one part of the programme may impact other parts. 
The study, however, was limited as I was unable to explore the health professionals’ views 
in relation to high- and low-performing PCTs because of the restructuring of the NHS 
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following the 2012 Health and Social Care Act.  I had originally wanted to do this to enable 
me to produce an in-depth analysis of the variations in cervical screening coverage across 
England, specifically with reference to PCTs that have been identified as having 
exceptional coverage.  The vision was that I would be able to explore the issues more fully 
with in-depth interviews with people who work on the screening delivery side.  This may 
have formed the basis of case studies to use as examples of best practice or to identify 
PCTs that would benefit from further support.   
The study was limited by the number of participants recruited to the study.  Unfortunately, 
political events overtook my study when the coalition government, at the time, announced 
that the NHS would be reorganised, and as part of that reorganisation PCTs would no 
longer be in effect as of 1st April 2013 (NHS Choices, 2015).  At that time, I was still working 
on the analyses to identify the high- and low-performing PCTs.  Towards the end of 2012 I 
decided that I would contact some health professionals working in the NHS Cervical 
Screening Programme, even though I had not yet identified if they were working in high- 
or low-performing PCTs. However, my attempts to arrange interviews in late 2012/early 
2013 were either met with silence or with responses to suggest that I contact them again 
towards late summer/early autumn 2013 when things had ‘settled down’ again following 
the impending reorganisation of the NHS.  This further delayed the start of this study and 
also ultimately posed challenges to the recruitment of participants, as the reorganisation 
itself meant the disbanding of PCTs and displacement of many staff from their original 
posts, and that others, as I later found out, left the NHS altogether. Therefore, the sample 
was also largely dictated by who I could contact, rather than on any purposive sampling to 
explore the differences between high and low performing areas.  This is acknowledged as a 
limitation of the study. In combination with the small sample size, this has meant that my 
findings are unlikely to have reached saturation, and therefore, the findings may be limited 
in their capacity to uncover all salient points.   
Exploring the views of health professionals working in the NHS Cervical Screening 
Programme could still contribute to my understanding of the complex relationship 
between the many factors known to affect cervical screening coverage. There is still a 
great deal of crossover between PCTs and the new Clinical Commissioning Groups (CCGs) 
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so some of the PCT-specific points raised in the interviews continue to have some 
relevance.  Further, the reorganisation of the NHS also opened up the opportunity to 
explore how organisational change may be considered to affect screening coverage.  Of 
course, this did not affect the interpretation of findings from the quantitative studies, as 
these changes were subsequent to the periods included in the earlier studies.  Yet, they 
still provided a vehicle for the health professionals to consider how the organisational 
structure of the NHS, and now Public Health England, may affect screening coverage.   
7.5 Conclusion 
This study provided an opportunity to consider the views of health professionals in the 
NHS Cervical Screening Programme and, as far as I am aware, is the only study to address 
the impact of the NHS reorganisation on the delivery of the NHS Cervical Screening 
Programme.  Screening programme delivery was considered to be strongly supported by 
dedicated staff and good staff training.  The standardisation of screening invitations and 
supporting information was considered to have both positive and negative effects on 
screening coverage.  However, any recommendations for changes to the delivery of the 
NHS Cervical Screening Programme, even at a smaller area-level, need to be considered in 
relation to their effect on other parts of the programme.   Health promotion initiatives 
were considered to require greater evaluation.  Many of the populations already identified 
as being associated with lower screening coverage (deprived, ethnic minority, younger 
women) and levels of knowledge and awareness, previous experiences and emotional and 
practical barriers were considered important areas for consideration.   
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Chapter 8: Potential Mediators of the Association between SES and 
Screening Attendance (Study 5) 
8.1 Introduction 
In Study 3, I investigated the relationship between area-level cervical screening coverage 
and income deprivation, and other area-level factors that may explain the variation in 
cervical screening attendance.  In Study 4, I sought further explanation for the variation in 
PCT-level cervical screening coverage by analysing the views of professionals who work in 
the NHS Cervical Screening Programme.  This enabled me to consider the local factors that 
may affect cervical screening attendance, gather evidence of other factors that are either 
not available through routine data or that may not yet have been considered relevant, and 
to see if the views of the professionals help further explain the evidence I had found to 
date.  In this study I sought to consider women’s individual beliefs about the cervical 
screening programme, and if they mediate the association between socioeconomic status 
and cervical screening attendance.   
A psychological approach was considered appropriate as this addresses the role that 
eligible women’s own perceived benefits of cervical screening play in influencing cervical 
screening attendance.   
Advances in the understanding of health behaviour have been supported by the use of 
social cognition models, an array of theories that have been developed to promote 
understanding of the choices and actions that people make in relation to their health 
(Stephens, 2008).  Broadly, these psychological approaches seek to establish the extent to 
which an individual’s beliefs, knowledge and awareness affect health behaviour.  A full 
introduction of social cognition models is beyond the scope of this thesis but I will provide 
an overview of two of the most prominent models within its realm: the Health Belief 
Model; and the Theory of Planned Behaviour.  This is intended to provide the general 
theoretical framework in which this study operated.    
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The Health Belief Model suggests that health behaviour decisions are based on an 
individual’s perception of disease, their perceived severity of the disease and of their own 
susceptibility to it; the balance of the perceived benefits of taking preventative action and 
the barriers to such action (Becker and Maiman, 1975).  The ultimate likelihood of the 
health behaviour being actioned is also subject to external cues such as health promotion 
campaigns (local or national) and advice from others.  One simplistic interpretation of how 
the Health Belief Model may frame cervical screening attendance could be to suggest that 
attendance would be higher in women who perceive cervical cancer as a personal threat, 
and that any barriers to screening attendance would be outweighed by the women’s 
overall perception of the benefit of cervical screening as a means to prevent cervical 
cancer.   
The Theory of Planned Behaviour, an extension of the Theory of Reasoned Action, suggests 
inter-related concepts such as attitudes towards a behaviour, perceived behavioural 
control and subjective norms form the basis of an individual’s intentions, and that 
intentions predict behaviour (Ajzen, 1991).  The translation from intention to action is 
central to the theory.  Intentions are considered to be constrained, or supported, by an 
individual’s access to resources including money, availability of time or even support from 
others.  In this respect, a health behaviour may be actioned on the basis that the person 
has access to the necessary opportunities or resources for performing the action, and has 
formed the intention of doing so.  One simplistic interpretation of how the Theory of 
Planned Behaviour may frame cervical screening attendance could be to suggest that 
attendance would be higher in women who have formed the intention to attend screening 
based on their perception that cervical screening is beneficial, that they have the means to 
attend and that they know their friends also attend screening.  This intention to attend 
screening would form the basis upon which we could predict their actual attendance.   
The Theory of Planned Behaviour has both similarities to, and differences from, the Health 
Belief Model (Gerend and Shepherd, 2012).  They both take an individual-level approach 
and are largely based upon the assumption that people are rational decision-makers.  The 
concept of perceived barriers from the Health Belief Model may be considered to be 
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similar to the perceived behavioural control of the Theory of Planned Behaviour, insofar as 
they both reflect the extent to which an individual believes they are able to carry out the 
behaviour.  This could also be interpreted as representing the individual’s perceived self-
efficacy in performing the health behaviour. The main difference between the models is 
the integration of intention as a predictor of health behaviour in the Theory of Planned 
Behaviour; although, it has been considered that perceived susceptibility and perceived 
barriers in the Health Belief Model could be viewed as precursors of intention, although 
they are not explicitly declared as such in the model (Gerend and Shepherd, 2012).   
Von Wagner’s et al’s conceptual framework of the psychosocial determinants of 
socioeconomic inequalities in cancer screening participation, draws upon social cognition 
models, as it considers attitudes to mediate the association between socioeconomic status 
and screening attendance (C. von Wagner et al., 2011).  These attitudes include women’s 
response efficacy regarding the beneficial effects of screening (for example, knowledge of 
the benefits of cancer screening and early detection). These attitudes are then 
counterbalanced with the person’s ability to process the information available to them (for 
example, levels of health literacy) and how their overall intentions, or intention to attend 
screening is translated into action.  This is a useful framework for the wider consideration 
of how socioeconomic status may be associated with variation in cancer screening 
attendance.   
I was able to test the mediating role of perceived benefits using data that had been 
collected as part of a population-based survey conducted in 2009.  The survey had been 
designed to  collect data on the Cervical Cancer Awareness Measure (Simon et al., 2011).  
Inevitably, the data items available for use were limited, but they included some items 
about the perceived benefits of cervical screening.  These items provided me with the 
opportunity to explore potential mediators of the association between socioeconomic 
status and cervical screening attendance.   
Evidence has suggested that perceived benefits of cervical screening may be associated 
with cervical screening attendance.   Women who believe ‘there’s no point in going for 
screening without symptoms’ (Waller et al., 2009),  ‘I don’t want to know if they have 
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cervical cancer’ (Lo et al., 2013), or ‘I don’t trust the cervical screening test’ (Sutton and 
Rutherford, 2005) are more likely to be overdue for cervical screening, while women who 
believe that cervical screening is effective are more likely to attend (Sutton and 
Rutherford, 2005).  Other studies indicate that women of lower socioeconomic status are 
less aware of the benefits of screening (Lostao et al., 2001; Sutton and Rutherford, 2005; 
Wardle et al., 2004) and therefore may be less likely to perceive screening attendance as a 
worthwhile health behaviour.   
The aim of the study was therefore to investigate whether perceived benefits of cervical 
screening mediate the association between socioeconomic status and self-reported 
cervical screening attendance.    
8.2 Method 
8.2.1 Recruitment 
The survey was conducted by the social research agency, TNS BMRB12, using random 
location sampling.  The survey runs weekly and comprises of different modules from 
various clients merged into one questionnaire. Participants are recruited using stratified 
random location sampling and are interviewed at home using Computer Assisted Personal 
Interviewing (CAPI) in the presence of trained interviewers (Stubbings et al., 2009).  The 
sample size was 1392 English-speaking women; of whom 933 were between 25 and 64 
years old (i.e. eligible for cervical screening).  Of these, 51 women reported having had a 
hysterectomy, 5 did not know their screening status, 6 declined to answer the screening 
status question, 4 said they had not been invited for a test, 1 did not provide her 
education level, and 2 did not provide their housing tenure; these women were excluded 
from the analyses.  Women aged 25 years (n = 22) were also excluded because they may 
not have received their first screening invitation.  This left a sample of 842.   
                                                        
12 www.tns-bmrb.co.uk 
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No identifiable information was collected from respondents so the data were anonymous 
and therefore exempt from ethical approval.  This is in accordance with the UCL Research 
Ethics Committee Exemptions guidelines, which state that ‘Research involving the use of 
non-sensitive, completely anonymous educational tests, survey and interview 
procedures when the participants are not defined as "vulnerable" and participation will 
not induce undue psychological stress or anxiety’ is exempt (UCL Research Ethics 
Committee, 2015). 
8.2.2 Measures 
Perceived Benefits of Cervical Screening 
As part of a longer interview which included the Cervical Cancer Awareness Measure 
(Simon et al., 2011), some results of which are reported elsewhere (Low et al., 2012), 
perceived benefits of cervical screening were assessed.  Respondents were asked to 
indicate how much they agreed or disagreed with three statements: 1) ‘the chances of 
curing cervical cancer are better when the disease is discovered at an early stage’; 2) 
‘cervical screening can pick up cell changes that can go on to become cervical cancer’; and 
3) ‘cervical screening is effective in preventing cervical cancer’, with response options 
ranging from ‘Strongly Agree’ to ‘Strongly Disagree’ on a 5-point Likert scale.  Respondents 
could also indicate ‘Don’t Know’ or refuse to answer the question; these responses were 
coded as missing and were not included in the analyses.  Responses were dichotomised to 
‘Agree’ (Strongly agree/Agree) vs ‘Do not agree’ (all other responses).   
Screening Status 
Women were asked if they had taken part in cervical screening, and how recently, from 
which a screening status of ‘up-to-date’ or ‘overdue’ was determined.  For women aged 
26–49 years ‘up-to-date’ was defined as having been screened within the last 3 years, and 
for women aged 50–64 years ‘up-to-date’ was defined as having been screened within the 
last 5 years.  Respondents who exceeded these limits, or who had never had a test, were 
classified as ‘overdue’.   
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SES and Demographic Factors 
Included items to assess age, ethnicity, marital status and occupational status (employed 
full-time, employed part-time, or not working/unemployed).   The number of participants 
in any one ethnic minority group was low, so these respondents were grouped together to 
create a dichotomous variable of white or non-white.   Marital status was defined as 
married (including living as married), single and other (including 
separated/divorced/widowed).    
Markers of SES included housing tenure (own outright/with mortgage, rent privately/from 
a housing association), car ownership (yes/no), education and social class.  Education was 
grouped into higher-level (degree); mid-level (A levels/Highers, higher education below 
degree, other or still studying); and low-level (O Level/GCSE, ONC, BTEC and no formal 
qualifications).  Women who responded ‘other’ were placed in this group as they did not 
give evidence of qualifications.   
In Studies 1, 2 and 3, I used the income domain of the IMD as an area-level marker of SES 
but income was not available in the survey data. It was preferable to use the available 
individual-level markers of SES, particularly in light of the analyses of individual-level 
psychosocial data. I explored using different markers of SES. One approach used individual 
level occupational social grade as a measure of SES (see Appendix 8). In this chapter, three 
other markers of SES available (housing tenure, car ownership and education) were used 
to create an index of socioeconomic status, similar to the Townsend Material Deprivation 
Index scores (Townsend et al., 1986).  As discussed in Chapter 2, the Townsend Index is an 
index of area-level socioeconomic deprivation derived from census information on housing 
tenure, car ownership, unemployment and over-crowded households.  Using multiple 
indicators of SES may more ably represent the wider social determinants of health, rather 
than purely focusing on income deprivation (Marmot, 2005). Using the individual-level SES 
data from the survey, SES was indexed by allocating 1 point each for owning a home or 
having a car, plus one point for mid-level education and 2 points for higher-level 
education.  This resulted in scores ranging from 0 (lower SES) to 4 (higher SES), which is 
similar to composite SES measures used in other studies (K. A. Robb et al., 2009; Wardle et 
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al., 2004).  However, in the analyses the two lower SES groups (0 and 1) were combined 
into Group 1 to balance cell sizes.  This resulted in an SES index ranging from 1 to 4.  
8.2.3 Analyses 
A rim weighting technique, created by TNS BMRB, was used to achieve a demographic 
profile within the full sample (n = 1392) that was representative of women in England aged 
16 years and over.  The weights were calculated to give a mean weight of 1 for the full 
sample. Target profiles were set for occupational status, parity, age group, social grade 
and geographical region.  Analysis of the weighted data was carried out using the Complex 
Samples Function in SPSS v21.  Chi-square tests were used to assess the demographic 
differences across the SES for both weighted and unweighted data (unreported).  
Weighted data were used for the analysis of the subsample of data (n = 797).  The mean 
weight of the subsample, was no longer equal to one so when weights were applied, this 
reduced the sample size to 797.  The reduction in sample size was due to the adjustments 
of the weightings and not to missing data within the subsample.   
Mediation analysis was carried using the Baron and Kenny approach (Baron and Kenny, 
1986).  Figure 24 outlines Baron and Kenny’s four-step criteria for mediation, described 
using the variables included in this analyses. Criterion 1: there should be a statistically 
significant relationship between SES and Screening Status (Path C).  Criterion 2: variation in 
the socioeconomic status variable (SES Group) should be significantly associated with 
variation in the potential mediator(s), that is, perceived benefits of cervical screening (path 
A).  Criterion 3: variation in the perceived benefits of cervical screening should be 
significantly associated with variation in Screening Status (Dependent Variable), (path B).  
Criterion 4: that the statistically significant relationship (path C) should no longer be 
significant, or reduced, when Path A and Path B are controlled for.  The method of 
Freedman et al. (1992) was used to estimate the percentage of the effect of SES on 
screening status mediated by the belief variables (Freedman et al., 1992).    
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Figure 24. Adapted from Baron and Kenny Diagram of Statistical Mediation Model (1986) 
 
 
Chi-square tests were used to assess associations between i) screening status and SES 
group, ii) perceived benefits of cervical screening and screening status, and iii) perceived 
benefits and SES group.  The effects of potential mediating variables were examined in 
four logistic regression models on the odds ratios associated with being overdue for 
screening.  Model 1 included univariate analyses of SES and the demographic variables 
(Age, Marital Status and Work Status) found to be statistically significantly associated with 
both screening status and SES. Variables that were significant at the 5% level in the 
univariate analysis were included in the subsequent multivariate analysis and Wald tests 
used to determine which remained significant, given the presence of other independent 
variables.  Models 2 and 3 modelled the independent effects of each belief variable, and 
Model 4 included both belief variables.   A reduction in the Wald tests and odds ratios 
associated with being overdue for screening when other variables were added was taken 
to indicate that these variables mediated some of the effect of SES on screening status. 
The size (percentage) of the mediating effect of SES on screening status was calculated for 
each model (Freedman et al., 1992).     
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8.3 Results 
8.3.1 Sociodemographic Characteristics 
Table 14 details the sample characteristics using weighted data, grouped by SES group.  
Analyses reported here use the weighted data.  Participants were aged 26–64 years (M = 
42.0).  Lower SES groups were more likely to be younger (χ2 = 23.42, df = 6, p = 0.003), 
from non-white ethnic backgrounds (χ2 = 15.99, df = 3, p = 0.001), single (χ2 = 90.78, df = 6, 
p < 0.001), and not working (χ2 = 41.09, df = 6, p < 0.001).  
Table 14. Demographics and SES (1 = lowest SES and 4 = highest SES), (Weighted n = 797) 
 SES Group  
 
1 
(n=180) 
Low SES 
2 
(n=265) 
3 
(n=178) 
4 
(n=174) 
High SES 
Stat. test of group 
difference 
Age % 
26–35yrs 38.6 21.5 23.6 28.4 
χ2 = 23.42, df = 6,  
p = 0.003 36–49yrs 38.1 40.2 42.6 43.8 
50–64yrs 23.3 38.3 33.8 27.8 
Ethnicity % 
White  81.2 92.6 90.9 89.5 χ2 = 15.99, df = 3,  
p = 0.001 Non-white 18.8 7.4 9.1 10.5 
Marital Status % 
Married 46.8 82.7 78.6 76.9 
χ2 = 90.78, df = 6,  
p < 0.001 
Single 32.3 8.5 8.4 10.9 
Other 20.9 8.7 13.0 12.2 
Work Status % 
Full-time 21.8 29.6 47.2 40.8 
χ2 = 41.09, df = 6,  
p < 0.001 
Part-time 35.2 41.3 28.4 37.5 
Not working/ 
unemployed 
43.1 29.1 24.4 21.6 
N.B. Weighted (n = 797) 
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8.3.2 Screening Status, SES and Demographic Variables 
There was a significant association between SES and screening status (see Table 15).  This 
satisfies criterion 1 of the four-steps to mediation (Path C in Figure 24). Women in lower 
SES groups were more likely to be overdue for screening than women in higher SES groups 
(28% in lowest SES vs 12% in highest SES group), but the effect was not linear across the 
intermediate groups.  Younger women were more likely to be overdue than older women 
(23% of 26–35 year-olds vs 14% of 50–64 year-olds). Single women were more likely to be 
overdue than other marital status groups (28% single vs 18% married/other).  Women in 
full-time work were more likely to be overdue than those working part-time (22% vs 14%).  
Ethnicity was not significantly associated with screening status.   
Table 15. Screening Status, SES and Demographic Factors Ɨ, (Weighted n = 797) 
 Screening Status  
 Overdue %  
(n = 154) 
Up-to-date %  
(n = 643) 
Test for 
association 
SES     
1 – Lowest SES Group 27.7 (50) 72.3 (130) 
χ2 = 16.86, df = 
3, p = 0.002 
2 16.8 (44) 83.2 (220) 
3 22.0 (39) 78.0 (139) 
4 – Highest SES Group 12.0 (21) 88.0 (154) 
Age     
26–35 years 23.4 (51) 76.6 (167) 
χ2 = 8.93, df = 2, 
p = 0.016 
36–49 years 21.2 (69) 78.8 (258) 
50–64 years 13.5 (34) 86.5 (218) 
Ethnicity    
White 18.6 (131) 81.4 (576) χ2 = 3.15, df = 1, 
p = 0.066 Non-white 26.3 (23) 73.7 (65) 
Marital Status    
Married 18.0 (104) 82.0 (473) 
χ2 = 6.22, df = 2, 
p = 0.046 
Single 27.7 (32) 72.3 (83) 
Other   18.1 (19) 81.9 (86) 
Work Status    
Full-time 22.0 (54) 78.0 (192) 
χ2 = 6.38, df = 2, 
p = 0.047 
Part-time 14.1 (37) 85.9 (224) 
Not working/unemployed 20.7 (44) 79.3 (168) 
 Ɨ May not add to 100% (797) due to rounding or missing values 
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Potential explanatory variables (age, marital status and work status) were all associated 
with both SES and screening status so these variables were considered for inclusion in the 
multivariate analyses.  The associations between these explanatory variables are reported 
in Table 16.  The variables were tested for collinearity using the Tolerance and Variance 
Inflation Factor (VIF) in SPSS.  All variables were in the range 0.799 – 0.951 for Tolerance 
and 1.051 – 1.252 for VIF and therefore collinearity was not detected.  
Table 16. Inter-relationship between potential explanatory variables and belief variables 
 Age Ethnicity Marital 
Status 
Work 
Status 
The 
chances 
of curing 
cervical 
cancer 
are 
better... 
Cervical 
screening 
can pick 
up cell 
changes… 
Age 
 
-      
Ethnicity 
 
 
χ2=30.27, 
df=2, 
p<.001 
-     
Marital Status 
 
 
χ2=97.38, 
df=4, 
p<.001 
χ2=17.89, 
df=4, 
p<.001 
-    
Work Status 
 
 
χ2=12.40, 
df=4, 
p=.015 
χ2=15.32, 
df=4, 
p<.001 
χ2=23.58, 
df=4, 
p<.001 
-   
The chances of 
curing cervical 
cancer are better... 
 
χ2=21.69, 
df=4, 
p<.001 
χ2=38.36, 
df=2, 
p<.001 
χ2=15.46, 
df=4, 
p=.004 
χ2=6.28, 
df=4, 
p=.180 
-  
Cervical screening 
can pick up cell 
changes…. 
 
χ2=31.90, 
df=4, 
p<.001 
χ2=87.89, 
df=2, 
p<.001 
χ2=10.88, 
df=4, 
p=.028 
χ2=16.13, 
df=4, 
p=.003 
χ2=171.37
, df=4, 
p<.001 
- 
Cervical screening 
is effective… 
χ2=8.73,  
df=4, 
p=.068 
χ2=6.05,  
df=2, 
p=.048 
χ2=4.59,  
df=4, 
p=.332 
χ2=2.84,  
df=4, 
p=.585 
χ2=118.09
, df=4, 
p<.001 
χ2=87.06 
df=4, 
p<.001 
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8.3.3 SES Differences in Perceived Benefits of Cervical Screening 
Associations between SES and the belief variables are shown in Table 17.   Of the highest 
SES group, 99% agreed the ‘chances of curing cervical cancer are better when the disease 
is discovered at an early stage’ compared with 88% of the lowest SES group and 96% vs 
83% agreed that ‘cervical screening can pick up cell changes that can go on to become 
cervical cancer’.  Agreeing that ‘cervical screening is effective in preventing cervical cancer’ 
was not significantly associated with SES.  The perceived benefits ‘the chances of curing 
cervical cancer are better when the disease is discovered at an early stage’ and ‘cervical 
screening can pick up cell changes that go on to become cervical cancer’ satisfied Criterion 
2 of the four-step criteria for mediation (Path A).  
Table 17. Perceived benefits of cervical screening by SES Ɨ, (Weighted n= 797) 
 % (n)  
 SES 1 
(n = 180) 
Low 
SES 2 
(n = 265) 
SES 3 
(n = 178) 
SES 4 
(n = 174) 
High 
Test for 
association 
The chances of curing cervical cancer 
are better when…. 
Agree 88.0 (158) 93.6 (248) 97.6 (174) 99.1 (172) χ2=26.33, 
df=3,  
p < 0.001 
Disagree/Neither 
12.0 (21) 6.4 (17) 2.4 (5) 0.9 (2) 
 
Cervical screening can pick up cell  
changes…. 
Agree 83.2 (148) 90.5 (240) 95.3 (168) 96.4 (167) χ2=25.47, 
df=3,  
p < 0.001 
Disagree/Neither 
16.8 (30) 9.5 (25) 4.7 (8) 3.6 (6) 
 
Cervical screening is effective in  
preventing cervical cancer 
 
Agree 85.1 (153) 74.9 (198) 80.3 (143) 82.8 (144) χ2=8.55, 
df=3,  
p=0.06 
Disagree/Neither 
14.9 (27) 25.1 (66) 19.7 (35) 17.2 (30) 
Ɨ Numbers may not agree with total due to rounding or missing values 
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8.3.4 Screening Status and Beliefs about Cervical Screening 
The next set of analyses examined the association between screening status and the 
perceived benefit variables (see Table 18).  Two of the three perceived benefits of cervical 
screening showed significant associations with screening status.  Women who were up-to-
date were more likely to agree that the ‘chances of curing cervical cancer are better when 
the disease is discovered at an early stage’ than those who were overdue (96% vs 89%).  
They were also more likely to agree that ‘cervical screening can pick up cell changes that 
can go on to become cervical cancer’ (93% vs 85%).  There was no significant association 
with agreeing that ‘cervical screening is effective in preventing cervical cancer’.  The 
perceived benefits ‘the chances of curing cervical cancer are better when the disease is 
discovered at an early stage’ and ‘cervical screening can pick up cell changes that go on to 
become cervical cancer’ satisfied Criterion 3 of the four-step criteria for mediation (Path 
B). 
Table 18. Perceived benefits of cervical screening by screening status Ɨ, (Weighted n = 797) 
 
Overdue 
(n = 154) 
Up-to-
date 
(n = 643) 
Test for 
association 
The chances of curing cervical cancer are better  
When the disease is discovered at an early stage 
Agree 89.0 (137) 95.8 (615) χ2 = 11.53, df = 
1, 
p < 0.001 
Disagree/Neither 11.0 (17) 4.2 (27) 
 
Cervical screening can pick up cell changes that 
can go on to become cervical cancer 
Agree 85.2 (130) 92.6 (593) χ2 = 9.02, df = 
1, p = 0.002 Disagree/Neither 14.8 (23) 7.4 (47) 
 
Cervical screening (the smear or Pap test) is 
effective in preventing cervical cancer 
Agree 76.0 (117) 81.1 (521) χ2 = 2.13, df = 
1, p = 0.154 Disagree/Neither 24.0 (37) 18.9 (121) 
Ɨ Numbers may not agree with total due to rounding or missing values 
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8.3.5 Mediational Analyses of the Relationship between SES and Screening Status 
Four logistic regression models with screening status (overdue/up-to-date) as the 
dependent variable tested mediation.  Odds ratios (OR) for being overdue are shown in 
Table 19. 
Model 1 
Model 1 included univariate analyses of SES, age, marital status and work status (with 
Wald F, p-values and ORs for the variables shown in Table 19).  Age was significantly 
associated with being overdue for screening, Wald F (3.829), p = 0.022. Women aged 50-
64 years were less likely to be overdue for screening (OR = 0.37, 95% CI: 0.20 – 0.69) in 
comparison to younger women aged 25-35 years. Marital Status was significantly 
associated with being overdue for screening, Wald F (3.089), p = 0.046. Single women 
were more likely to be overdue for screening than married women (OR = 1.75, 95% CI: 
1.12-2.74), p = 0.046.  Work Status, overall, was not significantly associated with being 
overdue for screening, Wald F (2.833), p = 0.059, although there were indications that 
women who worked part-time were less likely to be overdue for cervical screening than 
those who worked full-time (OR = 0.58, 95% CI: 0.36 – 0.94).   
SES was significantly associated with being overdue for screening, Wald F (5.461) p= 0.001. 
The lower SES groups were significantly more likely to be overdue for screening than the 
highest SES group (reference category), with the exception of SES Group 2 where the size 
of the effect was non-significant (OR = 1.64, 95% CI: 0.88–3.07).  The OR for being overdue 
for screening in the lowest SES group was 3.34 (95% CI: 1.77–6.29).  This satisfied Criterion 
1, that there should be a statistically significant relationship between SES and Screening 
Status, of the four-steps of mediation (Path C, Figure 24).   
Model 2 
Model 2 included SES, the control variables that had been statistically significant in Model 
1 (age and marital status), and the perceived benefit of screening ‘the chances of curing 
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cervical cancer are better when the disease is discovered at an early stage’.  Neither Age 
nor Marital Status were significantly associated with screening status, Wald F (2.237), p = 
0.107 and Wald F (0.522), p = 0.594 respectively.   
The perceived benefit was associated with screening attendance, where the OR for being 
overdue for screening was statistically significant for those who disagreed or neither 
agreed nor disagreed with the statement (OR = 2.19, 95% CI: 1.20–3.99), Wald F (6.578), p 
= 0.010.  
This model showed a reduction in the odds ratios associated with being overdue across 
SES groups in comparison with Model 1 and a reduction in statistical significance, Wald F 
(3.166), p = 0.024.  The OR for being overdue for screening in the lowest SES group was 
2.31 (95% CI: 1.26–4.27).   This indicates that this variable may mediate some of the 
association between SES and screening status to a small degree.   
This satisfied Criterion 4, that the statistically significant relationship (Path C, Figure 24) 
should no longer be significant, or should be reduced, when the potential mediators and 
other control variables are accounted for. Freedman’s estimate for the percentage of the 
association between deprivation in the lowest SES group (SES Group 1) and screening 
status mediated by this perceived benefit variable is 30.8%.   
Model 3 
Model 3 included SES, the control variables that had been statistically significant in Model 
1, and the perceived benefit ‘Cervical screening can pick up cell changes that can go on to 
become cervical cancer’.  Neither Age nor Marital Status were associated with screening 
status, Wald F (2.220), p = 0.109 and Wald F (0.547), p = 0.579 respectively.   
The perceived benefit variable was associated with screening status, where the odds for 
being overdue for screening for screening were statistically significant for those who 
disagreed or neither agreed nor disagreed with the statement (OR = 1.77, 95% CI: 1.05–
3.00), Wald F (4.664), p 0.031. Women in SES groups 1 and 3 had significantly increased 
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odds of being overdue for screening compared with women in the highest SES group. The 
odds ratios were lower in this model in comparison with Model 1 and there was a 
reduction in statistical significance, Wald F (3.045), p = 0.028.  
This result could be considered to have satisfied Criterion 4, that is, that the statistically 
significant relationship (Path C, Figure 24) should no longer be significant, or should be 
reduced, when the potential mediators and other control variables are accounted for.  
Freedman’s estimate for the percentage of the association between deprivation in the 
lowest SES group (SES Group 1) and screening status mediated by this perceived benefit 
variable is 31.7%.     
Model 4 
Model 4 included SES and both perceived benefit variables, but no longer included Age 
and Marital Status as they were no longer significantly associated with Screening Status in 
Models 3 and 4).  
The perceived benefit of screening ‘the chances of curing cervical cancer are better when 
the disease is discovered at an early stage’ remained significantly associated with 
screening status where those who disagreed or neither agreed no disagreed were more 
likely to be overdue for screening (OR = 2.01, 95% CI: 1.04 – 3.89), Wald F (4.337), p = 
0.038.  However, the perceived benefit ‘Cervical screening can pick up cell changes that 
can go on to become cervical cancer’ was no longer significantly associated with screening 
status, Wald F (2.020), p = 0.156.   
Women in SES groups 1 and 3 had significantly increased odds of being overdue for 
screening compared with women in the highest SES group. The odds ratios were lower in 
this model in comparison with Model 1 and there was a reduction in statistical 
significance, Wald F (3.531), p = 0.015.  
This satisfied Criterion 4, that the statistically significant relationship (Path C) should no 
longer be significant, or should be reduced, when the potential mediators and other 
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control variables are accounted for.  Freedman’s estimate for the percentage of the 
association between deprivation in the lowest SES group (SES Group 1) and screening 
status mediated by this perceived benefit variable is 31.1%.   
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Table 19. SES and perceived benefit predictors for being overdue for screening 1 
 Overdue 
% (n) 
Model 1 
 
Wald F, p 
OR (95% CI) 
Model 2 
Incl. Chances of Cure..  
Wald F, p 
OR (95% CI) 
Model 3 
Incl. Screening Picks Up… 
Wald F, p 
OR (95% CI) 
Model 4 
Both Variables 
Wald F, p 
OR (95% CI) 
SES Group   F (5.461), 0.001 F (3.166), 0.024 F (3.045), 0.028 F (3.531), 0.015 
1 (n = 180) 27.7 (50) 3.34 [1.77–6.29] 2.31 [1.26–4.27] 2.28 [1.23–4.21] 2.30 [1.26–4.19] 
2 (n = 265) 16.8 (44) 1.64 [0.88–3.07] 1.46 [0.80–2.69] 1.49 [0.81–2.74] 1.36 [0.74–2.49] 
3 (n = 178) 22.0 (39) 2.48 [1.30–4.72] 2.10 [1.12–3.94] 2.15 [1.15–4.02] 2.04 [1.09–3.83] 
4 (high SES, n = 174) 12.0 (21) 1.00 1.00 1.00 1.00 
Age  F (3.829), 0.022 F (2.237), 0.107 F (2.220), 0.109  
26–35 years 23.4 (51) 1.00 1.00 1.00  
36–49 years 21.2 (69) 0.96 [0.63-1.48] 0.98 [0.65-1.49] 0.96 [0.63-1.47]  
50–64 years 13.5 (34) 0.37 [0.20-0.69] 0.60 [0.36-1.01] 0.60 [0.36-1.01]  
Marital Status  F (3.089), 0.046  F (0.522), 0.594 F (0.547), 0.579  
Married 18.0 (104) 1.00 1.00 1.00  
Single 27.7 (32) 1.75 [1.12-2.74] 1.29 [0.79-2.11] 1.30 [0.79-2.14]  
Other  18.1 (19) 1.01 [0.59-1.72] 1.02 [0.58-1.79] 1.04 [0.59-1.82]  
Work Status  F (2.833), 0.059    
Full-time 22.0 (54) 1.00    
Part-time 14.1 (37) 0.58 [0.36-0.94]    
Not working/unemployed 20.7 (44) 0.78 [0.50-1.24]    
The chances of curing cervical cancer…   F (6.578), 0.010  F (4.337), 0.038 
Disagree/Neither Agree Nor Disagree 11.0 (17)  2.19 [1.20–3.99]  2.01 [1.04–3.89] 
Agree 89.0 (137)  1.00  1.00 
Cervical screening can pick up cell changes…    F (4.664), 0.031 F (2.020), 0.156 
Disagree/Neither Agree Nor Disagree 14.8 (23)   1.77 [1.05–3.00] 1.53 [0.85–2.74] 
Agree 85.2 (130)   1.00 1.00 
1.  Reference Category (Up To Date) n = 643, overdue n = 154.  
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8.4 Discussion 
As expected from the results found in Study 1 and Study 2, being overdue for cervical 
screening was more common in women from lower socioeconomic backgrounds.  The 
finding is also consistent with previous research which has associated lower levels of 
cervical screening attendance with women of lower socioeconomic status (Baker and 
Middleton, 2003; Bang et al., 2012; Moser et al., 2009).   
The statements ‘The chances of curing cervical cancer are better when the disease is 
discovered at an early stage’ and ‘Cervical screening can pick up cell changes that can go 
on to become cervical cancer’ were endorsed more readily by those who were up-to-date 
with screening and in the higher SES groups.  Using the Baron and Kenny approach, it is 
possible to infer that the two beliefs explained 31% of the association between SES and 
screening status; consistent with the idea that socioeconomic differences in beliefs about 
screening might be a pathway to socioeconomic differences in screening behaviour. 
However, it is acknowledged that these findings should be interpreted cautiously given 
that causality cannot be inferred with cross-sectional data.  
The results are consistent with existing evidence of disparities in perceived benefits of 
cervical screening (Lo et al., 2013; Robb et al., 2010; Sutton and Rutherford, 2005; Wardle 
et al., 2004).  In particular, the view that cervical cancer is better diagnosed at an early 
stage was more readily endorsed by higher SES groups in both Model 2 and Model 4.  It 
may be that women of lower socioeconomic status are more likely to know of someone 
who has died of cervical cancer, as mortality rates of cervical cancer are higher and 
survival rates are poorer for this group.  This may contribute to this group being less likely 
to endorse the benefits of cervical screening.  Hence, the more sceptical views of the 
lowest SES group may explain, at least is some small part, their lower attendance at 
cervical screening.  Lower SES groups have been found to be more fatalistic about cancer 
and place lower value on its early detection (Beeken et al., 2011).   
Current research of socioeconomic variation in known barriers to screening may broaden 
the potential avenues in which to explore other individual-level mediators of 
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socioeconomic status and cervical screening attendance.  Cancer fatalism, a belief that 
death is inevitable when cancer is diagnosed, has been found to mediate the association 
between socioeconomic status and colorectal cancer screening (Miles, Rainbow, & 
Wagner, 2011).  SES differences in fatalistic beliefs are also implicated in socioeconomic 
variation in the perceived value of early detection of cancer and in help seeking with a 
potential symptom of cancer (Beeken, Simon, Wagner, Whitaker, & Wardle, 2011).  
A recent study of positively and negatively framed cancer beliefs found significant 
variation in the endorsement of negatively framed cancer beliefs across SES groups 
(Quaife et al., 2015).  However, there was little SES variation in positive cancer beliefs, of 
which one stated ‘cancer can often be cured’.  This may help explain the results of this 
study.  It may be that while the positively framed messages used in this study were 
significantly associated with screening status, it may be that a negatively framed cancer 
belief may have explained a higher percentage of the association between SES and 
screening status.   
Cancer fear, a multifaceted construct, has been associated with colorectal cancer 
screening, however, different aspects of cancer fear appear to support or hinder screening 
attendance (Vrinten, Waller, Wagner, & Wardle, 2015). This may be because some aspects 
of cancer fear may act to support the intention to attend screening, while others aspects 
have more relevance to the translation of those intentions into action (Power et al., 2008).  
However, cancer fear has been found to be particularly prevalent among women rather 
than men, and in those with lower levels of education (Vrinten, Jaarsveld, Waller, Wagner, 
& Wardle, 2014) rendering the exploration of its potential relationship with cervical 
screening attendance to be an important avenue for further investigation.   
Health literacy may be another contender for further investigation. Higher levels of wealth 
(Kobayashi, Wardle, & von Wagner, 2014) and higher levels of education are associated 
with better health literacy and may act as a mediator of better health (Galobardes, Shaw, 
Lawlor, Lynch, & Smith, 2006).  Lower health literacy has been associated with lower levels 
of information seeking and confidence to participate in cancer screening (von Wagner, 
Semmler, Good, & Wardle, 2009), and has also been identified as a barrier to colorectal 
cancer screening uptake (Kobayashi et al., 2014).  As far as I am aware, neither cancer 
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fatalism, cancer fear nor health literacy have been explored as a potential mediators of the 
association between SES and cervical screening attendance.   
Younger women and women in full-time work were more likely to be overdue for cervical 
screening. This may suggest that life difficulties and practical barriers play a part in 
undermining screening attendance.  In the previous chapter, Study 4, professionals who 
work in the NHS Cervical Screening Programme considered women’s busy lives, lack of 
time and difficulty getting childcare as barriers to cervical screening attendance. Younger 
women, rather than older women, were found to raise practical issues more commonly 
than other barriers to screening in a qualitative study (Waller et al., 2011).  This was 
supported by findings in a related qualitative study of professionals’ views of barriers to 
cervical screening attendance where difficulties in finding time to attend screening were 
considered to be a particular challenge for younger women who were working and/or had 
children to look after (Waller et al., 2011).  Findings from a population-based survey 
carried out in England in 2008–09 found practical barriers to be predictive of cervical 
screening attendance (Waller et al., 2009).  It is not known if practical barriers mediate the 
association between socioeconomic status and cervical screening attendance but, given 
the apparent relevance of these issues to cervical screening attendance, further research 
in this area may be warranted.   
The consideration of social cognition models in this study has provided a useful framework 
for understanding health behaviour. However, social cognition models can be limited in 
the extent to which an individual’s actions are set within a social and cultural context 
(Crossley, 2000).  Although some social cognition models do take into account the effects 
of peer-group pressure or social norms these may not reach the level of sophistication 
required to fully understand socioeconomic patterns of health behaviour.  Social cognition 
models have been criticised for their over reliance on the rational evaluation of health 
choices and therefore may not sufficiently accommodate for behaviours that do not 
appear logical.  This may marginalise the wider inclusion of emotional factors, socio-
cultural factors and issues of power or freedom of choice.  One example in which cultural 
factors may affect screening may be where a woman needs to seek permission from a 
spouse to attend screening, or hide their attendance from their partner (Holroyd et al., 
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2004), although given the predominantly white sample in this survey this consideration, 
and other socio-cultural or religious factors were not considered relevant to this study.   
8.4.1 Strengths and Limitations 
The primary focus of the survey was to collect data on the Cervical Cancer Awareness 
Measure (Simon et al., 2011), and it was not specifically designed to explore SES and 
cervical screening.  This limited the study in two key areas: the sample size; and the 
availability of relevant independent variables.   
With regards to the sample size, it was important that the beliefs about cervical screening 
were gathered from women who were eligible for the programme at the time of the 
survey.  As a consequence, a subsample of eligible women (n = 842) from the full survey 
sample (n = 1392) were selected for analysis.  This number was further reduced when 
weights, constructed by BMRB for the full sample, were applied to the subsample.  
However, sensitivity analyses undertaken to assess the demographic differences across the 
SES for both weighted (n = 797) and unweighted data (n = 842) found no significant 
differences.   
The study was also limited in its ability to test the mediating effects of other belief 
variables or other pathways to socioeconomic variation in cervical screening attendance.  
In particular, it would have been interesting to have explored any potential differences in 
SES variation in the endorsement of positive and negatively framed beliefs on screening 
status, or to include other items that may have explored cancer fear or fatalism.    
The use of the SES index may have limited the findings in this study. This may be due to 
critique of the individual components of the index or the combined effect of these 
individual components may not adequately represent an individual’s socioeconomic 
status, or both (Braveman PA et al., 2005).  The SES index comprised car ownership, home 
ownership and education. Asset based SES indictors such as car ownership and home 
ownership may be subject to different interpretations across place or time, as wider 
economic circumstances vary.  The Townsend Index uses similar area-level measures 
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(Townsend et al., 1986).  However, the mediation effects were also analysed using 
individual level occupational social grade (see Appendix 8) with similar results.   
While the Baron and Kenny approach to mediation has been used extensively, it has been 
subject to criticism (Krause et al., 2010; Zhao et al., 2010) which may limit the 
interpretation of the potential mediating effects. Two key areas of criticism relate to the 
criteria set by Baron and Kenny: 1) that a statistically significant relationship needs to be 
determined between the independent and dependent variable before commencing with 
the mediation analyses (Path C, Figure 24). In this study that relates to the association 
between SES and screening status; and 2) that the aforementioned statistically significant 
relationship becomes non-significant when the potential mediator variables are entered 
into the model (Krause et al., 2010).  
In relation to 1) it is argued that a significant relationship between the independent and 
dependent variables may not be discernible if the association is subject to either 
suppression or dilution (Krause et al., 2010).  Suppression is where two or more mediators 
may cancel each other, for example, where one mediator may support a positive 
association between SES and screening status and another mediator may support a 
negative association between SES and screening status.  In this study, the relationship 
between SES and cervical screening behaviour was statistically significant and therefore 
this point may not be relevant.  However, even if it were not statistically significant, both 
beliefs entered into the model had the same directional effect.  Dilution may occur should 
the association between the SES and screening status be distant, perhaps where more 
than one mediator is linked.  For example, it may be considered that perceived benefits of 
cervical screening and practical barriers to cervical screening may be linked in a pathway 
from SES to screening status.  For example, perhaps perceived benefits of cervical 
screening are linked to the motivation to overcome practical barriers to cervical screening 
attendance, and that it is this linked association that more accurately describes the 
relationship between socioeconomic status and cervical screening attendance.  If this were 
the case, then the association between SES and screening status may be found to be 
weaker or, indeed, not statistically significant.   
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Point 2) is in relation the Baron and Kenny criteria that the statistically significant 
relationship between the independent and dependent variables (Criterion 4, see Analyses 
section) should become non-significant to demonstrate that the variable(s) being tested 
do indeed mediate the association, in this case between SES and screening status.  This is 
considered to be problematic since the difference may be trivial if the initial direct effect 
relationship was only marginally significant, for example p = 0.049.  However, in this 
instance used in this example, mediation was inferred if the Odds Ratios were reduced, 
and the extent of the mediating effect estimated using Freedman’s method (Freedman et 
al., 1992). 
Other criticisms of the Baron and Kenny approach suggest that the individual criteria as 
laid out in the steps to mediation are not necessarily independent and that structural 
equation models (SEM) that estimate the overall effect simultaneously may be a superior 
method to determine mediation (Zhao et al., 2010). Finally, since the data in the study 
were derived from a cross-sectional survey, causation cannot be assessed.  Longitudinal 
data may be better placed to identify robust mediational effects because it can consider if 
the effect is maintained over time, or if it may be subject to particular conditions 
(MacKinnon et al., 2007).   
Further limitations of the study include that the cervical cancer screening status was self-
reported, and therefore may be subject to recall bias. A meta-analyses of self-reported 
cancer screening attendance in the USA indicated that national survey data may 
underestimate actual screening attendance (Rauscher et al., 2008).  I am unable to 
accurately report a response rate for this survey as TNS do not record the number of 
households they attempt to recruit from.   
8.5 Conclusion 
This study provided an opportunity to consider the beliefs of women eligible for an 
invitation to the cervical screening programme within my thesis.  Beliefs about the 
benefits of cervical screening were found to mediate the association between 
socioeconomic status and screening attendance.  The study demonstrated an alternative 
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approach to further understanding of socioeconomic inequalities in cervical screening 
attendance.  This approach may uncover salient factors that mediate the association 
between socioeconomic status and screening attendance, and therefore it has the 
potential to inform future strategies for intervention.  This is useful because it may be 
considered relatively easier to address downstream issues, such as perceptions of 
screening, than upstream factors such as income deprivation or lower levels of education. 
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Chapter 9: Socioeconomic Variation in Attendance at Colposcopy 13 
(Study 6) 
9.1 Introduction 
As highlighted in Chapter 1, colposcopy is an essential part of the NHSCSP.  Women who 
receive an abnormal screening result are referred to colposcopy for further diagnosis and 
treatment.   Non-attendance increases risk that cervical abnormalities are not treated and, 
consequentially, increases risk of cervical cancer incidence and mortality.  Cervical 
screening is only protective if further advice, or medical intervention when required, is 
followed.   
National colposcopy attendance rates are published annually by the NHS Cervical 
Screening Programme (NHSCSP) (Health and Social Care Information Centre, 2012a).  The 
attendance data are sourced from colposcopy clinics using what is known as the KC65 
return.  The KC65 was introduced in 2001 as part of the NHS Cancer Information Strategy 
which aimed to improve the delivery of care to those with cancer, or suspected cancer 
(HSCIC, 2013).  The data gathered by the KC65 are used as a quality assurance measure of 
the colposcopy clinic performance at local, regional and national levels, and also informs 
the progress of the government’s target to reduce invasive cervical cancer incidence.  The 
minimum data required by the KC65 include the number of women referred to colposcopy 
by referral indication (screening test or clinical indication) and result of referral screening 
test (inadequate, borderline changes, mild/moderate/severe dyskaryosis, severe 
dyskaryosis/?invasive carcinoma, ?glandular neoplasia, and other); time from referral to 
first appointment (less than or equal to two weeks, two to four weeks, four to eight weeks, 
eight to twelve weeks, over twelve weeks); first attendance by type of procedure (no 
treatment, diagnostic biopsy (punch), excision, ablation and biopsy result, if known) and 
result of referral; waiting times for time from biopsy to informing patient of result; and 
biopsies by type and outcome.  Where time from referral to first (and subsequent) 
appointment is recorded, the appointment type (first appointment, treatment or follow-
                                                        
13 A version of this paper has been published in the British Journal of Cancer and can be found in 
Appendix 10 (Douglas, Wardle, Massat & Waller, 2015). 
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up) is also reported, alongside the appointment status (attended, cancelled by patient – in 
advance, cancelled by patient – on the day, cancelled by clinic, did not attend (DNA) – no 
advance warning, DNA – arrived late, DNA – left without being seen).  These data enabled 
attendance at appointment level, including patient and clinic cancellations, to be 
monitored (HSCIC, 2013).   
9.1.1 Colposcopy Attendance 
In England almost 440,000 colposcopy appointments were made in 2012–13 (Health and 
Social Care Information Centre, 2013).  These comprised new referrals following an 
abnormal screening result, return for treatment and follow-up appointments.  
Approximately 205,000 new referrals to colposcopy were made in England in this year, of 
which around 30,000 appointments (14.8%) were cancelled by either the patient or the 
clinic and around 16,000 appointments (7.6%) were not attended by the patient without 
advance warning (Health and Social Care Information Centre 2012).  There were 
approximately 33,000 return for treatment appointments, of which around 4,300 (12.9%) 
were cancelled by the patient or clinic and around 1,300 (4%) were not attended.  The 
lowest levels of attendance were reported for follow-up appointments where around 
41,000 (20.5%) of the 200,000 follow-up appointments were cancelled by the patient or 
clinic, and around 27,000 (13.5%) were not attended without advance warning.   
While access to the NHS Cervical Screening Programme, including colposcopy, is free at 
the point of access, there are substantial costs attached to the programme to carry out 
cytological surveillance, and further diagnoses and treatment where necessary (TOMBOLA 
Group, 2009).  I am unaware of any published costs that are specific to missed colposcopy 
appointments, however, in 2012–13, it was estimated that missed outpatient hospital 
appointments cost the NHS around £108 per appointment (NHS England, 2014).  Non-
attendance at colposcopy is therefore likely to represent a substantial, financial burden to 
the NHS, in addition to the aforementioned health risks for women.   
The patterns of cancellation and non-attendance reported in 2012 –13 (Health and Social 
Care Information Centre, 2013) are reflective of data reported in other annual reports  
(Health and Social Care Information Centre, 2012a; NHS Information Centre, Screening and 
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Immunisations Team, 2011).  These data indicate that the percentage of appointments 
that are cancelled or not attended may vary according to the appointment type: first 
referral, return for treatment, or follow-up.  Across all types of appointments cancellations 
were more frequent than non-attendance without advance notice.  First referral and 
follow-up colposcopy appointments have particularly high cancellation and non-
attendance rates.  However, these appointment-level data do not provide the opportunity 
to assess patient-level attendance.  That is, to assess if a women who cancels one 
appointment does attend a subsequent appointment within a reasonable timeframe.   
A review of non-attendance at colposcopy from 1986 to 1997 sought clarity on non-
attendance rates by reviewing a number of studies that tracked both patient and 
appointment-level attendance (Lester and Wilson, 1999).  Like the KC65 reported data, the 
scale of non-attendance was found to vary according to the type of appointment: first 
referral, assessment/treatment, or follow-up.  However, the authors found the extent of 
non-attendance difficult to clearly establish for a number of reasons.  Firstly, the definition 
of non-attendance varied widely across studies.  Non-attendance may be referred to as 
default, patient compliance, patient adherence, treatment refusal and dropout.   Secondly, 
the measure of what constituted non-attendance was defined by the attendance rate 
definition, which was also found to be subject to wide variation.  Attendance rate 
definitions included, but were not limited to, the following: the proportion of women who 
attended within 18 months of appointment; the proportion of women who attended 
within 6 months of original appointment; the proportion of women who ever attended; 
and the proportion of women who eventually attended.  It was difficult to meaningfully 
compare the extent of non-attendance across the studies and, therefore, to meaningfully 
generalise national rates of attendance/non-attendance.  Despite these difficulties the 
authors suggested that non-attendance rates may be in the realms of 3%, 11% and 12% for 
what they respectively term assessment/treatment, first and second follow-up 
appointments (Lester and Wilson, 1999).  
Generalisability of the extent of non-attendance may also be hampered by the pragmatic 
way in which many research studies gather data.  Since there is no central database of 
patient-level colposcopy attendance, research studies are dependent upon access to data 
from individual colposcopy clinics or as part of other clinical trials that are not necessarily 
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set up to specifically address colposcopy non-attendance.  A study of colposcopy non-
attendance in an Aberdeen clinic in 1989–1991 found around 12% did not attend their first 
follow-up appointment and 20% did not attend their second follow-up appointment 
(Flannelly et al., 1994).  Another study using data from a colposcopy clinic in Fife, Scotland 
in 1999 found colposcopy non-attendance rates of around 10% for assessment, 19% for 
first follow-up and 20% for second follow-up (Patterson et al., 1995).  In 1999–2002, the 
Trial of Management of Borderline and Other Low-grade Abnormalities (TOMBOLA), a 
randomised control trial, was set up within the Cervical Screening Programme across three 
areas in the UK – Grampian and Tayside in Scotland, and Nottinghamshire in England – to 
evaluate if cytological surveillance or colposcopy was the most efficient strategy for the 
management of borderline and low-grade abnormalities (Cotton et al., 2006).  As such, it 
provided a good opportunity to assess a number of issues related to colposcopy 
attendance across multiple locations and colposcopy clinics.  Non-attendance rates of the 
2,213 women randomised to colposcopy within the trial were around 7%.  This figure 
differs somewhat from the aforementioned non-attendance rates within Scottish 
colposcopy clinics and, indeed, from those suggested in Lester and Wilson’s (1999) paper.  
The differences may be due to differences in the way the data were collected.  
9.1.2 Socioeconomic Variation in Colposcopy Non-attendance 
Evidence for socioeconomic or sociodemographic variation in colposcopy attendance is 
scarce.  TOMBOLA did, however, investigate the association between socio-demographic 
and lifestyle characteristics and colposcopy attendance in the colposcopy arm of the trial.  
Older women (aged 40–59 years) and those who had received post-school education were 
more likely to attend colposcopy, while women who were not in paid employment and 
those who were current smokers were significantly less likely to attend colposcopy.  A 
retrospective study of appointment records from a colposcopy clinic in Wales in 1996–
1998 found younger women more likely to not attend colposcopy (Kiran and 
Jayawickrama, 2002).  Another retrospective study of attendance at a colposcopy clinic in 
Newcastle, England in 1989–90 found women who did not attend were significantly more 
likely to be younger, of lower social class and to be resident in more deprived areas 
(Sanders et al., 1992).  Late attendance at follow-up cervical cytology tests (another arm of 
the TOMBOLA trial) was associated with non-attendance at a subsequent follow-up 
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appointment, and has also been associated with lower levels of post-school education 
(Sharp et al., 2012b).   
The TOMBOLA group also investigated variation in attendance by ethnic group but did not 
find any significant difference between white and non-white participants (Sharp et al., 
2012a). However, their study population was 95% white and therefore may not have been 
able to detect any underlying differences.  However, ethnicity was found to have a linear 
association with colonoscopy uptake following a positive faecal occult blood test result in 
the NHS Bowel Cancer Screening Programme (Morris et al., 2012).   
9.1.3 Non-attendance at Colposcopy as a Risk Factor for Cervical Cancer 
The NHSCSP audit of invasive cervical cancer states that a delay in colposcopy attendance 
following referral from an abnormal cytology result is particularly significant as this 
suggests delay in providing diagnosis and treatment, or the return of a previously treated 
cervical abnormality (NHS Cancer Screening Programme, 2011).   A ‘screen detected’ 
cervical cancer is defined by the audit as ‘a cancer that is diagnosed after a referral to 
colposcopy, where that referral is due to a cytology test taken at least 3 weeks, and no 
more than 4 months, prior to diagnosis’.   
The Colposcopy and Programme Management Guidelines (2nd Edition) state that default 
rates should be no more than 15% (NHS Cancer Screening Programme, 2010).  Cancer 
policy requires colposcopy clinics to have written protocols for the management of non-
attenders and sets standards for the recommended duration between referral to 
colposcopy and first offered appointment (NHS Cancer Screening Programme, 2011).  The 
policy states that at least 90% of all women should be offered a colposcopy appointment 
within eight weeks of referral, and more quickly if the cytology results suggest moderate 
or severe dyskaryosis (within four weeks of referral) or severe/?invasive or ?glandular 
neoplasia (within two weeks of referral). In 2012–13, the NHSCSP in England met all these 
objectives: 98% of all referrals were offered an appointment within 8 weeks; 97% of 
referrals with moderate or severe dyskaryosis were offered an appointment within 4 
weeks; 94% of referrals with severe/?invasive were offered an appointment within 2 
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weeks; and 93% of referrals for ?glandular neoplasia were offered an appointment within 
2 weeks.   
To recap, the literature suggests that there may be variation in colposcopy attendance. It 
is unclear if this may be due to the ways in which the data were gathered (smaller datasets 
gathered at individual colposcopy clinics versus larger datasets gather as part of a 
randomised control trial) or if it may indicate geographical variation in colposcopy 
attendance, as was been found with cervical screening coverage in Chapters 4 and 6.  
National colposcopy data are gathered at appointment level and are likely to overestimate 
patient level colposcopy attendance, but nonetheless there are indications of a variation in 
appointment level colposcopy attendance (Health and Social Care Information Centre, 
2014).  Emerging evidence suggests that colposcopy attendance may also be subject to 
socioeconomic variation, with studies cited here using measures such as education, 
employment, social class and area-level deprivation.   
Given the variation in non-attendance for first referral, treatment and follow-up 
appointments, an analysis of colposcopy non-attendance needs to be clear about the 
appointment type under investigation.  Lower attendance rates in first referral colposcopy 
appointments may be considered particularly problematic since women are required to 
attend these appointments for further investigation following an abnormal screening 
result and may, therefore, be at risk of delayed diagnoses and treatment.  National 
appointment-level data for England showed that 77% of referrals to colposcopy following 
an abnormal screening test in 2012–13 were attended; but this underestimates 
attendance at the individual level, because it fails to account for women who miss or 
cancel one appointment but attend a second one soon afterwards (Health and Social Care 
Information Centre, 2013).  Appointment-level data may mask demographic patterns of 
attendance if certain groups are disproportionately likely to rearrange yet subsequently 
attend appointments. 
9.1.4 Aims of the Study 
The aims of this study were to explore, using patient level data, socioeconomic variation in 
attendance at first referral to colposcopy following an abnormal screening test result.  The 
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study may shed further light on the rates of patient level non-attendance at colposcopy in 
England.  It may also indicate if socioeconomic variation in colposcopy attendance may be 
an additional pathway to understanding why women of lower socioeconomic status may 
go on to have poorer cervical cancer outcomes.   
9.2 Methods 
9.2.1 Patient-level Colposcopy Data 
The recent adoption of the Cyres Colposcopy Software for colposcopy management in 
some regions in England provides the opportunity to access anonymised patient level 
appointment data (Cyres Ltd, 2013).  The availability of such data enables patient-level 
colposcopy attendance to be assessed.   This system has been adopted by the East of 
England region and data from this region have been sourced by the author.  The East of 
England region covers a screening eligible population of approximately 1.5 million women 
(O. ONS, 2014).  It lies to the North East of London and its southern region is within 
London commuter territory (see Figure 25). Anonymised data were extracted from the 
East of England Cyres Colposcopy database for all women referred to colposcopy between 
2006 and 2013.   
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Figure 25. Regions of England 
 
Copyright: Contains National Statistics Data ©Crown copyright and  
database right (2011). Reproduced under the Open Government Licence. 
9.2.2 Measures 
Colposcopy attendance 
The rationale for analysing colposcopy attendance eight weeks after referral was that 98% 
of all women referred to colposcopy following an abnormal screening result are offered an 
appointment within 8 weeks of receiving an abnormal screening result (NHS Cancer 
Screening Programme 2011).  From within this population, 97% of women with moderate 
or severe dyskaryosis were offered an appointment within 4 weeks, and 94% of women 
with severe dyskaryosis/ ?invasive carcinoma and 93% of women with ?Glandular 
neoplasia were offered an appointment within 2 weeks.  Therefore, an eight week post 
referral period was considered the shortest reasonable time in which all women could be 
expected to have attended their appointment. 
The rationale for analysing colposcopy attendance within four months of referral was that 
this is the timeframe in which, if diagnosed, cervical cancer would be deemed ‘screen 
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detected’.  Thereafter, untreated abnormalities may be considered to contribute to higher 
rates of interval cervical cancer (Herbert et al., 2009).  This timescale would also widen the 
scope to consider women who may have not been able to attend within the 8 week 
period, perhaps due to rescheduling of their initial appointment, and could therefore act 
as a form of sensitivity analyse to the eight week post referral measure of attendance.   
Attendance rates are anticipated to be lower than the four month time point since women 
will have had less opportunity to reschedule their allocated colposcopy appointment, 
should they wish to do so.  However, given the majority (98%) of women are offered an 
appointment within eight weeks and, therefore, at least have been provided with an 
opportunity to attend, it would be interesting to ascertain if early indications of a 
socioeconomic variation in attendance could be detected within this time frame.   
Colposcopy attendance was ascertained by tracking a patient from her initial referral for 
colposcopy to her appointment status eight weeks post-referral.  Women were 
categorised as ‘attenders’ (attended within eight weeks) or ‘non-attenders’ (did not attend 
within eight weeks, regardless of subsequent attendance).  A secondary analysis examined 
attendance using a four month time-frame (so ‘attenders’ were those who had attended 
within four months of referral).   
Age 
Age at time of referral was downloaded from the East of England Cyres Colposcopy 
database for all women.  Age was included in the analyses because it has been found to be 
associated with cervical screening coverage and therefore may be relevant for colposcopy 
attendance. Age was transformed into a categorical variable, categorised as 25–34 years, 
35–44 years and 45–64 years.  
Income Deprivation 
For each individual, data were downloaded on Lower Super Output Area (LSOA) for the 
post code of their home address at the time of referral.  The LSOA data were used to link 
to publicly available area-level data on deprivation (the income domain of the Index of 
Multiple Deprivation, IMD) (Department for Communities and Local Government, 2011). 
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LSOA-level income is likely to be fairly homogenous and therefore may describe individual-
level income reasonably well (ONS, 2007).  However, it is acknowledged that limiting the 
measurement of deprivation to income alone may be considered as a weakness of this 
study (as discussed in earlier chapters).  Therefore, sensitivity analyses using the full Index 
of Multiple Deprivation score was conducted.  
The income domain score of the IMD was transformed into a categorical variable.  IMD 
scores were divided into quintiles based on national data downloaded from the Office for 
National Statistics (Knowledge & Information Team, Public Health England, 2011).  
National quintiles were chosen to enable the results to reflect a national perspective of 
deprivation, and therefore to have relevance beyond the East of England region.   
Ethnicity  
The aforementioned LSOA data were used to link publicly available area-level data on 
ethnic diversity (percentage of the population from white ethnic backgrounds) (ONS, 
2014b).  Ethnicity was controlled for in the analysis because it had been found to be a 
significant factor in the variation in cervical screening coverage in Study 2, and was often 
associated with deprivation. Ethnic diversity (the percentage of white population) was 
divided into quintiles based on national data downloaded from the Office of National 
Statistics.  (Knowledge & Information Team, Public Health England, 2011).  National 
quintiles were chosen to enable the results to reflect a national perspective of ethnicity, 
and therefore to have relevance beyond the East of England region.     
Cervical Screening Indicators 
The cytology indicator from the originating abnormal screening test was downloaded from 
the East of England Cyres Colposcopy database for all women as follows: Inadequate; 
Negative; Low-grade dyskaryosis; Borderline (squamous); High-grade (moderate); High-
grade (severe); High-grade ?invasive; and ?Glandular neoplasia.   
The NHS Screening Programme guidelines require that women with more severe cervical 
screening indicators are given priority when colposcopy appointments are scheduled (NHS 
Cancer Screening Programme, 2011).  The Screening Test Indicators were transformed into 
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a categorical variable that grouped the screening test indicators according to their 
invitation period, categorised as Appointment Within 8 Weeks (borderline and low-grade 
dyskaryosis); Appointment Within 4 Weeks (high-grade moderate or severe cervical) and 
Appointment Within 2 Weeks (high-grade ?invasive or ?Glandular neoplasia).  Inadequate 
and Negative screening indicators were excluded from the analyses because these did not 
present a clear indication of the cervical cytology.  
9.2.3 Analyses 
Differences in colposcopy attendance by area-level quintiles of deprivation, individual age 
(grouped as mentioned previously), area-level quintiles of ethnicity and cervical screening 
indicator were tested using chi-square tests.  Univariate and multivariate logistic 
regression was used to regress colposcopy attendance status (using eight week and four 
month cut-offs) against the income domain of the IMD, age, ethnicity and cervical 
screening indicator. Interactions of deprivation and age were also tested. It was 
hypothesised that patterns of attendance would mirror those in primary cervical 
screening, with younger women, women of lower SES and women from areas with a lower 
percentage of white population less likely to attend.  Women whose cervical screening 
result indicated more advanced cervical abnormalities were expected to attend sooner 
than those with less advanced abnormalities as they were invited to attend colposcopy 
sooner.  Attendance was expected to be at higher four months after first referral than at 
eight weeks after referral as that will allow more time for women to attend.   
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9.3 Results  
9.3.1 Descriptive Statistics 
There were 27,193 women referred for colposcopy during the time period.  For women 
who were referred to colposcopy on more than one occasion, only the first referral was 
included in the sample.  The women in the sample had a mean age of 35 years (standard 
deviation = 9.1) (see Table 20).  Only 8.5% were resident in the most deprived areas (Q1) 
and 5.6% were resident in areas with the least percentage of white population.  Women 
lived predominantly in less deprived areas with a higher percentage of white population 
(quintiles 2–5).  The majority of women (55.2%) had low-grade or borderline screening test 
indications.  The percentage of the sample who were excluded (Inadequate and Negative) 
or had no data for the Cervical Screening Indicator (Missing) was 4.7%. 
Table 20.  Sample characteristics of women referred to colposcopy 
 % (n) Min–Max Mean  Std Dev 
Income domain (IMD) Quintiles 
Q1 – Least Income 8.5 (2305) 0.236–0.538 0.306 0.064 
Q2 22.3 (6064) 0.142–0.235 0.182 0.026 
Q3 26.7 (7255) 0.088–0.142 0.114 0.016 
Q4 22.5 (6115) 0.056–0.088 0.070 0.009 
Q5 – Most Income 20.1 (5454) 0.005–0.055 0.039 0.012 
Age at referral 
25–34 years 55.0 (14949) 25–34 29 2.9 
35–44 years 27.7 (7539) 35–44 39 2.9 
45–64 years 17.3 (4705) 45–64 51 5.2 
Ethnicity (% White population) 
Q1 – Lowest % White 5.6 (1529) 41.8–71.7 69.8 7.6 
Q2 26.9 (7304) 77.8–91.9 87.0 3.7 
Q3 29.3 (7965) 92.0–96.3 94.4 1.2 
Q4 20.2 (5502) 96.4–98.0 97.3 0.5 
Q5 – Highest % White 18.0 (4893) 98.1–99.8 98.7 0.4 
Cervical Screening Indicator (invitation period)    
Low-grade/borderline (8 weeks) 55.2 (15,004) - - - 
Moderate/severe (4 weeks) 38.2 (10,380) - - - 
?invasive/?Glandular neoplasia (2 wks) 1.9 (514) - - - 
Inadequate/Negative/Missing (N/A) 4.7 (1295)    
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9.3.2 Colposcopy Attendance and Explanatory Variables 
Colposcopy attendance was 89.3% at eight weeks after referral (see Table 21).  Area-level 
income deprivation was statistically significantly associated with colposcopy attendance.  
Attendance was lowest in the quintile with least income (Q1, 86.6%) and higher in the 
quintile with most income (Q5, 89.1%); however, attendance was highest in Q4 where 
90.2% attendance was observed.  Age was not significantly associated with colposcopy 
attendance at eight weeks after referral.  There was a linear association between 
colposcopy attendance at eight weeks after referral and area-level ethnicity, where 
attendance was lowest in the quintile with the lowest percentage of white population (Q1, 
85.0%) and highest in the quintile with the highest percentage of white population (Q5, 
92.7%).  There was a linear association between colposcopy attendance at eight weeks 
after referral and the cervical screening indicator. Colposcopy attendance was lowest in 
those with low-grade and borderline abnormalities (88%) where the women will be 
offered an appointment within eight weeks of referral, and progressively higher for the 
remaining two categories where women will be offered a colposcopy appointment within 
four weeks (93%) and two weeks respectively (95%). 
Colposcopy attendance was 94.1% when observed respectively at four months after 
referral (see Table 21).  Area-level income deprivation was statistically significantly 
associated with colposcopy attendance at both times.  Attendance was lowest in the 
quintile with least income (Q1, 92.5%) and higher in the quintile with most income (Q5, 
94.1%); however, attendance was highest in Q4 where 94.4% attendance was observed.  
Age was significantly associated with colposcopy attendance at four months after referral.  
There was a linear association between colposcopy attendance at four months after 
referral and area-level ethnicity, where attendance was lowest in the quintile with the 
lowest percentage of white population (Q1, 91.8%) and highest in the quintile with the 
highest percentage of white population (Q5, 96.0%). Colposcopy attendance was lowest in 
those with low-grade and borderline abnormalities (94%) where the women will be 
offered an appointment within eight weeks of referral, and progressively higher for the 
remaining two categories where women will be offered a colposcopy appointment within 
four weeks (95%%) and two weeks respectively (95%). 
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Table 21. Variables associated with colposcopy attendance within eight weeks of referral 
 Attendance 
at eight 
weeks  
row % (n) 
89.3 (24,294) 
Test of 
linear 
association 
Attendance at 
four months  
 
row % (n)   
94.1 (25, 594) 
Test of 
linear 
association 
IMD quintiles 
Q1 – Low income 86.6 (1996) 
ᵡ2=23.98, 
df=4, 
p<0.001 
92.5 (2131) 
ᵡ2=13.97, 
df=4, 
p=0.007 
Q2 89.6 (5434) 94.5 (5731) 
Q3 89.4 (6486) 94.1 (6828) 
Q4 90.2 (5517) 94.4 (5771) 
Q5 – High income 89.1 (4861) 94.1 (5133) 
Age at referral 
25–34 years 89.5 (13372) ᵡ2=4.63, 
df=2, 
p=0.099 
93.9 (14038) ᵡ2=9.28, 
df=2, 
p=0.010 
35–44 years 88.8 (6691) 94.0 (7083) 
45–64 years 89.9 (4231) 95.1 (4473) 
Ethnicity  
Q1 – Lowest % White 85.0 (1299) 
ᵡ2=124.89, 
df=4, 
p<0.001 
91.8 (1403) 
ᵡ2=54.44, 
df=4, 
p<0.001 
Q2 87.5 (6391) 93.5 (6826) 
Q3 89.0 (7085) 93.9 (7476) 
Q4 90.6 (4983) 94.3 (5191) 
Q5 – Highest % White 92.7 (4536) 96.0 (4698) 
Cervical Screening Indicator (invitation period)    
Low-grade/borderline (8 wks) 88.1 (13,220) ᵡ2=160.34, 
df=2, 
p<0.001 
93.9 (14,082) ᵡ2=9.08, 
df=2, 
p=0.011 
Moderate/severe (4 wks) 92.7 (9625) 94.7 (9829) 
?invasive/?Glandular (2 wks) 94.9 (488) 95.3 (490) 
     
Colposcopy attendance within eight weeks of referral 
Colposcopy attendance eight weeks after referral was predominantly higher in less 
deprived areas.  In the unadjusted analyses, women in the most deprived area were 
significantly less likely to have attended colposcopy eight weeks after referral (86.6% 
compared with 89.1% in the least deprived quintile, OR = 0.79, 95% CI: 0.68-0.91), see 
Table 22. Age was not associated with colposcopy attendance. There was no interaction 
between age and deprivation (p=0.151).   
Women living in areas with a lower percentage of white population were progressively less 
likely to attend colposcopy across all quintiles, such that 85.0% of women living in areas 
with the lowest percentage white population attended colposcopy in comparison with 
92.7% in areas with the highest percentage white population (OR = 0.45, CI: 0.37-0.53).   
Women with indication of more advanced cervical abnormalities were progressively more 
likely to attend colposcopy, with 94.9% of women with a ?invasive/?glandular screening 
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result indication attending within eight weeks in comparison with 88.1 of women with 
low-grade or borderline indicators (OR = 2.53, CI:1.70-3.77).   
In multivariate analyses colposcopy attendance remained significantly less likely in women 
in the most deprived areas when compared to the least deprived areas (OR = 0.73, 95% CI: 
0.59-0.90).  Women living in areas with a lower percentage of white population were 
progressively less likely to attend colposcopy across all quintiles, such that 85.0% of 
women living in areas with the lowest percentage white population attended colposcopy 
in comparison with 92.7% in areas with the highest percentage white population (OR = 
0.51, CI: 0.42-0.62).  Women with indication of more advanced cervical abnormalities were 
progressively more likely to attend colposcopy in comparison with those with low-grade or 
borderline indicators, such that women with a ?invasive/?glandular screening result had 
an OR = 2.52, CI:1.69-3.76.   
Colposcopy attendance within four months of referral 
Colposcopy attendance four months after referral was lower in the most deprived quintile 
(Q1) (see Table 23).  In the unadjusted analysis, women living in the most deprived areas 
were significantly less likely to attend colposcopy (92.5% compared with 94.1%; OR = 0.76, 
95% CI: 0.63–0.93). Women aged 45–64 years were significantly more likely to attend 
colposcopy than women aged 25–34 years (95.1% compared with 93.9%, OR = 1.25, 95% 
CI: 1.08–1.45).  There was no interaction between income deprivation and age (p=0.650).   
Women living in areas with a lower percentage of white population were progressively less 
likely to attend colposcopy across all quintiles in comparison with areas with the highest 
percentage white population, such that 91.8% of women living in areas with the lowest 
percentage white population attended colposcopy in comparison with 96.0% in areas with 
the highest percentage white population (OR = 0.46, CI: 0.37-0.58).  Women with 
indication of moderate/severe cervical abnormalities were more likely to attend 
colposcopy within four months (94.7% versus 93.9% of women with low-grade or 
borderline indicators, OR = 1.17, CI: 1.05-1.30).   
In the multivariate model, income deprivation was no longer significantly associated with 
colposcopy attendance within four months of referral. Older women (45-64 years) were 
Chapter 9: Socioeconomic Variation in Attendance at Colposcopy  (Study 6) 
 
 
- 231 - 
 
more likely to attend colposcopy than younger women (OR = 1.26, 95% CI: 1.07 – 1.47). 
Women living in areas with a lower percentage of white population were progressively less 
likely to attend colposcopy, such that women living in areas with the lowest percentage 
white population had an OR = 0.48, CI: 0.37-0.61.  Women with indication of 
moderate/severe cervical abnormalities were more likely to attend colposcopy within four 
months (OR = 1.19, CI: 1.06-1.32). 
Sensitivity Analyses using the Full Index of Multiple Deprivation (IMD) 
Similar results were found when the models were run using the full IMD.  The results are 
reported in Appendix 9.  
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Table 22. Variables associated with colposcopy attendance within eight weeks of referral, * p <0.05 
 
Sample column   
% (n) 100 (27,193) 
Attendance at eight weeks 
row % (n), 89.3 (24,294) 
Unadjusted models Adjusted model 
OR (95% CI) p-value OR (95% CI) p-value 
Income Domain quintiles 
Q1 – Low Income 8.5 (2305) 86.6 (1996) 0.79 (0.68–0.91) 0.001* 0.79 (0.68–0.92) 0.003* 
Q2 22.3 (6064) 89.6 (5434) 1.05 (0.94–1.19) 0.400 1.04 (0.91–1.18) 0.569 
Q3 26.7 (7255) 89.4 (6486) 1.03 (0.92–1.15) 0.622 0.92 (0.81–1.04) 0.147 
Q4 22.5 (6115) 90.2 (5517) 1.13 (1.00–1.27) 0.053 1.03 (0.91–1.18) 0.629 
Q5 – High Income 20.1 (5454) 89.1 (4861) 1.00 – 1.00 – 
Age at referral 
25–34 years 55.0 (14949) 89.5 (13372) 1.00 –   
35–44 years 27.7 (7539) 88.8 (6691) 0.93 (0.85–1.02) 0.111   
45–64 years 17.3 (4705) 89.9 (4231) 1.05 (0.94–1.17) 0.353   
Ethnicity       
Q1 – Lowest % White 5.6 (1529) 85.0 (1299) 0.45 (0.37-0.53) <0.001* 0.51 (0.42-0.62) <0.001* 
Q2 26.9 (7304) 87.5 (6391) 0.55 (0.49-0.63) <0.001* 0.63 (0.55-0.72) <0.001* 
Q3 29.3 (7965) 89.0 (7085) 0.63 (0.56-0.72) <0.001* 0.67 (0.58-0.76) <0.001* 
Q4 20.2 (5502) 90.6 (4983) 0.76 (0.66-0.87) <0.001* 0.74 (0.64-0.86) <0.001* 
Q5 – Highest % White 18.0 (4893) 92.7 (4536) 1.00 - 1.00 - 
Cervical Screening Indicator (invitation period)      
Low-grade/borderline (8 wks) 55.2 (15,004) 88.1 (13,220) 1.00 - 1.00 - 
Moderate/severe (4 wks) 38.2 (10,380) 92.7 (9625) 1.72 (1.57-1.88) <0.001* 1.72 (1.58-1.90) <0.001* 
?invasive/?Glandular (2 wks) 1.9 (514) 94.9 (488) 2.53 (1.70-3.77) <0.001* 2.52 (1.69-3.76) <0.001* 
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Table 23. Variables associated with colposcopy attendance within four months of referral, * p <0.05  
 
Sample column  
% (n), 100 (27,193) 
Attendance at four months  
row % (n), 94.1 (25, 594) 
Unadjusted models Adjusted model‡ 
OR (95% CI) p-value OR (95% CI) p-value 
Income Domain Quintiles 
Q1 – Low Income 8.5 (2305) 92.5 (2131) 0.76 (0.63–0.93) 0.006* 0.86 (0.71-1.06) 0.160 
Q2 22.3 (6064) 94.5 (5731) 1.08 (0.92–1.26) 0.362 1.13 (0.95-1.33) 0.145 
Q3 26.7 (7255) 94.1 (6828) 1.00 (0.86–1.16) 1.000 0.96 (0.81-1.12) 0.587 
Q4 22.5 (6115) 94.4 (5771) 1.05 (0.89–1.23) 0.549 1.00 (0.85-1.18) 0.980 
Q5 – High Income 20.1 (5454) 94.1 (5133) 1.00 – 1.00 – 
Age at referral 
25–34 years 55.0 (14949) 93.9 (14038) 1.00 – 1.00 – 
35–44 years 27.7 (7539) 94.0 (7083) 1.01 (0.90–1.13) 0.893 1.03 (0.92-1.17) 0.533 
45–64 years 17.3 (4705) 95.1 (4473) 1.25 (1.08–1.45) 0.003* 1.26 (1.07-1.47) 0.005* 
Ethnicity       
Q1 – Lowest % White 5.6 (1529) 91.8 (1403) 0.46 (0.37-0.58) <0.001* 0.48 (0.37-0.61) <0.001* 
Q2 26.9 (7304) 93.5 (6826) 0.59 (0.50-0.70) <0.001* 0.61 (0.51-0.73) <0.001* 
Q3 29.3 (7965) 93.9 (7476) 0.64 (0.54-0.75) <0.001* 0.64 (0.53-0.76) <0.001* 
Q4 20.2 (5502) 94.3 (5191) 0.69 (0.58-0.83) <0.001* 0.68 (0.57-0.83) <0.001* 
Q5 – Highest % White 18.0 (4893) 96.0 (4698) 1.00 - 1.00 - 
Cervical Screening Indicator (invitation period)      
Low-grade/borderline (8 wks) 55.2 (15,004) 93.9 (14,082) 1.00 - 1.00 - 
Moderate/severe (4 wks) 38.2 (10,380) 94.7 (9829) 1.17 (1.05-1.30) 0.005* 1.19 (1.06-1.32) 0.002* 
?invasive/?Glandular (2 wks) 1.9 (514) 95.3 (490) 1.34 (0.88-2.03) 0.171 1.32 (0.87-2.00) 0.192 
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9.4 Discussion 
This study explored socio-demographic variation in patient-level colposcopy attendance 
following an abnormal screening result in the NHS Cervical Screening Programme in 
England.  The sample comprised 27,193 women from the East of England who had been 
referred to colposcopy between 2006 and 2012.  Attendance was examined using two 
separate measures: attendance within eight weeks of referral, and attendance within four 
months of referral.  Attendance within eight weeks of referral was chosen as an initial 
measure of attendance because national appointment level statistics indicate that 98% of 
women will have had the opportunity to attend during this time period.  Attendance within 
four months of referral was chosen as an alternative measure of attendance because this is 
the time period in which cancer, if detected, is considered to be screen-detected.    
Colposcopy attendance was high at both the eight week post referral point (89.3%) and four 
months post referral point (94.1%) indicating that the non-attendance rates meet the 
Colposcopy and Programme Management Guidelines (2nd Edition) recommendation that 
non-attendance rates should not exceed 15%. The rates of attendance at four months post 
referral for women with low-grade/borderline indicators (93.9%) are comparable to the 
attendance rates of 93.3% for women with low-grade abnormalities randomised for 
immediate colposcopy (non-attendance was failure to attend two appointments) found 
within TOMBOLA, the multi-centre population-based randomised controlled trial nested in 
the NHS Cervical Screening Programme (Sharp et al., 2012a).  This particular arm of the 
TOMBOLA trial offers a reasonably good comparison to my sample because it includes data 
collected at regional level, across many colposcopy units, and measures women’s 
attendance at colposcopy following an abnormal result.  However, it should be noted that 
TOMBOLA is specific to women considered to have low-grade abnormalities.  In my sample, 
women with moderate/severe (94.7%) and ?invasive/?Glandular (95.3%) cervical screening 
indicators were found to have even higher rates of attendance.  Not surprisingly, 
attendance levels in this study were higher than the 77% national attendance rates, or 80% 
East of England attendance rates, reported annually for this type of colposcopy 
appointment (first referral) since they are reporting appointment level attendance.  This 
suggests that a significant proportion of women may be re-booking their original colposcopy 
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appointment.  High levels of attendance have also been reported for referral to colonoscopy 
following a positive faecal occult blood test (FOBT) in the colorectal cancer screening 
programme where colonoscopy uptake was 88% (Morris et al., 2012).  These findings 
suggest that once an invitation to take part in cancer screening is accepted then compliance 
with recommended follow-up and treatment is likely to be high.   
There were high levels of colposcopy attendance overall, yet women from more income 
deprived areas were significantly less likely to attend cervical screening at both eight week 
and four months post referral.  This trend was consistent even where the effects of area-
level ethnicity and screening indication were taken into consideration. However, there was 
no interaction between deprivation and age on colposcopy attendance.  The TOMBOLA 
study did not look at the association between colposcopy attendance and area-level 
deprivation, but did find attendance was lower in women with no post-school education, 
another marker of lower socioeconomic status (Sharp et al., 2012b). Other British studies 
that did look at an association between colposcopy attendance and area-level deprivation 
did not specifically address first referral colposcopy appointments (Balasubramani et al., 
2008; Sanders et al., 1992).  However, if socioeconomic variation in these appointments is 
apparent then it could substantiate my own findings, and also offer some indication of a 
continuing pattern of socioeconomic variation in treatment and follow-up care for the 
prevention of cervical cancer.  Sanders et al. (1992) retrospectively examined patient level 
data from a colposcopy clinic in Newcastle and found women living in the two most 
deprived areas (quartiles of area-level deprivation, linking women’s postcode to the 
Townsend Index) were significantly less likely to attend any of the colposcopy appointments 
(referral, treatment or follow-ups).   The same study also found colposcopy attendance to 
be lower among women of lower social class (Social class 4 and 5) (Sanders et al., 1992).  
Balasubramani et al. (2008) measured intention to attend a return to treatment colposcopy 
appointment in women recruited from two colposcopy clinics in England and found women 
living in the two most deprived areas (quintiles of area-level deprivation, linking the 
women’s postcode to the Carstairs Index) were significantly less likely to intend to attend 
colposcopy.   
Interestingly, when the association between colposcopy attendance and income deprivation 
is contrasted with the association between cervical screening coverage in women and 
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deprivation it is evident that the association is more linear between cervical screening 
coverage and deprivation.  In my sample, which included women aged 25–64 years, women 
who lived in the middle-income areas (quintiles 2, 3 and 4) were more likely to attend 
colposcopy (at both eight weeks and four months post referral) than women living in the 
least deprived area.  Although this was not statistically significant, it does indicate a 
different pattern of association from that found between cervical screening coverage and 
deprivation, certainly when all eligible women are included in the sample.  It is feasible that 
women living in less deprived areas, who are content to attend cervical screening as part of 
the NHS Cervical Screening Programme, may opt for a colposcopy appointment at a private 
colposcopy clinic, hence the lower attendance in these women in comparison to those living 
in middle-income quintiles.  There is not, to the best of my knowledge, any published 
evidence to support this theory.  However, as part of my qualitative interview study of 
professionals’ views of factors associated with cervical screening coverage (Chapter 7), a 
lead colposcopist confirmed that a number of women cancel their first referral to 
colposcopy following an abnormal screening result citing their preference to be seen 
privately.  It was not possible to quantify the extent to which this occurs, nor the 
socioeconomic status of the individual women.  However, it may be considered reasonable 
to suppose that where it does occur it is women with the financial means to pay for private 
colposcopy who are able to make this choice.  If this were to be the case, and could be 
accurately recorded, then the association between colposcopy attendance and income 
deprivation may be more classically linear.   
The lower attendance at colposcopy in women of lower SES found in this study is a cause for 
concern.  The sample included women who have received an abnormal screening test result 
following routine cervical screening and was inclusive of all referral indications from 
borderline/mild dyskaryosis through to potentially severe/invasive carcinoma with urgent 
clinical indications.  The percentage of women who received either a treatment or 
procedure at their first referral to colposcopy was 63.5% for all of England, and 67.1% for 
East of England region, in 2012–13 (Health and Social Care Information Centre, 2013).  This 
indicates that around two-thirds of the women referred to colposcopy following an 
abnormal result go on to have some sort of treatment or procedure at colposcopy.  For 
women of lower SES, who, as was discussed in Chapter 1, may be more likely to be high-risk 
HPV positive, this presents a real risk that cervical abnormalities are not treated. Therefore, 
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while the difference observed in this study may only be around 2%, this may translate to a 
few thousand women across England. This will inevitably expose these women to greater 
risk of development of cervical cancer, and may help to explain at least some of the 
socioeconomic variation in cervical incidence discussed in Chapter 1.    
Older women (aged 45–64 years) were generally more likely to attend colposcopy than 
younger women for colposcopy attendance four months after referral. Older women were 
more likely to attend colposcopy in a number of other studies, including attendance in the 
colposcopy arm of the TOMBOLA trial (Sharp et al., 2012a), across all types of colposcopy 
appointments in a Newcastle colposcopy clinic (Sanders et al., 1992) and in a colposcopy 
clinic in Fife (Patterson et al., 1995).  It is interesting, however, that the age difference only 
became apparent in the four months post referral analyses. While women aged 45–64 years 
may be more likely to eventually attend colposcopy, it is feasible that their delayed 
colposcopy attendance could be due to lower levels of concern about cervical cancer.  An 
analysis of age differences in primary cervical screening attendance suggests that older 
women may have a lower perceived risk of cervical cancer (Waller et al., 2011).  This same 
study found older women less likely to express difficulties in making an appointment or 
finding time to attend screening as a barrier to attendance.  However, gaining further 
understanding of delayed attendance is an important avenue for future research since ‘late 
attenders’ at first referral to colposcopy may be more likely to miss subsequent colposcopy 
appointments (Sharp et al., 2012b). 
Lower attendance at colposcopy was most striking for women living in areas with a lower 
percentage of white population.  This linear trend was significant at both eight weeks and 
four months post referral and after taking the effects of deprivation, age and cervical 
screening indication into account. The TOMBOLA trial indicated that non-white women may 
be more likely to default from colposcopy but this was not statistically significant (Sharp et 
al., 2012a). However, this may have been because only 4% of their study sample identified 
as non-White.  My study indicates that women living in more ethnically diverse populations 
are at particular risk of missing out on the diagnostic and treatment benefits offered by 
colposcopy.  In one study, colposcopy attendance in inner-city Manchester was increased by 
the provision of an information leaflet in multiple languages (Tomlinson et al., 2004), 
therefore consideration of how this may be implemented more widely may be useful.  
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Women with moderate/severe and ?invasive/?Glandular, that is more advanced cervical 
screening indications, were more likely to attend colposcopy than those with low-
grade/borderline indications.  This trend is likely to be due to the priority given to women 
with more advanced cervical screening indicators when colposcopy appointments are 
scheduled, 4 weeks and 2 weeks respectively, and the perceived importance of attending 
among women.  However, at four months post referral, attendance in women with 
?invasive/?glandular indications (with a 2 week invitation period) was no longer statistically 
significantly higher than other groups.  This is most likely to be due to the efforts by 
colposcopy clinic staff to prioritise the attendance of those with the most severe indicators 
and for the increased time for women with low-grade/borderline indications (and lower 
priority colposcopy appointment invitation) to attend.   
Non-attendance in itself may be problematic as missed appointments lead to appointment 
delay. Appointment delay is where there is a longer duration from the point of referral and 
the proposed colposcopy appointment date.  Appointment delay is considered to 
exacerbate missed appointments, where women either cancel the appointment or do not 
attend without prior notice (Lester and Wilson, 1999; TOMBOLA Group, 2009).  
Unfortunately, the higher the number of missed appointments, the greater the delay 
between referral to colposcopy and the scheduled appointment.  Thus, a negative feedback 
loop of increased non-attendance and appointment delay may ensue. 
The revised Colposcopy and Management Guidelines of the NHS Cervical Screening 
Programme state that colposcopy units are required to audit the records of non-attenders 
to inform strategies to improve colposcopy attendance (NHS Cancer Screening Programme, 
2010). The guidelines suggest non-attendance may occur due to fear or anxiety related to 
cancer or to the procedure itself, menstruation, work or childcare responsibilities, transport 
to the clinic, lengthy waiting times and forgetting the appointment.  These reasons are 
generally supported in research literature but less is known about their potential association 
with socioeconomic status.   
Women’s anxiety may be related to fear or apprehension of the diagnostic outcome of the 
test, or to anticipation of the pain or discomfort that may occur during the colposcopy 
procedure itself (Lester and Wilson, 1999).  Referral to colposcopy following an abnormal 
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cervical screening test result was associated with distress and anxiety in women recruited 
from a colposcopy clinic in Ireland (Kola and Walsh, 2012).  A study of women recruited via 
an English cervical cytology laboratory, explored the psychological effects of receiving an 
inadequate screening test and found women with higher levels of anxiety were at greater 
risk of not attending a future screening test appointment (French et al., 2004).  However, in 
studies carried out as part of TOMBOLA, anxiety was not associated with attendance (Sharp 
et al., 2012a), nor were higher levels of anxiety associated with markers of SES (level of 
education and employment status) (Gray et al., 2006).  Emotional barriers to cervical 
screening, while commonly cited by women as reasons for non-attendance, were not found 
to predict cervical screening uptake in a population-based survey (Waller et al., 2009).  It is 
therefore plausible that emotional barriers to colposcopy may not provide an explanation 
for socioeconomic variation in colposcopy attendance, but further research in this area 
would provide further clarification.   
In an audit of colposcopy attendance at a clinic in Thailand, benchmarked by the NHS 
Cervical Screening Guidelines for the management of colposcopy, menstruation was also 
cited as a reason for non-attendance (Kietpeerakool et al., 2011).  Naturally, this would be 
likely to affect younger women, rather than older women.   
Childcare commitments were cited as one of the specific reasons for non-attendance at 
colposcopy in a retrospective analyses of colposcopy attendance in a Newcastle colposcopy 
clinic, where 93% of non-attenders had childcare responsibilities (Sanders et al., 1992).  
Childcare commitments were raised as reasons for lower attendance at cervical screening in 
Chapter 7, and it is feasible that this may act as a barrier to colposcopy attendance.  While 
childcare commitments were cited as a reason for not attending cervical screening in focus 
groups of women living in deprived areas in Northern Ireland (Logan and McIlfatrick, 2011), 
they were not found to be socially patterned (measured as level of education) in a 
population study of barriers to cervical screening (Waller et al., 2009).   
Practical barriers, such as a shorter travel time to the clinic, have also been associated with 
colposcopy attendance (Balasubramani et al., 2008).  Shorter distance to breast screening 
units have also been associated with higher breast screening coverage (Maheswaran et al., 
2006).  Breast screening units, like colposcopy clinics, are often based in local hospitals and 
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therefore neither has the convenience of taking place in a local general practice.  The cost of 
travel has also been associated with lower colposcopy attendance (Brooks et al., 2002), and 
feasibly exerts a more prohibitive pressure on more deprived women.  Difficulty arranging 
transport was associated with adults of lower SES in a population-based survey of barriers 
to seeking medical advice (K. Robb et al., 2009), although it is unclear if this would also be 
reflected in barriers to colposcopy attendance.   
Forgetting appointments has been cited in as a reason for colposcopy non-attendance in a 
number of studies (Brooks et al., 2002; Miller et al., 1997; Sanders et al., 1992).  While 
Sanders et al. (1992) collected socioeconomic characteristics of participants in their study, 
they did not report this information in relation to those who cited forgetting the 
appointment as their reason for non-attendance.  Socioeconomic characteristics of women 
participating in the other studies were not collected.   
While my consideration of socioeconomic variation in barriers to colposcopy is not 
exhaustive, it is evident that there is limited research available in this area.  Minimising 
missed appointments which increase the risk of the development of cervical cancer (NHS 
Cancer Screening Programme, 2011) remains important despite the high rates of 
attendance found in this study overall.  The unnecessary financial burden of missed 
appointments has  potentially become of greater significance since the national rollout of 
HPV Triage in 2012, given the increased volume of colposcopy referrals (Albrow et al., 2012; 
Health and Social Care Information Centre, 2013; Kelly et al., 2011).   Further, in the event of 
the introduction of HPV self-testing (Racey et al., 2013), the management of cervical 
abnormalities will still take place at colposcopy.   Timely colposcopy attendance, therefore, 
remains an essential component of a successful cervical screening programme for some 
time to come.   
9.4.1 Strengths and Limitations 
This study is novel in its ability to generalise retrospective patient-level colposcopy 
attendance at first referral following an abnormal screening result within the NHS Cervical 
Screening Programme in England.  The sample included over 27,192 women and spanned 
colposcopy attendance from 2006 to 2012.  Colposcopy attendance data were sourced from 
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KC65 data via the Cyres Software database to provide individual level colposcopy 
attendance data, thereby overcoming some of the drawbacks of self-reported attendance 
data or appointment-level data.  Most other studies that examined patient level colposcopy 
attendance were published before this time period.    
While the use of area-level data on income deprivation may be considered a weakness of 
the study, these data are not routinely collected by the cervical screening programme.  
Income domain data were matched at the LSOA level, which are small, homogenous 
geographical areas designed for neighbourhood statistical analyses (ONS, 2007).  The 
income domain of the IMD was chosen as the measure of deprivation, rather than the full 
IMD score that encompasses all seven domains of the IMD.  As previously discussed in Study 
1, this may be considered a weakness of the study as this fails to capture to other complex 
dimensions of socioeconomic deprivation.  Sensitivity analyses using the full IMD were 
conducted to assess potential differences when multiple domains of deprivation are 
considered.  The results were similar to those using the income domain of IMD only and are 
reported in Appendix 9.  
The study used data from the East of England region which has relatively high colposcopy 
attendance in comparison with other regions (Health and Social Care Information Centre, 
2013), but linking the area-level measures to national quintiles may increase the 
generalisability of these results for other regions in England.   Most other studies reported 
patient level colposcopy attendance source data from one or two colposcopy clinics and, 
therefore, were not generalisable beyond a small area.   
9.5 Conclusion 
The findings in this study have potential implications for cervical cancer outcomes and the 
cervical screening programme.  The high attendance rates at colposcopy overall are 
encouraging since they indicate that once women have accepted an invitation to cervical 
screening they are likely to accept a referral to colposcopy.  Lower attendance among 
women in the most income-deprived areas is of concern, since this indicates that even when 
women in more deprived areas attend cervical screening they remain at higher risk of 
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missing out on the benefits of the programme, namely the prevention or earlier diagnosis of 
cervical cancer. 
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Chapter 10: Discussion 
The research in this thesis was prompted by the ongoing concern about socioeconomic 
inequalities in health and how to tackle them.  Cervical cancer was chosen as a particular 
area of interest because it is preventable and yet women still die from this disease in the 
UK every year.  Women of lower SES have disproportionally poorer cervical cancer 
outcomes.  While women of lower SES are likely to be exposed to more risk factors for 
cervical cancer, it should be preventable if attendance at cervical screening, and 
colposcopy where recommended, is equitable across all SES groups.  Understanding 
socioeconomic inequalities in cervical screening may help inform strategies to prevent 
poorer outcomes in cervical cancer for women of lower SES. 
10.1 Summary of Findings 
The principal aim of this thesis was to understand socioeconomic inequalities in cervical 
cancer screening, and to explore the pathways that link SES and poorer attendance at 
cervical screening and colposcopy.  In Chapter 3, I set out four questions which I sought to 
address in my thesis.  Below I have summarised my findings in relation to these questions. 
10.1.1 Are Socioeconomic Inequalities in Cervical Screening Coverage in England 
Improving? (Study 1) 
Study 1 Findings 
Study 1 explored if the cervical screening coverage gap, the mean coverage difference 
between the most and least deprived women, had narrowed in recent years.  A cervical 
screening coverage gap was found across all age groups and all areas, and was greater in 
younger women than in either older women or all eligible women.   
There were significant changes to cervical screening coverage over the time period in 
England (excluding London) in a pattern that reflected the ‘Jade Goody’ effect.  
Unfortunately, the peak levels of cervical screening coverage in 2008 and 2009 were not 
long-lasting and have since fallen into decline, and no significant difference in screening 
coverage was found at the end of the period.  The patterns of screening coverage over 
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time were similar across all SES groups, and the lack of interaction between deprivation 
and time confirmed that the association between coverage and deprivation remained 
stable.  
For PCTs in London, there was no significant difference in the screening coverage over the 
period and, perhaps surprisingly, the ‘Jade Goody’ effect was not detectable.  Patterns of 
association between deprivation and cervical screening coverage did not significantly 
differ across the time period, despite the obvious presence of a cervical screening 
coverage gap.   
For younger women in all PCTs in England, there was a significant increase in cervical 
screening coverage.  In this group, there was a distinct ‘Jade Goody’ effect, and coverage 
was higher at the end of the period in comparison with the beginning.  Unfortunately, 
however, cervical screening coverage is in steady decline and should the current trend 
continue, it may fall below the level found prior to Goody’s diagnosis and death.  The 
patterns of association between deprivation and cervical screening coverage were similar 
across the time period, indicating that despite the increase in coverage over the time 
period, there was no significant difference by SES group. 
For older women in all PCTs in England, cervical screening coverage has been in steady 
decline.  This pattern was reflected across all SES groups which indicated that there was no 
interaction between deprivation and time over the period.  While cervical screening 
coverage in older women has generally been higher than coverage in younger women, the 
levels are beginning to converge.  For example, cervical screening coverage in the most 
deprived group of older women is now comparable with screening coverage in the least 
deprived group of younger women.  
Despite the differences in the trends in cervical screening coverage over the time period, 
no evidence was found to suggest that there has been any improvement in socioeconomic 
inequalities in cervical screening coverage over the years 2007–08 to 2012–13.    
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Study 2 Findings 
Study 2 explored whether the continued socioeconomic inequalities in cervical screening 
coverage may be explained by programme-specific or population-specific factors by 
comparing the cervical screening coverage gap in older women (age 50–64 years) with the 
breast screening coverage gap (women aged 53–70 years) over the same time period.   
 
For breast screening coverage in all PCTs in England, there was a significant interaction 
between deprivation and time on breast screening coverage, largely driven by the 
improvement in breast screening coverage in the most deprived areas.   This was quite 
different from the trends found for cervical screening coverage for women of comparable 
age.  However, cervical screening coverage is higher overall than breast screening 
coverage.   
 
This result indicates that programme-specific factors may affect the different rates of 
coverage and, potentially, socioeconomic inequalities in screening coverage.  It is 
encouraging that the NHS Breast Screening Programme has seen a significant increase in 
breast screening coverage over the time period.  However, this sits in direct contrast to the 
decline in cervical coverage found across all SES groups.   
10.1.2 Which Factors Support or Hinder Higher Cervical Screening Coverage in PCTs 
in England? (Study 3 and 4) 
Study 3 Findings 
Study 3 explored the factors which may hinder or support higher cervical screening 
coverage by using regression models to fit cervical screening coverage in younger and 
older women with programme-delivery and population-level factors. Population factors, 
rather than programme-delivery factors, were found to explain more of the variation in 
cervical screening coverage in younger and older women.  However, both population-level 
and programme-delivery factors were more strongly associated with cervical screening 
coverage in younger rather than older women.   
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Five high-performing and five low-performing PCTs were identified in the analyses.  The 
high-performing PCTs tended to either have relatively high screening coverage despite 
having population factors associated with lower screening coverage, or were PCTs that did 
not appear to face these same challenges.  Low-performing PCTs for cervical screening 
coverage in younger women were London based, and had relatively higher ethnic minority 
population, higher percentage of younger women although were generally more 
educated.  Low-performing PCTs for cervical screening coverage in older women were also 
urban PCTs but had more women without higher education.      
Study 4 Findings 
The health professionals interviewed in Study 4 considered higher cervical screening 
coverage as being supported by local and national health promotion campaigns, requiring 
the necessary staff to support general practices to deliver the programme, including staff 
training and assisting with data list cleansing.  The efficiency of the NHS Cervical Screening 
Programme such as the new structure embedded as a result of the NHS reorganisation in 
2013 and the longstanding commitment to 14-day turnaround for delivery of results were 
also considered important. Factors considered to hinder higher cervical screening 
coverage included emotional and practical barriers to attendance, lower awareness of the 
cervical screening programme, its benefits and its relevance to different populations, and 
previous bad experiences at screening.  General practice issues such as the 
implementation of incentives of the Quality Outcomes Framework and exception reporting 
were considered potentially problematic. There was also concern that the reorganisation 
of the NHS in 2013 had led to a loss of local knowledge and local area support that may 
hinder training of general practice staff and assistance with local health promotion 
campaigns.  ‘City effects’, such as population mobility, difficulty for general practices to 
maintain the volume of patient records and, potentially, a greater propensity for some 
women to attend cervical screening privately, were also cited as factors that may explain 
lower coverage in London, and possibly other larger cities too. 
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10.1.3 Do Perceived benefits of Cervical Screening Mediate the Association between 
Socioeconomic Status and Cervical Screening Coverage?  (Study 5) 
Study 5 Findings 
Women of lower SES, younger women and those in full-time employment were more likely 
to be overdue for cervical screening.  Women who were up-to-date with their cervical 
screening invitations and those in higher SES groups were more likely to agree with the 
statements on perceived benefits of cervical screening, and in mediation analysis, these 
beliefs were found to explain a significant portion of the association between SES and 
screening status.   
10.1.4 Do Socioeconomic Inequalities in Attendance at Referral to Colposcopy 
following an Abnormal Cervical Screening Test contribute to Socioeconomic 
Inequalities in Cervical Cancer? (Study 6) 
Study 6 Findings 
Attendance at colposcopy at eight weeks and four months post-referral was generally 
high, however, women living in less deprived areas were more likely to attend colposcopy 
than women living in more deprived areas, even after accounting for age and area-level 
ethnicity.  Older women, rather than younger women, were more likely to have attended 
screening at four months post referral.   
The cervical screening indicator had a significant effect on colposcopy attendance, such 
that women with more advanced indicators (moderate/severe and ?invasive/?Glandular) 
were more likely to attend screening than women with low grade/borderline 
abnormalities (reference group) within 8 weeks of referral.  At four months post referral, 
women with a moderate/severe cervical screening indicator were still significantly more 
likely to attend colposcopy than the reference group but this was not the case for women 
with more the ?invasive/?Glandular indicators.  This last finding is encouraging as it 
suggests that women with indicators of more advanced abnormalities are being supported 
to attend sooner.   
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There was also a distinct ethnic gradient in colposcopy attendance at both 8 weeks and 4 
months post referral, even after adjustment for the effects of deprivation, age and cervical 
screening indication.   
Socioeconomic inequalities in colposcopy attendance were found at eight weeks post 
referral but were no longer significant at four months post referral.  This indicates that 
while women of lower SES may be slower to attend colposcopy they may be supported to 
attend in time.  However, attendance at colposcopy is potentially of greatest concern in 
communities with a lower proportion of white population.   
10.2 Overview 
Overall, the studies in my thesis have explored different pathways to understand 
socioeconomic inequalities in cervical cancer screening: my background review of 
evidence for socioeconomic inequalities in the high-risk HPV status, including exposure to 
cervical cancer risk factors; socioeconomic inequalities in cervical screening coverage; an 
exploration of potential individual-level mediators of SES and cervical screening 
attendance; and evidence of socioeconomic inequalities in colposcopy attendance.  It is 
clear that there is no simple, quick-fix answer to addressing this issue and it is likely to 
require attention to different levels of engagement and the complex interactions between 
the various factors.   
Women of lower SES do appear to be at greater risk of being high-risk HPV positive, and 
this was supported by evidence that these women were more often exposed to, or 
partaking in health behaviours that increased their risk for acquiring and maintaining high-
risk HPV infection.  However, this is an insufficient explanation for socioeconomic 
inequalities in cervical cancer outcomes because cervical cancer can be prevented through 
participation in the NHS Cervical Screening Programme.  However, it is clear that equitable 
access to the NHS Cervical Screening Programme remains problematic despite the long-
term availability of the programme and successive policies to promote wider participation.   
Variation in cervical screening coverage in areas across England may be more sensitive to 
population characteristics than programme-delivery characteristics, at least for the factors 
considered in this thesis.  More deprived populations that also had lower levels of 
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education were particularly susceptible to poorer cervical screening coverage.  There were 
also key differences in the associations between cervical screening coverage and 
deprivation, education and ethnicity in both younger and older age groups. This study was 
also able to assess the difference in cervical screening coverage across different ethnic 
minority groups.  In particular, higher levels of cervical screening coverage were found in 
ethnic minority groups with higher levels of education than in other ethnic minority 
groups.  With regards to programme-delivery factors, cervical screening coverage is 
supported by the greater availability of general practice staff.   
Area-level effects, particularly in relation to London, indicate that the association between 
deprivation and cervical screening coverage is weaker, and the overall picture of what 
contributes to lower cervical screening coverage in the city remains unclear.   
Health professionals expressed concern about lower cervical screening coverage in 
younger women, ethnic minority women and those of lower SES.  They were also 
concerned about the delivery of the cervical screening programme, citing the need for 
greater flexibility in screening appointment times, the pros and cons of standardised 
versus targeted invitation letters to particular populations of women, and the need to 
ensure all general practice staff are motivated to promote cervical screening attendance.  
Local health-promotion campaigns were generally acknowledged to be successful when 
they were co-ordinated across the service, but there was little evidence of any substantive 
evaluation of the impact of local health-promotion campaigns on cervical screening 
uptake.   
While the perceived benefits of cervical screening are considered as having some 
mediating effect on the association between SES and cervical screening attendance, the 
wider consideration of other potential mediators is useful.  This may include the wider 
consideration of socioeconomic variation in cancer fear and cancer fatalism, practical 
barriers and other psychosocial factors.  These may be more modifiable than the wider 
social constructs of lower income and lower education.  This pathway may extend beyond 
the understanding of socioeconomic inequalities in cervical screening coverage, and 
therefore also offer potential routes in which to intervene on SES and poorer cervical 
screening coverage.   
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Colposcopy attendance is generally high, which is a welcome indication that when women 
choose to accept their invitation to cervical screening that they are likely to follow further 
medical advice. Yet, evidence of socioeconomic inequalities in colposcopy non-attendance 
is of particular importance because it highlights the risk that precancerous changes may go 
untreated in a population with an abnormal cervical screening test result.  Around two-
thirds of all women who attend colposcopy following an abnormal screening test result go 
on to have treatment.  This may be higher in women of lower SES who are more likely to 
be high-risk HPV positive.   
The findings from this thesis open up areas for further research.  These will be discussed in 
the relevant section below.  
10.2.1 SES Measures and Women 
In chapter 2, I discussed the implications for the interpretation of research findings when 
using different measures of SES in health research which focusses specifically on women.  
In this section, I will discuss the implications and interpretation of the measures of SES 
used in each of my studies in the context of their applicability to promoting further 
understanding of the pathways by which SES is associated with either cervical screening 
coverage or colposcopy attendance in England.   
Studies 1 and 2 associated area-level income (the percentage of households receiving 
income support) with cervical screening coverage.  As mentioned in the previous section, 
individual-level measures of SES are not available for national cervical screening coverage 
which enforced the use of an area-level measure.  Income may be preferable to other 
area-level measures of SES for women as it can be valid at both an individual-level and a 
household-level.  For example, for women who live alone, their individual income is equal 
to their household income, whereas, women whose household income is supplemented 
by another member of the household may, in some cases, be in a better financial position 
overall.   However, equivalised household income, which adjusts household income for 
size and composition (ONS, 2012), would need to be used to ascertain if this were indeed 
the case.   
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Although the NHS Cervical Screening Programme is free at the point of access, the 
enduring pattern of lower attendance in more income-deprived areas found in studies 1 
and 2 could be interpreted in terms of the relatively greater challenge for women who live 
in such areas to overcome the logistics of attending screening.  This may be due to the 
financial implications of arranging childcare, as some low-income women may not be able 
to afford this.  The cost of transport may also be more prohibitive for women living in 
these areas.  Or, it may be that attending screening is not a priority for women who may 
have relatively greater ongoing financial worries.   
Cervical screening attendance is more normative in less deprived areas indicating that 
those in more deprived areas may not have the same access to supportive social networks 
to facilitate attendance.  This may operate in terms of the willingness or availability of 
others to offer free childcare but may also include other issues, such as encouragement to 
attend screening or the opportunity to discuss any difficulties, or indeed, reservations 
about screening with others.  However, it cannot be determined that this is the pathway 
to lower screening attendance given the sole use of income as a measure of SES in studies 
1 and 2, as screening attendance is likely to be more socially normative in areas with, for 
example, higher levels of education.  
Study 3 also used area-level income as a measure of SES and found cervical screening to be 
lower in more deprived areas.  Therefore, these results can be interpreted along similar 
lines to those in studies 1 and 2.  However, this study also incorporated area-level 
education and therefore opened other potential pathways for consideration.  The measure 
was the percentage of the population without any higher education and was not specific 
to women’s higher education per se.  This was considered to be appropriate because study 
3 compared screening coverage across age groups.  Comparisons between younger and 
older women on the basis of education level could be problematic given that younger 
women generally have greater opportunities to access higher education.   
Study 3 found a positive association between the percentage of the population without 
higher education and cervical screening attendance in younger women (in univariate 
analyses) but this was no longer significant when the results were adjusted for other 
population factors.  There was no association between higher education and cervical 
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screening in older women. These results were surprising as the cervical screening 
literature suggests that higher education would be positively associated with cervical 
screening coverage.  The potential pathways for the expected outcome may include the 
higher levels of health literacy in more educated populations that may promote the 
understanding of the value of screening or in engagement with the screening invitation 
and associated health information. Women with higher education are more likely to have 
a professional job, as previously discussed, and are therefore likely to have fewer barriers 
to attendance due to their employment conditions.  However, these potential pathways 
cannot be inferred from the results of Study 3.  It is likely that the particular measure was 
insensitive to the effects of education on screening attendance, perhaps for the 
aforementioned limitations of area-level measures and/or to the specific education 
measure applied across all age groups of women.   
Study 5 used data from a cross-sectional population-based survey and aimed to investigate 
if perceived benefits of cervical screening mediated the association between cervical 
screening (self-reported cervical screening attendance) and SES (an individual-level index 
of SES measures).  The index comprised housing tenure, car ownership and education and 
was similar to indices used in other studies of socioeconomic inequalities in cervical 
screening.  While such an index may be an acceptable means of establishing the 
association between socioeconomic status and health outcomes, unfortunately it can also 
limit the interpretation of the results in terms of the potential mechanisms through which 
SES may be operating.  This is because the index combines all of the explanatory factors 
into an overall score.  In retrospect, entering the individual measures independently into 
the model could have been more informative.  Had the perceived benefits been found to 
mediate the association between education and cervical screening attendance but did not 
mediate the association between home or car ownership and cervical screening, then the 
findings could have suggested, for example, that health literacy was a pathway to higher 
attendance.   
Study 6 associated area-level income (the percentage of households receiving income 
support) with colposcopy attendance.  Colposcopy attendance was significantly lower in 
more deprived areas at both eight weeks post referral (in both univariate and adjusted 
models) and was significantly lower at four months post referral in univariate analyses (but 
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not when adjusted for: age; ethnicity; and cervical screening indication/invitation period).  
One interpretation of these findings may be that financial issues are an initial, but not 
insurmountable, barrier to colposcopy attendance. Colposcopy appointments generally 
take place in dedicated colposcopy clinics within hospitals and may be more expensive or 
lengthy than the journey to a local GP for the originating cervical screening appointment. 
Access to childcare may also pose as another financial barrier, either because low-income 
women may need to align their appointment with a week/month that they have the 
resources to cover childcare costs or because they may be reliant on the favour and 
convenience of friends and neighbours to look after their child/children for free.  It could 
be that reminder letters and other mechanisms of the fail-safe process (letter to the GP to 
inform them of their patient’s non-attendance at colposcopy) may support women to 
prioritise their colposcopy appointment even where financial costs are an initial obstacle. 
Women in lower paid jobs with less autonomy or flexibility may need longer to negotiate a 
suitable time to attend a colposcopy appointment and hence may be more susceptible to 
delay their initial allocated colposcopy appointment.   
This thesis has used area-level and individual-level measures of SES covering income, 
education and an index of socioeconomic status.  This has enabled the interpretation of 
these results to incorporate different pathways or mechanisms to attendance at cervical 
screening and colposcopy appointments.   
10.3 Strengths and Limitations  
10.3.1 Sampling 
Studies 1, 2, 3 and 6 relied heavily on area-level data, including screening coverage data 
from the NHS Cancer Screening Programmes website and other population level factors, 
such as income deprivation and ethnicity from administrative sources. Although screening 
coverage data were aggregated to area-level, data were based on actual attendance and 
were not subject to the inherent biases of self-reported data such as recall bias or 
response bias.  Care was taken to moderate the interpretation of the results with respect 
to the ‘ecological fallacy’ where area-level population data should not be assumed to 
represent individuals. Data were collected at the smallest geographic unit possible, Lower 
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Super Output Area (LSOAs).  LSOAs are relatively small, homogenous areas comprising 
around 1500 residents and 650 households, and are considered to offer as good a 
representation of their population as can be derived from within the limitations of area-
level data (ONS, 2011b).  Further, the NHS Cervical Screening Programme does not hold 
information on a woman’s income, ethnicity, and levels of education, therefore these data 
are just not available.  Had I used a population-based survey to gather this information, it 
would have been expensive and would also have been limited in its ability to answer my 
questions regarding the area-level variation in cervical screening coverage across England.  
The benefits of using these data are that I was able to utilise accurate data on cervical 
screening coverage, rather than the disadvantages of self-reported screening, and that I 
was able to analyse the association between cervical screening attendance and 
deprivation across the whole of England.  The benefits of this approach are exemplified in 
the atypical pattern of association between cervical screening coverage and deprivation in 
London in comparison to other areas of the country.  
Study 4 offered an alternative form of data by interviewing health professionals about the 
factors they felt were important for cervical screening coverage, albeit with a small 
sample. It would have been interesting if I had also been able to speak with women 
directly about their reasons for not attending cervical screening but there are already 
many existing studies in this area (Waller et al., 2011; Logan and McIlfatrick, 2011; Jepson 
et al., 2007). The women’s perspective was limited to the few items used in the 
population-based survey utilised in Study 5.  However, this study did offer the opportunity 
to investigate an alternative pathway from SES to cervical screening attendance.   
10.3.2 Combining Quantitative and Qualitative Methods 
The mixed methods approach used in this thesis enabled me to choose the different 
methods to answer my questions.  The quantitative studies allowed me to look at the 
variety of factors that may affect cervical screening coverage across England, taking into 
account programme-delivery characteristics and population-level characteristics.  The 
qualitative study with health professionals working in the NHS Cervical Screening 
Programme allowed for an alternative analysis of these factors and the opportunity to 
explore these factors in a more holistic manner.  However, integrating the findings from 
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such different methodological approaches was not without its challenges.  Study 3 
produced evidence of the association between cervical screening coverage and a variety of 
different factors in an effort to address the factors that hinder or support cervical 
screening.  The views of the health professionals were much more holistic, with each 
professional giving their own perspective in light of their experience of working in the NHS 
Cervical Screening Programme, although this was limited by the small sample size.   
10.4 Implications of findings 
10.4.1 Contribution to Literature 
Study 1 found that there has been no discernible improvement in the cervical screening 
coverage gap in recent years.  Inequalities in cervical screening coverage are ongoing and 
did not change significantly over the period 2007 to 2012. This updates the existing 
literature on socioeconomic inequalities in cervical screening because it focuses on the 
screening coverage gap and considers potential interactions between deprivation and 
cervical screening coverage over time (Bang et al., 2012; Moser et al., 2009). This finding 
renews to the call to continued efforts to improve the cervical screening coverage gap as a 
means of reducing cancer incidence (Weller and Campbell, 2009). In contrast, the 
socioeconomic inequalities in colposcopy attendance, found in Study 6, were smaller than 
those found for cervical screening coverage. Colposcopy attendance was relatively high, 
and this is perhaps an indication that once women have attended cervical screening they 
are likely to also attend colposcopy, if advised.  However, there is plausible yet anecdotal 
evidence of the potential for a wider colposcopy attendance gap than found in my study, if 
some women of higher SES are actually attending colposcopy at private clinics.  This may 
counter the suggestion by some earlier studies of the limited benefit from efforts to 
improve default rates at colposcopy (Balasubramani et al., 2008; Lester and Wilson, 1999).  
Socioeconomic variation in colposcopy attendance may be viewed as another missed 
opportunity in which to improve cervical cancer outcomes in women of lower SES.  
Study 2 found evidence of a reduction in the coverage gap for breast cancer screening. 
Women in a National Statistics Omnibus survey reported higher attendance at breast 
screening than cervical screening (Moser et al., 2009). However, as far as I am aware, no 
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other study has reported a reduction in the socioeconomic inequalities in breast cancer 
screening in the UK and therefore these are novel findings. Given the difficulty in effecting 
any meaningful change to socioeconomic inequalities in screening coverage overall, the 
improvement in breast screening coverage among the women in the most deprived SES 
group is worth further exploration. It is recommended that future research seek to explore 
the specific factors that may have led to this improvement and how they can be further 
applied within the breast screening programme to support improved attendance in other 
SES groups also.  Further, any lessons that could be learned from further research in this 
area may offer valuable lessons for the NHS Cervical Screening Programme.  There is 
evidence that socioeconomic inequalities in breast cancer survival have been improving 
over time (Lyratzopoulos et al., 2011).  This may provide some encouragement for 
improved breast cancer outcomes since survival rates are better when breast cancer is 
screen-detected, even in more deprived women who have poor prognosis  (Morris et al., 
2015).   
The findings from Study 3 were unique. Other studies have addressed PCT level cervical 
screening coverage and its association with primary care factors (Bang et al., 2012) but this 
is the first time that individual areas have been identified as performing relatively well or 
poorly after consideration of such factors. While national strategies to improve cancer 
screening uptake continue to require further research and prioritisation (Weller and 
Campbell, 2009), identifying areas that could be used as exemplars of best practice may 
fast track improvements elsewhere.  Further, and perhaps more importantly, areas 
identified with poorer cervical screening coverage that also have a range of factors known 
to hinder cervical screening uptake may be targeted to received additional support.  While 
PCTs have been replaced by Clinical Commissioning Group (CCGs), with the exception of 
Sefton, all other low performing PCTs identified in this study have the same geographical 
footprint as their respective CCG.  Therefore, there is still relevance to the findings of this 
study.  Further, the research methods used can also be applied to other areas or 
institutions, including CCGs if desired.  
The findings from Study 4 provided a means of reflecting on the different factors that 
hinder or support cervical screening coverage.  The process illuminated ambiguity in the 
potential effect of some factors.  For example, the current standardised invitation to 
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cervical screening was found to be both a support and a hindrance.  Most interestingly, the 
health professionals provided insight into the potential effects of organisational change on 
cervical screening coverage.  It remains to be seen if these changes will ultimately be of 
benefit to NHS Cervical Screening Programme.  However, should significant change in 
cervical screening coverage be found in future studies addressing the period during and 
since the reorganisation of the NHS, then this study may offer insight that may support 
interpretation of their findings. 
The findings from Study 5 indicate that perceived benefits of the NHS Cervical Screening 
Programme explain some of the association between SES and cervical screening 
attendance. While the study was limited in the number of belief factors able to be 
included in the study, it did support other findings in the literature that suggest that such 
factors are important. 
Study 6 addressed socioeconomic inequalities in colposcopy attendance.  The study was 
unique in so far as it is the first study to analyse individual level colposcopy attendance at a 
regional level within the UK.  Larger scale studies to date have generally relied upon 
appointment-level attendance data, which is limited in its capacity to represent patient-
level attendance.  While other studies that have used patient-level data, they have 
generally had a smaller sample size, as their data were often derived from individual 
colposcopy clinics, or were sourced from participants taking part in a wider clinical trial.  
The contributions to current literature include the findings that women of lower SES are 
slower to attend colposcopy than other SES groups and therefore may need to be 
supported to attend sooner. When attendance is prioritised, as is the case in women with 
indications of more advanced cervical abnormalities, colposcopy attendance is higher.  
While this may, in part, be due to the encouragement given to these women to attend, it 
may also be due to the greater urgency from the women themselves when they receive 
the notification that they have a more advanced cervical abnormality. Ethnic variation in 
colposcopy attendance was most striking in this study.  It is recommended that future 
research further explores ethnic variation in colposcopy attendance. 
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10.4.2 Contribution to Policy and Practice 
In Study 1, I found that there was no discernible improvement in socioeconomic 
inequalities in cervical screening coverage since 2007.  This is an important finding in the 
context of policy and practice because it indicates that efforts since 2007 have failed to 
make a meaningful impact on socioeconomic inequalities in cervical screening coverage, 
despite best efforts. Recommendations to policy and practice as a consequence of these 
findings suggest that new policy measures are required.  Given the different patterns of 
association between deprivation and screening coverage in younger and older women, it is 
likely that action to deal with socioeconomic inequalities should also be mindful of the 
target age group.  The findings of this study suggest that without a change in policy there 
may be no change in socioeconomic inequalities in cervical cancer coverage in the longer 
term.  
There have been improvements in breast screening coverage over the same period.  The 
improvements in the breast screening programme, with largely the same older population 
of women invited to cervical screening, indicates that the progress is due to factors within 
the breast screening programme.  The breast screening coverage gap has narrowed due to 
the improved screening attendances rates in women of lower SES.  It is unclear if this may 
be due to the policies in place to improve socioeconomic inequalities in the NHS Breast 
Screening Programme, targeted interventions to support lower SES women into breast 
screening or if changes to the delivery of the programme may have made it more 
accessible.  The improvements noted for the NHS Breast Screening Programme may offer 
valuable lessons for adaptive policies to reduce screening inequalities in the other 
screening programmes, potentially with more relevance to the bowel screening 
programme where current socioeconomic inequalities are greatest.   
Prior to the research undertaken in this thesis in Study 3, there had been no literature 
published on the identification of high- and low-performing PCTs.  While PCTs no longer 
exist, many of the same geographical areas can be mapped to the new Clinical 
Commissioning Groups (CCGs) and the fundamental variation in cervical screening 
coverage is likely to remain unchanged.  The identification of high-performing areas, that 
is, areas that have exceptionally high levels of coverage after taking into consideration 
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programme-delivery factors and population factors, offers the opportunity for these areas 
to be further investigated as potential examples of best practice.  The identification of low-
performing areas also offers the opportunity for these areas to receive further support to 
tackle the particular challenges they face.   
As mentioned in the previous section, socioeconomic variation in colposcopy attendance 
indicates a point in the cervical screening programme for further intervention to reduce 
poorer cervical cancer outcomes. The findings suggest that women with more advanced 
cervical screening test indicators attend colposcopy sooner.  In part, this is due to current 
policies which target the provision of earlier appointments for advanced cervical 
abnormalities. This finding may inform strategies to support other women at risk of 
delayed attendance or non-attendance.  While women of lower SES are slower to attend a 
colposcopy appointment following an abnormal screening test result and may need to be 
supported to attend sooner, women who live in more ethnically diverse communities are 
most likely to not to attend.  Therefore, it is recommended that policies are amended to 
seek ways in which women from ethnic minority populations can be supported into 
attending colposcopy.  This may include changes to the priority given to their 
appointments or to addressing the means by which ethnic minority women are invited to 
attend colposcopy or are provided information or reassurance about what the 
appointment may entail.  All areas across England are required to have fail-safe policies to 
support colposcopy attendance.  If colposcopy attendance is to be improved, evaluation of 
these fail-safe policies, including their implementation, should be reviewed to determine 
their suitability for different SES groups and ethnic-minority populations.   
10.5 Future Research 
10.5.1 The Screening Coverage Gap – what can be learnt from improvements in the 
breast screening coverage gap? 
Further work could be undertaken to ascertain why the breast screening coverage gap has 
narrowed, yet the cervical screening coverage gap has not.  Potential areas for further 
exploration include investigating if the narrowing of the breast screening coverage gap 
was attributable to increased awareness of the benefits of breast cancer screening, 
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adaptive changes to the accessibility in the NHS Breast Screening Programme to lower SES 
women, or successful reminder interventions.  
It is important to note that breast screening coverage had been lower than cervical 
screening coverage and therefore may have had more improvements to make in the first 
instance.  In this respect, insight from the breast screening programme may offer valuable 
lessons to the colorectal screening programme which has lower levels of uptake, and a 
significant coverage gap.  Work to compare barriers to screening across the three 
programmes has highlighted important similarities and distinctions to screening coverage 
(Lo et al., 2013). Further work to identify key components that may inform future 
strategies to improve screening coverage is recommended.  
10.5.2 Is there a ‘London effect’ on Cervical Screening Coverage? 
Both cervical and breast screening coverage were lower in London.  There were distinct 
patterns of association between screening coverage and deprivation in London too, where 
the association tended to be much weaker.  There were a number of reasons suggested 
for these findings, not least of which was that the area-level measure of income 
deprivation (income domain of the IMD) may not be sensitive enough to detect poverty 
within London.  Other issues relating to high population diversity and population mobility 
may require further investigation.  It is unclear, however, if these issues are particular to 
London, or if they may be generalisable to other large cities – a ‘city effect’.  
Further work in this area may include investigation of the patterns of screening coverage 
in London in comparison with other large cities.  From my findings in Study 3, I would 
suggest further analyses of screening coverage and its association with a number of 
different factors, as follows.  Is the association between screening coverage and 
deprivation also weaker in other inner city/large city areas?  What are the patterns of 
association between screening coverage and distinct ethnic minority groups?  My findings 
suggest that other factors associated with ethnic minority groups, including level of 
education and specific religious beliefs may be associated with variations in screening 
coverage.  This may be important for cities which, like London, have greater ethnic 
diversity.  Further work may also include a comparison on these factors across screening 
programmes to determine which factors are common across all three programmes, and, 
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therefore, may be considered a ‘city effect’, or, alternatively, may be specific to the 
screening programme in question.  Certainly, I found similar patterns of association 
between deprivation and both cervical and breast screening coverage.  Would these 
patterns still hold for bowel screening uptake where the eligibility extends to both sexes?  
Finally, further investigation of the workload for general practices and their ability to cope 
with potentially higher administration of the cervical screening programme, in particular, 
may be warranted.  Could a higher administrative burden be carried for city general 
practices?  The results of such investigations may contribute to a wider understanding of 
the means to support screening uptake in city locations but also potentially to the support 
for particular groups of the population and for delivery of the respective programmes.   
10.5.3 Cervical Cancer Prevention – targeting socioeconomic inequalities in 
colposcopy attendance to reduce avoidable deaths from cervical cancer 
Socioeconomic inequalities in colposcopy attendance occur despite the provision of fail-
safe policies to support attendance.  This presents a problem for the NHS Cancer Screening 
Programme since around two-thirds of all women who present at colposcopy following an 
abnormal screening test result go on to have some sort of diagnostic procedure and/or 
treatment.  Women of lower SES are more likely to have a high-risk HPV positive status.  
Further research into the reasons why women, who have already attended cervical 
screening, choose not to attend colposcopy is needed.  Little is known about what these 
reasons may be, although research is available on the anxiety and stress felt by women 
who receive an abnormal screening test result, many of whom still go on to attend 
colposcopy.  Other psychosocial or practical barriers may need to be identified.  An 
evaluation of fail-safe policies, and of variations in such policies across areas in England, 
may indicate ways in which these policies may be more effective. 
Ways in which socioeconomic variation colposcopy may be investigated are suggested 
here.  This may be particularly interesting to address in areas that are less affluent than 
the East of England, where my data were sourced.  A study of this type may undertake 
similar analysis to my study and use logistic regression to regress colposcopy attendance 
for women against age, deprivation, education and ethnicity.  I would also recommend 
that system-level and individual-level barriers to colposcopy attendance be investigated. 
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Such a study may use qualitative research methods to explore the professionals’ views of 
the implementation of ‘fail-safe’ policies to support colposcopy attendance and to explore 
potential barriers to women’s colposcopy attendance.  If the professionals were to be 
recruited from colposcopy clinics in low-/medium-/high-income areas and with 
low/medium/high mix of ethnic minority populations then further understanding of 
challenges in different areas may be gathered.  I would also recommend that women’s 
views of facilitators and barriers to colposcopy attendance may be investigated, even 
though this may be a challenging group to recruit for.  One suggestion may be to contact 
women identified as having been referred to colposcopy following an abnormal screening 
result and who were more than four months overdue to complete a brief questionnaire 
(by post/online/phone) on reasons for not attending colposcopy.  Women who 
participated in the questionnaire could also be invited to attend a semi-structured 
interview to discuss in greater detail their reasons for not attending colposcopy 
(practical/psychosocial/knowledge) and to consider what supports, if any, may have 
enabled them to attend.      
10.6 Final Remarks 
Poorer cervical cancer outcomes for women of lower SES remain evident in the UK despite 
the availability of the NHS Cervical Screening Programme.  This thesis argued that 
targeting efforts to improve cervical screening attendance and colposcopy attendance are 
important pathways to future intervention on socioeconomic inequalities in cervical 
cancer.  Evidence was found for large discrepancies in cervical screening coverage across 
England, and areas have been identified for further support or as exemplars of best 
practice.  The population characteristics of some areas may support further targeted 
interventions to increase cervical screening coverage in groups at-risk of not attending.  
Evidence was found of socioeconomic variation in colposcopy attendance, and this should 
be highlighted as an opportunity for improving cervical cancer outcomes in a population 
already identified as having cervical abnormalities.  Work remains to be done to address 
the socioeconomic inequalities in cervical screening and colposcopy attendance, and this 
thesis has identified some ways in which continued efforts can be focused.   
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Appendix 1: Inequalities in Cervical Screening Coverage (Chapter 4) 
 
A copy of the published paper begins on the following page. 
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Appendix 2: Deprivation and Cervical Screening Coverage in England 
(including sensitivity analyses using Full Index of Multiple 
Deprivation) 
Appendix Table 1. All England Cervical screening coverage – all eligible women by deprivation quintile (Q1 – Low, 
Q5 – High) 
Yr 
Dep.  
Qs 
 
All eligible women - England 
Using Income Domain  
All eligible women – England 
Using Full IMD 
B 
95% CIs 
SE p B 
95% CIs 
SE p 
Lower Upper Lower Upper 
07 Q1 80.39 79.24 81.54 0.58 – 80.13 78.96 81.31 0.60 – 
Q2 -0.31 -1.94 1.32 0.82 0.710 -0.09 -1.75 1.57 0.84 0.915 
Q3 -2.49 -4.11 -0.88 0.82 0.003* -2.64 -4.29 -0.99 0.83 0.002* 
Q4 -3.15 -4.78 -1.53 0.82 <0.001† -2.26 -3.93 -0.60 0.84 <0.008* 
Q5 -5.27 -6.90 -3.64 0.82 <0.001† -4.93 -6.59 -3.27 0.84 <0.001† 
08 Q1 80.94 79.77 82.10 0.59 – 80.69 79.51 81.87 0.60 - 
Q2 -0.51 -2.15 1.14 0.83 0.541 -0.26 -1.93 1.41 0.85 0.757 
Q3 -2.74 -4.37 -1.11 0.83 0.001* -2.92 -4.57 -1.26 0.84 0.001 
Q4 -3.34 -4.99 -1.69 0.83 <0.001† -2.44 -4.12 -0.77 0.85 0.004 
Q5 -5.48 -7.13 -3.84 0.83 <0.001† -5.22 -6.89 -3.54 0.85 <0.001† 
09 Q1 80.92 79.81 82.03 0.56 – 80.72 79.59 81.85 0.57 - 
Q2 -0.62 -2.20 0.95 0.80 0.44 -0.48 -2.08 1.12 0.81 0.552 
Q3 -2.78 -4.34 -1.22 0.79 0.001* -3.10 -4.68 -1.51 0.80 <0.001† 
Q4 -3.40 -4.98 -1.83 0.80 <0.001† -2.39 -3.99 -0.80 0.81 0.004* 
Q5 -5.46 -7.04 -3.89 0.80 <0.001† -5.27 -6.86 -3.67 0.81 <0.001† 
10 Q1 80.70 79.70 81.69 0.50 – 80.50 79.47 81.53 0.52 - 
Q2 -0.71 -2.11 0.70 0.71 0.324 -0.76 -2.22 0.70 0.74 0.307 
Q3 -2.63 -4.03 -1.24 0.71 <0.001† -2.95 -4.40 -1.51 0.73 <0.001† 
Q4 -3.64 -5.04 -2.23 0.71 <0.001† -2.50 -3.96 -1.04 0.74 0.001* 
Q5 -5.56 -6.96 -4.15 0.71 <0.001† -5.33 -6.79 -3.87 0.74 <0.001† 
11 Q1 80.67 79.65 81.69 0.52 – 80.48 79.43 81.53 0.53 - 
Q2 -0.77 -2.21 -0.68 0.73 0.307 -0.80 -2.28 0.68 0.75 0.286 
Q3 -2.46 -3.90 -1.03 0.72 0.001* -2.97 -4.44 -1.50 0.74 <0.001† 
Q4 -3.56 -5.00 -2.12 0.73 <0.001† -2.21 -3.69 -0.72 0.75 0.001* 
Q5 -5.26 -6.70 -3.81 0.73 <0.001† -5.11 -6.59 -3.63 0.75 <0.001† 
12 Q1 80.21 79.15 81.26 0.53 – 80.04 78.96 81.12 0.55 - 
Q2 -0.67 -2.16 0.84 0.76 0.38 -0.82 -2.35 0.709 0.77 0.291 
Q3 -2.34 -3.82 -0.86 0.75 0.002* -2.84 -4.36 -1.33 0.76 <0.001† 
Q4 -3.17 -4.66 -1.68 0.75 <0.001† -1.84 -3.37 -0.32 0.77 0.018* 
Q5 -4.90 -6.39 -3.41 0.75 <0.001† -4.70 -6.23 -3.18 0.77 <0.001† 
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Appendix Table 2. All England: cervical screening coverage in younger and older women by deprivation quintiles 
Yr 
Dep 
Qs 
 
Cervical screening (25–49 years) Cervical screening (50–64 years) 
B 
95% CIs 
SE P B 
95% CIs 
SE P 
Lower Upper Lower Upper 
07 Q1 71.29 69.64 72.94 0.84  81.68 80.79 82.56 0.49  
Q2 0.54 -1.80 2.87 1.18 0.651 -0.88 -2.13 0.37 0.63 0.165 
Q3 -2.50 -4.82 -0.19 1.17 0.034* -2.67 -3.91 -1.42 0.63 <0.001† 
Q4 -3.29 -5.62 -0.95 1.18 0.006* -2.58 -3.83 -1.33 0.63 <0.001† 
Q5 -5.58 -7.92 -3.24 1.18 
<0.001
† 
-4.25 -5.50 -3.00 0.63 <0.001† 
08 Q1 75.38 73.96 76.80 0.72  81.59 80.61 82.58 0.50  
Q2 -0.58 -2.59 1.42 1.01 0.565 -1.19 -2.58 0.20 0.70 0.092 
Q3 -3.50 -5.49 -1.51 1.01 0.001* -2.78 -4.15 -1.40 0.70 <0.001† 
Q4 -4.69 -6.70 -2.69 1.01 
<0.001
† 
-2.82 -4.21 -1.43 0.70 <0.001† 
Q5 -6.99 -8.99 -4.98 1.01 
<0.001
† 
-4.51 -5.90 -3.13 0.70 <0.001† 
09 Q1 78.82 75.40 78.25 0.72  80.29 79.41 81.18 0.45  
Q2 -0.74 -2.76 1.27 1.02 0.467 -1.20 -2.45 0.05 0.63 0.059 
Q3 -3.21 -5.20 -1.21 1.01 0.002* -2.61 -3.85 -1.37 0.63 <0.001† 
Q4 -4.42 -6.43 -2.40 1.02 
<0.001
† 
-2.42 -3.68 -1.17 0.63 <0.001† 
Q5 -7.06 -9.07 -5.05 1.02 
<0.001
† 
-3.94 -5.20 -2.69 0.63 <0.001† 
10 Q1 76.64 75.35 77.94 0.66  79.39 78.60 80.19 0.40  
Q2 -0.84 -2.67 0.99 0.93 0.367 -1.25 -2.37 -0.12 0.57 0.030* 
Q3 -3.11 -4.93 -1.29 0.92 0.001* -2.49 -3.61 -1.38 0.56 <0.001† 
Q4 -4.62 -6.45 -2.78 0.93 
<0.001
† 
-2.61 -3.74 -1.38 0.57 <0.001† 
Q5 -7.13 -8.96 -5.29 0.93 
<0.001
† 
-4.04 -5.16 -2.92 0.57 <0.001† 
11 Q1 76.20 74.86 77.54 0.68  79.20 78.40 79.99 0.40  
Q2 -0.80 -2.69 1.10 0.96 0.408 -1.28 -2.41 -0.16 0.57 0.026* 
Q3 -2.61 -4.48 -0.73 0.95 0.007* -2.40 -3.52 -1.28 0.57 <0.001† 
Q4 -4.22 -6.12 -2.33 0.96 
<0.001
† 
-2.48 -3.61 -1.35 0.57 <0.001† 
Q5 -6.56 -8.45 -4.67 0.96 
<0.001
† 
-3.69 -4.82 -2.56 0.57 <0.001† 
12 Q1 74.10 72.73 75.48 0.70  78.80 78.05 79.56 0.38  
Q2 -0.76 -2.70 1.19 0.98 0.443 -1.07 -2.14 0.01 0.54 0.051 
Q3 -2.61 -4.53 -0.68 0.98 0.008* -2.28 -3.34 -1.22 0.54 <0.001† 
Q4 -3.93 -5.87 -1.97 0.98 
<0.001
† 
-2.04 -3.11 -0.97 0.54 <0.001† 
Q5 -6.20 -8.14 -4.25 0.98 
<0.001
† 
-3.42 -4.49 -2.35 0.54 <0.001† 
* p < 0.01, † p < 0.001 
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Appendix 3: Socioeconomic Inequalities in Cervical Screening 
Coverage Over Time 
 
In the Appendix, the results of the mixed ANOVA for all PCTs in England are presented 
below.   
England 
A mixed ANOVA was conducted to determine whether there were statistically significant 
differences in cervical screening coverage from 2007 to 2012 and to test if there was an 
interaction between deprivation and time on cervical screening coverage. The assumption 
of sphericity was violated, as assessed by Mauchley’s test of sphericity, χ2 (14) = 576.22, p 
< 0.001, therefore a Greenhouse-Geisser correction was applied.  
The main effect of deprivation showed there was a statistically significant difference in 
cervical screening coverage between deprivation quintiles F (4, 46) = 16.34, p < 0.001, 
partial η2 = 0.309. Cervical screening coverage in the most deprived quintile (Q5) was 
notable lower than cervical screening coverage in other quintiles, particularly the least 
deprived (Q1 and Q2), see Figure 26.   
The main effect of time showed a statistically significant difference in cervical screening 
coverage across the years, F (1.77, 259.21) = 9.424, p < 0.001, η2 = 0.061.  This is likely to 
be due to an increase in cervical screening coverage in 2008, followed by a subsequent fall 
in coverage in 2010, see Figure 26.   
There was no significant interaction between deprivation and time on cervical screening 
coverage for all women aged 25-64 years, F(7.10, 259.21) = 0.990, p = 0.440, partial η2 = 
0.026.   
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Figure 26. Cervical Screening Coverage by Deprivation Quintile - England 
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Appendix 4: Inequalities in Breast Screening Coverage (Chapter 5) 
Appendix Table 3. Quintiles of Deprivation and Breast Screening Coverage –England (including sensitivity 
analyses) 
Yr 
Dep.  
Qs 
 
All eligible women - England 
Using Income Domain  
All eligible women – England 
Using Full IMD 
B 
95% CIs 
SE p  
95% CIs 
SE p 
Lower Upper Lower Upper 
07 Q1 78.61 76.07 81.14 1.28 - 78.21 75.55 80.87 1.35 - 
Q2 -1.27 -4.86 2.31 1.81 -0.06 -1.43 -5.19 2.34 1.90 0.455 
Q3 -5.56 -9.12 -2.01 1.80 -0.28* -4.94 -8.68 -1.21 1.89 0.010* 
Q4 -4.94 -8.53 -1.36 1.81 -0.24* -5.07 -8.83 -1.31 1.90 0.009* 
Q5 
-12.28 -15.86 -8.69 1.81 -0.60** -10.63 -14.39 -6.87 1.90 
<0.001
** 
08 Q1 79.24 76.89 81.60 1.19 - 79.07 76.59 81.56 1.26 - 
Q2 -1.28 -4.61 2.05 1.69 -0.07 -2.27 -5.79 1.25 1.78 0.204 
Q3 -6.05 -9.36 -2.75 1.67 -0.32** -4.63 -8.12 -1.14 1.77 0.010* 
Q4 -4.62 -7.95 -1.26 1.68 -0.24* -5.66 -9.18 -2.14 1.78 0.002* 
Q5 
-11.51 -14.84 -8.18 1.69 -0.61** -10.10 -13.62 -6.59 1.78 
<0.001
** 
09 Q1 79.06 77.14 80.99 0.97 - 79.09 77.11 81.06 1.00 - 
Q2 -0.99 -3.71 1.73 1.38 -0.06 -1.64 -4.43 1.16 1.41 0.248 
Q3 -4.10 -6.79 -1.40 1.37 -0.27* -4.32 -7.09 -1.54 1.40 0.002* 
Q4 -4.55 -7.27 -1.83 1.38 -0.29* -4.18 -6.97 -1.38 1.41 0.004* 
Q5 
-9.70 -12.42 -6.98 1.38 -0.62** -9.32 -12.12 -6.53 1.41 
<0.001
** 
10 Q1 79.22 77.61 80.83 0.82 - 78.90 77.26 80.53 0.83 - 
Q2 -1.21 -3.49 1.07 1.15 -0.09 -0.48 -2.80 1.83 1.17 0.680 
Q3 -3.68 -5.94 -1.42 1.14 -0.28* -4.11 -6.40 -1.82 1.16 0.001* 
Q4 -4.45 -6.73 -2.17 1.15 -0.33** -3.74 -6.05 -1.43 1.17 0.002* 
Q5 
-8.84 -11.12 -6.56 1.15 -0.66** -8.22 -10.53 -5.91 1.17 
<0.001
** 
11 Q1 78.99 77.45 80.54 0.78 - 78.51 76.95 80.06 0.79 - 
Q2 -1.03 -3.22 1.16 1.11 -0.08 0.02 -2.18 2.23 1.12 0.983 
Q3 -3.75 -5.93 -1.58 1.10 -0.29* -3.77 -5.96 -1.59 1.11 0.001* 
Q4 -4.12 -6.31 -1.93 1.11 -0.32** -3.29 -5.49 -1.08 1.12 0.004* 
Q5 
-8.70 -10.89 -6.51 1.11 -0.70** -8.10 -10.30 -5.90 1.12 
<0.001
** 
12 Q1 78.11 76.51 79.71 0.81 - 77.70 76.09 79.30 0.81 - 
Q2 -0.51 -2.78 1.75 1.15 -0.04 0.38 -1.89 2.65 1.15 0.741 
Q3 -3.62 -5.87 -1.38 1.14 -0.28* -3.79 -6.04 -1.54 1.14 0.001* 
Q4 -3.93 -6.20 -1.67 1.15 -0.30* -3.08 -5.35 -0.81 1.15 0.008* 
Q5 
-8.34 -10.60 -6.07 1.15 0.63** -7.82 -10.09 -5.55 1.15 
<0.001
** 
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Appendix 5: Variation in cervical and breast screening coverage in 
England (published paper) 
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Appendix 6: Characteristics of High- and Low-Performing PCTs 
Characteristics of High-Performing PCTs 
There were five high-performing PCTs, of which Enfield PCT and Nottinghamshire County 
PCT performed well for cervical screening coverage in both younger and older women, and 
North and East Lincolnshire Care Trust, Waltham Forest PCT and Sunderland PCT 
performed well for older women only.  The descriptive characteristics of these PCTs are 
presented alongside the mean descriptive statistics for all 151 PCTs in Table 15.  
Enfield PCT 
Enfield, a London PCT, performed well for cervical screening coverage in younger and 
older women.  Coverage for older woman was 80% and therefore slightly higher than the 
mean coverage of 77% for older women in all PCTs.  However, its coverage for younger 
women at 72% was slightly below the mean coverage of 73% for younger women in all 
PCTs, indicating that its relatively good performance was held despite other more 
challenging factors.  For population factors, the percentage deprivation (24% vs 16%), 
Asian, Black or Mixed Ethnic population (34% vs 15%), ‘other ethnic’ population (5% vs 1%) 
and urbanisation (99% vs 81%) were all higher in Enfield than the respective mean in all 
PCTs in England. The percentage of women without higher education (23%) and GP 
registered women aged 25-29 years (20%) in the PCT were similar to the mean of all PCTs.  
For programme-delivery factors, the average practice list size, practitioner headcount per 
100,000 and the number of practice staff working full-time were below the respective 
mean of all PCTs in England.  However, the number of single-handed practices and 
percentage of practitioners qualified outside the UK were higher than the national mean.  
Nottinghamshire County PCT 
Nottinghamshire County, an East Midlands PCT, performed well for cervical screening 
coverage in younger and older women.  Its actual coverage for both younger (80% vs 73%) 
and older women (81% vs 77%) were higher than the mean for all PCTs in England.  For 
population factors, the percentage deprivation (12% vs 16%), Asian, Black or Mixed Ethnic 
population (5% vs 15%), ‘other ethnic’ population (0.3% vs 1.2%), urbanisation (69% vs 
81%) and GP registered women 25-29 years (17% vs 20%) were all lower than the 
  
- 310 - 
 
respective mean in all PCTs in England.  The percentage of those without higher education 
was slightly higher than the mean of all PCTs (25% vs 23%).  For programme-delivery 
factors, the percentage of single-handed general practices (7.0 vs 14%) and practitioners 
qualified outside the UK (20.0 vs 26%) and practitioner headcount per 100,000 population 
(65% vs 69%) were lower than the respective mean of all England PCTs.  The average 
practice list size (6,905 vs 6,656) was broadly comparable with the mean of all PCTs in 
England. The average number of Practice staff working full-time (1,103 vs 513) was much 
higher in Nottinghamshire County PCT than the mean for all PCTs in England.  
North East Lincolnshire PCT 
North East Lincolnshire, a Yorkshire and Humber PCT, performed well for cervical 
screening coverage in older women only. Its cervical screening coverage was higher than 
the mean for all PCTs in England for younger (79% vs 73%) and older women (81% vs77%). 
For population factors, the percentage deprivation (19% vs 16%) and women without 
higher education (30% vs 23%) were higher than the respective mean in all PCTs in 
England. The percentage Asian, Black or Mixed Ethnic population (2% vs 15%) was lower 
than the mean for all PCTs.  The percentage of ‘other ethnic’ population, urbanisation and 
GP registered women aged 25-29 years were broadly comparable with the respective 
mean for all PCTs in England.  For programme-delivery factors, the average practice list 
size (4,698 vs 6,652) and the number of practice staff working full-time (333 vs 513) were 
lower than the respective mean for all PCTs in England.  The practitioner headcount per 
100,000 population was broadly comparable with the mean in all PCTs, and the 
percentage of single-handed practices (29% vs 14%) and percentage of practitioners 
qualified outside the UK (57.0% vs 26%) were higher than the national mean. 
Waltham Forest PCT 
Waltham Forest, a London PCT, performed well for cervical screening coverage in older 
women only.  Cervical screening coverage for younger women (69% vs 73%) was below the 
mean for all PCTs in England, and higher for older women (79% vs 77%).  For population 
factors, the percentage of deprivation (24% vs 16%), Asian, Black or Mixed Ethnic 
population (43% vs 15%), ‘other ethnic’ population (4% vs 1%) and urbanisation (100% vs 
81%) were higher than the respective mean for all PCTs in England.  The percentage of 
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women without further education was slightly lower (21% vs 23%) than the mean for all 
England PCTs.  For programme-delivery factors, the average number of practice staff 
working full-time (397 vs 514) was lower than the respective mean for all PCTs in England.   
The average practice list size (6,156 vs 6,656) was broadly comparable and the practitioner 
headcount per 100,000 (72% vs 69%) population was a little higher than the mean for all 
PCTs in England. However, the percentage of single-handed practices (21.0 vs 14%) and 
the percentage of practitioners qualified outside the UK (53.0 vs 26%) were both higher 
than the national mean. 
Sunderland PCT 
Sunderland, a PCT in the North East of England, performed well for cervical screening 
coverage in older women only.  Cervical screening coverage for younger women (78% vs 
73%) and older women (80% vs 77%) was higher than the mean for all PCTs in England.  
For programme delivery factors, this PCT had higher levels of deprivation (20% vs 16%), 
women without higher education (29% vs 23%) and urbanisation (99% vs 81%) than the 
mean for all PCTs in England, but had lower levels of Asian, Black or Mixed Ethnic 
populations (4% vs 15%).  The percentage of ‘other ethnic’ populations (0.3 vs 1.2%) and 
percentage of GP registered women aged 25-29 years (both 20%) were comparable to the 
mean for all PCTs in England.  For programme-delivery factors in Sunderland PCT, the 
average practice list size (5,170 vs 6,652) and the number of practice staff working full-
time (416 vs 513) were below the respective mean of all PCTs in England.  The percentage 
of single-handed practices (15% vs 14%) and the practitioner headcount per 100,000 
population (67% vs 69%) were broadly comparable with the mean for all PCTs.  Finally, the 
percentage of practitioners qualified outside the UK (36% vs 26%) was higher than the 
mean for all PCTs.   
Summary of characteristics for all high-performing PCTs 
All high-performing PCTs had relatively high cervical screening coverage for older women, 
of which two, Enfield and Nottinghamshire County, also performed exceptionally well for 
cervical screening coverage in younger women.  Deprivation, the percentage of women 
without higher education, urbanisation, the percentage of single-handed practices and 
percentage of practitioners qualified outside the UK tended to be higher than the national 
  
- 312 - 
 
mean and the number of practice full-time practice staff, with one notable exception, 
tended to be below the national mean.  Other characteristics either had no distinct 
pattern of association across the high-performing PCTs (the percentage of ethnic minority 
populations and the average practice list size) or were broadly comparable to the mean for 
all England PCTs (the percentage of GP registered women aged 25-29 years and the 
practitioner headcount per 100,000 population).
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Appendix Table 4. Descriptive statistics for PCT-level characteristics of High Performing PCTs (Younger Women and Older Women) 
 All PCTs Younger & Older Women Older Women Only 
  (n=151) Enfield 
Nottinghamshire 
County 
North East 
Lincolnshire 
Waltham 
Forest 
Sunderland 
 Mean  (SD) Actual Actual Actual Actual Actual 
Cervical Coverage (%)       
Younger women 73.4  (4.4) 72.0 80.4 78.9 68.9 77.8 
Older women 77.2  (2.5) 79.5 81.4 81.1 79.4 79.6 
Population factors        
% Deprivation 16.2  (5.8) 23.7 11.9 19.1 24.0 20.0 
% Without higher education 23.0  (5.1) 23.0 25.0 29.5 20.8 29.1 
% Asian, Black or Mixed ethnicity 15.1  (15.4) 33.9 4.5 2.3 43.7 3.8 
% ‘Other ethnic’ minority 1.2  (1.6) 5.1 0.3 0.3 4.1 0.3 
% Urbanisation 81.2  (21.5) 99.3 68.7 83.9 100 98.9 
% GP Registered women aged 25-29 years 19.5  (4.2) 20.2 16.9 18.3 19.7 20.1 
Programme-delivery factors       
Average practice list size 6656.2  (1371.2) 4903.6 6905.6 4698.7 6156.4 5170.1 
% Single-handed practices 13.5  (10.2) 26.0 7.0 29.0 21.0 15.0 
Practitioner headcount per 105 population 68.7  (8.3) 58.3 65.1 66.2 71.8 67.4 
Practice staff FTE 513.7  (296.7) 278.6 1103.6 333.7 397.1 416.0 
% Practitioners qualified outside UK 26.4  (14.7) 47.0 20.0 57.0 53.0 36.0 
FTE, Full-Time Equivalent; SD, Standard Deviation 
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Characteristics of Low-Performing PCTs 
There were five low-performing PCTs, of which Camden PCT, Hammersmith & Fulham PCT 
and Harrow PCT performed poorly for cervical screening coverage in younger women and 
Birmingham East & North PCT and Sefton PCT performed poorly for cervical screening 
coverage in older women.  The descriptive characteristics of these PCTs are presented 
alongside the mean descriptive statistics for all 151 PCTs in Table 16. 
Camden PCT 
Camden, a London PCT, performed poorly for cervical screening coverage in younger 
women only.  Cervical screening coverage for younger women was 59%, the lowest 
coverage among all PCTs in England, and also returned lower screening coverage in older 
women (72% vs 77%) than the mean for all PCTs in England.  Camden had a higher 
percentage of deprivation (19% vs 16%),  Asian, Black & Mixed populations (30% vs 15%), 
‘other ethnic’ populations (4% vs 1%), urbanisation (100% vs 81%) and GP registered 
women aged 25-29 years (31% vs 20%) than the respective mean for all PCTs, however, it 
had fewer women without higher education (13% vs 23%). With the exception of the 
practitioner headcount per 100,000 population, all programme-delivery factors were 
lower than the respective mean for all PCTs in England, and this was notably so for the 
percentage of single-hand practices (0.2% vs  14%) and practitioners qualified outside the 
UK (0.1% vs 26%).   
Hammersmith & Fulham PCT 
Hammersmith & Fulham, a London PCT, was a poor performing PCT for cervical screening 
coverage in younger women only.  It joined Fulham PCT as the joint lowest for cervical 
screening coverage in younger women (59%) out of all PCTs in England, and also had low 
cervical screening coverage in older women (69% vs 77%).  It’s population factors are also 
broadly comparable with Fulham PCT in so far as it has higher levels of deprivation (19% vs 
16%), Asian, Black or Mixed Ethnic populations (26% vs 15%), ‘other ethnic’ populations 
(6% vs 1%), urbanisation (100% vs 81%) and % GP registered women aged 25-29 years 
(27% vs 20%) but had fewer women without higher education (13% vs 23%) than the 
respective mean for all PCTs in England.  Similarly, the pattern for programme-delivery 
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factors were comparable with Fulham PCT.  With the exception of the practitioner 
headcount per 100,000 population, all programme-delivery factors were lower than the 
respective mean for all PCTs in England, and this was notably so for the percentage of 
single-hand practices (0.2% vs  14%), average number of practice staff working full-time 
(216 vs 514) and practitioners qualified outside the UK (0.3% vs 26%).   
Harrow PCT 
Harrow, a London PCT, was the third and final PCT identified as a poor performing PCT for 
cervical screening coverage in younger women (63% vs 73%).  Cervical screening coverage 
for older women was just below the mean for all PCTs in England (76% vs 77%).  Harrow 
had a much higher percentage of Asian, Black or Mixed Ethnic population (55% vs 15%) 
and also had higher levels of ‘other ethnic’ population (3% vs 1%) and urbanisation (100% 
vs 81%).  However, it had comparable levels of deprivation (15% vs 16%) and GP registered 
women aged 25-29 years (both 20%) with the mean for all PCTs in England, and had fewer 
women without higher education (17% vs 23%).  Harrow followed a similar pattern for 
programme-delivery factors to Camden and Hammersmith & Fulham PCTs.  That is, all 
programme-delivery factors were lower than the respective mean for all PCTs in England 
with the exception of the practitioner headcount per 100,000 population.   
Birmingham North & East PCT 
Birmingham North & East, a West Midlands PCT, performed poorly for cervical screening 
coverage in older women.  Cervical screening coverage was lower than the mean for all 
PCTs in England for both younger (68% vs 73%) and older women (73% vs 77%).  The 
percentage of deprivation (26% vs 16%), women without higher education (31% vs 23%), 
Asian, Black or Mixed population (35% vs 15%) and urbanisation (99% vs 81%) were higher 
than the respective mean in all PCTs in England.  The percentage ‘other ethnic’ minority 
population (both 1%) and GP registered women aged 25-29 years (22% vs 20%) were 
similar to the respective mean for all PCTs in England.  For programme-delivery factors, all 
were lower than the respective mean for all PCTs in England, particularly the percentage of 
single-handed practices (0.3 vs 14%) and the practitioners qualified outside the UK (0.3 vs 
26%).   
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Sefton PCT 
Sefton, a North West PCT, performed poorly for cervical screening in older women (72% vs 
77%), and also had lower cervical screening coverage for younger women (70% vs 73%) 
than the mean for all PCTs in England. In comparison with the mean values for all PCTs in 
England, the percentage deprivation (17% vs 16%), women without higher education (25% 
vs 23%) and GP registered women (17% vs 20%) were broadly comparable.  Sefton had 
lower levels of Asian, Black or Mixed Ethnic population (2% vs 15%) and ‘other ethnic’ 
population (0.3 vs 1%) and higher levels of urbanisation (97% vs 81%).  All programme-
delivery factors were lower than the respective mean of all PCTs in England: average 
practice list sizes (5,017 vs 6,652), practitioner headcount per 100,000 population (63% vs 
69%), percentage of single-handed practices (0.2 vs 14%), practice staff working full-time 
(360 vs 513), percentage of practitioners qualified outside the UK (0.2 vs 26%).   
Summary of characteristics of low-performing PCTs 
All low-performing PCTs for cervical screening coverage in younger women were in London 
and had fewer women without higher education, more women from ethnic minority 
populations and a higher percentage of younger women aged 25-29 years. Their average 
practice lists size were broadly comparable with the national mean and they tended to 
have a higher percentage of practitioner headcount per 100,000 population but the 
number of full-time practice staff was consistently below the national mean for all PCTs in 
England. The PCTs identified with low cervical screening coverage in older women also had 
a high percentage of urbanisation.  They had higher percentages of women without higher 
education and from Asian, Black and Mixed ethnic populations.  They had below average 
practice lists sizes but had more single-handed practices, fewer practitioners per 100,000 
population and fewer full-time practice staff. 
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Appendix Table 5. Descriptive statistics for PCT-level characteristics of Low Performing PCTs (Younger Women and Older Women) 
 All PCTs Younger Women Older Women 
  (n=151) Camden 
Hammersmith & 
Fulham 
Harrow 
Birmingham 
East & North 
Sefton 
 Mean  (SD) Actual Actual Actual Actual Actual 
Cervical Coverage (%)       
Younger women 73.4  (4.4) 58.7 58.7 62.9 67.8 70.4 
Older women 77.2  (2.5) 72.0 69.1 75.6 72.8 71.8 
Population factors        
% Deprivation 16.2  (5.8) 19.1 19.3 14.9 26.2 16.9 
% Without higher education 23.0  (5.1) 12.7 12.8 16.8 31.4 25.1 
% Asian, Black or Mixed ethnicity 15.1  (15.4) 29.9 26.4 54.8 34.9 2.3 
% ‘Other ethnic’ minority 1.2  (1.6) 3.8 5.5 2.9 1.2 0.3 
% Urbanisation 81.2  (21.5) 100 100 99.7 99.4 97.1 
% GP Registered women aged 25-29 years 19.5  (4.2) 30.5 27.0 20.0 21.9 16.5 
Programme-delivery factors       
Average practice list size 6656.2  (1371.2) 6123.2 6287.5 6364.5 5760.6 5017.6 
% Single-handed practices 13.5  (10.2) 22.0 16.0 11.0 28.0 21.0 
Practitioner headcount per 105 population 68.7  (8.3) 79.0 74.8 70.0 64.2 62.7 
Practice staff FTE 513.7  (296.7) 256.1 215.5 305.4 482.2 360.1 
% Practitioners qualified outside UK 26.4  (14.7) 13.0 27.0 34.0 31.0 17.0 
FTE, Full-Time Equivalent; SD, Standard Deviation 
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Appendix 7: Factors Associated with Cervical Screening Coverage 
(chapter 7) 
Appendix 7: Ethics Letter Page 1 
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Appendix 7: Ethics Letter Page 2 
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Appendix 7: Demographic Questionnaire 
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Appendix 8: Potential Mediators of SES and Screening Attendance 
(chapter 8) 
Potential Mediators of SES and Screening Attendance: Using Social Grade 
as the measure of SES 
This appendix details the methods and results for Study 5 when Social Grade is used as the 
measure of SES 
Methods 
Recruitment 
Recruitment methods were as outlined in Chapter 8. 
Measures 
The measures used in this alternative analysis of Study 5 were as outlined in Chapter 8, 
with the exception of the measure of SES.  In this example, occupational social grade was 
used as the marker of SES. The occupational social grade, was collected as part of the TNS 
BMRB survey described earlier.  Social Grade relates to the main household earner and 
therefore may not necessarily reflect the occupational status of the individual woman.  It is 
based on the occupation, type of organisation worked for, job title and whether self-
employed (Ipsos MediaCT, 2009).  Social Grade consists of the following categories: A – 
high managerial, administrative or professional; B – Intermediate managerial, 
administrative or professional; C1 – Supervisory, clerical and junior managerial, 
administrative or professional; C2 – Skilled manual workers; D – Semi and unskilled manual 
workers; and E – State pensioners, casual or lowest grade workers, unemployed with state 
benefits only.  Of the population, 4% are allocated social grade A so this category is often 
grouped with category B.  Similarly, 8% of the population fall within social grade E, so this 
category is often grouped with category D.  This produces four social grades: AB, C1, C2 
and DE.  
Results 
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Sociodemographic Characteristics 
Appendix Table 5 details the sample characteristics using unweighted data, grouped by 
Social Grade.  Analyses reported here use the unweighted data.  Participants were aged 
26–64 years (M = 42.0).  Lower Social Grade groups were more likely to be younger (χ2 = 
13.25, df = 6, p = 0.04), from non-white ethnic backgrounds (χ2 = 12.28, df = 3, p = 0.006), 
single (χ2 = 74.19, df = 6, p < 0.001), and not working (χ2 = 153.35, df = 9, p < 0.001).  
 
Appendix Table 6. Demographics and Social Grade 
 Social Grade  
 
AB 
(n = 190) 
High SES 
C1 
(n = 241) 
C2 
(n = 163) 
DE 
(n = 248) 
Low SES 
Stat. test of 
group difference 
Age % 
26–35yrs 30.5 28.6 33.7 41.5 
χ2 = 13.25, df = 6, 
p = 0.039 36–49yrs 43.2 44.4 42.3 31.9 
50–64yrs 26.3 27.0 23.9 26.6 
Ethnicity % 
White  89.5 87.4 91.4 80.6 χ2 = 12.28, df = 3, 
p = 0.006 Non-white 10.5 12.6 8.6 19.4 
Marital Status % 
Married 77.9 72.1 80.4 48.4 
χ2 = 74.19, df = 6, 
p < 0.001 
Single 12.1 12.5 11.7 33.5 
Other 10.0 15.4 8.0 18.1 
Work Status % 
Full-time 37.4 40.7 27.6 9.3 
χ2 = 153.35, df = 
9, p < 0.001 
Part-time 28.4 29.5 44.2 18.5 
Not working/ 
unemployed 
25.3 23.7 21.5 63.3 
Retired 8.9 6.2 6.7 8.9  
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Screening Status, Social Grade and Demographic Variables 
There was a significant association between Social Grade and screening status (see 
Appendix Table 7).   Women in lower social grade groups were more likely to be overdue 
for screening than women in higher social grade groups (26% in social grade DE vs 16% in 
social grade AB).  Younger women were more likely to be overdue than older women (25% 
of 26–35 year-olds vs 16% of 50–64 year-olds). Single women were more likely to be 
overdue than other marital status groups (29% single vs 20% of married and 21% of 
Other).  Ethnicity and Work Status were not significantly associated with screening status.  
Age and marital status were associated with social grade and screening status and were 
controlled for in the multivariate analyses. 
 
Appendix Table 7. Screening Status, social grade and Demographic Factors Ɨ 
 Screening Status  
 Overdue %  
(n = 181) 
Up-to-date %  
(n = 661) 
Test for linear 
association 
Social Grade     
AB – Highest SES Group 15.8 (30) 84.2 (160) 
χ2 = 6.76, df = 1, 
p = 0.009 
C1 20.3 (49) 79.7 (192) 
C2 23.3 (38) 76.7 (125) 
DE – Lowest SES Group 25.8 (64) 74.2 (184) 
Age     
26–35 years 24.9 (71) 75.1 (214) 
χ2 = 6.95, df = 2, 
p = 0.031 
36–49 years 22.6 (76) 77.4 (261) 
50–64 years 15.5 (34) 84.5 (186) 
Ethnicity    
White 20.6 (150) 79.4 (577) χ2 = 2.85, df = 1, 
p = 0.092 Non-white 27.7 (31) 72.3 (81) 
Marital Status    
Married 19.6 (112) 80.4 (460) 
χ2 = 6.49, df = 2, 
p = 0.039 
Single 29.0 (45) 71.0 (110) 
Other  21.1 (24) 78.9 (90) 
Work Status    
Full-time 23.2 (55) 76.8 (182) 
χ2 = 7.21, df = 3, 
p = 0.065 
Part-time 15.6 (38) 84.4 (205) 
Not working/unemployed 23.9 (71) 76.1 (226) 
Retired 26.2 (17) 73.8 (48)  
 Ɨ May not add to 100% (797) due to rounding or missing values 
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Screening Status and Perceived Benefits of Cervical Screening 
The next set of analyses examined the association between screening status and the 
perceived benefit variables (see Appendix Table 8).  The three perceived benefits of 
cervical screening showed significant associations with screening status.  Women who 
were up-to-date were more likely to agree that the ‘chances of curing cervical cancer are 
better when the disease is discovered at an early stage’ than those who were overdue 
(94% vs 87%).  They were more likely to agree that ‘cervical screening can pick up cell 
changes that can go on to become cervical cancer’ (92% vs 82%). They were also more 
likely to agree that cervical screening is effective in preventing cervical cancer (82% vs 
74%).    
 
Appendix Table 8. Perceived benefits of cervical screening by screening status Ɨ 
 
Overdue 
(n = 181) 
Up-to-date 
(n = 661) 
Test for 
association 
The chances of curing cervical cancer are better  
When the disease is discovered at an early stage 
Agree 86.7 (156) 94.1 (621) χ2 = 11.24,  
df = 1, 
p < 0.001 
Disagree/Neither 13.3 (24) 5.9 (39) 
 
Cervical screening can pick up cell changes  
that can go on to become cervical cancer 
Agree 82.1 (147) 91.5 (603) χ2 = 13.18,  
df = 1,  
p < 0.001 
Disagree/Neither 17.9 (32) 8.5 (56) 
 
Cervical screening is effective 
in preventing cervical cancer 
Agree 74.4 (134) 81.7 (539) χ2 = 4.63,  
df = 1,  
p = 0.031 
Disagree/Neither 25.6 (46) 18.3 (121) 
Ɨ Numbers may not agree with total due to rounding or missing values 
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Social Grade Differences in Perceived Benefits about Cervical Screening 
Associations between social grade and the perceived benefits variables are shown in 
Appendix Table 9.   Of the highest social grade group (AB), 98% agreed the ‘chances of 
curing cervical cancer are better when the disease is discovered at an early stage’ 
compared with 90% of the lowest social grade group (DE), and 95% vs 83% agreed that 
‘cervical screening can pick up cell changes that can go on to become cervical cancer’.  
Agreeing that ‘cervical screening is effective in preventing cervical cancer’ was not 
significantly associated with social grade.   
 
Appendix Table 9. Perceived benefits of cervical screening by SES Ɨ 
 % (n)  
 AB 
(n = 190) 
High SES 
C1 
(n = 241) 
C2 
(n = 163) 
DE 
(n = 248) 
Low SES 
Test for 
association 
The chances of curing cervical cancer  
are better when the disease is  
discovered at an early stage 
Agree 98.4 (186) 92.9 (224) 88.3 (144) 90.3 (223) χ2 = 15.40, 
df = 3,  
p = 0.002 
Disagree/Neither 
1.6 (3) 7.1 (17) 11.7 (19) 9.7 (24) 
 
Cervical screening can pick up cell  
changes that can go on to become  
cervical cancer 
Agree 95.2 (179) 92.1 (222) 89.6 (146) 82.5 (203) χ2 = 21.04, 
df = 3,  
p < 0.001 
Disagree/Neither 
4.8 (9) 7.9 (19) 10.4 (17) 17.5 (43) 
 
Cervical screening is effective  
in preventing cervical cancer 
 
Agree 79.9 (151) 79.3 (191) 82.2 (134) 79.8 (197) χ2 = 0.587, 
df = 3,  
p = 0.899 
Disagree/Neither 
20.1 (38) 20.7 (50) 17.8 (29) 20.2 (50) 
Ɨ Numbers may not agree with total due to rounding or missing values 
  
  
- 326 - 
 
Mediational Analyses of the Relationship between SES and Screening Status 
Four logistic regression models with screening status (overdue/up-to-date) as the 
dependent variable tested mediation.  Odds ratios (OR) for being overdue are shown in 
Appendix Table 10. 
Model 1 included SES and the control variables age and marital status.  The lowest social 
grade group (DE) was significantly more likely to be overdue for screening than the highest 
SES group (reference category), OR = 1.71, 95% CI: 1.05–2.81.  
Model 2 included SES, the control variables, and the perceived benefit variable ‘the 
chances of curing cervical cancer are better when the disease is discovered at an early 
stage’.   This perceived benefit had an independent association with screening attendance, 
where the OR for being overdue for screening was statistically significant for those who 
disagreed with the statement (OR = 2.07, 95% CI: 1.20–3.60). This model showed a small 
reduction in the odds ratios associated with being overdue across social grade groups in 
comparison with Model 1, and there was no longer a statistically significant difference 
between the highest (reference category, AB) and the lowest social grade group (DE).  This 
indicates that it slightly mediated the association between social grade and screening 
status.  Freedman’s estimate for the percentage of the association between social grade 
and screening status mediated by this belief variable is 2.5%.   
Model 3 included SES, the control variables, and the perceived benefit ‘Cervical screening 
can pick up cell changes that can go on to become cervical cancer’.  This perceived benefit 
had an independent association with screening attendance, where the OR for being 
overdue for screening for screening was statistically significant for those who disagreed 
with the statement (OR = 2.03, 95% CI: 1.25–3.30).  Freedman’s estimate for the 
percentage of association between SES and screening status mediated by this belief 
variable is 4.2%.   
Model 4 included SES, the control variables, and both perceived benefit variables.  This 
model showed a small reduction in the odds ratios associated with being overdue across 
social grade groups in comparison with Model 1, and there was no longer a statistically 
significant difference between the highest (reference category, AB) and the lowest social 
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grade group (DE).  This indicates that it slightly mediated the association between social 
grade and screening status.  Freedman’s estimate for the percentage of association 
between SES and screening status mediated by both belief variables is 5.1%.   
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Appendix Table 10. SES and belief predictors for being overdue for screening: regression models controlling for age and marital status 
 Overdue 
% (n) 
Model 1 
SES 2 
Model 2  
SES &  
Chances of Cure 
Better at Early 
Stage 
Model 3 
SES &  
Screening Picks Up 
Cell Changes 
Model 4 
SES &  
Both Variables 2 
Social Grade       
DE (low SES, n = 248) 25.8 (64) 1.71 [1.05–2.81] 1.57 [0.95–2.56] 1.48 [0.89–2.44] 1.44 [0.89–2.38] 
C2 (n = 163) 23.3 (38) 1.61 [0.94–2.75] 1.47 [0.86–2.53] 1.53 [0.89–2.62] 1.46 [0.85–2.51] 
C1 (n = 241) 20.3 (49) 1.36 [0.82–2.25] 1.28 [0.77–2.13] 1.31 [0.79–4.72] 1.27 [0.76–2.11] 
AB (high SES, n = 190) 15.8 (30) 1.00 1.00 1.00 1.00 
      
Social Grade (Continuous)‡  1.18 [1.02-1.37] 1.15 [0.99-1.34] 1.13 [0.97-1.31] 1.12 [0.96-1.30] 
      
The chances of curing cervical cancer 
are better when the disease is 
discovered at an early stage 
     
Disagree/Neither Agree Nor Disagree 13.3 (24)  2.07 [1.20–3.60]  1.66 [0.90–3.08] 
Agree 86.7 (156)  1.00  1.00 
 
Cervical screening (the smear or Pap 
test) can pick up cell changes that can 
go on to become cervical cancer 
     
Disagree/Neither Agree Nor Disagree 17.9 (32)   2.03 [1.25–3.30] 1.62 [0.94–2.81] 
Agree 82.1 (147)   1.00 1.00 
2.  Reference Category (Overdue) n = 181, Up To Date n = 661. 3.  Numbers are Odds Ratios with confidence intervals in parentheses, ‡ Used to 
determine Freedman’s estimate of mediation 
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Appendix 9: Socioeconomic Variation in Colposcopy Attendance 
(chapter 9) 
Sensitivity Analyses using Full IMD 
Descriptive Statistics 
Appendix Table 11. Descriptive Statistics for Income Domain and Full IMD Quintiles 
 % (n) Min–Max Mean  Std Dev 
Income domain (IMD) Quintiles 
Q1 – Least Income 8.5 (2305) 0.236–0.538 0.306 0.064 
Q2 22.3 (6064) 0.142–0.235 0.182 0.026 
Q3 26.7 (7255) 0.088–0.142 0.114 0.016 
Q4 22.5 (6115) 0.056–0.088 0.070 0.009 
Q5 – Most Income 20.1 (5454) 0.005–0.055 0.039 0.012 
Full IMD Quintiles 
Q1 – Most Deprived 7.1 (1943) 34.150–87.805 44.510 9.544 
Q2 21.2 (5762) 21.342–33.943 26.383 3.528 
Q3 23.0 (6245) 13.776–21.313 17.269 2.177 
Q4 23.6 (6427) 8.482–13.765 10.973 1.509 
Q5 – Least Deprived 25.1 (6816) 1.011–8.456 5.535 1.832 
Linear associations 
Appendix Table 12. Variables associated with colposcopy attendance 
 Attendance at eight 
weeks, row % (n)  
89.3 (24,294) 
Test of 
linear 
association 
Attendance at four 
months, row % (n)   
 94.1 (25, 594) 
Test of 
linear 
association 
IMD quintiles 
Q1 – Low income 86.6 (1996) 
ᵡ2=23.98, 
df=4, 
p<0.001 
92.5 (2131) 
ᵡ2=13.97, 
df=4, 
p=0.007 
Q2 89.6 (5434) 94.5 (5731) 
Q3 89.4 (6486) 94.1 (6828) 
Q4 90.2 (5517) 94.4 (5771) 
Q5 – High income 89.1 (4861) 94.1 (5133) 
Full IMD Quintiles 
Q1 – Most Deprived 87.0 (1690) 
ᵡ2=26.32, 
df=4, 
p<0.001 
92.6 (1799) 
ᵡ2=12.60, 
df=4, 
p=0.013 
Q2 89.5 (5158) 94.3 (5436) 
Q3 89.3 (5576) 94.1 (5876) 
Q4 90.6 (5826) 94.6 (6083) 
Q5 – Least Deprived 88.7 (6044) 93.9 (6400) 
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Appendix Table 13. Variables associated with colposcopy attendance within eight weeks of referral, * p <0.05 
 
Sample column   
% (n) 100 (27,193) 
Attendance at eight weeks 
row % (n), 89.3 (24,294) 
Unadjusted models Adjusted model 
OR (95% CI) p-value OR (95% CI) p-value 
Full IMD Quintiles 
Q1 – Most Deprived 7.1 (1943) 87.0 (1690) 0.85 (0.73-0.99) 0.041* 0.84 (0.72-0.99) 0.040* 
Q2 21.2 (5762) 89.5 (5158) 1.09 (0.97-1.22) 0.131 1.07 (0.94-1.21) 0.308 
Q3 23.0 (6245) 89.3 (5576) 1.07 (0.95-1.19) 0.263 0.95 (0.84-1.07) 0.379 
Q4 23.6 (6427) 90.6 (5826) 1.24 (1.11-1.39) <0.001** 1.12 (0.99-1.27) 0.066 
Q5 – Least Deprived 25.1 (6816) 88.7 (6044) 1.00 – 1.00 – 
Ethnicity       
Q1 – Lowest % White 5.6 (1529) 85.0 (1299) 0.45 (0.37-0.53) <0.001* 0.51 (0.42-0.62) <0.001* 
Q2 26.9 (7304) 87.5 (6391) 0.55 (0.49-0.63) <0.001* 0.62 (0.54-0.71) <0.001* 
Q3 29.3 (7965) 89.0 (7085) 0.63 (0.56-0.72) <0.001* 0.67 (0.58-0.76) <0.001* 
Q4 20.2 (5502) 90.6 (4983) 0.76 (0.66-0.87) <0.001* 0.74 (0.64-0.86) <0.001* 
Q5 – Highest % White 18.0 (4893) 92.7 (4536) 1.00 - 1.00 - 
Cervical Screening Indicator (invitation period)      
Low-grade/borderline (8 wks) 55.2 (15,004) 88.1 (13,220) 1.00 - 1.00 - 
Moderate/severe (4 wks) 38.2 (10,380) 92.7 (9625) 1.72 (1.57-1.88) <0.001* 1.71 (1.57-1.87) <0.001* 
?invasive/?Glandular (2 wks) 1.9 (514) 94.9 (488) 2.53 (1.70-3.77) <0.001* 2.51 (1.69-3.74) <0.001* 
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Appendix Table 14. Variables associated with colposcopy attendance within four months of referral, * p <0.05 
 
Sample column  
% (n), 100 (27,193) 
Attendance at four months  
row % (n), 94.1 (25, 594) 
Unadjusted models Adjusted model‡ 
OR (95% CI) p-value OR (95% CI) p-value 
Full IMD Quintiles 
Q1 – Low Income 7.1 (1943) 87.0 (1690) 0.81 (0.67-0.99) 0.038* 0.92 (0.75-1.13) 0.432 
Q2 21.2 (5762) 89.5 (5158) 1.08 (0.93-1.26) 0.291 1.16 (0.99-1.35) 0.069 
Q3 23.0 (6245) 89.3 (5576) 1.04 (0.90-1.20) 0.640 1.02 (0.88-1.19) 0.765 
Q4 23.6 (6427) 90.6 (5826) 1.15 (0.99-1.33) 0.064 1.15 (0.99-1.34) 0.071 
Q5 – High Income 25.1 (6816) 88.7 (6044) 1.00 – 1.00 - 
Age at referral 
25–34 years 55.0 (14949) 93.9 (14038) 1.00 – 1.00 – 
35–44 years 27.7 (7539) 94.0 (7083) 1.01 (0.90–1.13) 0.893 1.04 (0.92-1.17) 0.516 
45–64 years 17.3 (4705) 95.1 (4473) 1.25 (1.08–1.45) 0.003* 1.26 (1.07-1.47) 0.004* 
Ethnicity       
Q1 – Lowest % White 5.6 (1529) 91.8 (1403) 0.46 (0.37-0.58) <0.001* 0.48 (0.38-0.62) <0.001* 
Q2 26.9 (7304) 93.5 (6826) 0.59 (0.50-0.70) <0.001* 0.61 (0.52-0.74) <0.001* 
Q3 29.3 (7965) 93.9 (7476) 0.64 (0.54-0.75) <0.001* 0.65 (0.55-0.78) <0.001* 
Q4 20.2 (5502) 94.3 (5191) 0.69 (0.58-0.83) <0.001* 0.69 (0.58-0.84) <0.001* 
Q5 – Highest % White 18.0 (4893) 96.0 (4698) 1.00 - 1.00 - 
Cervical Screening Indicator (invitation period)      
Low-grade/borderline (8 wks) 55.2 (15,004) 93.9 (14,082) 1.00 - 1.00 - 
Moderate/severe (4 wks) 38.2 (10,380) 94.7 (9829) 1.17 (1.05-1.30) 0.005* 1.18 (1.06-1.32) 0.003* 
?invasive/?Glandular (2 wks) 1.9 (514) 95.3 (490) 1.34 (0.88-2.03) 0.171 1.32 (0.87-1.99) 0.196 
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Appendix 10: Paper published in BJC 
 
Please see paper on next page. 
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Colposcopy attendance and deprivation: A 
retrospective analysis of 27193 women in 
the NHS Cervical Screening Programme 
E Douglas1, J Wardle1, N J Massat2and 
J Waller*,1 1 
Health Behaviour Research Centre, Department of Epidemiology & Public Health, University College London, Gower 
Street, London WC1E 6BT, UK and 2Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen 
Mary University of London, London, UK 
Background: Attendance for cervical screening is socially graded, but little is known about patterns of attendance for 
colposcopy following an abnormal screening result. 
Methods: Logistic regression was used to regress colposcopy attendance status for 27 193 women against age and 
area-level deprivation, adjusting for ethnicity. 
Results: Colposcopy attendance was high at 8 weeks (89%) and 4 months post-referral (94%) but women living in the 
most deprived areas were significantly less likely to attend. 
Conclusions: The high overall attendance rates at colposcopy are encouraging but lower attendance among women 
in the most income-deprived areas indicates that even when these women attend primary cervical screening, they 
remain at higher risk of missing out on the benefits of the programme. 
Introduction of an organised cervical screening 
programme in the UK in 1988 dramatically reduced 
cervical cancer incidence and mortality (Quinn et al, 
1999; Peto et al, 2004), and protected the population 
against rises in incidence that would probably have 
occurred because of changes in sexual behaviour 
(Mercer et al, 2013). The cervical screening 
programme offers 3–5 yearly testing for cytological 
abnormalities (Health and Social Care Information 
Centre, 2013), with referral to colposcopy for further 
investigation and treatment if abnormalities are 
detected. The success of the programme depends on 
high attendance at both primary screening and 
colposcopy. 
Screening attendance has consistently been found to 
be lower in women who live in more deprived areas 
(Baker and Middleton, 2003; Webb et al, 2004; Bang 
et al, 2012), have lower levels of education (Sabates 
and Feinstein, 2006) or lower socioeconomic status 
(SES) (Moser et al, 2009). Other factors such as 
younger age (Lancucki et al, 2010; Albrow et al, 2012) 
and non-white ethnicity (Webb et al, 2004; Moser et al, 
2009) are strong predictors of lower attendance 
although ethnicity may be confounded with SES. Much 
less is known about patterns of attendance at 
colposcopy follow up. In the TOMBOLA trial, 
colposcopy attendance was very high (around 93%) 
(Sharp et al, 2012). However, attendance was lower in 
women who were younger and less educated. Late 
attendance for colposcopy (more than 6 months after 
the original appointment) was also associated with 
having less education, and it predicted non-attendance 
for subsequent colposcopy appointments (Sharp et al, 
2012). 
We know of no analyses of socioeconomic patterns 
of attendance at colposcopy using individual-level 
attendance data from the national screening 
programme. National appointment level data for 
England showed attendance of 77% in 2012–2013; but 
this underestimates attendance at the individual level, 
 
  
   2015.176 
  
 
- 334 - 
 
because it fails to account for women who miss or 
cancel one appointment but attend a second one soon 
afterwards (Health and Social Care Information 
Centre, 2013). Appointment-level data may mask 
demographic patterns of attendance if certain groups 
are disproportionately likely to rearrange but 
subsequently attend appointments. 
We used patient-level data, which is now available 
in some areas in England (NHS Cancer Screening 
Programme, 2011), to explore demographic 
differences in colposcopy attendance. We 
hypothesised that patterns of attendance would mirror 
those in primary screening, with women of lower SES 
less likely to attend. 
MATERIALS AND METHODS 
Data and variables. The source of data were the East of 
England Cyres Colposcopy database, covering a 
screening eligible population of B1.5 million women 
(ONS, 2014a). Anonymised data were extracted for all 
women referred to colposcopy following an abnormal 
screening result from 2006–2013. Referral date is 
defined as the date at which cytology is reported. 
Colposcopy attendance was ascertained by tracking 
patients from referral to appointment status 8 weeks 
later, allowing them to re-book their initial 
appointment within that time period. Women were 
categorised as ‘attenders’ or ‘non-attenders’ at 8 
weeks. This time interval was chosen because 98% of 
women referred to colposcopy are offered an 
appointment within 8 weeks (Health and Social Care 
Information Centre, 2013). A secondary analysis 
examined attendance at 4 months. This interval was 
chosen because cervical cancer detected o4 months 
after a screening referral is considered to be ‘screen-
detected’ (NHS Cancer Screening Programme, 2011). 
For each individual, data were downloaded on age 
and Lower Super Output Area (LSOA) for the postcode 
of their home address at the time of referral. We used 
LSOA to access local area-level values for deprivation 
(the income domain of the Index of Multiple 
Deprivation) (Department for Communities and Local 
Government, 2011) and ethnic diversity (percentage of 
the population from white ethnic backgrounds) (ONS, 
2014b). The income domain was chosen because it is 
likely to be relatively homogeneous within LSOAs and 
so is more likely to reflect individual-level income 
(ONS, 2007). 
Categorical variables were constructed for age (25–
34, 35–44 and 45–64 years) and deprivation (quintiles 
based on national data (Knowledge & Information 
Team, Public Health England, 2011)). Ethnic diversity 
was used as a continuous variable. 
The study was exempt from the need for ethical 
approval under the UCL Ethics Committee guidelines. 
Analysis. Multiple logistic regression (Hosmer and 
Lemeshow, 2004) was used to regress colposcopy 
attendance status (using 8week and 4-month cut-offs) 
against age and deprivation, prior to and after adjusting 
for ethnicity. 
 
RESULTS 
Characteristics of the sample. During 2006–2013, 27 
193 women were referred for colposcopy. Where an 
individual woman had more than one colposcopy 
referral, we only included the first. Women had a mean 
age of 35 years (standard deviation ¼ 9.1), mostly lived 
in areas within the upper four quintiles of deprivation, 
reflecting the relative affluence of the East of England 
in comparison with the country as a whole, and came 
from areas of predominantly white ethnicity. 
Colposcopy attendance and socio-demographic 
variables. Overall, 89.3% of women attended for 
colposcopy within 8 weeks (Table 1). In unadjusted 
analyses, women in the lowest quintile of income had 
significantly lower odds of attendance compared with 
the highest income quintile (86.6% compared with 
89.1%, odds ratio (OR) ¼ 0.79, 95% CI: 0.68–0.91). 
There was no significant association between age and 
attendance within 8 weeks. In the model adjusted for 
area-level ethnic diversity, the OR for the lowest 
income group was slightly attenuated but remained 
significant (OR ¼ 0.83, 95% CI: 0.72–0.97). 
When we examined attendance within 4 months, 
mean attendance was 94% (Table 2). In the unadjusted 
analysis, women living in the lowest income area were 
significantly less likely to attend (92.5% vs 94.1%; 
OR¼ 0.76, 95% CI: 0.63–0.93). In the adjusted model, 
women living in the lowest quintile remained 
significantly less likely to attend, though as before, the 
association was slightly attenuated after adjustment for 
area-level ethnicity (OR ¼ 0.81, 95% CI: 0.67–0.98). 
Women aged 45–64 years were significantly more 
likely to attend colposcopy in unadjusted (OR¼ 1.25, 
95% CI: 1.08–1.45) and adjusted models (OR¼ 1.23, 
95% CI: 1.06–1.43), than women in the 25–34 year 
reference category. 
DISCUSSION 
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This is the first study of individual-level colposcopy 
attendance following an abnormal screening result in 
the organised cervical screening programme in 
England. We investigated attendance within 8 weeks, 
which is the value used in appointment-level statistics, 
and attendance within 4 months to include ‘late 
attenders’ who may still attend within the time frame 
in which cervical cancer, if diagnosed, is considered to 
be ‘screen-detected’ (NHS Cancer Screening 
Programme, 2011). 
Attendance within 8 weeks of referral was lower 
than attendance in the multi-centre population-based 
randomised controlled trial nested in the NHS Cervical 
Screening Programme (TOMBOLA) (Sharp et al, 
2012) (89% compared with 93%) but our 4-
monthlattendance was similar (94%). There is a fail-
safe process in place in England to manage women 
who do not attend colposcopy to minimise loss to 
follow-up. This includes sending reminder letters and 
informing the GP of non-attendance, but may vary 
between colposcopy clinics (NHS Cancer Screening 
Programme, 2010). The higher attendance at 4 months 
may be in part due to efforts to encourage women to 
attend over the extended period; efforts that appear to 
be effective across all quintiles of deprivation. 
High levels of attendance (88%) have also been 
reported for referral to colonoscopy following a 
positive faecal occult blood test in the colorectal cancer 
screening programme (Morris et al, 2012). These 
findings suggest that once a cancer screening invitation 
is accepted, compliance with recommended follow-up 
and treatment is likely to be high. That said, 
minimising missed appointments, which increase the 
risk of delayed diagnosis of cervical cancer (NHS 
Cancer Screening Programme, 2011) and are costly to 
the NHS (Bech, 2005), remains important despite 
overall high rates of attendance. 
Women from the most income-deprived areas had 
lower colposcopy attendance at both time points, even 
after adjusting for area-level ethnicity, but the dose–
response association often observed between screening 
uptake and SES was not seen. This suggests that 
barriers to colposcopy attendance may be concentrated 
in the most deprived groups, although this requires 
further exploration. The association between 
deprivation and low uptake is consistent with findings 
from two retrospective studies of colposcopy clinic 
data in England (Sanders et al, 1992; Orbell et al, 
2006). The TOMBOLA study also found that 
attendance was lower in women with no post-school 
education (Sharp et al, 2012). 
Older women (aged 45–64 years) were significantly 
more likely to attend colposcopy within 4 months than 
younger women, consistent with the TOMBOLA study 
(Sharp et al, 2012). The significant association between 
age and colposcopy attendance was, however, not 
found at 8 weeks. This suggests that of the women who 
have not attended at 8 weeks, older women are more 
likely to have delayed attendance but attended within 4 
months. Analyses of age differences in primary 
cervical screening attendance suggest that older 
women are less likely to cite difficulties in either 
making an appointment or finding time to attend 
screening, but may have a lower perceived risk of 
cervical cancer (Waller et al, 2011), which may lead to 
delayed attendance. ‘Late attenders’ at first referral to 
colposcopy have been found to be more likely to not 
attend subsequent follow-up colposcopy appointments 
(Sharp et al, 2012), therefore gaining further 
understanding of this issue is an important avenue for 
future research. 
Explanations for non-attendance at colposcopy 
include physical (Marteau et al, 1990), psychological 
(Marteau et al, 1990; Wardle et al, 1995; McCaffery et 
al, 2006; Gray et al, 2006), educational (Lindau et al, 
2006) and practical factors (Orbell et al, 2006; 
Balasubramani et al, 2008; Linsell et al, 2010). One 
study found evidence that history of domestic violence 
is a strong predictor of colposcopy default and loss to 
follow-up (Collier and Quinlivan, 2014), but there is 
limited research on socio-demographic variation in 
barriers to colposcopy. Further research in this area is 
warranted. 
This study benefited from the use of a very large 
sample of women from the NHS screening programme. 
However, using area level variables for SES and 
ethnicity is a potential weakness of the study. 
Socioeconomic status and ethnicity data are not 
routinely collected by the cervical screening 
programme, but we were able to match to LSOA level. 
Lower Super Output Areas are small, homogenous 
geographical areas designed for neighbourhood 
statistical analyses (ONS, 2007). The East of England 
region has relatively high colposcopy attendance in 
comparison with other regions (Health and Social Care 
Information Centre, 2013), but linking the area-level 
measures to national quintiles may increase the 
relevance of these results for other regions in England. 
We were not able to look at mediators of the 
demographic patterns observed, and future work might 
usefully investigate the relationship between 
deprivation and other factors such as practical barriers 
and psychological well-being. 
CONCLUSION 
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The high attendance rate at colposcopy is encouraging 
because it indicates that, in this area of England at least, 
women who accept an invitation to cervical screening 
are likely to accept a referral to colposcopy. However, 
lower attendance among women in the most income-
deprived areas is of concern because this suggests that 
even when they attend cervical screening, they are at 
increased risk of missing out on the benefits of the 
programme. There is a need for research designed to 
understand the mechanisms through which deprivation 
is linked to lower colposcopy attendance to inform 
future intervention development. 
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Table 1. Analyses of variables associated with colposcopy attendance within 8 weeks of 
referral 
 
Sample 
column % (n) 
8 week 
attenders row 
% (n) 
OR (95% CI) P-
value 
OR (95% CI) P-value 
 100 
(27193) 
89.3 (24294)     
Income quintile 
Q1—Low income 8.5 (2305) 86.6 (1996) 0.79 (0.68–0.91) 0.001* 0.83 (0.72–0.97) 0.016* 
Q2 22.3 (6064) 89.6 (5434) 1.05 (0.94–1.19) 0.400 1.12 (0.99–1.26) 0.075 
Q3 26.7 (7255) 89.4 (6486) 1.03 (0.92–1.15) 0.622 1.04 (0.93–1.16) 0.514 
Q4 22.5 (6115) 90.2 (5517) 1.13 (1.00–1.27) 0.053 1.12 (0.99–1.26) 0.075 
Q5—High income 20.1 (5454) 89.1 (4861) 1.00 — 1.00 — 
Age 
25–34 years 55.0 (14949) 89.5 (13372) 1.00 — 1.00 — 
35–44 years 27.7 (7539) 88.8 (6691) 0.93 (0.85–1.02) 0.111 0.92 (0.84–1.00) 0.053 
45–64 years 17.3 (4705) 89.9 (4231) 1.05 (0.95–1.17) 0.353 1.03 (0.92–1.15) 0.607 
Abbreviations: CI¼ confidence 
interval; OR¼ odds ratio. 
*Po0.05. a 
Adjusted for area-level ethnic diversity (as a continuous variable). 
Table 2. Analyses of variables associated with colposcopy attendance within 4 months of 
referral 
 Sample 
column % (n) 
4 month 
attenders row 
% (n) 
OR (95% CI) P-value OR (95% CI) P-value 
 100 (27 193) 94.1 (25594)     
Income quintile 
Q1—Low income 8.5 (2305) 92.5 (2131) 0.76 (0.63–0.93) 0.006* 0.81 (0.67–0.98) 0.031* 
Q2 22.3 (6064) 94.5 (5731) 1.08 (0.92–1.26) 0.362 1.13 (0.97–1.33) 0.122 
Q3 26.7 (7255) 94.1 (6828) 1.00 (0.86–1.16) 1.000 1.01 (0.87–1.18) 0.875 
Q4 22.5 (6115) 94.4 (5771) 1.05 (0.89–1.23) 0.549 1.04 (0.89–1.22) 0.593 
Q5—High income 20.1 (5454) 94.1 (5133) 1.00 — 1.00 — 
Age 
25–34 years 55.0 (14949) 93.9 (14038) 1.00 — 1.00 — 
35–44 years 27.7 (7539) 94.0 (7083) 1.01 (0.90–1.13) 0.893 1.00 (0.89–1.12) 0.941 
45–64 years 17.3 (4705) 95.1 (4473) 1.25 (1.08–1.45) 0.003* 1.23 (1.06–1.43) 0.006* 
Abbreviations: CI¼ confidence 
interval; OR¼ odds ratio. 
*Po0.05. a 
Adjusted area-level ethnic diversity (as continuous variables). 
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